company,headline,sentiment,date
Merck Co. Inc.,"Reuters
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
The U.S. Food and Drug Administration declined to approve Merck and Japan-based Daiichi Sankyo's lung cancer treatment, which belongs to a lucrative class...
.
27 Jun 2024",-0.8689,24-06-27
Merck Co. Inc.,"Fierce Pharma
Formulated Solutions inks deal to buy former Merck, Bayer manufacturing facility
Formulated Solutions, a Florida CDMO focused on consumer healthcare solutions, reached an agreement to purchase the former Merck & Co. and Bayer...
.
20 Dec 2022",0.8519,22-12-20
Merck Co. Inc.,"Merck KGaA
Agreement with Inspirna for Ompenaclid | Merck
Merck has entered a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), in development for advanced colorectal cancer.
.
4 Jan 2024",0.4588,24-01-04
Merck Co. Inc.,"Merck KGaA
Merck Completes Acquisition of the Chemical Business of Mecaro
Merck announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical...
.
2 Jan 2023",0.0,23-01-02
Merck Co. Inc.,"Delaware Valley University
DelVal Alumna Accepts Scientist Position at Merck & Co, Inc.
Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey, that works to tackle some of the world's most unmet medical needs.
.
31 May 2023",0.3182,23-05-31
Merck Co. Inc.,"Business Wire
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH)...
.
25 Nov 2024",0.0,24-11-25
Merck Co. Inc.,"Yahoo Finance
Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now
The labor market shows resilience despite a slowdown in job gains and an uptick in the unemployment rate to 4.1%. Inflation has cooled significantly, nearing...
.
9 Nov 2024",0.3818,24-11-09
Merck Co. Inc.,"CSRwire
Merck: Supporting Colleagues Working With Cancer
There are so many unknowns after a cancer diagnosis — whether or not you receive support at work shouldn't be one of them. Published 05-04-23.
.
4 May 2023",-0.8465,23-05-04
Merck Co. Inc.,"Merck.com
How Merck scientists are driving next-generation cancer research
Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth.
.
3 Apr 2024",-0.836,24-04-03
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?
IN_THIS_ARTICLE: ... We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are going to take a look...
.
23 Oct 2024",0.6549,24-10-23
Merck Co. Inc.,"Yahoo Finance
Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health ...
Merck & Co Inc (NYSE:MRK) reported a 4% increase in revenues for the quarter, or 7% on a constant currency basis, driven by strong performance in key areas like...
.
1 Nov 2024",0.836,24-11-01
Merck Co. Inc.,"Pharmaceutical Technology
Merck completes acquisition of Harpoon Therapeutics
Harpoon will function as a wholly owned subsidiary of MSD. Credit: Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates.
.
12 Mar 2024",0.3818,24-03-12
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (MRK) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
The most recent, Ozempic and Mounjaro, offer significant advantages over previous products and have accelerated class growth,” “Indeed, the newest generations...
.
17 Dec 2024",0.7351,24-12-17
Merck Co. Inc.,"The Fiji Times
US plans shift of Merck COVID treatment to commercial market
(Reuters) - The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the middle of next month and...
.
5 Oct 2023",0.2732,23-10-05
Merck Co. Inc.,"CSRwire
MSD Latin America President Sarah Aiosa
We're proud to celebrate Sarah M. Aiosa, SVP and president, Latin America, for being recognized as one of The Association of Latino Professionals for Americas'...
.
25 Oct 2023",0.7783,23-10-25
Merck Co. Inc.,"Reuters
Merck in talks to buy Harpoon Therapeutics for around $700 mln - Bloomberg News
Merck & Co is in advanced talks to buy cancer drugmaker Harpoon Therapeutics Inc for around $700 million, Bloomberg News reported on Sunday, citing people...
.
7 Jan 2024",-0.5267,24-01-07
Merck Co. Inc.,"Forbes
Is MRK Stock Undervalued At $100?
Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.
.
7 Nov 2024",0.0,24-11-07
Merck Co. Inc.,"Insider Monkey
Is Merck & Co., Inc. (MRK) the Best Cheap Beginner Stock to Invest In?
Overall MRK ranks 2nd on our list of the cheap beginner stocks to invest in. While we acknowledge the potential of MRK as an investment, our conviction lies in...
.
26 Sept 2024",0.34,
Merck Co. Inc.,"Business Wire
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), today announced the initiation of INTerpath.
.
28 Oct 2024",-0.128,24-10-28
Merck Co. Inc.,"Merck.com
Welcome home: Celebrating our new global headquarters
Colleagues across our company celebrated our “homecoming” and ushered in a new era of collaboration for patients around the world with a ribbon-cutting at...
.
29 Jun 2023",0.886,23-06-29
Merck Co. Inc.,"Amazon Web Services (AWS)
MSD Builds HawkAVI Platform on AWS to Reduce Product Reject Rates
Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for...
.
23 Nov 2022",0.4588,22-11-23
Merck Co. Inc.,"FOX40
Merck Facing Two New Wrongful Death Suits From Mothers Of 10- And 12-Year-Old Girls Who Died After Receiving Gardasil
The deaths of these two young girls brings home the seriousness of the allegations against Merck: they exaggerated Gardasil's benefits and ignored the risks...
.
16 Feb 2024",-0.8316,24-02-16
Merck Co. Inc.,"CSRwire
Merck & Co. Named as a 2022 Best Place to Work for LGBTQ+ Equality
We are honored to be recognized by The Human Rights Campaign Foundation as a 2022 “Best Place to Work for LGBTQ+ Equality.
.
4 Mar 2022",0.8402,22-03-04
Merck Co. Inc.,"Seeking Alpha
Merck: A Low-Hanging Fruit To Pick (NYSE:MRK)
Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, is now a $258 billion (by...
.
23 Dec 2024",0.0,24-12-23
Merck Co. Inc.,"Reuters
Moderna, Merck begin late-stage study for mRNA cancer therapy
Moderna and Merck & Co said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with...
.
11 Dec 2023",-0.8689,23-12-11
Merck Co. Inc.,"Pharmaceutical Technology
Merck reports 2% increase in worldwide sales in Q4 2022
Merck's GAAP EPS from continuing operations was $1.18, indicating a 22% decline. Credit: Copyright © 2023 Merck & Co., Inc., Rahway, NJ,...
.
3 Feb 2023",0.5994,23-02-03
Merck Co. Inc.,"Business Wire
Merck Announces Third-Quarter 2024 Financial Results
Total Worldwide Sales Were $16.7 Billion, an Increase of 4% From Third Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 7%.
.
31 Oct 2024",0.5994,24-10-31
Merck Co. Inc.,"Insider Monkey
Merck & Co. Inc. (MRK): A Strong Investment as KEYTRUDA Sales Drive Revenue Growth
We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to take a look at where Merck & Co.
.
30 Sept 2024",0.8779,
Merck Co. Inc.,"Reuters
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line treatment for a type of...
.
8 Dec 2023",-0.8885,23-12-08
Merck Co. Inc.,"GovCon Wire
Who Are the Merck & Co., Inc Leaders and Executives?
Rob Davis was named Merck's Chief Executive Officer and President in July 2021. He previously served as the president of Merck's operating divisions.
.
24 Oct 2022",-0.5574,22-10-24
Merck Co. Inc.,"PR Newswire
Merck Animal Health's Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary Teams
PRNewswire/ -- Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA...
.
15 Jan 2024",0.7096,24-01-15
Merck Co. Inc.,"MarketWatch
Merck & Co. Inc. stock falls Monday, underperforms market
Shares of Merck & Co. Inc. MRK. -0.53%. sank 0.91% to $88.53 Monday, on what proved to be an all-around grim trading session for the stock market,...
.
1 Aug 2022",-0.3612,22-08-01
Merck Co. Inc.,"Forbes
Should You Pick Merck Stock At $115 After A Q2 Beat?
Merck (NYSE: MRK) recently reported its Q2 results, with revenues and earnings exceeding our estimates. The company garnered $16.1 billion in revenue and...
.
1 Aug 2024",0.0,24-08-01
Merck Co. Inc.,"Contract Pharma
Merck
We aspire to be the premier research-intensive biopharmaceutical company. We're at the forefront of research to deliver innovative health solutions.
.
21 Dec 2024",0.5574,24-12-21
Merck Co. Inc.,"BioSpace
Gardasil Chinese Distribution Issue Still a Mystery to Analysts
After Merck noted the issue in its Q2 earnings call without providing specifics, analysts are left in the dark about the HPV vaccine's future in China.
.
7 Aug 2024",0.0,24-08-07
Merck Co. Inc.,"Yahoo Finance
Why Is Merck & Co., Inc. (MRK) Among the Best Dividend Stocks to Invest In?
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other dividend stocks.
.
19 Dec 2024",0.6369,24-12-19
Merck Co. Inc.,"Pharmaceutical Technology
Merck’s net income for Q1 2024 increases by 69% to $4.76bn
Merck & Co Inc (MSD) has reported a significant increase in net income attributable to shareholders, reaching $4.76bn in the first quarter (Q1) of 2024.
.
26 Apr 2024",0.5994,24-04-26
Merck Co. Inc.,"Nasdaq
Merck (MRK) Up 17% YTD on Keytruda Strength: Should You Buy?
Merck's MRK stock has risen 17.5% so far this year, underperforming an increase of 24.2% for the industry, as seen in the chart below.
.
16 Jul 2024",0.6705,24-07-16
Merck Co. Inc.,"Reuters
Merck pursuing next-generation breaks in cardiometabolic drugs
Merck is focused on second- and third-generation opportunities in the cardiometabolic drugs market, which includes weight-loss treatments, the company said...
.
11 Jun 2024",0.6369,24-06-11
Merck Co. Inc.,"BNN Bloomberg
Merck Snags Chinese Cancer Drug For Up to $3.3 Billion
Merck & Co. will buy Prometheus Biosciences Inc. for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs.
.
14 Nov 2024",-0.4767,24-11-14
Merck Co. Inc.,"Reuters
Germany's Merck raises 2024 forecast on healthcare, electronics units' performance
The maker of pharmaceuticals, lab gear and specialty chemicals now expects net sales to be between 20.7 billion euros ($22.49 billion) and 22.1 billion euros...
.
26 Jul 2024",0.0,24-07-26
Merck Co. Inc.,"Forbes
Why Did Merck Stock Rise 65%?
Investors have rewarded MRK stock thanks to the massive uptick for its blockbuster drug – Keytruda.
.
6 Sept 2024",0.875,
Merck Co. Inc.,"CNBC
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
Merck reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda and HPV...
.
1 Feb 2024",0.7506,24-02-01
Merck Co. Inc.,"citybiz
Merck Animal Health to Acquire Vence
MADISON, N.J.–(BUSINESS WIRE)–Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc.,...
.
22 Sept 2022",0.4215,
Merck Co. Inc.,"Reuters
Merck stops testing combo drug for skin cancer as more patients discontinue
Merck said on Monday it had discontinued an experimental combination treatment testing a new type of immunotherapy in patients with a severe form of skin...
.
13 May 2024",-0.8225,24-05-13
Merck Co. Inc.,"Business Wire
CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older
CDC'S ACIP Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older.
.
23 Oct 2024",0.4215,24-10-23
Merck Co. Inc.,"Simply Wall Street
Market Still Lacking Some Conviction On Merck & Co., Inc. (NYSE:MRK)
There wouldn't be many who think Merck & Co., Inc.'s ( NYSE:MRK ) price-to-earnings (or ""P/E"") ratio of 20.2x is worth...
.
15 Oct 2024",0.0,24-10-15
Merck Co. Inc.,"GlobeNewswire
Unnatural Products, Inc. Enters Research Collaboration with Merck
Santa Cruz, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to enable the next...
.
23 Jan 2024",0.0,24-01-23
Merck Co. Inc.,"Business Wire
Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors
Merck's WELIREG Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors.
.
22 Nov 2024",0.8316,24-11-22
Merck Co. Inc.,"Stock Titan
Career on Purpose (Episode 1): Merck's Skills-First Program
Discover Merck's innovative 'Skills-First' program, attracting talent without four-year degrees. Learn how this biopharmaceutical leader is reshaping career...
.
4 Oct 2024",0.8316,24-10-04
Merck Co. Inc.,"Reuters
Merck to discontinue drug for bacterial infection
Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.
.
23 Dec 2024",-0.5423,24-12-23
Merck Co. Inc.,"Reuters
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda,...
.
25 Apr 2024",0.3612,24-04-25
Merck Co. Inc.,"Reuters
Merck's colorectal cancer therapy fails late-stage trial
Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously treated...
.
25 Sept 2024",-0.765,
Merck Co. Inc.,"MarketWatch
Merck & Co. Inc. stock underperforms Thursday when compared to competitors
slid 1.75% to $105.27 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index.
.
27 Jul 2023",-0.6124,23-07-27
Merck Co. Inc.,"Merck.com
FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug...
.
26 Mar 2024",0.6705,24-03-26
Merck Co. Inc.,"Reuters
Merck wins UK approval for lung disease drug acquired in $11 billion deal
UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung condition, marking another win...
.
31 Dec 2024",0.9062,24-12-31
Merck Co. Inc.,"Yahoo Finance
Why Is Merck Stock Trading Higher On Monday?
On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary...
.
25 Nov 2024",0.0,24-11-25
Merck Co. Inc.,"Reuters
Concern over Merck's Gardasil sales in China sink shares
Merck & Co said on Tuesday that shipments of its Gardasil vaccine in the important China market declined in the second quarter, sparking investor concerns,...
.
30 Jul 2024",0.4588,24-07-30
Merck Co. Inc.,"Corrs Chambers Westgarth
Patent claims to metabolites in Australia: when will use of a prodrug be infringing?
The development of prodrug formulations may present challenges to patent owners seeking to enforce patent claims to the active metabolite.
.
11 Aug 2023",0.4588,23-08-11
Merck Co. Inc.,"Merck KGaA
Rockville Expansion | Merck
Merck, a leading science and technology company, invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA.
.
16 Nov 2022",0.0,22-11-16
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (MRK) Among the Best Low Volatility Stocks to Buy Right Now?
Although valuations are higher than usual, Rechtschaffen believes that with the right efficiencies in place, the market could see a 10% rise, offering...
.
31 Dec 2024",0.6908,24-12-31
Merck Co. Inc.,"Reuters
Merck's RSV shot helps protect infants in mid-to-late stage study
Merck's antibody-based shot met the main goal of a mid-to-late stage trial, when tested to protect infants against a disease caused by the respiratory...
.
23 Jul 2024",0.7783,24-07-23
Merck Co. Inc.,"Insider Monkey
Merck & Co., Inc. (MRK): A Bull Case Theory
Published on October 30, 2024 at 12:44 pm by Ricardo Pillai in News, Stock Analysis ... We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive...
.
30 Oct 2024",0.0,24-10-30
Merck Co. Inc.,"Business Wire
Merck to Acquire EyeBio
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biote.
.
29 May 2024",0.2263,24-05-29
Merck Co. Inc.,"Accenture
AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development
At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, today announced it is working with Accenture to help Merck,...
.
29 Nov 2023",0.7269,23-11-29
Merck Co. Inc.,"Fierce Biotech
Merck & Co. signs $208M deal to acquire startup in bid to improve ADC safety
Merck & Co. led the antibody-drug conjugate (ADC) shopping spree last year with its multi-billion dollar deal with Daiichi Sankyo, but now the U.S. pharma...
.
8 Apr 2024",0.431,24-04-08
Merck Co. Inc.,"Business Wire
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
The trial is evaluating the noninferiority of subcutaneous administration of pembrolizumab, Merck's anti-PD-1 therapy, available for intravenous use as...
.
19 Nov 2024",0.0,24-11-19
Merck Co. Inc.,"Business Wire
Merck to Participate in the Citi 2024 Global Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and...
.
26 Nov 2024",0.4215,24-11-26
Merck Co. Inc.,"Merck.com
Betty Larson
Betty Larson joined the company in April 2024 as the executive vice president and chief human resources officer.
.
2 Apr 2024",0.0,24-04-02
Merck Co. Inc.,"Business Wire
Merck Announces First-Quarter 2025 Dividend
The Board of Directors has declared a quarterly dividend of $0.81 per share of the company's common stock for the first quarter of 2025.
.
19 Nov 2024",0.296,24-11-19
Merck Co. Inc.,"Merck.com
Inspiring innovation through diversity and inclusion
A diverse and inclusive workforce inspires innovation and is fundamental to our company's success.
.
25 Jan 2024",0.9274,24-01-25
Merck Co. Inc.,"CSRwire
How Merck Is Using 3D Printing To Create Innovative Solutions
3D technology is helping optimize workstreams, shorten turn-around times, reduce costs and drive innovation. Published 08-26-22. Submitted by Merck & Co.,...
.
26 Aug 2022",0.9136,22-08-26
Merck Co. Inc.,"Reuters
Merck's Bridion faces generic threat from drugmaker Hikma
Merck has received a letter that Hikma Pharmaceuticals US unit has sought a pre-patent expiry approval from the US FDA to sell a generic version of its...
.
26 Feb 2024",-0.0772,24-02-26
Merck Co. Inc.,"BioSpace
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
The mesothelioma approval for the Keytruda combination regimen potentially unlocks a $12 billion market opportunity, according to a recent report from...
.
18 Sept 2024",0.8225,
Merck Co. Inc.,"Investing.com
Merck stock downgraded by BMO amid Gardasil, Keytruda concerns
On Friday, BMO Capital Markets adjusted its stance on Merck (NS:PROR) & Co., Inc. (NYSE:MRK) stock, shifting its rating from Outperform to Market Perform.
.
20 Dec 2024",0.0,24-12-20
Merck Co. Inc.,"Business Wire
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they...
.
18 Dec 2024",0.7579,24-12-18
Merck Co. Inc.,"Barchart.com
Here's What To Expect From Merck & Co.'s Next Earnings Report
Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in pharmaceuticals, vaccines, and animal health,...
.
17 Oct 2024",0.0,24-10-17
Merck Co. Inc.,"Yahoo Finance
Why Merck & Co. (MRK) Is the Best Beginner Stock to Invest in Now?
We recently published a list of 11 Best Beginner Stocks To Invest In Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK)...
.
8 Dec 2024",0.8555,24-12-08
Merck Co. Inc.,"Yahoo Finance
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Ken Griffin's portfolio stocks to buy.
.
20 Nov 2024",0.5994,24-11-20
Merck Co. Inc.,"Pharmaceutical Technology
Ginkgo Bioworks and Merck partner to bolster biologic manufacturing
Ginkgo Bioworks has entered into a new partnership with Merck (MSD) to bolster biologic manufacturing in a deal worth up to $490m .
.
8 Aug 2023",0.2263,23-08-08
Merck Co. Inc.,"Insider Monkey
Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio’s Bridgewater Is Crazy About?
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio's Bridgewater is crazy about.
.
2 Dec 2024",-0.5859,24-12-02
Merck Co. Inc.,"Barchart.com
Merck & Co. Stock: Is Wall Street Bullish Or Bearish?
With a market cap of $258 billion, Merck & Co., Inc. (MRK) is a global healthcare company, operating in the pharmaceutical and animal health sectors.
.
4 Nov 2024",0.0,24-11-04
Merck Co. Inc.,"Yahoo Finance
Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other Dow stocks.
.
27 Oct 2024",0.6369,24-10-27
Merck Co. Inc.,"Reuters
Merck to buy Harpoon Therapeutics for $680 million
Merck & Co said on Monday it would buy cancer drug developer Harpoon Therapeutics for about $680 million, reinforcing its oncology portfolio with...
.
8 Jan 2024",-0.6597,24-01-08
Merck Co. Inc.,"Reuters
US FDA declines to approve Merck's chronic cough drug
The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday, marking the second rejection...
.
21 Dec 2023",0.0,23-12-21
Merck Co. Inc.,"Bloomberg
Merck Looks to Join the Obesity Drug Frenzy
Merck & Co. is seeking new obesity-fighting drugs called GLP-1s, joining a host of companies angling for a slice of the exploding market.
.
4 Jan 2024",-0.0258,24-01-04
Merck Co. Inc.,"Reuters
Merck sees Gardasil China woes carrying into 2025
Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories...
.
31 Oct 2024",-0.7003,24-10-31
Merck Co. Inc.,"BNN Bloomberg
Merck Snags Chinese Obesity Drug in Nearly $2 Billion Deal
Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.
.
18 Dec 2024",0.2263,24-12-18
Merck Co. Inc.,"World Pharmaceutical Frontiers
Merck licenses Hansoh Pharma’s investigational diabetes drug
Merck has signed an exclusive license agreement with Chinese biopharmaceutical company Hansoh Pharma, for HS-10535.
.
19 Dec 2024",0.5719,24-12-19
Merck Co. Inc.,"TechTarget
Merck & Co.'s $40B Acquisition of Pharmaceutical Company Seagen
The prospective Merck & Co. acquisition of Seattle-based biotech firm Seagen would be the largest pharmaceutical acquisition since 2020 if it is completed.
.
4 Aug 2022",0.0,22-08-04
Merck Co. Inc.,"BioSpace
Keytruda Redeems Itself in Head and Neck Cancer as Merck Lands Potential $1.9B I&I Collab
After a 2022 failure, Merck's mega-blockbuster has rallied in head and neck cancer. The company dropped data from a successful Phase III trial as a...
.
8 Oct 2024",-0.8519,24-10-08
Merck Co. Inc.,"Business Wire
Merck and Ridgeback Biotherapeutics Announce Initiation of Phase 3 Study (MOVe-NOW) Evaluating LAGEVRIO™ (molnupiravir) for the Treatment of COVID-19 in High-Risk Adults
The Phase 3 MOVe-NOW clinical trial to evaluate LAGEVRIO TM (molnupiravir), an investigational oral antiviral COVID-19 medicine, for the treatment of adults...
.
5 Dec 2024",0.0,24-12-05
Merck Co. Inc.,"Pharmaceutical Technology
Merck plans €300m investment at new German research centre
Merck KGaA (Merck) has announced an investment of more than €300m ($320.8m) in a new Life Science Research Center at its global headquarters in Darmstadt,...
.
25 Apr 2024",0.0,24-04-25
Merck Co. Inc.,"NJIT News |
Merck and NJIT's New Jersey Innovation Institute Partner on Health Care Startup Development
MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their...
.
29 Jun 2022",0.9169,22-06-29
Merck Co. Inc.,"Business Wire
Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024
Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at IPVC 2024.
.
12 Nov 2024",0.6124,24-11-12
Merck Co. Inc.,"SiliconANGLE
Merck’s cloudification strategy sets example for others in critical industries
Pharmaceutical company Merck & Co Inc. has seen its move to the cloud happen gradually at scale to ensure it fulfills both of the aforementioned areas.
.
6 Dec 2022",0.3182,22-12-06
Merck Co. Inc.,"Merck.com
Proteins in space: taking our research to the final frontier
Merck Research Laboratories scientist Paul Reichert works with the International Space Station to drive innovation.
.
29 Jun 2022",0.3818,22-06-29
Merck Co. Inc.,"Yahoo Finance
Merck & Co. Inc. (MRK): Billionaire D.E. Shaw Is Bullish On This Stock Right Now
In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against the other stocks.
.
27 Dec 2024",0.0,24-12-27
Merck Co. Inc.,"Contract Pharma
Hanmi, Merck Enter Clinical Collaboration & Supply Agreement
Hanmi Pharmaceutical, a biopharma company in Korea that focuses on oncology, obesity/metabolism, and rare diseases, has entered into a Clinical Trial...
.
24 Apr 2024",0.4939,24-04-24
Merck Co. Inc.,"Business Wire
Merck to Present New Long-Term Data for Tulisokibart (MK-7240), an Investigational Anti-TL1A Monoclonal Antibody, in Inflammatory Bowel Disease at UEG Week 2024
Tulisokibart is an investigational humanized monoclonal antibody directed to a novel target, tumor necrosis factor (TNF)-like cytokine 1A (TL1A), that is...
.
26 Sept 2024",-0.0772,
Merck Co. Inc.,"Yahoo Finance
Why Merck & Co. (MRK) Is Among the Best Affordable Stocks to Buy Right Now
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best affordable stocks to buy.
.
6 Dec 2024",0.8555,24-12-06
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (MRK) the Best Pharma Dividend Stock to Buy In 2024?
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other pharma dividend stocks.
.
30 Dec 2024",0.6369,24-12-30
Merck Co. Inc.,"Fortune
J&J, Merck, Boston Scientific go on $6.4B buying spree
In some cases, drugmakers are paying more than double a company's stock price to secure promising therapies.
.
8 Jan 2024",0.6249,24-01-08
Merck Co. Inc.,"PR Newswire
Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)
PT886 is Phanes' first-in-class bispecific antibody targeting claudin 18.2 and CD47; KEYTRUDA® (pembrolizumab) is Merck's anti-PD-1.
.
16 Oct 2023",0.4939,23-10-16
Merck Co. Inc.,"Business Wire
Merck to Participate in the Jefferies London Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Joseph Romanelli, president,...
.
14 Nov 2024",0.4215,24-11-14
Merck Co. Inc.,"Business Wire
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP) today announced that the companies...
.
8 Jan 2024",0.4215,24-01-08
Merck Co. Inc.,"Yahoo Finance
Merck & Co., Inc. (MRK) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era
The drop came on the back of rising Treasury yields, which typically soar if investors re-calibrate their rate estimates upwards as bonds with lower rates are...
.
7 Nov 2024",-0.25,24-11-07
Merck Co. Inc.,"Yahoo Finance
With 79% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing
Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their...
.
12 Nov 2024",0.3612,24-11-12
Merck Co. Inc.,"PYMNTS.com
DOJ Antitrust Chief Gail Slater Assembles Veteran Team for Key Cases
Merck & Co. has been granted immunity from an antitrust lawsuit accusing the company of misleading regulators in order to stifle competition.
.
8 Oct 2024",-0.5106,24-10-08
Merck Co. Inc.,"Business Wire
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been notified that TRC Capital Investment...
.
22 Nov 2024",0.0516,24-11-22
Merck Co. Inc.,"Reuters
Court revives more than 500 lawsuits over Fosamax femur fracture risk
A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis drug Fosamax increased the risk...
.
20 Sept 2024",-0.5896,
Merck Co. Inc.,"Merck.com
How we’re collaborating to address antimicrobial resistance – and why we can’t do it alone
Shared commitments like the AMR Action Fund are vital to make progress against this public health threat. September 8, 2023. Share this article.
.
8 Sept 2023",0.7351,
Merck Co. Inc.,"Merck.com
How we can strengthen vaccination programs and build vaccine confidence together
How Merck is working globally and locally to help improve vaccine confidence and supply vaccines for communities that might otherwise be without them.
.
21 Feb 2024",0.926,24-02-21
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co. (MRK) a Cheap NYSE Stock to Invest in Now?
We recently published a list of 10 Cheap NYSE Stocks To Invest In Now. In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK)...
.
20 Dec 2024",0.0,24-12-20
Merck Co. Inc.,"Bloomberg Law News
Merck $1.4 Billion Cyberhack Settlement Ends 'Warlike' Act Claim
Pharmaceutical giant Merck & Co. Inc. struck an 11th-hour settlement with insurers Wednesday, evading a New Jersey Supreme Court review of its massive...
.
4 Jan 2024",0.3818,24-01-04
Merck Co. Inc.,"Pan American Health Organization (PAHO)
PAHO and Merck to work together to improve maternal health in the Americas
New York City, New York, September 20, 2023 (PAHO) - The Pan American Health Organization (PAHO) and Merck, known as MSD outside the United States and...
.
20 Sept 2023",0.6908,
Merck Co. Inc.,"Pharmaceutical Technology
Merck & Co bolsters neurogenerative portfolio with Caraway acquisition
Merck & Co (MSD) will acquire all outstanding shares of Caraway, which has a preclinical-stage drug portfolio, through a subsidiary.
.
21 Nov 2023",0.7351,23-11-21
Merck Co. Inc.,"Reuters
Scholz promises support for pharma sector in Germany as Merck invests
German Chancellor Olaf Scholz said he was committed to supporting the pharmaceuticals sector with tax advantages for research and cutting red tape for...
.
25 Apr 2024",0.8834,24-04-25
Merck Co. Inc.,"Business Roundtable
Robert M. Davis
Robert M. Davis Merck & Co., Inc., Chairman and Chief Executive Officer. Business Roundtable member profile.
.
8 May 2024",0.0,24-05-08
Merck Co. Inc.,"Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (“Prometheus”) (Nasdaq: RXDX) today announced that...
.
16 Apr 2023",0.7003,23-04-16
Merck Co. Inc.,"Reuters
Merck immune from antitrust claim that it misled FDA about mumps vaccine, court rules
Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine in order to ward off competition...
.
7 Oct 2024",-0.2263,24-10-07
Merck Co. Inc.,"BioWorld MedTech
Alteogen names MSD as partner in revised, potential $3.8B+ deal
Alteogen Inc., of Daejeon, South Korea, named MSD International Business GmbH as its counterpart in a near-$4 billion technology transfer agreement inked in...
.
23 Feb 2024",0.4939,24-02-23
Merck Co. Inc.,"Reuters
Merck's lung cancer drug combo fails trial in setback for new therapy class
Merck said on Thursday a combination treatment testing a new type of immunotherapy failed to significantly slow disease progression in lung cancer patients...
.
7 Dec 2023",-0.9423,23-12-07
Merck Co. Inc.,"MarketWatch
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Merck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products.
.
17 Jun 2024",0.5994,24-06-17
Merck Co. Inc.,"Merck.com
Amplifying the power of women in chemistry
Graduate students are eligible for the Merck Research Award, which promotes diversity in chemistry and career advancement opportunities for female chemists.
.
8 Mar 2023",0.8176,23-03-08
Merck Co. Inc.,"Pharmaceutical Technology
Merck agrees to acquire Imago for $1.35bn
Merck has signed a definitive agreement for the acquisition of Imago BioSciences for a total equity price of nearly $1.35bn.
.
22 Nov 2022",0.6124,22-11-22
Merck Co. Inc.,"Reuters
Merck's RSV antibody for infants effective in reducing some types of infections in study
Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory syncytial...
.
18 Oct 2024",0.4767,24-10-18
Merck Co. Inc.,"BioSpace
CDC Backs Merck’s Capvaxive, Tees Up Pneumococcal Competition With Pfizer
In a potential challenge to Pfizer's Prevnar 20, Merck's Capvaxive has been recommended by the Centers for Disease Control and Protection for use in...
.
1 Jul 2024",0.2263,24-07-01
Merck Co. Inc.,"Business Wire
Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
Merck is discontinuing the Phase 3 KeyVibe-003 and KeyVibe-007 trials, which are evaluating the fixed-dose combination of vibostolimab and pembrolizumab in...
.
16 Dec 2024",0.0,24-12-16
Merck Co. Inc.,"Reuters
Merck to buy eye-focused drug developer EyeBio for as much as $3 bln
Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with...
.
29 May 2024",0.2732,24-05-29
Merck Co. Inc.,"Business Wire
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of CN201 from Curon Biophar.
.
1 Oct 2024",0.4215,24-10-01
Merck Co. Inc.,"Reuters
Merck's therapy for rare lung condition shown to help reduce risk of death in study
Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition which causes high blood pressure...
.
25 Nov 2024",-0.8519,24-11-25
Merck Co. Inc.,"Yahoo Finance
Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer
On Monday, Merck & Co Inc (NYSE:MRK) announced topline data from the Phase 3 KEYLYNK-001 trial. The trial evaluating Keytruda (pembrolizumab) plus...
.
9 Dec 2024",-0.6597,24-12-09
Merck Co. Inc.,"Reuters
Merck defeats appeal by nearly 1,200 shingles vaccine plaintiffs
Merck has beaten back an appeal by nearly 1200 plaintiffs who claimed their cases were improperly dismissed by the federal judge overseeing mass torts...
.
17 Jul 2024",-0.6249,24-07-17
Merck Co. Inc.,"Faegre Drinker Biddle & Reath LLP
Merck Animal Health Acquires Virtual Fencing Company Vence Corp
Merck & Co., Inc., completed the acquisition of Vence Corp, a California-based company specializing in virtual fencing for agricultural applications.
.
13 Dec 2024",0.0,24-12-13
Merck Co. Inc.,"Pink Sheet
Merck's Pneumococcal Vaccine Market Expansion Stalled By Ever-Changing, Crowded Field
The CDC's ACIP again punted a decision on whether to make a pneumococcal vaccine available to all adults 50 and older amid concerns over cost and equity...
.
25 Jul 2024",-0.2023,24-07-25
Merck Co. Inc.,"Insider Monkey
Merck & Co., Inc. (MRK): A Good Undervalued Stock to Invest In Now
It expects non-GAAP EPS of between $7.94 and $8.04. Analysts at Cantor Fitzgerald reaffirmed an “Overweight” rating on the shares of Merck & Co., Inc. (NYSE:MRK)...
.
26 Aug 2024",0.6249,24-08-26
Merck Co. Inc.,"Reuters
Merck stops testing combo drug for lung cancer
Merck said on Thursday it had discontinued a trial testing a combination immunotherapy treatment in patients with a type of lung cancer after an interim...
.
8 Aug 2024",-0.886,24-08-08
Merck Co. Inc.,"Reuters
US FDA approves Merck's pneumococcal vaccine for adults
Merck said on Monday the U.S. Food and Drug Administration has approved its next-generation vaccine to protect adults against the pneumococcal disease.
.
18 Jun 2024",0.7964,24-06-18
Merck Co. Inc.,"Business Wire
Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection
Merck Announces Topline Results from Phase 3 Trials Evaluating Once-Daily, Oral Doravirine/Islatravir for the Treatment of Adults with HIV-1 Infection.
.
19 Dec 2024",0.0,24-12-19
Merck Co. Inc.,"Reuters
Merck to test single-dose regimen of HPV vaccine Gardasil 9
Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and...
.
13 Mar 2024",0.0,24-03-13
Merck Co. Inc.,"CSRwire
Merck Scientists Launch Research Award to Support Rising Che
Program provides career development and networking opportunities, fosters equity and inclusion. Published 01-19-22. Submitted by Merck & Co., Inc.
.
19 Jan 2022",0.8316,22-01-19
Merck Co. Inc.,"GlobeNewswire
Modifi Biosciences Acquired by Merck
Modifi Biosciences, a leader in the development of direct DNA modification enabled cancer therapeutics, today announced that the company has been acquired by...
.
23 Oct 2024",-0.6597,24-10-23
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now?
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other pharma stocks.
.
4 Nov 2024",0.6369,24-11-04
Merck Co. Inc.,"GlobeNewswire
Portage Biotech Announces Collaboration with Merck to
WESTPORT, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel...
.
5 Sept 2023",0.0,
Merck Co. Inc.,"Stock Titan
Merck Crowned America's Most Responsible Company for Second Straight Year
Merck leads Newsweek's corporate responsibility rankings, earning top spots across multiple prestigious sustainability lists while maintaining focus on...
.
5 Dec 2024",0.6478,24-12-05
Merck Co. Inc.,"Insider Monkey
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now?
Merck & Co., Inc. (NYSE:MRK) reported strong second-quarter results, with total sales increasing 7% to $16.1 billion. Meanwhile, KEYTRUDA saw sales grow by 16%.
.
18 Nov 2024",0.8176,24-11-18
Merck Co. Inc.,"STAT
Merck lays off workers amid rough pharma job market
Today's biotech news includes the latest on Pfizer's hemophilia A therapy, Jeff Shuren's exit from the FDA, and more.
.
24 Jul 2024",0.0,24-07-24
Merck Co. Inc.,"WSJ
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
Acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the multibillion-dollar eye-drug market.
.
29 May 2024",-0.6369,24-05-29
Merck Co. Inc.,"Reuters
Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years
An experimental messenger RNA cancer vaccine developed by Moderna and Merck & Co paired with Merck's Keytruda cut the chance of recurrence or death from...
.
14 Dec 2023",-0.7269,23-12-14
Merck Co. Inc.,"Reinsurance News
Merck reaches settlement with insurers over $1.4bn NotPetya cyber attack
It's been reported that pharmaceutical giant Merck & Co. Inc. and its insurers have reached an agreement over the $1.4 billion in losses Merck alleged.
.
10 Jan 2024",-0.25,24-01-10
Merck Co. Inc.,"CSRwire
Vaccines: Our History, Our Legacy
Merck and its legacy companies have been working to discover and develop vaccines for more than a century. Published 04-14-22. Submitted by Merck & Co., Inc...
.
14 Apr 2022",0.0,22-04-14
Merck Co. Inc.,"PR Newswire
DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform
PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced an.
.
4 Jun 2024",-0.802,24-06-04
Merck Co. Inc.,"Yahoo Finance
Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’
We recently compiled a list of the Jim Cramer's Latest Game Plan: 20 Stocks to Watch. In this article, we are going to take a look at where Merck & Co.,...
.
29 Oct 2024",0.0,24-10-29
Merck Co. Inc.,"CNBC
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Merck reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and...
.
25 Apr 2024",0.7269,24-04-25
Merck Co. Inc.,"Insurance Journal
Merck Settles Coverage Dispute With Insurers Over War Exclusion in NotPetya Attack
Merck & Co. Inc. has reportedly reached a deal with insurers over a closely-watched coverage dispute related to a massive cyberattack in 2017.
.
5 Jan 2024",-0.9217,24-01-05
Merck Co. Inc.,"Business Wire
Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants
Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Infants.
.
17 Oct 2024",0.4019,24-10-17
Merck Co. Inc.,"GlobeNewswire
Pfizer, Amneal Pharmaceuticals, and Merck & Co. Lead the
Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The.
.
1 Aug 2023",0.0,23-08-01
Merck Co. Inc.,"Reuters
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln
Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said...
.
23 Oct 2024",-0.7906,24-10-23
Merck Co. Inc.,"Merck.com
Supporting colleagues working with cancer
“One of the most important things a company can do to support a colleague living with cancer is to listen and understand their needs,” Kitchen said.
.
14 Apr 2023",-0.4779,23-04-14
Merck Co. Inc.,"Yahoo Finance
Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
Merck MRK announced that it has entered into an exclusive licensing deal with China-based privately-held biotech company LaNova Medicines for the latter's...
.
15 Nov 2024",-0.5994,24-11-15
Merck Co. Inc.,"PR Newswire
Merck Animal Health Launches Sure Petcare Animo® GPS
PRNewswire/ -- Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co, Inc., Rahway, N.J., USA...
.
18 Oct 2022",0.6249,22-10-18
Merck Co. Inc.,"Nasdaq
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?
Merck's MRK stock has declined 14.4% in the past six months against an increase of 9.7% for the Large Cap Pharmaceuticals industry.
.
21 Oct 2024",0.3182,24-10-21
Merck Co. Inc.,"Business Wire
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007.
.
8 Dec 2024",0.4215,24-12-08
Merck Co. Inc.,"Yahoo Finance
Top Research Reports for Visa, Netflix & Merck
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Netflix, Inc. (NFLX) and Merck & Co., Inc. (MRK),...
.
21 Oct 2024",0.2023,24-10-21
Merck Co. Inc.,"MarketWatch
Merck & Co. Inc. stock rises Tuesday, outperforms market
inched 0.51% higher to $116.53 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index.
.
25 Apr 2023",0.0,23-04-25
Merck Co. Inc.,"CSRwire
Merck Joins Novartis-Led Collaboration To Increase Diversity in Clinical Trials
Through a new collaboration with Beacon of Hope, Merck will operate clinical trials through four Historically Black Medical School clinical trial Centers of...
.
29 Jul 2022",0.6369,22-07-29
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (MRK) the Best American Dividend Stock to Buy Right Now?
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other American dividend stocks.
.
10 Dec 2024",0.6369,24-12-10
Merck Co. Inc.,"USC Annenberg
Cristal N. Downing
Cristal N. Downing is executive vice president and chief communications & public affairs officer of Merck & Co., Inc., one of the world's largest...
.
8 Jun 2024",0.0,24-06-08
Merck Co. Inc.,"Pharmaceutical Technology
Merck opens $195.7m expanded distribution centre in Germany
German science and technology company Merck KGaA has announced the opening of its expanded Life Science distribution centre at Schnelldorf, which involved...
.
6 Jun 2024",0.0,24-06-06
Merck Co. Inc.,"Pharmaceutical Technology
Merck plans €300m investment in South Korea’s bioprocessing unit
Merck KGaA has announced an investment of over €300m ($326.1m) to establish a new bioprocessing production centre in Daejeon, South Korea.
.
21 Mar 2024",0.0,24-03-21
Merck Co. Inc.,"Newswire.ca
Health Canada Approves KEYTRUDA® in combination with trastuzumab and chemotherapy, as a first-line treatment for patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma whose tum
CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab),...
.
12 Feb 2024",0.891,24-02-12
Merck Co. Inc.,"markets.businessinsider.com
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
Oppenheimer initiated coverage on Gossamer Bio Inc (NASDAQ:GOSS), a clinical-stage biopharmaceutical company, with an Outperform rating and a price target...
.
25 Jun 2024",0.6705,24-06-25
Merck Co. Inc.,"CSRwire
Black Scientists, Innovators and Employees are Key to Merck’s History of Invention and Progress
Learn about scientific contributions of Black employees in the company's history and how its diversity initiatives have shaped its legacy of invention.
.
8 Mar 2023",0.4215,23-03-08
Merck Co. Inc.,"Merck.com
A new foundation for future talent
The Merck Biotechnology Learning Center will provide opportunities for NC A&T students to look inside the biopharmaceutical industry and understand what a...
.
22 Apr 2024",0.6597,24-04-22
Merck Co. Inc.,"Reuters
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Moderna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster cancer therapy Keytruda improved survival and showed...
.
3 Jun 2024",-0.6369,24-06-03
Merck Co. Inc.,"Reuters
Merck's HIV treatment meets main goal in two late-stage studies
Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in adults receiving another form of...
.
19 Dec 2024",0.0,24-12-19
Merck Co. Inc.,"Pharmaceutical Technology
Merck KGaA plans investment in new facility in Germany
Merck KGaA announced a €62m ($66.6m) investment to construct a quality control facility at Darmstadt in Germany.
.
12 Jun 2024",0.0,24-06-12
Merck Co. Inc.,"Simply Wall Street
We Wouldn't Be Too Quick To Buy Merck & Co., Inc. (NYSE:MRK) Before It Goes Ex-Dividend
That's intriguing, but the combination of growing dividends despite declining earnings can typically only be achieved by paying out a larger percentage of...
.
12 Jun 2024",0.2617,24-06-12
Merck Co. Inc.,"Merck.com
Prostate cancer: stigma, early screening and support
A prostate cancer survivor and a caregiver and advocate want to inspire more people to talk about the disease.
.
26 Apr 2024",-0.1531,24-04-26
Merck Co. Inc.,"MarketWatch
Merck & Co. Inc. stock rises Tuesday, still underperforms market
Shares of Merck & Co. Inc. MRK. +0.69%. inched 0.21% higher to $113.32 Tuesday, on what proved to be an all-around great trading session for the stock...
.
27 Jun 2023",0.743,23-06-27
Merck Co. Inc.,"Reuters
Merck says Keytruda injection on par with approved IV version in trial
Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of...
.
19 Nov 2024",0.3523,24-11-19
Merck Co. Inc.,"Yahoo Finance
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Merck is expected to post earnings of $1.90 per share for the current quarter, representing a year-over-year change of +6,233.3%. Over the last 30 days, the...
.
8 Nov 2024",0.296,24-11-08
Merck Co. Inc.,"Clinical Trials Arena
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Merck & Co Inc (MSD) has discontinued a Phase III trial investigating a co-formulation of vibostolimab and pembrolizumab (Keytruda) for patients with resected...
.
14 May 2024",-0.5267,24-05-14
Merck Co. Inc.,"Business Wire
Merck Announces FDA Acceptance of Biologics License Application for Clesrovimab, an Investigational Long-Acting Monoclonal Antibody Designed to Protect Infants from RSV Disease During their First RSV Season
The US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for clesrovimab (MK-1654), the company's investigational...
.
17 Dec 2024",0.7717,24-12-17
Merck Co. Inc.,"3BL Media
How Merck Is Using 3D Printing To Create Innovative Solutions
Merck's 3D Technologies (3DT) organization is transforming the way we work in the discovery, development and commercialization of our medicines and vaccines.
.
25 Aug 2022",0.6908,22-08-25
Merck Co. Inc.,"Insider Monkey
Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts
Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts · Our Methodology · Analyst Upside Potential: 21.81% · Forward P/E, as...
.
26 Sept 2024",0.7003,
Merck Co. Inc.,"Merck.com
Black scientists, innovators and employees are key to Merck's history of invention and progress
Learn about scientific contributions of Black employees in our company's history and how our diversity initiatives have shaped our legacy of invention.
.
2 Feb 2023",0.4215,23-02-02
Merck Co. Inc.,"Forbes
Is An Earnings Beat In The Cards For Merck Stock?
Merck (NYSE: MRK) will report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $15.9 billion and adjusted earnings of $2.20.
.
26 Jul 2024",0.0,24-07-26
Merck Co. Inc.,"Nasdaq
Merck Loses Around $32B in 3 Months: Time to Sell the Stock?
Merck's MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.
.
20 Sept 2024",-0.3612,
Merck Co. Inc.,"Yahoo Finance
Top Analyst Reports for Alphabet, Oracle & Merck
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Oracle Corporation (ORCL) and Merck & Co.,...
.
10 Dec 2024",0.2023,24-12-10
Merck Co. Inc.,"GuruFocus
Merck & Co Inc (MRK): A Comprehensive Analysis of its Dividend P
An in-depth look at Merck & Co Inc's dividend history, yield, growth rates, and future prospects Merck & Co Inc(MRK) recently announced a dividend of $0.73...
.
14 Sept 2023",0.7003,
Merck Co. Inc.,"GuruFocus
Merck & Co Inc's Dividend Analysis
Merck & Co Inc (MRK, Financial) recently announced a dividend of $0.77 per share, payable on 2024-01-08, with the ex-dividend date set for 2023-12-14.
.
13 Dec 2023",0.296,23-12-13
Merck Co. Inc.,"Yahoo Finance
Hedge Funds Bet Big On Merck & Co. (MRK): Top Healthcare Stock to Watch
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most promising healthcare stocks according to hedge...
.
23 Nov 2024",0.5849,24-11-23
Merck Co. Inc.,"Merck.com
VIDEO: Aiming for health equity and business success
Empowered at work and in a leading fellowship program, Josette Gbemudu is determined to make a difference. March 2, 2023. Share this article.
.
2 Mar 2023",0.8074,23-03-02
Merck Co. Inc.,"Business Wire
Merck to Hold Third-Quarter 2024 Sales and Earnings Conference Call Oct. 31
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call.
.
1 Oct 2024",0.4215,24-10-01
Merck Co. Inc.,"Verizon
Verizon elects Caroline A. Litchfield to its board of directors
Verizon announced the election of Caroline A. Litchfield, Executive Vice President and Chief Financial Officer of Merck & Co., Inc., to the Verizon Board of...
.
27 Jun 2024",0.0,24-06-27
Merck Co. Inc.,"OPKO Health, Inc.
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
ModeX Therapeutics is a clinical-stage biopharmaceutical company developing innovative multispecific biologics for cancer and infectious disease.
.
8 Mar 2023",0.296,23-03-08
Merck Co. Inc.,"Merck.com
Women in science? Absolutely
Strong career paths and cutting-edge science draw more women scientists — like chemists and engineers — to our small molecule process R&D team.
.
3 Feb 2023",0.7474,23-02-03
Merck Co. Inc.,"GlobeNewswire
Kelun-Biotech Announces Oncology Research Collaboration and License Agreement with MSD
CHENGDU, China, July 26, 2022 (GLOBE NEWSWIRE) -- Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), a clinical-stage biotech...
.
26 Jul 2022",0.4939,22-07-26
Merck Co. Inc.,"Rowan Today
Engineering for good: She’s already on the job to make the world better
Lauren Repmann graduated from Rowan University with a biomedical engineering degree in December and now works for Merck in North Carolina.
.
4 May 2022",0.7003,22-05-04
Merck Co. Inc.,"Reuters
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit...
.
14 Nov 2024",-0.8689,24-11-14
Merck Co. Inc.,"Yahoo Finance
Is Merck & Co., Inc. (MRK) the Most Promising Long-Term Stocks According to Hedge Funds?
In this article, we will look at where Merck & Co., Inc. (NYSE:MRK) ranks among the most promising long-term stocks according to hedge funds.
.
17 Oct 2024",0.7172,24-10-17
Merck Co. Inc.,"Yahoo Finance
Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View
MRK posts better-than-expected third-quarter results. The company lowers its guidance, likely due to the soft sales performance of the Gardasil vaccines.
.
31 Oct 2024",-0.0516,24-10-31
Merck Co. Inc.,"Packaging World
Colleen Hutter, Executive Director of Packaging Technical Operations, Merck & Co.
My name is Colleen Hutter (nee Baker). I am the Executive Director of Packaging Technical Operations for Merck & Co., Inc., Rahway, NJ, USA.
.
5 Aug 2024",0.0,24-08-05
Merck Co. Inc.,"insights.citeline.com
Merck’s Newly Approved Capvaxive Could Have Edge Over Prevnar 20 In Adults
Merck & Co. believes Capvaxive has an advantage in the adult market because the vaccine is designed specifically to treat serotypes that are the most prevalent...
.
18 Jun 2024",0.7579,24-06-18
Merck Co. Inc.,"Yahoo Finance
Here’s What is Powering Merck & Co.’s (MRK) Earnings Growth
GreensKeeper Asset Management, an investment management company, released its third quarter investor letter. A copy of the letter can be downloaded here.
.
5 Dec 2024",0.6249,24-12-05
Merck Co. Inc.,"Yahoo Finance
How Much Would It Take To Earn $100 A Month From Merck Stock
Merck & Co. (NYSE:MRK) is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines,...
.
10 Dec 2024",0.7783,24-12-10
Merck Co. Inc.,"Merck.com
The Wall Street Journal names Merck among top 10 best-managed companies
Our company has been recognized for our leadership and strong performance powering the work we do for patients and everyone who depends on us.
.
11 Jan 2024",0.6249,24-01-11
Merck Co. Inc.,"Reuters
Merck to buy Elanco's aqua health business for $1.3 billion
Merck said on Monday would buy Elanco Animal Health's aqua business for $1.3 billion in cash, strengthening its portfolio of aquatic pet and livestock...
.
7 Feb 2024",0.4939,24-02-07
Merck Co. Inc.,"Reuters
Merck seeks more deals to prepare for Keytruda's revenue decline
Merck & Co on Thursday said it was in the market for deals of up to around $15 billion as it plans for a loss of revenue from its aging cancer immunotherapy...
.
1 Feb 2024",-0.7717,24-02-01
Merck Co. Inc.,"BioSpace
Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal
Despite recent enthusiasm around the PD-1/VEGF space, BMO Capital Markets analyst Evan Seigerman noted that Merck's pact with LaNova Medicines is more...
.
14 Nov 2024",-0.2746,24-11-14
Merck Co. Inc.,"Reuters
US FDA approves Merck's therapy for rare lung condition
The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries,...
.
27 Mar 2024",0.5106,24-03-27
Merck Co. Inc.,"Financial Times
Merck to open £1bn London research centre with plea for government support of industry
Merck's research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground...
.
14 Oct 2023",0.7089,23-10-14
Merck Co. Inc.,"MarketWatch
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Shares of Merck & Co. Inc. inched 0.28% higher to $106.64 Tuesday, on what proved to be an all-around grim trading session for the stock market,...
.
22 Oct 2024",-0.7666,24-10-22
Merck Co. Inc.,"The Federalist Society
Litigation Update: Merck et al. v. Becerra et al.
Pharmaceutical company Merck & Co., Inc. (Merck) filed a lawsuit against the U.S. Department of Health and Human Services (HHS) challenging the Medicare...
.
2 Jul 2024",-0.2732,24-07-02
Merck Co. Inc.,"Yahoo Finance
Top Analyst Reports for Broadcom, Merck & Qualcomm
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck & Co. (MRK) and Qualcomm (QCOM),...
.
21 Nov 2024",0.2023,24-11-21
Merck Co. Inc.,"Business Wire
Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and LaNova Medicines Ltd. (LaNova), a privately held clinical-stage biotechnology...
.
14 Nov 2024",0.5106,24-11-14
Merck Co. Inc.,"Business Wire
Merck to Acquire Caraway Therapeutics, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced today that the companies have entere.
.
21 Nov 2023",0.4215,23-11-21
Merck Co. Inc.,"The Acquirer's Multiple
Merck & Co Inc (MRK) DCF Valuation: Is The Stock Undervalued?
Based on the DCF valuation, the stock is undervalued. The DCF value of $135.54 per share is higher than the current market price of $101.25. The Margin of...
.
19 Dec 2024",0.5574,24-12-19
Merck Co. Inc.,"Business Wire
Merck to Participate in the UBS Global Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president,...
.
6 Nov 2024",0.4215,24-11-06
Merck Co. Inc.,"Bloomberg Law News
Merck DEI Program Targeted by Edward Blum Group for EEOC Review
A Merck & Co. Inc. diverse leadership program unlawfully excludes White and Asian workers, according to an EEOC charge filed by a group tied to the...
.
7 Oct 2024",0.0,24-10-07
Merck Co. Inc.,"U.S. Environmental Protection Agency (.gov)
2024 Green Chemistry Challenge Winners | US EPA
EPA announced the winners of the 2024 Green Chemistry Challenge Awards for new and innovative green chemistry technologies.
.
26 Sept 2024",0.9136,
Merck Co. Inc.,"ExecutiveGov
Top 3 Government Contracts Won by Merck & Co. Inc
Merck will receive roughly $1.2 billion to provide approximately 1.7 million courses of molnupiravir to the government.
.
23 Dec 2022",0.6705,22-12-23
Merck Co. Inc.,"Business Wire
NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:
.
24 Sept 2024",0.4215,
Merck Co. Inc.,"Insider Monkey
Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds
Overall MRK ranks 1st on our list of the most promising cancer stocks according to hedge funds. While we acknowledge the potential of MRK as an investment, our...
.
25 Nov 2024",-0.6565,24-11-25
Merck Co. Inc.,"GlobeNewswire
Oncology Pharmaceuticals Market Research 2024-2029, Profiles of Major Players - Bristol-Myers Squibb, Merck & Co, F. Hoffmann-La Roche, Johnson & Johnson, and AstraZeneca
This report seeks to deliver an in-depth analysis of the worldwide oncology pharmaceuticals (cancer medications) market. It includes a thorough overview of.
.
31 Dec 2024",0.0,24-12-31
Merck Co. Inc.,"BioWorld MedTech
FDA rejects Merck cough drug NDA, briefly weighing on Bellus
Merck & Co Inc. has had a setback with its chronic cough drug gefapixant after the FDA rejected its NDA, a decision that also briefly hit the share price of...
.
24 Jan 2022",-0.6486,22-01-24
Merck Co. Inc.,"Reuters
Merck scraps two late-stage trials of cancer drug Keytruda
Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on Thursday,...
.
29 Aug 2024",-0.743,24-08-29
Merck Co. Inc.,"Yahoo Finance
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
.
22 Nov 2024",0.4767,24-11-22
Merck Co. Inc.,"Nasdaq
Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals
In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts.
.
3 Oct 2024",0.5106,24-10-03
Merck Co. Inc.,"Merck.com
Stomach cancer: understanding the signs and symptoms
Stomach cancer, also known as gastric cancer, is commonly diagnosed in men and people older than 55. Learn more about stomach cancer causes and how to...
.
3 Nov 2023",-0.9618,23-11-03
Merck Co. Inc.,"Reuters
Germany's Merck open to more M&A for its Life Science division
German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600...
.
17 Oct 2024",0.0,24-10-17
Merck Co. Inc.,"Yahoo Finance
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Jim Cramer recently talked about.
.
18 Nov 2024",0.0,24-11-18
Merck Co. Inc.,"Business Wire
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new results from a Phase 2...
.
19 Oct 2024",0.4215,24-10-19
Merck Co. Inc.,"Equitypandit
Merck & Co to Acquire Imago BioSciences for $1.35 Billion
On Monday, Merck & Co Inc said it would acquire Imago BioSciences Inc, the cancer drug developer, for a total equity value of USD 1.35 billion to extend its...
.
21 Nov 2022",-0.3182,22-11-21
Merck Co. Inc.,"Financial Times
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
US pharmaceutical group Merck has agreed to buy EyeBio, a start-up backed by UK venture capitalist Kate Bingham, for up to $3bn.
.
28 May 2024",0.296,24-05-28
Merck,"Fierce Pharma
Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll
Johnson & Johnson and Merck are laying off employees in China. J&J's cuts are largely impacting its medtech sector in China while Merck's cuts surround its...
.
20 Nov 2024",-0.5267,24-11-20
Merck,"www.worldvision.org
RESPONDING TO NATURAL DISASTERS: Medical assistance where it’s needed most
At Merck, known as MSD outside of the U.S. and Canada, their purpose is to use the power of leading-edge science to save and improve lives around the world.
.
17 Jun 2022",0.6124,22-06-17
Merck,"Merck.com
TL1A: Exploring a potentially important target for inflammatory bowel disease
Our TL1A research. Our scientists are investigating tumor necrosis factor-like ligand 1A (TL1A), which has been shown to be increased in inflamed intestinal...
.
9 Oct 2024",-0.2732,24-10-09
Merck,"Reuters
Merck to buy Harpoon Therapeutics for $680 million
Merck & Co (MRK.N) said on Monday it would buy cancer drug developer Harpoon Therapeutics (HARP.O) for about $680 million, reinforcing its oncology portfolio...
.
8 Jan 2024",-0.6597,24-01-08
Merck,"Fierce Biotech
Bill & Melinda Gates Institute licenses 2 of Merck's TB antibiotic candidates
The Bill & Melinda Gates Medical Research Institute has snapped up the exclusive global license to two of Merck's preclinical antibacterial candidates.
.
18 Oct 2022",0.128,22-10-18
Merck,"ROI-NJ
Merck’s head of global clinical development announces retirement; successor named
Merck's head of global clinical development and chief medical officer, Merck Research Laboratories, Roy Baynes, will be retiring from the Kenilworth-based...
.
23 Mar 2022",0.2263,22-03-23
Merck,"The New York Times
Under Bernie Sanders’s Glare, Pharmaceutical Chiefs Defend Their Prices (Published 2024)
The top executives of three major companies appeared before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.
.
8 Feb 2024",-0.0516,24-02-08
Merck,"Merck KGaA
India - Seeking ties to the jewel in the crown | Merck
The joint venture Sarabhai Merck Ltd. Baroda, founded in 1958, is dissolved in 1969. ... 3/3. The foundation of E. Merck (India) Pvt. Ltd. in 1967 is of great...
.
7 Sept 2022",0.3612,
Merck,"Fierce Biotech
BMS, Merck KGaA push protein degrader ambitions with $2.3B Amphista partnerships
BMS, Merck KGaA push protein degrader ambitions with $2.3B Amphista partnerships ... Bristol Myers Squibb and Merck KGaA are diving deeper into the protein...
.
4 May 2022",-0.6908,22-05-04
Merck,"North Penn Now
Harleysville Man Arrested in Connection with Merck Employee Who Fatally Overdosed While at Work
A Harleysville man is facing felony drug charges in connection with the fatal overdose of 36-year-old Trevor Edwards, whose body was found in December 2020 at a...
.
27 Jan 2022",-0.9468,22-01-27
Merck,"CNBC
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer ... Moderna and Merck released more positive three-year data Monday on their...
.
3 Jun 2024",0.0754,24-06-03
Merck,"Fierce Biotech
Amgen, Merck KGaA add to budding constellation of ADC deals amid the modality's meteoric rise
Amgen, Merck KGaA add to budding constellation of ADC deals amid the modality's meteoric rise ... The pool of Big Pharmas competing to develop game-changing...
.
27 Dec 2022",0.0,22-12-27
Merck,"Business Wire
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.
Merck intends to complete today the acquisition of Imago through a merger of Merck's wholly owned subsidiary with and into Imago, with Imago being the...
.
11 Jan 2023",0.0,23-01-11
Merck,"Merck KGaA
Now is the Time to Talk about Type 2 Diabetes
Now is the Time to Talk about Type 2 Diabetes · 1. People underestimate their risky chance of T2D diagnosis. 7/10 people were aware of T2D risk factors prior to...
.
14 Aug 2024",-0.4767,24-08-14
Merck,"KoreaTimes
Global pharmaceutical firm Merck Life Science mulling building new facilities in Korea
Global pharmaceutical company Merck Life Science is considering building manufacturing facilities in Korea's central city of Daejeon, the industry ministry...
.
3 May 2023",0.0,23-05-03
Merck,"Merck.com
VIDEO: Aiming for health equity and business success
VIDEO: Aiming for health equity and business success ... Josette Gbemudu is motivated to ensure everyone has the chance to be as healthy as possible. As an...
.
2 Mar 2023",0.9493,23-03-02
Merck,"Fierce Pharma
Merck & Co. inks pact with Indonesia's Bio Farma to make HPV vaccine
Merck & Co. inks pact with Indonesia's Bio Farma to make HPV vaccine ... Merck & Co. ... Merck & Co. and Indonesia's Bio Farma entered a licensing agreement for the...
.
15 Dec 2022",0.4939,22-12-15
Merck,"Asia Financial
China Decoupling Unfeasible, Would Carry Huge Costs: Merck CEO
The boss of the German drugs, lab equipment and semiconductor chemicals maker warned against an escalation of tensions with Beijing ... Decoupling from China is...
.
6 Jun 2023",-0.3612,23-06-06
Merck,"CNN
Merck says it’s working to reduce levels of cancer-causing compound in popular diabetes drugs
Merck told CNN that it has identified the root cause of the nitrosamine formation in certain batches of its products that contain sitagliptin, an active...
.
19 Jan 2023",0.5994,23-01-19
Merck,"Yahoo Finance
Here's Why We Think Merck (NYSE:MRK) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making...
.
23 Oct 2022",0.7964,22-10-23
Merck,"African Business
Merck Foundation Chief Executive Officer (CEO) & Zimbabwe First Lady announce Zimbabwean Winners of their Media Awards to break Infertility Stigma, Support Girl Education and Diabetes- Hypertension awareness
The Zimbabwean winners of Merck Foundation Africa Media Recognition “More Than a Mother” Awards 2023 and “Diabetes and Hypertension” Awards 2023.
.
22 May 2024",0.9509,24-05-22
Merck,"Merck.com
Podcast: Meet the dealmakers
Podcast: Meet the dealmakers · Harnessing our legacy · The speed and determination to get it done · Balancing the internal and the external · Working hand-in-...
.
1 Jun 2023",0.4019,23-06-01
Merck,"Fierce Pharma
The top 20 pharma companies by 2022 revenue
For the first time in biopharma history, a company has topped the $100 billion mark in annual revenue. Pfizer passed that milestone, propelled by its...
.
18 Apr 2023",0.2023,23-04-18
Merck,"Merck KGaA
Gases Facility in Hometown, Pennsylvania | Merck
Merck Announces Significant Investment in the World's Largest Integrated Specialty Gases Facility in Hometown, Pennsylvania. Merck today announced an agreement...
.
12 Apr 2023",0.2023,23-04-12
Merck,"WNEP
Pharmaceutical plant in Northumberland County to close
Merck has been part of Northumberland County since 1950, but the pharmaceutical company's Cherokee plant in Riverside will close in about two years.
.
24 Mar 2022",0.0,22-03-24
Merck,"Endpoints News
Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'
CEO Rob Davis told investors and analysts during the company's Q3 call on Thursday. But he's got his eye on “a list of potential places to play” when it comes...
.
27 Oct 2022",-0.5574,22-10-27
Merck,"Bloomberg Law News
Merck DEI Program Targeted by Edward Blum Group for EEOC Review
Merck DEI Program Targeted by Edward Blum Group for EEOC Review ... A Merck & Co. Inc. diverse leadership program unlawfully excludes White and Asian workers,...
.
7 Oct 2024",0.0,24-10-07
Merck,"Fortune
J&J, Merck, Boston Scientific go on $6.4B buying spree
The deals include Merck & Co.'s $680 million purchase of cancer drugmaker Harpoon Therapeutics Inc., Boston Scientific Corp.'s $3.7 billion acquisition of...
.
8 Jan 2024",-0.6597,24-01-08
Merck,"Financial Times
Hipgnosis founder Merck Mercuriadis to step down after Blackstone deal
Chair of group set up to manage music rights will exit when $1.6bn purchase is completed.
.
2 Jul 2024",0.0,24-07-02
Merck,"Hoard's Dairyman
Merck Animal Health Receives FDA Approval of AROVYN™
Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck. ... Merck Animal Health is...
.
4 Mar 2022",0.4767,22-03-04
Merck,"UKNow
Markey receives Merck Foundation grant to advance equitable cancer care in Kentucky
The University of Kentucky Markey Cancer Center received a grant through the Alliance for Equity in Cancer Care (the Alliance), an initiative funded by the...
.
7 Oct 2022",-0.5859,22-10-07
Merck,"BioSpace
Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?
A longtime biopharma executive laid out the business case for Moderna selling its half of the companies' shared investigational personalized cancer vaccine.
.
24 Jul 2024",-0.4588,24-07-24
Merck,"Fierce Biotech
Merck KGaA's BTK drug flunks pivotal multiple sclerosis trials, sending shockwaves through the sector
Evobrutinib, the German drugmaker's contender for a blockbuster opportunity, failed to beat Sanofi's Aubagio in two phase 3 multiple sclerosis (MS) clinical...
.
6 Dec 2023",0.2732,23-12-06
Merck,"Fierce Biotech
Merck-Gilead's weekly HIV combo maintains viral suppression
A weekly combination of Merck & Co.'s islatravir and Gilead's approved HIV med Sunlenca maintained a high rate of viral suppression in patients with HIV.
.
6 Mar 2024",0.4215,24-03-06
Merck,"3BL Media
A Nobel Prize for a Longtime Merck Collaborator
Princeton University's David WC MacMillan has been awarded the 2021 Nobel Prize in chemistry, alongside co-winner Benjamin List.
.
14 Jan 2022",0.8519,22-01-14
Merck,"Reuters
Senator Warren urges U.S. patent office to scrutinize Merck's Keytruda
US Senator Elizabeth Warren sent the nation's top patent regulator a letter urging close scrutiny of Merck & Co's (MRK.N) requests for new patents on its...
.
23 Feb 2023",0.2023,23-02-23
Merck,"Forbes
Should You Pick Merck Stock Over Coca-Cola?
If we compare the current valuation multiple to the historical average, Coca-Cola fares slightly better. Merck stock trades at 4.7x revenues, compared to its...
.
31 Aug 2023",0.3832,23-08-31
Merck,"Pharmaceutical Technology
Merck’s Biodevelopment Centre Expansion, Martillac, France
Location of Merck's biodevelopment centre. Merck's new commercial facility is located in Technopole Bordeaux Montesquieu in Martillac, France. The location...
.
8 Feb 2023",0.0,23-02-08
Merck,"Fierce Pharma
Akeso, Summit's PD-1 bispecific crushes Merck's Keytruda in study, signaling potential new standard in lung cancer
Akeso and Summit Therapeutics' ivonescimab, a PD-1/VEGF bispecific drug, handily beat Merck's Keytruda at delaying tumor progression or death in first-line...
.
8 Sept 2024",-0.93,
Merck,"Reuters
Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years
An experimental messenger RNA cancer vaccine developed by Moderna (MRNA.O) and Merck & Co (MRK.N) paired with Merck's Keytruda cut the chance of recurrence or...
.
14 Dec 2023",-0.296,23-12-14
Merck,"Business Wire
(lenvatinib) in Patients With Certain Types of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Merck and Eisai Provide Update on Phase 3 LEAP-010 Trial Evaluating KEYTRUDA + LENVIMA in Patients With Certain Types of Recurrent or Metastatic HNSCC.
.
25 Aug 2023",0.4939,23-08-25
Merck,"3BL Media
Black Scientists, Innovators and Employees are Key to Merck’s History of Invention and Progress
Learn about scientific contributions of Black employees in the company's history and how its diversity initiatives have shaped its legacy of invention.
.
7 Mar 2023",0.4215,23-03-07
Merck,"Reuters
Germany's Merck to open semiconductor base in China
Merck said earlier this year it will invest at least another one billion yuan ($150.18 million) in China by 2025 to support the chip industry. Of that amount,...
.
31 May 2022",0.4019,22-05-31
Merck,"Alabama News Center
Alabama-based Acclinate collaborates with Merck to expand diversity in clinical trials
Acclinate is a digital health company focused on improving health equity through predictive analytics technology and community engagement.
.
12 Dec 2023",0.8658,23-12-12
Merck,"Merck KGaA
Smart Manufacturing and Cutting Time to Market in Half
It consists of specialized production units with standardized interfaces that are flexibly combined as required. All modules are interconnected and communicate...
.
13 Nov 2022",0.5423,22-11-13
Merck,"Yahoo Finance
Top Analyst Reports for Merck, CVS Health & American Tower
There are concerns about Merck's ability to grow its non-oncology business ahead of Keytruda loss of exclusivity later in the decade. ... Shares of CVS Health...
.
6 Apr 2022",0.4588,22-04-06
Merck,"Fierce Biotech
BigHat, cherry-picking opportunities amid stormy market, pens pact with Merck & Co.
BigHat Biosciences has remained dry under its ever-expanding umbrella, announcing a multiprotein deal with Merck & Co. while growing its team 30% since the...
.
29 Nov 2022",0.5106,22-11-29
Merck,"Fierce Biotech
Amgen and Merck become first industry partners of academic clinical trial diversity initiative
Amgen and Merck will help Equitable Breakthroughs in Medicine Development (EQBMED) enroll patients in local clinical trials as part of the partnership's pilot...
.
16 Sept 2024",0.4019,
Merck,"Fierce Pharma
Taking its best shot at Roche, Merck scores in phase 3 trial of subcutaneous Keytruda
Merck has shown in a phase 3 trial that its subcutaneous version of Keytruda measures up its original formula which is administered by IV.
.
19 Nov 2024",0.7579,24-11-19
Merck,"Business Wire
Merck to Acquire Caraway Therapeutics, Inc.
Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to $610 million.
.
21 Nov 2023",0.0,23-11-21
Merck,"Bulletin of the Atomic Scientists
Merck’s COVID drug may be creating transmissible mutated viruses
“In 2021, I wrote `A new drug to treat covid could create a breeding ground for mutant viruses,'” Lin wrote on the X social media site on Monday. “We can now...
.
27 Sept 2023",0.7184,
Merck,"Merck KGaA
Water, Sanitation & Hygiene Interventions to Fight Schistosomiasis
Ensuring access to safe water, sanitation and hygiene (WASH) is therefore critical for the control and elimination of schistosomiasis, as well as of other water...
.
22 Mar 2022",0.296,22-03-22
Merck,"Merck KGaA
Digital Twin Collaboration p-Chip | Merck
Highly durable and small as a grain of salt, its uniquely traceable, light-activated p-Chip crypto anchor functions like a digital twin for physical items. This...
.
28 Nov 2023",0.3612,23-11-28
Merck,"Business Wire
Merck to Participate in the UBS Global Healthcare Conference
Merck Research Laboratories are scheduled to participate in a fireside chat at the UBS Global Healthcare Conference on Wednesday, Nov. 13, 2024.
.
6 Nov 2024",0.0,24-11-06
Merck,"Fierce Biotech
Merck & Co. opts in on Orion's hormone-dependent cancer candidates
Merck & Co. opts in on Orion's hormone-dependent cancer candidates ... Merck & Co. is expanding a research partnership with Orion into an exclusive licensing pact...
.
1 Jul 2024",-0.8519,24-07-01
Merck,"STAT
Merck drug for rare cardiovascular condition approved in U.S.
Merck will sell the drug, called sotatercept, under the brand name Winrevair. It will be priced at $14,000 per vial, which is injected every three weeks.
.
26 Mar 2024",0.4215,24-03-26
Merck,"PR Newswire
The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck
PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences,...
.
18 Jul 2023",0.0,23-07-18
Merck,"Fierce Pharma
AZ, Merck's Lynparza wins FDA nod in prostate cancer subgroup following advisory committee vote
Lynparza can now be used in combination with Johnson & Johnson's Zytiga and a corticosteroid to treat patients with mCRPC whose tumors have BRCA mutations.
.
1 Jun 2023",0.25,23-06-01
Merck,"The Guardian
Beyoncé’s ex-manager fights ejection from his music royalties fund
Merck Mercuriadis promised to turn songs into gold on launching Hipgnosis. Now, a review could see him ousted.
.
19 Oct 2023",-0.0516,23-10-19
Merck,"Reuters
Merck stops testing combo drug for skin cancer as more patients discontinue
Merck (MRK.N) said on Monday it had discontinued an experimental combination treatment testing a new type of immunotherapy in patients with a severe form of...
.
13 May 2024",-0.8225,24-05-13
Merck,"NJIT News |
NJIT Students Find Summer Work at Merck, Meta, Apple, National Institutes of Health and More
NJIT Students Find Summer Work at Merck, Meta, Apple, National Institutes of Health and More ... NJIT students have found excellent work in co-ops and internships...
.
21 Jul 2022",0.5719,22-07-21
Merck,"Reuters
India says safety concerns restricting use of Merck COVID pill
India has not added Merck's (MRK.N) COVID-19 pill to its national treatment protocol for the disease due to known safety concerns that have restricted its use...
.
5 Jan 2022",0.1027,22-01-05
Merck,"Fierce Biotech
Merck KGaA's multiple sclerosis drug hit with partial FDA hold, adding to BTK-liver injury links
The FDA has clamped down on trials of Merck KGaA's contender in response to evidence of damage to the liver of two patients.
.
12 Apr 2023",-0.6705,23-04-12
Merck,"C&EN
Merck & Co. to acquire Imago BioSciences
The pharma giant will pay a total of $1.35 billion for Imago BioSciences. Merck's acquisition of Imago strengthens the larger firm's presence in hematology.
.
23 Nov 2022",0.3818,22-11-23
Merck,"Fierce Pharma
Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office
Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office ... Megablockbuster Keytruda was last year's best-selling...
.
14 Mar 2024",-0.6597,24-03-14
Merck,"Fierce Biotech
Merck's next-gen pneumococcal vaccine strides forward after 2 phase 3 wins
Merck's next-gen pneumococcal vaccine strides forward after 2 phase 3 wins ... Merck & Co.'s next-generation pneumococcal vaccine has secured success in a pair of...
.
27 Jul 2023",0.93,23-07-27
Merck,"Fierce Pharma
The top 10 biopharma M&A deals in 2021
Biopharma merger and acquisition (M&A) activity was subdued in 2021, and it would have approached a record low for recent years but for a flurry of deals in...
.
18 Jan 2022",-0.0387,22-01-18
Merck,"Merck KGaA
New Life Science Distribution Center in Brazil | Merck
Merck Opens new € 20 Million Distribution Center in Brazil ... Merck, a leading science and technology company, will open a new, € 20 million distribution center...
.
27 Feb 2024",0.0,24-02-27
Merck,"AVMA Journals
Merck Animal Health Veterinary Team study reveals factors associated with well-being, burnout, and mental health among nonveterinarian practice team members
The goal was to assess the levels of burnout, well-being, and mental health of nonveterinarian employees of veterinary practices.
.
19 Jul 2024",0.0,24-07-19
Merck,"The Pharmaceutical Journal
NICE terminates appraisal of medicine for the treatment of persistent cough
NICE has terminated its appraisal of gefapixant (Lyfnua; Merck Sharp & Dohme) for the treatment of refractory or unexplained chronic cough in adults.
.
23 May 2024",0.7944,24-05-23
Merck,"Reuters
Explainer: How does Merck's COVID-19 pill compare to Pfizer's?
The drugs are being studied to see if they can prevent infection in people exposed to the virus. Here is an explanation of the differences in the two pills.
.
31 Jan 2022",-0.0516,22-01-31
Merck,"NPR
Doctors find limited use for less effective COVID pill
These antiviral pills – molnupiravir from Merck and Paxlovid from Pfizer – help stop the virus from spreading throughout the body, when taken early in the...
.
22 Feb 2022",0.3415,22-02-22
Merck,"South China Morning Post
Merck’s Covid-19 drug linked to new virus mutations, study says
Merck & Co's Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk.
.
2 Feb 2023",0.0772,23-02-02
Merck,"Pharmaceutical Technology
Merck opens $195.7m expanded distribution centre in Germany
Merck KGaA has announced the opening of its expanded Life Science distribution centre at Schnelldorf, which involved an investment of €180m ($195.7m).
.
6 Jun 2024",0.0,24-06-06
Merck,"BioSpace
Merck Touts 100% Complete Response Rate for Anti-ROR1 ADC as First-Line Lymphoma Treatment
Merck on Sunday unveiled initial data from the Phase II waveLINE-007 study, demonstrating that its investigational antibody-drug conjufate zilovertamab vedotin...
.
9 Dec 2024",-0.0258,24-12-09
Merck,"KCCI
Merck sues federal government, calling plan to negotiate Medicare drug prices extortion
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion.
.
6 Jun 2023",-0.2732,23-06-06
Merck,"Merck KGaA
Merck at the European Coatings Show 2023 in Nuremberg
Merck, a leading science and technology company, will present novel products and innovative ideas for the paint and coatings industry at the European Coatings...
.
22 Mar 2023",0.6369,23-03-22
Merck,"YouTube · CNBC International Live
AI is driving semiconductor industry, says CEO Electronics at Merck KgaA
Kai Beckmann, a member of the executive board and the CEO Electronics at Merck KgaA, discusses the use of AI in the semiconductor industry.
.
21 Oct 2024",0.0,24-10-21
Merck,"Forbes
Pick Either Johnson & Johnson Stock Or Its Peer – Both May Offer Similar Returns
We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar returns over the next three...
.
17 Jan 2023",0.0,23-01-17
Merck,"Merck KGaA
Merck Expands Renewable Energy Through Virtual Power Purchase Agreement with Recurrent Energy
Merck Expands Renewable Energy Through Virtual Power Purchase Agreement with Recurrent Energy · 16-year renewable energy contract for the Liberty County Solar...
.
15 May 2023",0.959,23-05-15
Merck,"NJIT News |
Merck and NJIT's New Jersey Innovation Institute Partner on Health Care Startup Development
The MDSS is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation, with investments...
.
29 Jun 2022",0.8126,22-06-29
Merck,"astroawani.com
COVID-19: Pil Merck gagal halang jangkitan dalam kalangan isi rumah
Sambutan terhadap pil Merck berkurangan kerana ia terbukti hanya 30 peratus berkesan berbanding 90 peratus untuk Paxlovid Pfizer.
.
22 Feb 2023",0.0,23-02-22
Merck,"Fierce Pharma
Merck's Keytruda bounces back from pair of trial flops with ⁠interim win in earlier lung cancer
The Keytruda win comes right on the heels of back-to-back losses for the drug. On Tuesday, Merck disclosed a phase 3 trial flop for Keytruda in tandem with...
.
1 Mar 2023",-0.5106,23-03-01
Merck,"Delano.lu
Thomas Klein succeeds Michael Savenay at helm of Quintet Luxembourg
Thomas Klein, currently group head of asset servicing, has been promoted to CEO of Quintet Luxembourg. Michael Savenay will take over the reins of Merck Finck.
.
11 Jan 2023",0.8176,23-01-11
Merck,"Reuters
Merck KGaA widens work on 'DNA damage' drugs in deal with China's Hengrui
Merck KGaA widens work on 'DNA damage' drugs in deal with China's Hengrui ... FRANKFURT, Oct 30 (Reuters) - Germany's Merck KGaA (MRCG.DE) , opens new tab on...
.
30 Oct 2023",-0.7506,23-10-30
Merck,"Fierce Pharma
MilliporeSigma boosts its gene therapy manufacturing capability with $600M acquisition of Mirus Bio
Merck KGaA and its CDMO arm MilliporeSigma are increasing their presence in gene therapy manufacturing with a $600 million buyout of Mirus Bio.
.
23 May 2024",0.3182,24-05-23
Merck,"Merck KGaA
Female role models from Merck as encouragers for professions in natural sciences
Our Merck colleagues Dr. Tatjana Ross, (chemist and Director Medicinal Chemistry), Mariam Jamil (apprentice chemical laboratory assistant) and Lea Buchheimer (...
.
11 May 2022",0.6124,22-05-11
Merck,"Fierce Biotech
Merck strikes 2nd ADC deal with Kelun-Biotech, paying $35M for rights to unnamed asset
Merck has secured global rights to an investigational ADC for $35 million upfront and up to $901 million in milestones.
.
26 Jul 2022",0.4019,22-07-26
Merck,"Fierce Pharma
Merck, Viatris close in on settlement in long-running Januvia patent case
Last fall, the court ruled in favor of Merck, finding Viatris liable for infringing certain Januvia patents that are set to expire later this decade. The court...
.
21 Mar 2023",0.5859,23-03-21
Merck,"CSRwire
35 Years: The Mectizan® Donation Program
In 1987, Merck committed to donate Mectizan – as much as needed, for as long as needed – with the goal to help eliminate river blindness.
.
16 Jun 2022",0.5859,22-06-16
Merck,"thesun.my
Merck charged in France over changes to popular thyroid drug
PARIS: The French unit of German pharmaceuticals firm Merck said Wednesday that it had been charged with “aggravated deceit” for failing to inform pat...
.
19 Oct 2022",-0.4767,22-10-19
Merck,"BioProcess International
Merck KGaA bolsters oncology pipeline with Hengrui partnership
The partnership sees Merck gain a worldwide exclusive license (ex-China) to advance, manufacture and commercialize Hengrui's DNA damage response (DDR) inhibitor...
.
31 Oct 2023",0.1779,23-10-31
Merck,"Merck KGaA
Merck Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
Merck Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3 · Organic sales: -2% to +2% to a total of € 20.5 billion to € 21.9 billion –...
.
9 Nov 2023",0.4973,23-11-09
Merck,"Business Wire
Saama Collaborates with Merck to Build Machine Learning-Powered Clinical Data Layer to Strengthen Merck’s Clinical Development Capabilities
Saama today announced a multi-year agreement with Merck, known as MSD outside the United States and Canada, to build and operationalize a new clinical data...
.
10 Aug 2022",0.8074,22-08-10
Merck,"Fierce Pharma
Seagen's Padcev, Merck's Keytruda shine as bladder cancer combo
On Tuesday, Seagen and Astellas revealed some positive data from one of the cohorts in the phase 1b/2 urothelial cancer trial.
.
26 Jul 2022",-0.7351,22-07-26
Merck,"Investor's Business Daily
Why Merck Is Already On The Hunt For Its Next Big Deal
Merck Hasn't Even Closed Its Last Buyout, But It's Already Hunting For The Next Deal ... Merck (MRK) stock jumped Thursday after the pharma Goliath said it's...
.
1 Feb 2024",0.0,24-02-01
Merck,"Fierce Pharma
EMA warns of shortage of IVF drug Cetrotide because of Merck KGaA manufacturing issue
A manufacturing issue with Merck KGaA's subsidiary EMD Serono has led to a shortage of the IVF drug Cetrotide, says the European Medicines Agency.
.
11 Aug 2022",-0.5267,22-08-11
Merck,"BioSpace
Merck Axes Two Keytruda Phase III Cancer Trials Due to Disappointing Data
The pharma is terminating the Phase III KEYNOTE-867 in non-small cell lung cancer (NSCLC) after an interim analysis showed that Keytruda, when administered...
.
29 Aug 2024",-0.9186,24-08-29
Merck,"Fierce Pharma
Formulated Solutions inks deal to buy former Merck, Bayer manufacturing facility
Bayer took over the facility as part of its $14.2 billion acquisition of Merck's consumer care business in 2014. The plant also had a stint of ownership by...
.
20 Dec 2022",0.5994,22-12-20
Merck,"Endpoints News
They sold their last biotech to Merck. Now they're back with a PARP outfit named after a London street
News Reporter. In 2016, Peter Trill and Alan Wise sold IOmet Pharma (an I/O outfit as the name suggests) to Merck for $400 million. Now, some six years later,...
.
24 May 2022",0.4767,22-05-24
Merck,"Newswire.ca
MERCK CANADA ANNOUNCES COLLABORATION WITH VECTOR INSTITUTE TO FURTHER ADVANCE ITS ARTIFICIAL INTELLIGENCE CAPABILITIES AND DRIVE INNOVATION IN HEALTHCARE
We are thrilled to welcome Merck Canada to Vector's sponsor community. Together with Vector, Merck's strong commitment to innovation in health will help realize...
.
8 Feb 2024",0.9728,24-02-08
Merck,"Merck KGaA
Merck Annual General Meeting Elects New Supervisory Board
Specifically, the following members will represent the shareholders in the new Supervisory Board: Michael Kleinemeier (Chair), Katja Garcia Vila, Dr. Carla...
.
26 Apr 2024",0.0,24-04-26
Merck,"Pharmaceutical Technology
Proxygen and Merck partner to develop molecular glue degraders
Proxygen and Merck partner to develop molecular glue degraders. Proxygen will receive up to $2.55bn in payments based on the achievement of specified milestones...
.
5 Apr 2023",-0.7184,23-04-05
Merck,"Medical Dialogues
Merck India appoints Pratima Reddy as Country Speaker
Mumbai: Merck, a science and technology company, today announced that Pratima Reddy as their Country Speaker for India. Pratima takes on this role in...
.
4 Jul 2023",0.0,23-07-04
Merck,"BioSpace
Merck’s Former Asthma Blockbuster Singulair Could Be Linked to Mental Health Problems: Reuters
FDA researchers have found new evidence of a molecular link between Merck's former blockbuster asthma drug montelukast—which is now marketed by spinoff Organon...
.
22 Nov 2024",0.7269,24-11-22
Merck,"Merck KGaA
Merck Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing
Merck, a leading science and technology company, launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs).
.
10 Sept 2024",0.128,
Merck,"Business Standard
Drugmaker Merck has strong fourth quarter as Covid-19 treatment debuts
Drugmaker Merck has strong fourth quarter as Covid-19 treatment debuts · The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations...
.
3 Feb 2022",0.7269,22-02-03
Merck,"WKOK.com
Merck Riverside Plant Closing Starting in 2024
Merck is set to close its Riverside plant starting in 2024. Northumberland County Commissioner Sam Schiccatano told WKOK Thursday he was notified of the plans.
.
24 Mar 2022",0.0,22-03-24
Merck,"CIO
Merck Life Sciences banks on RPA to streamline regulatory compliance
Merck leveraged unattended bots from Automation Anywhere to automate and streamline the creation, management, and distribution of its regulatory processes.
.
5 Jun 2023",0.2732,23-06-05
Merck,"ZAWYA
Merck Foundation Chief Executive Officer (CEO) Meets the President and the First Lady of Sierra Leone to Underscore their Long-Term Commitment to Reshape Public Healthcare Landscape in the Country
Merck Foundation CEO recognizes the efforts of the First Lady of Sierra Leone as the Ambassador of “More Than a Mother” campaign.
.
18 Aug 2022",0.3818,22-08-18
Merck,"Business Wire
(lenvatinib) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
Merck and Eisai Provide Update on Phase 3 LEAP-002 Trial Evaluating KEYTRUDA Plus LENVIMA Versus LENVIMA Monotherapy in uHCC.
.
3 Aug 2022",0.0,22-08-03
Merck,"Reuters
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Drugmaker Merck (MRK.N) will pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs, they said, in a deal that could be worth...
.
20 Oct 2023",-0.8807,23-10-20
Merck,"Fierce Pharma
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Fierce Pharma Asia—Plant expansions at Novo, Novartis, Merck KGaA; Kyowa Kirin's pricing record; BeiGene's PD-1 nod ... Three large pharma companies plan to...
.
22 Mar 2024",0.0,24-03-22
Merck,"Pharmaceutical Technology
Merck to invest $468.4m to boost manufacturing capacity in Ireland
Merck to invest $468.4m to boost manufacturing capacity in Ireland. Merck plans to construct a new filtration manufacturing site at Blarney Business Park for...
.
24 May 2022",0.6597,22-05-24
Merck,"Reuters
Merck set to remove cancer-causing chemical from top diabetes drugs - Bloomberg News
The FDA said in August certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and Janumet, were contaminated with a possible carcinogen.
.
17 Jan 2023",0.4404,23-01-17
Merck,"Seeking Alpha
Merck Stock: Strong Oncology Pipeline (NYSE:MRK)
Summary · Merck has an outstanding oncology portfolio that will drive growth in the foreseeable future. · Strong fundamentals and cash position ensure Merck's...
.
2 Aug 2022",0.9413,22-08-02
Merck,"GlobeNewswire
AUM Biosciences Announces Clinical Trial Collaboration and
Plan to conduct a global Phase 2 clinical trial to evaluate MNK inhibitor (AUM001) in combination with MSD's anti-PD-1 therapy KEYTRUDA for the treatment...
.
5 May 2022",-0.0772,22-05-05
Merck,"PharmaVoice
Merck’s New Jersey campus is getting a biotech makeover
Merck's New Jersey campus is getting a biotech makeover. With a purchase of the pharma giant's Kenilworth campus, Onyx Equities is looking to make the spot a go...
.
11 Jul 2023",0.0,23-07-11
Merck,"Merck KGaA
Inauguration of the new premises of the Merck-TU Darmstadt Biology learning lab
Inauguration of the new premises of the Merck-TU Darmstadt Biology learning lab ... The joint biology learning laboratory from Merck and the TU Darmstadt is in...
.
16 Nov 2022",0.0,22-11-16
Merck,"YouTube · Yahoo Finance
FDA approves Merck treatment for lung disease, stock rises
The Food and Drug Administration has approved Winrevair, Merck's (MRK) latest drug to treat pulmonary arterial hypertension, a lung condition.
.
27 Mar 2024",0.802,24-03-27
Merck,"ETHRWorld.com
Shiv Kumar joins Merck India as Head of Human Resources
Merck India, a leading science and technology company with expertise spanning sectors like Healthcare, Life Science and Electronics, has appointed Shiv Kumar...
.
6 Apr 2022",0.3612,22-04-06
Merck,"Barron's
Merck Tops Profit Estimates on Strong Keytruda and Gardasil Sales
Merck reported second-quarter adjusted earnings of $1.87 a share, topping analysts' estimates. But the stock fell a little more than 1% after its guidance...
.
28 Jul 2022",0.705,22-07-28
Merck,"Fierce Pharma
As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing
As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing ... ImmunityBio last week won the FDA's approval for its...
.
3 May 2024",0.5574,24-05-03
Merck,"Reuters
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Merck & Co (MRK.N) on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda.
.
25 Apr 2024",0.3612,24-04-25
Merck,"The Herald - Breaking news.
Zim reaps rewards from First Lady’s partnership with Merck Foundation
ZIMBABWE is reaping immense benefits from the partnership between First Lady Dr Auxillia Mnangagwa and an international organisation Merck Foundation which...
.
20 May 2022",0.6908,22-05-20
Merck,"SWA.co.id
Evie Yulin, Gesit Memimpin Transformasi Merck
Evie, yang menjadi Presiden Direktur PT Merck Tbk. sejak 1 Januari 2020, jelas harus bekerja keras dan mengajak timnya untuk menelurkan strategi yang tepat guna...
.
1 Sept 2022",0.0,
Merck,"Universität Bonn
Mulliken Center of the University of Bonn and Merck cooperate in machine learning project
The three-year collaboration program focuses on developing new tools for computational chemical modeling as well as new representations of molecules.
.
14 Jun 2022",0.2732,22-06-14
Merck,"Fierce Biotech
AACR: Merck, Moderna show off therapeutic cancer vax data, with phase 3 launch before year-end
Merck and Moderna plan on next testing the cancer therapy and Keytruda combo in patients with non-small cell lung cancer.
.
16 Apr 2023",-0.9349,23-04-16
Merck,"Bloomberg.com
Merck’s Covid Drug Linked to Virus Mutation Patterns, Study Says
Merck's Covid Drug Linked to Virus Mutation Patterns, Study Says.
.
25 Sept 2023",0.0,
Merck,"Global Competition Review
Spain hits Merck with €39 million abuse fine for sham litigation
Spain hits Merck with €39 million abuse fine for sham litigation ... Spain's antitrust watchdog has fined Merck €38.9 million for abusing its dominant position in...
.
25 Oct 2022",-0.9081,22-10-25
Merck,"Merck KGaA
Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour
Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour · Over 250 events expected to reach more than 45,000 future scientists on two continents · Hands-on...
.
26 Apr 2023",0.0258,23-04-26
Merck,"Business Wire
Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from two pivotal Phase 3 trials.
.
19 Dec 2024",0.4215,24-12-19
Merck,"BioCentury
Nov. 21 Quick Takes: Merck buying neurology play Caraway
The pharma is acquiring the Cambridge, Mass.-based biotech for an undisclosed amount up front. If all of the deal's milestones are fulfilled, Caraway...
.
21 Nov 2023",0.6369,23-11-21
Merck,"Merck KGaA
Investment in Manufacturing Expansion - Cork, Ireland | Merck
At Blarney Business Park, Merck is going to build a new filtration manufacturing facility for almost €150 million. Once fully operational, it will increase the...
.
23 May 2022",0.3182,22-05-23
Merck,"The Sierra Leone Telegraph
Merck Foundation launch MARS Best African Woman Researcher Awards
Merck Foundation has launched its annual “MARS Best African Woman Researcher Awards” to acknowledge women in science.
.
17 Feb 2022",0.9169,22-02-17
Merck,"Environment+Energy Leader
Siemens and Merck Collaborate to Advance Digital Transformation in Manufacturing
This partnership is expected to set new standards for manufacturing by leveraging smart, modular systems that enhance production speed, flexibility, and...
.
17 Sept 2024",0.6249,
Merck,"BioPharma Dive
Merck, Pfizer lifted as CDC backs broader use of pneumococcal vaccines
A panel of advisers to the Centers for Disease Control and Prevention on Wednesday recommended lowering the age for routine pneumococcal vaccination from 65 to...
.
24 Oct 2024",-0.1027,24-10-24
Merck,"PharmaVoice
After working at Merck during the Vioxx scandal, this former sales rep is on a mission to fix the system
After working at Merck during the Vioxx scandal, this former sales rep is on a mission to fix the system. The founder and CEO for the Accreditation Council for...
.
11 Apr 2023",-0.7003,23-04-11
Merck,"U.S. Fish and Wildlife Service (.gov)
Slice® (Emamectin Benzoate)
SLICE is an aquaculture premix containing emamectin benzoate and is only available through Merck Animal Health.
.
4 Apr 2022",0.0,22-04-04
Merck,"Free Malaysia Today
Daiichi Sankyo, Merck announce US$22bil cancer drug deal
TOKYO: Shares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to US$22 billion...
.
20 Oct 2023",-0.5267,23-10-20
Merck,"BioSpace
Merck Expands Manufacturing Capacity for HPV Vaccines, Adds 150 Jobs
Merck strengthened its HPV vaccines manufacturing capacity with the expansion of its facility in Elkton, Virginia. Also, an additional 150 new jobs are...
.
4 Apr 2022",0.4939,22-04-04
Merck,"Bloomberg.com
Merck KGaA Gets Female Leadership Duo in First for Germany’s DAX
Germany's Merck KGaA will soon have women occupying the top two posts on its executive board, marking a first in a corporate world more noted for its...
.
8 May 2023",0.2023,23-05-08
Merck,"Pharmaceutical Technology
Merck KGaA plans investment in new facility in Germany
Merck KGaA has announced a €62m ($66.6m) investment to construct a new quality control facility for its Life Science business at its Darmstadt headquarters.
.
12 Jun 2024",0.0,24-06-12
Merck,"FirstWord Pharma
Merck & Co. deepens ADC ties with China-based biotech for up to $901 million
The latest collaboration comes amid rumours that Merck is negotiating to buy Seagen, a pioneer in the use of ADCs to treat cancer. A transaction, which may...
.
26 Jul 2022",-0.4019,22-07-26
Merck,"Yahoo Finance
Merck & Co., Inc.'s (NYSE:MRK) Stock Is Going Strong: Is the Market Following Fundamentals?
Most readers would already be aware that Merck's (NYSE:MRK) stock increased significantly by 27% over the past three...
.
2 Dec 2022",0.6597,22-12-02
Merck,"Business Wire
(pembrolizumab) Demonstrates Sustained Overall Survival Benefit Versus Ipilimumab in Advanced Melanoma
For patients with advanced melanoma, these long-term follow-up data showed the 10-year OS rate for KEYTRUDA was 34.0% versus 23.6% for ipilimumab. KEYTRUDA...
.
15 Sept 2024",0.7184,
Merck,"DVM360
New oral vaccine is launched for prevention of 2 canine respiratory pathogens
Merck Animal Health has announced the domestic launch of the first oral Bordetella bronchiseptica and canine parainfluenza virus vaccine with mucosal...
.
13 Sept 2022",0.128,
Merck,"CNN
Merck sues US government over new Medicare drug price negotiation program
“By coercing Merck to provide its drug products at government-set prices, the program takes property for public use without just compensation in violation of...
.
6 Jun 2023",-0.4939,23-06-06
Merck,"CNBC
Jim Cramer: Merck is a buy after the drugmaker's post-earnings dip — here's why
Jim Cramer: Merck is a buy after the drugmaker's post-earnings dip — here's why · News Tips · CNBC Newsletters · Advertise With Us. Please Contact Us · Privacy...
.
30 Jul 2024",0.3182,24-07-30
Merck,"ESG Today
Merck to Purchase Renewable Energy for 100% of Electricity Use in Europe from 2025
Merck has announced today that it will cover 100% of its current electricity purchases in the European Union (EU) and Switzerland with renewable energy from...
.
2 Nov 2023",0.4939,23-11-02
Merck,"CoStar
News | Biopharma Giant Merck & Co Prelets King's Cross Offices For £1 Billion Life Sciences Hub
RELATED ARTICLES ... Biopharmaceutical company MSD, or Merck & Co, has completed the prelet acquisition of 260,000 square feet of offices, research and laboratory...
.
31 May 2022",0.0,22-05-31
Merck,"Fierce Pharma
Fierce Pharma Asia—Merck's Romanelli returns; Sanofi's 'factory of the future'; Fujifilm's $450M contract
Merck's former China head will return to the Big Pharma to lead international human health operations after a short stint at a Chinese company.
.
22 Apr 2022",0.0,22-04-22
Merck,"Merck KGaA
Merck Completes Acquisition of Exelead and Plans to Invest More Than € 500 Million in Technology Scale-Up
Merck today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing...
.
23 Feb 2022",0.0,22-02-23
Merck,"Fierce Biotech
Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data
Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data ... A phase 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed...
.
17 Sept 2024",-0.296,
Merck,"North Carolina Agricultural and Technical State University
Merck, A&T launch joint Merck Biotechnology Learning Center
EAST GREENSBORO, N.C. (April 19, 2024) – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and North Carolina Agricultural and Technical...
.
19 Apr 2024",0.4215,24-04-19
Merck,"Business Wire
U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS™ for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk
U.S. FDA Accepts for Priority Review the sNDA for PREVYMIS™ for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk.
.
17 Feb 2023",0.1027,23-02-17
Merck,"WSJ
Justice Department Opts Not to Charge Merck KGaA Subsidiary Over Export Controls Scheme
Justice Department Opts Not to Charge Merck KGaA Subsidiary Over Export Controls Scheme · Two men, including a former employee of the German company's...
.
22 May 2024",0.7783,24-05-22
Merck,"Fierce Biotech
Merck KGaA doubles up on AI partners, tapping BenevolentAI and Exscientia for drug discovery push
Merck has selected three potential first-in-class and best-in-class targets to work on with each partner. BenevolentAI and Exscientia will work on small...
.
20 Sept 2023",0.0,
Merck,"Fierce Pharma
Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline
Merck KGaA took a hard fall last year, with its global sales declining by 6% to 21 billion euros ($22.7 billion).
.
7 Mar 2024",-0.1491,24-03-07
Merck,"Clinical Trials Arena
Merck to discontinue Phase III lung cancer trial due to futility
Merck to discontinue Phase III lung cancer trial due to futility. In a third interim analysis, Keytruda plus Lynparza regimen did not show improvement in...
.
8 Dec 2023",-0.9058,23-12-08
Merck,"Legacy.com
Michael GRANO Obituary (1952 - 2022) - Williamsville, NY - Buffalo News
Michael Dominic November 23, 2022, age 70. Beloved husband of 39 years to Martha Anne (nee Merck) Grano; loving father of Lisa (Jaremy) Perry, Andrea (David)...
.
27 Nov 2022",0.802,22-11-27
Merck,"Merck KGaA
Merck Presents Cutting-Edge Pharma and Electronic Materials Production to Robert Habeck
Merck, a leading science and technology company, today welcomed Robert Habeck, the German Federal Minister for Economic Affairs and Climate Action, at its...
.
29 Apr 2024",0.34,24-04-29
Merck,"YouTube · Bloomberg Podcasts
Merck CEO Rob Davis Talks Winrevair Approval | Bloomberg Talks
Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called...
.
28 Mar 2024",-0.4939,24-03-28
Merck,"Merck KGaA
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024 · Not intended for Canada-, UK- or US-based media · First-in-human data...
.
23 May 2024",-0.8689,24-05-23
Merck,"Singapore Economic Development Board (EDB)
Merck establishes first Digital Hub in Singapore
Merck establishes first Digital Hub in Singapore ... Merck, a leading science and technology company, today announced the opening of the Merck Digital Hub in...
.
29 Jan 2024",0.0,24-01-29
Merck,"Fierce Biotech
Merck turns to Acclinate to increase African American participation in cancer trials
Merck & Co. has teamed up with digital health company Acclinate to try and enroll more African American patients in its cancer drug studies.
.
30 Nov 2023",-0.8176,23-11-30
Merck,"Merck KGaA
7 success factors for managing transformations
1. Carry out a rigorous analysis. Transformation starts with an honest and rigorous analysis of what is going well, and, above all, what could be done better.
.
10 Jan 2022",0.8316,22-01-10
Merck,"Bloomberg.com
Penn Gets $84 Million in Biggest Gift Since President’s Ouster
The University of Pennsylvania received an $84 million gift from the former chief executive officer of Merck & Co., the biggest publicly disclosed donation...
.
25 Jan 2024",0.7003,24-01-25
Merck,"Reuters
Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO
Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.
.
4 Jan 2024",0.1531,24-01-04
Merck,"Yahoo Finance
Should Weakness in Merck & Co., Inc.'s (NYSE:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
In This Article: MRK. It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% over the past three...
.
4 Oct 2024",0.1027,24-10-04
Merck,"www.drugdiscoverytrends.com
Merck wins expanded indication for pneumococcal Vaxneuvance vaccine
Merck wins expanded indication for pneumococcal Vaxneuvance vaccine ... Merck & Co. (NYSE: MRK) has announced that the Vaxneuvance pneumococcal 15-valent...
.
22 Jun 2022",0.8126,22-06-22
Merck,"Business Wire
Merck Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
For the 2024 tour, the Curiosity Cube is sporting a new look, displaying photos of young scientists who are children of Merck employees. These employees work in...
.
17 Apr 2024",0.4404,24-04-17
Merck,"Fierce Biotech
Merck inks R&D deal with Intermountain spinoff Culmination Bio
Merck inks R&D deal with Intermountain spinoff Culmination Bio ... Merck & Co. signed a R&D collaboration deal with data and technology provider Culmination Bio,...
.
25 Jan 2024",0.0,24-01-25
Merck,"Forbes India
Merck's Atul Barjatya: The inclusive leader
Atul Barjatya has been in various managerial positions in the pharma industry for 26 years, and if there's one thing he believes in, it is leveraging motivated...
.
18 Jan 2022",0.0,22-01-18
Merck,"YouTube · CNBC Television
Merck tops earnings estimates on strong demand for Keytruda even as HPV vaccine sales fall
CNBC's Becky Quick reports on the company's quarterly earnings results.
.
31 Oct 2024",0.7269,24-10-31
Merck,"Fierce Biotech
Merck, Moderna unveil phase 3 trial details for closely watched mRNA cancer vaccine
A phase 3 trial coded V940-001 will test the combination of the mRNA vaccine, also known as V940, and Merck's PD-1 inhibitor Keytruda for post-surgery treatment...
.
10 Jul 2023",-0.6908,23-07-10
Merck,"Merck KGaA
TEPMETKO EC Approval - News | Merck
The European Commission (EC) has approved once-daily oral TEPMETKO (tepotinib) as monotherapy for the treatment of adult patients with advanced non-small cell...
.
18 Feb 2022",0.7845,22-02-18
Merck,"Medical Marketing and Media
Merck hires VP of immunology discovery
Merck hires VP of immunology discovery. Levesque to lead Exploratory Science Center. ... Merck has hired Marc Levesque as VP of immunology discovery and head of...
.
13 Jan 2022",0.0,22-01-13
Merck,"전자신문
Merck Korea to directly produce 'semiconductor polishing material' in first half of the year
Merck Korea announced on the 14th that they have completed construction of a semiconductor chemical mechanical polishing (CMP) slurry production facility at...
.
15 Feb 2022",0.0,22-02-15
Merck,"Merck KGaA
Michael Kleinemeier Chairman of the Merck Supervisory Board until the 2024 AGM
Merck, a leading science and technology company, today announced that the Supervisory Board has elected Michael Kleinemeier (66) as its Chair. Among other roles...
.
8 Feb 2024",0.0,24-02-08
Merck,"Investopedia
Top Stock Movers Now: Meta Platforms, IBM, Merck, and More
Meta Platforms (META) shares were a drag on the tech sector amid concerns about the social media giant's spending on artificial intelligence (AI).
.
25 Apr 2024",0.6369,24-04-25
Merck,"Bloomberg Law News
AstraZeneca, Merck Sue to Stop Copies of Cancer Drug Lynparza
AstraZeneca, Merck Sue to Stop Copies of Cancer Drug Lynparza ... AstraZeneca Plc and partner Merck & Co. filed lawsuits alleging that copies of Lynparza proposed...
.
8 May 2024",-0.93,24-05-08
Merck,"Nasdaq
Merck (MRK) Beats on Q2 Earnings and Sales, Ups 2023 View
Merck MRK reported an adjusted loss of $2.06 per share in second-quarter 2023, beating the Zacks Consensus Estimate of a loss of $2.17.
.
1 Aug 2023",-0.6597,23-08-01
Merck,"CNBC
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall · Earnings per share: $1.57 adjusted vs. $1.50 expected...
.
31 Oct 2024",0.9246,24-10-31
Merck,"Oxfam America
Pfizer, Moderna, Johnson & Johnson, Merck shareholders must vote to end unequal access to COVID-19 vaccines and medicines
According to an analysis by FiercePharma of 2022 pharmaceutical company revenues, Pfizer ranked #1. Johnson & Johnson ranked #2, Merck ranked #4 and Moderna...
.
27 Apr 2023",-0.34,23-04-27
Merck,"BioSpace
Merck Lowers Full-Year Sales Guidance Despite Strong Overall Q3 Results
Merck on Thursday reported 7% year-over-year growth in third-quarter revenues, which came in ahead of analyst forecasts, driven by its blockbuster cancer...
.
31 Oct 2024",0.5103,24-10-31
Merck,"STAT
Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
Sen. Bernie Sanders (I-Vt.) has proposed subpoenaing two pharmaceutical executives who refused to testify before his committee.
.
18 Jan 2024",-0.296,24-01-18
Merck,"Yahoo Finance
Does Merck (NYSE:MRK) Have A Healthy Balance Sheet?
The latest balance sheet data shows that Merck had liabilities of US$26.1b due within a year, and liabilities of US$42.9b falling due after that. Offsetting...
.
11 Oct 2024",-0.128,24-10-11
Merck,"Fierce Biotech
Merck KGaA drops xevinapant with phase 3 head and neck cancer trial on course for failure
Merck KGaA executives were reassuring analysts that the failure of a phase 3 trial of xevinapant was “unlikely.” Now that worst-case scenario has come to pass.
.
25 Jun 2024",-0.8519,24-06-25
Merck,"Korea JoongAng Daily
Germany's Merck acquiring chemical business of Mecaro
Darmstadt, Germany's Merck signed a definitive agreement to acquire the chemical business of Mecaro, a Pyeongtaek, Gyeonggi-based semiconductor material...
.
18 Aug 2022",0.4939,22-08-18
Merck,"CNBC
Merck's Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%
Merck's Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%. Published Thu, Mar 17 20222:17 PM EDT Updated Tue...
.
17 Mar 2022",-0.9674,22-03-17
Merck,"AZoCleantech
Merck KGaA : Quotes, Address, Contact
Merck KGaA ... Merck is a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production,...
.
15 Oct 2023",0.1779,23-10-15
Merck,"Fierce Biotech
Merck's next-gen pneumococcal vaccine receives FDA breakthrough status ahead of phase 3 trial
Another of Merck's pneumococcal vaccines, V114, has performed well when put into head-to-head matchups with Pfizer's blockbuster shot Prevnar 13. Merck hopes...
.
14 Apr 2022",0.7184,22-04-14
Merck,"Business Wire
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC
The third Phase 3 trial for the investigational individualized neoantigen therapy, V940 (mRNA-4157), focused on earlier stages of cancer.
.
28 Oct 2024",-0.7269,24-10-28
Merck,"Merck.com
Our Q3 2024 financial results
Our Q3 2024 financial results ... Merck's (NYSE: MRK) Q3 2024 financial results represent strong progress across the business and our diverse pipeline. Our...
.
31 Oct 2024",0.7269,24-10-31
Merck,"Forbes Africa
Merck Foundation CEO: Creating Songs With African Musicians to Raise Awareness
30 songs in English, French, Portuguese and local languages, with various local African artists to address issues like breaking infertility stigma, empowering...
.
11 Jan 2023",0.5719,23-01-11
Merck,"Fierce Pharma
Daiichi's lung cancer ADC rejected by FDA in blow to first project under Merck partnership
The FDA has rejected Daiichi Sankyo's Merck & Co.-partnered antibody-drug conjugate (ADC) patritumab deruxtecan.
.
26 Jun 2024",-0.9001,24-06-26
Merck,"BioPharma Dive
Merck shares slide as Gardasil sales drop in China
Merck shares slide as Gardasil sales drop in China. The surprise announcement on Tuesday prompted an investor sell-off that some analysts say may be overblown.
.
31 Jul 2024",0.3182,24-07-31
Merck,"Merck KGaA
Rethinking Outcomes - The Role of Patient Preference in Oncology Treatment
Conclusion. Good care and suitable treatment mean helping patients to choose the right treatment based on their individual priorities, when choices are...
.
9 Oct 2024",0.8074,24-10-09
Merck,"Common Dreams
Opinion | Why Should Drug Corporations Like Merck and Eli Lilly Even Exist?
These predatory corporations try to present themselves as socially responsible, but their business model continues to hurt the very people they claim to care...
.
15 Jun 2023",-0.3291,23-06-15
Merck,"Reuters
Merck opts to develop, sell cancer vaccine with Moderna
Merck opts to develop, sell cancer vaccine with Moderna ... Oct 12 (Reuters) - Merck & Co Inc (MRK.N) , opens new tab opted to jointly develop and potentially...
.
12 Oct 2022",-0.8689,22-10-12
Merck,"BioSpace
Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms
Massachusetts-based Pearl Bio is built on the work of Farren Isaacs and Michael Jewett. In 2013, Isaacs, a professor at Yale School of Medicine, published a...
.
12 Mar 2024",0.0,24-03-12
Merck,"Senator Patty Murray (.gov)
Senator Murray On Merck’s Lawsuit to Block Medicare from Being Able to Negotiate Lower Drug Prices
A lawsuit filed by Merck & Co in federal court today seeking to overturn historic provisions in the Inflation Reduction Act that finally empowered Medicare to...
.
6 Jun 2023",-0.7845,23-06-06
Merck,"Reuters
U.S. FDA panel to review expanded use of Merck-AstraZeneca's cancer drug
Merck & Co Inc and British drugmaker AstraZeneca PLC said on Thursday that an independent committee of advisers to the U.S. health regulator will review the...
.
2 Mar 2023",-0.6597,23-03-02
Merck,"Pharmaceutical Technology
Merck’s net income for Q1 2024 increases by 69% to $4.76bn
Merck's net income for Q1 2024 increases by 69% to $4.76bn. The company's sales for Q1 2024 increased by 9% to $15.77bn. ... MSD expects sales for full-year 2024...
.
26 Apr 2024",0.2732,24-04-26
Merck,"Merck KGaA
Letter from Belén Garijo - Merck Annual Report 2023
We remain firmly positioned to return to growth in 2024 and generate long-term, sustainable value for our owners, shareholders, customers, patients, employees,...
.
7 Mar 2024",0.6124,24-03-07
Merck,"BioSpace
Merck KGaA Fails Phase III Study in Head and Neck Cancer, Scraps Trials
Merck KGaA announced Monday that its drug candidate xevinapant failed the Phase III TrilynX study, unable to yield significant survival benefits in patients...
.
25 Jun 2024",-0.7964,24-06-25
Merck,"Built In
‘I’ve Learned How Dynamic I Am’: Merck’s Data Science and Informatics Team Nurtures Multidisciplinary Innovation
'I've Learned How Dynamic I Am': Merck's Data Science and Informatics Team Nurtures Multidisciplinary Innovation · What Merck Does · Translating Scientific...
.
17 Aug 2023",0.9349,23-08-17
Merck,"Fox Business
Merck in talks to buy cancer biotech Seagen: report
Drugmaker Merck & Co is reportedly in advanced talks to buy cancer-focused biotech company Seagen Inc. The deal could be worth roughly $40 billion or more.
.
7 Jul 2022",-0.3612,22-07-07
Merck,"BioSpace
Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time
Gefapixant is an orally available P2X3 receptor antagonist that works by preventing the signaling cascade in the airways that culminates in a cough reflex.
.
21 Dec 2023",-0.0772,23-12-21
Merck,"Fierce Biotech
Moderna plots lung cancer trial for Merck-partnered vax, piggybacking on Keytruda's recent win
In melanoma, Merck and Moderna found in a phase 2b trial that mRNA-4157 in combination with Keytruda reduced the risk of recurrence or death by 44% compared...
.
2 Aug 2023",-0.765,23-08-02
Merck,"Fierce Pharma
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
A federal judge said Merck & Co. and Glenmark Pharmaceuticals would have to face a jury trial over an alleged pay-for-delay deal on the cholesterol med Zetia.
.
21 Apr 2023",0.0,23-04-21
Merck,"Investor's Business Daily
Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else
Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else ... Viking Therapeutics (VKTX) stock plummeted Wednesday after Merck (MRK) threw...
.
18 Dec 2024",0.0,24-12-18
Merck,"Reuters
Concern over Merck's Gardasil sales in China sink shares
Merck & Co (MRK.N) said on Tuesday that shipments of its Gardasil vaccine in the important China market declined in the second quarter, sparking investor...
.
30 Jul 2024",0.4588,24-07-30
Merck,"Reuters
Merck lifts full-year forecast as Keytruda sales soar
Merck now expects to earn $7.32 to $7.37 per share for 2022, up from its prior view of $7.25 to $7.35. It beat analysts' estimates for adjusted profit in the...
.
27 Oct 2022",0.6249,22-10-27
Merck,"Business Plus
One Merck is Not The Same As The Other
Merck Inc had revenue of $48.7bn (€43bn) in 2021, and Merck KGaA in the old country had to make do with €19.7bn. Relations between the transatlantic cousins...
.
12 Aug 2022",0.0,22-08-12
Merck,"Fierce Biotech
Merck nails phase 3 sotatercept win, making good on its $11.5B Acceleron buy
Sotatercept passed a phase 3 test as an add-on treatment for patients with pulmonary arterial hypertension (PAH), improving patients' six-minute walk distance...
.
10 Oct 2022",0.8591,22-10-10
Merck,"cherokeephoenix.org
US adds Merck pill as 2nd easy-to-use drug against COVID-19
U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of...
.
1 Jan 2022",-0.3818,22-01-01
Merck,"HRD America
Merck, Amex execs warn against corporate retreat from DEI
Merck, Amex execs warn against corporate retreat from DEI ... Former Merck CEO Ken Frazier and former American Express CEO Ken Chenault have warned companies...
.
16 Oct 2024",-0.0772,24-10-16
Merck,"Business Wire
Tanzania President, Merck Foundation Chairman and CEO With 15 First Ladies Inaugurate Their 11th Africa Asia Luminary 2024
SAMIA SULUHU HASSAN emphasized, “I am delighted to host this prestigious conference in Tanzania and inaugurate it alongside the First Ladies of Africa and Asia.
.
5 Dec 2024",0.5106,24-12-05
Merck,"Fierce Biotech
Merck's cardiovascular future takes shape as sotatercept overachieves, PCSK9 inhibitor passes phase 2
The Cardio med aimed at treating pulmonary arterial hypertension improved patients' six-minute walk distance by more than 40 meters after 24 weeks compared to...
.
6 Mar 2023",0.4215,23-03-06
Merck,"Irvine Times
Merck Curiosity Cube off on European tour
The Curiosity Cube is equipped with the latest technology and provides a learning environment that allows visitors of all ages to experience the fun and wonders...
.
5 Jun 2022",0.5106,22-06-05
Merck,"PR Newswire
Amphista Therapeutics Enters Strategic Collaboration with Merck for Discovery and Development of Targeted Protein Degradation Therapeutics
Merck and Amphista will work collaboratively to discover and develop small molecule protein degraders for an initial three targets in oncology and immunology...
.
4 May 2022",-0.7506,22-05-04
Merck,"MarketWatch
Merck, Moderna say mRNA vaccine and Keytruda lowers the risk of death in melanoma patients
Merck & Co. Inc. and Moderna Inc. said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with...
.
13 Dec 2022",-0.9509,22-12-13
Merck,"Fierce Biotech
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Merck, flush with Keytruda cash and eyeing the loss of exclusivity on its megablockbuster, has agreed to pay $4 billion upfront to co-develop and co-...
.
20 Oct 2023",0.1779,23-10-20
Merck,"Clinical Trials Arena
Merck partners with HiberCell for Phase Ib renal carcinoma trial
The Phase Ib trial will evaluate the combination therapy of Welireg and HC-7366 in patients with clear cell renal cell carcinoma.
.
6 Dec 2023",0.3818,23-12-06
Merck,"Fierce Pharma
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market
The drug is set to remain top dog in the PARP space. That's according to a new report out by analysts at GlobalData, which predicts $4 billion in global sales...
.
24 Apr 2024",0.2023,24-04-24
Merck,"TheStreet
Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck & Co.
Seagen (SGEN) shares powered higher Thursday following a report from the Wall Street Journal that it's in advanced takeover talks with drugmaker Merck & Co. (...
.
7 Jul 2022",0.4939,22-07-07
Merck,"Fierce Pharma
Merck consolidates New Jersey operations at 'reimagined' headquarters in Rahway
Merck consolidates New Jersey operations at 'reimagined' headquarters in Rahway ... Merck is back home again in Rahway, New Jersey, at the site that it...
.
21 Jun 2023",0.0,23-06-21
Merck,"FirstWord Pharma
Merck & Co. pulls back on some cancer drug development with Kelun
Merck & Co. pulls back on some cancer drug development with Kelun ... Sichuan Kelun Pharmaceutical disclosed in a regulatory filing that its partner Merck & Co.
.
23 Oct 2023",-0.8689,23-10-23
Merck,"Wilson Sonsini
Firm Advises on IP and Patent Matters for Merck’s $10.8 Billion Acquisition of Prometheus
Wilson Sonsini Goodrich & Rosati advised Prometheus on IP and patent matters related to the transaction.
.
17 Apr 2023",0.0516,23-04-17
Merck,"Merck KGaA
Pimicotinib Topline Results | Merck
Phase III MANEUVER trial of pimicotinib met its primary endpoint, demonstrating significant improvement in objective response rate in TGCT-patients.
.
12 Nov 2024",0.5859,24-11-12
Merck,"unfoundation.org
UN Foundation welcomes the Merck Foundation’s contribution to its new Outbreak Prevention and Preparedness Fund
The Merck Foundation has made a generous contribution to its recently launched Outbreak Prevention and Preparedness Fund, which is designed to reinforce...
.
15 Aug 2024",0.7579,24-08-15
Merck,"Barron's
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
All that could limit the pain from what could be a major revenue cliff in 2028. That is when patents expire on Merck's cancer medicine Keytruda, exposing the...
.
27 Mar 2024",-0.8402,24-03-27
Merck,"American Veterinary Medical Association
Veterinary profession heading in right direction with mental health
Merck Animal Health released findings from its most recent comprehensive veterinary wellbeing study on January 15 at the 2024 Veterinary Meeting & Expo...
.
22 Jan 2024",0.3134,24-01-22
Merck,"Reuters
Merck KGaA raises prospect of return to sales growth next year
Germany's diversified group Merck KGaA (MRCG.DE) has raised the prospect of returning to revenue growth next year, recovering from a slump in demand.
.
19 Oct 2023",0.7964,23-10-19
Merck,"Fierce Pharma
Merck still scouting for M&A deals, even after $10.8B takeover of Prometheus
Merck has adjusted its guidance for 2023 from $57.7 billion to $58.9 billion, growing and narrowing it to a window of $58.6 billion to $59.6 billion.
.
1 Aug 2023",0.1779,23-08-01
Merck,"Fierce Biotech
Merck KGaA, Mersana abandon ADC licensing pact before the New Year
The antibody-drug conjugate (ADC) biotech and Merck KGaA have severed ties for a licensing pact related to one of Mersana's tech platforms.
.
22 Dec 2023",-0.6597,23-12-22
Merck,"BioPharma Dive
Merck keeps deal focus with Keytruda patent cliff on horizon
Merck & Co. plans to continue seeking out multibillion-dollar biotechnology deals to supplement its own drug research as it prepares for its dominant cancer...
.
1 Feb 2024",0.0,24-02-01
Merck,"The Korea Herald
Merck to acquire Mecaro’s chemical biz for 110m euros
Merck to acquire Mecaro's chemical biz for 110m euros ... German electronics technology firm Merck announced Wednesday that it has signed a deal to acquire the...
.
17 Aug 2022",0.0,22-08-17
Merck,"Business Wire
Ventus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officer
Industry veteran brings more than twenty years of experience in clinical development and expertise in inflammation and immunology.
.
2 May 2022",0.0,22-05-02
Merck,"Merck KGaA
Sustainability in Healthcare R&D
We understand that R&D is at the front line of creation for Merck and the choices we make have massive implications on the entire product life cycle. Up to 80%...
.
16 Jun 2023",0.2732,23-06-16
Merck,"Investopedia
S&P 500 Gains and Losses Today: Merck Stock Plunges on Guidance Cut
Merck (MRK) shares tumbled 9.8%, posting the steepest decline of any S&P 500 stock Tuesday, after the pharmaceutical giant lowered its full-year earnings...
.
30 Jul 2024",-0.1779,24-07-30
Merck,"Business Wire
Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy
KEYNOTE-564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC.
.
27 Jan 2024",-0.3612,24-01-27
Merck,"Reuters
Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine
O) , opens new tab said on Wednesday it signed a deal with Merck & Co Inc (MRK.N) , opens new tab potentially worth up to $922.5 million for its experimental...
.
8 Mar 2023",0.4767,23-03-08
Merck,"Pharmaceutical Technology
Merck Pharmaceutical Manufacturing Facility Expansion, Molsheim, France
US-based pharmaceutical company Merck will increase its manufacturing capabilities for the Mobius® single-use portfolio with an investment of more than €130m ($...
.
23 Sept 2022",0.3182,
Merck,"Building
Three chasing £120m King’s Cross life sciences job
Work set to start on Merck building early next year. Three firms are chasing a £120m-plus deal to build an office and life sciences centre opposite King's...
.
5 Jul 2022",0.0,22-07-05
Merck,"Fierce Pharma
Merck KGaA names winner of storytelling competition to boost schistosomiasis awareness in Ethiopia
Merck KGaA has recently tacked on an additional awareness-raising component to its efforts to eliminate the parasitic disease also known as bilharzia.
.
2 Apr 2024",0.7579,24-04-02
Merck,"Merck.com
Macrocyclic peptides: the next wave of drug discovery
“Macrocyclic peptides allow us to cast a wider net on the protein interactions we want to drug, providing a vast and untapped opportunity to access a wider...
.
14 Sept 2023",0.6124,
Merck,"Financial Times
Merck buys Prometheus Biosciences for almost $11bn
Pharmaceutical and biotech deals are rebounding after a dip last year.
.
16 Apr 2023",0.0,23-04-16
Merck,"Forbes
FDA Approves Merck’s New Drug For A Rare Lung Disease
The Food and Drug Administration approved a new drug to treat this disease called sotatercept which was developed and being marketed by pharmaceutical giant...
.
26 Mar 2024",0.802,24-03-26
Merck,"Merck KGaA
Bioelectronics for treating and monitoring disease | Merck
' We are developing bioelectronic therapies that work by stimulating nerve activity. By recording nerve signals and then targeting the precise sub-region...
.
27 Jan 2022",0.4404,22-01-27
Merck,"Canadian Occupational Safety
Michelle Hernandez, Merck & Co.
The associate director of occupational toxicology at Merck & Co., Hernandez says that her favorite part of the job is ensuring that everyone across the...
.
18 Jan 2022",0.7845,22-01-18
Merck,"Investor's Business Daily
Dow Jones Powerhouse, Merck, Dives On Surprise FDA Rejection
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection ... Merck (MRK) stock tumbled below its 50-day moving average Thursday after the Food and Drug...
.
27 Jun 2024",-0.5859,24-06-27
Merck,"BioSpace
Merck Acquires Imago and its LSD1 Inhibitors in $1.3B Deal (Updated)
With a $1.36 billion buyout, Merck is bolstering its oncology program with the acquisition of Biotech Bay-based Imago Biosciences, a company focused on chronic...
.
21 Nov 2022",0.1531,22-11-21
Merck,"WSJ
Merck KGaA Expects Organic Sales, Earnings Growth This Year
Germany's Merck KGaA expects to gradually return to organic growth this year after reporting a slump in earnings during 2023, which it called a...
.
7 Mar 2024",0.6369,24-03-07
Merck,"Fierce Pharma
Merck KGaA pledges $550M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead
Merck KGaA and it's US subsidiary MilliporeSigma revealed their deal to purchase Exelead for $780 million is done.
.
24 Feb 2022",0.0,22-02-24
Merck,"PR Newswire
Ginkgo Bioworks Announces Collaboration with Merck to Improve Biologic Manufacturing
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration with Merck.
.
7 Aug 2023",0.4404,23-08-07
Merck,"WSJ
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
The drug, which will sell under the name Winrevair, treats a condition called pulmonary arterial hypertension that affects nearly 40,000 people in the U.S. In...
.
26 Mar 2024",0.0,24-03-26
Merck,"Merck.com
Our Q1 2023 earnings report
Our Q1 2023 earnings report ... Merck's (NYSE: MRK) Q1 2023 results reflect continued strong underlying performance across key growth drivers, particularly in...
.
27 Apr 2023",0.7096,23-04-27
Merck,"Fierce Pharma
ESMO: With survival win, Merck's Keytruda redeems itself in early triple-negative breast cancer
ESMO: With survival win, Merck's Keytruda redeems itself in early triple-negative breast cancer ... Keytruda was approved by the FDA in early-stage triple-...
.
15 Sept 2024",0.1531,
Merck,"Fierce Pharma
AstraZeneca, Merck withdraw Lynparza's late-line ovarian cancer nod amid PARP inhibitor death concerns
AstraZeneca and Merck in August asked to voluntarily withdraw Lynparza's accelerated approval in late-line ovarian cancer, and the FDA quickly sanctioned the...
.
23 Sept 2022",-0.8979,
Merck,"Wion
A Covid pill from Merck showed more promise in reducing the risk of hospitalisation
A study last year by Merck, which developed the pill with the help of Ridgeback Biotherapeutics, found that the drug reduced the risk of hospitalisation by...
.
20 Feb 2022",0.2716,22-02-20
Merck,"KoreaTimes
[INTERVIEW] Korea is key partner to our display business: Merck
Merck has been working on developing display materials and expanding its production facilities in Korea to further strengthen partnerships with Korean display...
.
9 Jun 2022",0.3182,22-06-09
Merck,"Table.Media
Multi-million transaction: Merck sells pigments business to GNMI
After years of speculation about a sale, Merck is parting with its pigments business. The German pharmaceutical and technology group announced on Thursday that...
.
25 Jul 2024",0.0,24-07-25
Merck,"Business Wire
(lenvatinib) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma
Merck and Eisai are studying the KEYTRUDA plus LENVIMA combination through the LEAP (LEnvatinib And Pembrolizumab) clinical program in various tumor types,...
.
8 Dec 2023",-0.1531,23-12-08
Merck,"Prevention
New Skin Cancer Vaccine Cuts Risk of Relapse by 44%, Study Shows—Here’s What to Know
The vaccine comes from Merck and Moderna and is showing promise at lowering the risk of developing melanoma when it's combined with an immunotherapy drug.
.
22 Apr 2023",-0.8591,23-04-22
Merck,"FOX 29 Philadelphia
Merck, Moderna share positive progress of potential skin cancer vaccine
Merck, Moderna share positive progress of potential skin cancer vaccine ... Moderna's stock soared Tuesday after the COVID-19 vaccine maker detailed progress in...
.
13 Dec 2022",0.8481,22-12-13
Merck,"Merck.com
Here for Good: The human element inspiring our cancer research
Dr. Gregory Lubiniecki, vice president, oncology clinical research, is a senior leader who oversees cancer research. He's also a practicing clinician.
.
27 May 2022",-0.6249,22-05-27
Merck,"Reuters
Merck KGaA expects 2023 profit to slip as COVID demand wanes
Germany's Merck KGaA on Thursday predicted 2023 earnings would slip due to a decline at its electronic chemicals unit and a drop in COVID-related demand for...
.
2 Mar 2023",-0.0516,23-03-02
Merck,"Security Intelligence
How will the Merck settlement affect the insurance industry?
In June 2017, the NotPetya incident hit some 40,000 Merck computers, destroying data and forcing a months-long recovery process. The attack affected thousands...
.
28 Mar 2024",-0.4215,24-03-28
Merck,"BioPharma Dive
Merck to buy eye drug developer for $1.3B
Restorest, an antibody Merck will acquire via its proposed acquisition of EyeBio, is designed to treat vision loss due to retinal vascular leakage.
.
29 May 2024",0.34,24-05-29
Merck,"Business Wire
Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
Merck, through a subsidiary, has agreed to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated...
.
9 Aug 2024",0.5267,24-08-09
Merck,"WSJ
Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More
A deal would help Merck broaden its lineup of cancer drugs, currently led by Keytruda ... Merck & Co. is in advanced talks to acquire Seagen Inc. and...
.
7 Jul 2022",0.144,22-07-07
Merck,"Endpoints News
The bill on Merck’s C-suite shakeup includes about $30M for dual CEO pay packages
While Merck's lauded CEO Ken Frazier headed out to retirement in the middle of 2021, he nevertheless bagged a compensation package worth $15.2 million. That isn...
.
5 Apr 2022",-0.0258,22-04-05
Merck,"STAT
Merck may have a competition for ever-scarce BCG
Merck may have a competition for ever-scarce BCG · The need-to-know this morning · A deep dive into Amgen's experimental obesity drug, MariTide · Studying stem...
.
6 May 2024",0.0,24-05-06
Merck,"Medical Marketing and Media
J&J, Merck and Novartis announce slew of acquisitions as JPM 2024 kicks off
J&J, Merck and Novartis announce slew of acquisitions as JPM 2024 kicks off. J&J is picking up Ambrx Biopharma, Merck is acquiring Harpoon Therapeutics and...
.
8 Jan 2024",0.0,24-01-08
Merck,"Fierce Pharma
ASCO: Merck gives final look at Keytruda study in first-line cervical cancer. Will FDA change its mind?
Merck will present the final overall survival analysis to the FDA, but the chance of expanding a Keytruda approval in cervical cancer may yet be low.
.
25 May 2023",-0.7003,23-05-25
Merck,"Fierce Pharma
Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production⁠—again
Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production⁠—again ... After running into HPV vaccine supply shortfalls...
.
4 Apr 2022",0.0,22-04-04
Merck,"Merck KGaA
Annual General Meeting 2023 | Merck
Annual General Meeting Approves all Agenda Items. Merck held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved...
.
28 Apr 2023",0.4019,23-04-28
Merck,"ASCO Daily News
An Update on the Supply and Production of Bacille Calmette-Guérin
Key Points: Despite Merck producing between 600,000 to 870,000 vials of TICE Bacille Calmette-Guérin (BCG) annually, global demand for the product continues...
.
18 Jan 2023",-0.128,23-01-18
Merck,"Fierce Biotech
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Now, Kelun has revealed further changes to the scope of the agreement. Merck has taken up its option on SKB571, a bispecific ADC that Kelun sees primarily as a...
.
20 Aug 2024",0.6908,24-08-20
Merck,"Fierce Pharma Biopharma News & Insights
Merck’s Lynparza-Keytruda combo sputters in 2nd lung cancer trial. Will an ADC pairing work instead?
Merck's Lynparza-Keytruda combo sputters in 2nd lung cancer trial. Will an ADC pairing work instead? ... Merck & Co. ... Merck's attempt to use Lynparza to boost...
.
21 Mar 2024",-0.8796,24-03-21
Merck,"Business Wire
Merck Foundation CEO, Senator Dr. Rasha Kelej Awarded on International Women’s Day for Her Efforts Towards Women Empowerment and Supporting Girl Education
Business Executive Group awarded Senator Dr. Rasha Kelej, CEO of Merck Foundation, at their Global She Achievers Awards 2024, for her efforts to empower women...
.
15 Mar 2024",0.8834,24-03-15
Merck,"BioPharma Dive
Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy
Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy. The company is paying China-based biotech LaNova Medicines $588 million for the...
.
14 Nov 2024",-0.953,24-11-14
Merck,"Hits Daily Double
MERCK'S IN SYNC WITH TIMBERLAKE
Timberlake is represented by managers Rick Yorn and Josh Dembling at LBI Entertainment and Johnny Wright at Wright Entertainment Group and lawyers David Lande...
.
27 May 2022",0.6808,22-05-27
Merck,"BioSpace
Merck’s Gerberding to Lead Foundation for the National Institutes of Health
Dr. Julie L. Gerberding, Merck's chief patient officer and executive vice president of population health and sustainability, is retiring from the company after...
.
2 Mar 2022",0.0,22-03-02
Merck,"3BL Media
Fighting COVID-19: 'An Intersection Between My Military and Civilian Careers'
Col. Craig Maceri is using the skills he learned at Merck to help run a vaccination site for the National Guard.
.
6 Apr 2022",0.0516,22-04-06
Merck,"Free Malaysia Today
Merck’s shares drop after US pauses trials for new drug
Merck said today the US Food and Drug Administration (FDA) had paused the initiation of new patients on its multiple sclerosis evobrutinib drug.
.
12 Apr 2023",0.5267,23-04-12
Merck,"Fierce Biotech
Merck reveals HIV combo trial is back in the running after FDA partial hold lifted
Merck executives said on a first-quarter earnings call that the company is restarting a phase 2 trial testing a combination of islatravir and Gilead's...
.
27 Apr 2023",0.0,23-04-27
Merck,"Investor's Business Daily
The Centerpiece Of Merck's $11.5 Billion Acceleron Buy Just Scored A 'Must-Win'
He notes the first sotatercept patent will expire in 2026. Additional patents and protections could prevent generics from hitting the market until the mid-2030s...
.
10 Oct 2022",0.0258,22-10-10
Merck,"Investor's Business Daily
Merck Stock Pops After Snagging Its Latest Approval; The First In A Possible $10 Billion 'Renaissance'
Merck Stock Pops After Snagging Its Latest Approval; The First In A Possible $10 Billion 'Renaissance' ... Merck (MRK) stock popped Wednesday, pacing the Dow...
.
27 Mar 2024",0.7351,24-03-27
Merck,"Merck KGaA
Positive CHMP Opinion by EMA for Arpraziquantel to Treat Schistosomiasis in Preschool-Aged Children
EMA adopted a positive scientific opinion for arpraziquantel for the treatment of schistosomiasis in children aged 3 months to 6 years.
.
15 Dec 2023",0.872,23-12-15
Merck,"BioPharma Dive
Merck puts KRAS cancer drug competitor to the test
Merck puts KRAS cancer drug competitor to the test. The company has started a large lung cancer study that will compare its experimental KRAS inhibitor and...
.
4 Apr 2024",-0.9382,24-04-04
Merck,"BioSpace
Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
Merck's muscle relaxant reversal injection is now facing potential generic competition from Hikma Pharmaceuticals, which is seeking the FDA's approval for a...
.
27 Feb 2024",0.4404,24-02-27
Merck,"Endpoints News
Merck's $500M bet on Singapore leads to new manufacturing sites making Keytruda, Gardasil and future inhalers
Merck has also set up R&D, IT and other business units there, and part of the $500 million investment will go toward modernizing the IT infrastructure. All...
.
6 Oct 2022",0.0,22-10-06
Merck,"Investor's Business Daily
Merck's Weakness Could Mean Profits With This Bearish Option Trade
Merck stock is down 11% in the last three months and could potentially be headed for new lows. If Merck continues to move lower a bear put spread would be the...
.
14 Aug 2024",-0.4404,24-08-14
Merck,"Fierce Pharma
Big Pharma cyber flub: AstraZeneca blames 'user error' for patient data exposure
While the shadow of Merck & Co.'s NotPetya incident continues to hang over the pharma cybersecurity landscape, direct attacks are far from the only threat...
.
4 Nov 2022",-0.8074,22-11-04
Merck,"Business Wire
Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid (RGX-202)
Inspirna will receive an upfront payment of $45 million. Upon the achievement of certain development and sales milestones for ompenaclid, Inspirna is eligible...
.
4 Jan 2024",0.2732,24-01-04
Merck,"Fierce Pharma
Merck KGaA starts educating HCPs on cancer's wall of resistance, building awareness ahead of phase 3 data
With an interim analysis of a phase 3 clinical trial of xevinapant in LA SCCHN planned (PDF) for the fourth quarter, Merck KGaA has begun to ramp up educational...
.
26 Jun 2023",0.0,23-06-26
Merck,"MarketWatch
Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill
The HELP Committee's report said that Merck, Johnson & Johnson and Bristol Myers Squibb not only set “exorbitant prices” for new drugs in the U.S., but also...
.
7 Feb 2024",0.2997,24-02-07
Merck,"PMLiVE
Merck’s efinopegdutide shows promise in nonalcoholic fatty liver disease
Merck's efinopegdutide shows promise in nonalcoholic fatty liver disease ... Merck & Co – known as MSD outside the US and Canada – has said its investigational...
.
14 Jun 2023",0.5574,23-06-14
Merck,"Fierce Pharma
AstraZeneca, MSD tap sports to spark prostate cancer conversations via 'Never Miss' campaign
AstraZeneca and Merck & Co. are teaming up to launch a new, global prostate cancer awareness campaign called “Never Miss.""
.
14 Dec 2022",-0.8154,22-12-14
Merck,"PR Newswire
Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
The first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability.
.
5 Dec 2023",0.3182,23-12-05
Merck,"IDA Ireland
Merck Invests more than €440 Million in Ireland
Speaking from Davos today, IDA Ireland CEO Martin Shanahan said: “This significant investment announced today by Merck – the largest the global Life Sciences...
.
23 May 2022",0.2023,22-05-23
Merck,"Fierce Pharma
Merck's Keytruda dealt another blow in prostate cancer but readies new challenge to AZ's Imfinzi
While Keytruda suffered a defeat in prostate cancer, the popular PD-1 inhibitor registered a win to potentially challenge AstraZeneca's Imfinzi in a rare cancer...
.
25 Jan 2023",-0.8294,23-01-25
Merck,"Fierce Biotech
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3 ... An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic...
.
25 Sept 2024",-0.9349,
Merck,"FirstWord Pharma
Merck KGaA pins mid-term targets on evobrutinib “blockbuster” status
We are first in class,"" CEO Belen Garijo remarked. ... Merck is hoping that evobrutinib and another drug in its pipeline – the IAP antagonist xevinapant for head...
.
19 Oct 2023",-0.0258,23-10-19
Merck,"Reuters
Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
A Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a US appeals court said Thursday.
.
29 Sept 2022",0.5719,
Merck,"Fierce Pharma
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts ... Eli Lilly and Merck & Co. have identified...
.
3 Jan 2023",0.0,23-01-03
Merck,"Business Wire
Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.
Merck has entered into an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from...
.
14 Nov 2024",0.5106,24-11-14
Merck,"The Conversation
Australia approves two new medicines in the fight against COVID. How can you get them and are they effective against Omicron?
These are Lagevrio, made by American pharmaceutical company Merck Sharpe & Dohme, and Paxlovid, by Pfizer.
.
21 Jan 2022",0.4939,22-01-21
Merck,"The Healthcare Technology Report.
Kelun Pharma of China Sells Unknown Cancer Drug To Merck For $1.4B
Kelun Pharma of China Sells Unknown Cancer Drug To Merck For $1.4B ... U.S. pharma group Merck's already impressive immuno-oncology pipeline has been beefed up...
.
30 May 2022",-0.7579,22-05-30
Merck,"Fierce Biotech
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy ... Merck & Co. is focusing in on eye diseases with the $3 billion acquisition of...
.
29 May 2024",0.8625,24-05-29
Merck,"Legacy.com
SERENA HATCH Obituary (1928 - 2023) - Rupert, VT - Boston Globe
HATCH, Serena Famous for her party exits, Serena M. Hatch (""Bambi"") left us peacefully on April 12, 2023 at the age of 95.
.
15 Apr 2023",0.7269,23-04-15
Merck,"pharmaphorum
Merck bets on Inspirna’s colorectal cancer drug ompenaclid
Merck bets on Inspirna's colorectal cancer drug ompenaclid ... Germany's Merck KGaA is paying $45 million upfront for rights to a potentially first-in-class drug...
.
4 Jan 2024",-0.8689,24-01-04
Merck,"Merck.com
Building on our understanding of gynecologic cancers
As of 2022, these gynecologic cancers are some of the most commonly occurring cancer types for women worldwide. Even with advances in prevention and treatment,...
.
16 Dec 2024",-0.6872,24-12-16
Merck,"Medtruth
Merck Ordered To Release Gardasil Adverse Events Database
Merck was ordered by the federal judge overseeing the consolidated Gardasil lawsuits in multidistrict litigation (MDL) to produce its entire database of...
.
21 Apr 2023",-0.5994,23-04-21
Merck,"Fierce Biotech
New SEC charges allege insider trading related to Merck's acquisition of Pandion was a family affair
New SEC charges allege insider trading related to Merck's acquisition of Pandion was a family affair ... The feds are continuing to unravel a scheme to reap...
.
11 Nov 2022",-0.4939,22-11-11
Merck,"Fierce Pharma Biopharma News & Insights
Merck's attempt to palm off some talc litigation liabilities to Bayer dismissed by Delaware judge
A Delaware judge dismissed Merck's suit against Bayer in which it tried to hand off much of the blame due to Bayer's 2014 purchase of Merck's consumer care...
.
4 Apr 2023",-0.2023,23-04-04
Merck,"Business Wire
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis.
.
25 Nov 2024",0.0,24-11-25
Merck,"Fierce Biotech
Altoida snags Merck KGaA-led $14M funding round for Alzheimer's diagnostic app
The platform uses artificial intelligence and augmented reality to evaluate brain health, with an eye to helping predict and diagnose Alzheimer's and other...
.
30 Mar 2022",0.6486,22-03-30
Merck,"Reuters
Merck's RSV antibody for infants effective in reducing some types of infections in study
Merck (MRK.N) said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory...
.
18 Oct 2024",0.4767,24-10-18
Merck,"CTech
Larisa Amir appointed Managing Director of Merck R&D Center in Israel
Amir will be responsible for managing the center and will also focus on in-house innovation and external scouting for technologies and biotechnology...
.
13 Jun 2022",0.5994,22-06-13
Merck,"Fierce Pharma
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
A trial win sets Keytruda up for an expanded indication to officially challenge Bristol Myers Squibb's Opdivo in front-line stomach cancer.
.
16 Feb 2023",-0.7351,23-02-16
Merck,"Precision Medicine Online
Merck Talks Up Pipeline Diversification as Keytruda Sales Still Comprise 45 Percent of Q3 Revenues
Merck talks up pipeline diversification as Keytruda sales still comprise 45 percent of Q3 revenues. Oct 31, 2024 | Caroline Hopkins Legaspi
.
31 Oct 2024",0.0,24-10-31
Merck,"Business Wire
CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention
Merck Global Health Innovation Fund and Amgen Ventures lead round, which closed on the heels of a new national report calling for more equity in cancer...
.
3 Mar 2022",0.0258,22-03-03
Merck,"PharmaVoice
Merck and Moderna’s cancer vaccine snags a clinical win in a field decades old
Merck and Moderna's cancer vaccine snags a clinical win in a field decades old. Cancer vaccines are taking off in the clinic, and a partnership between Merck...
.
3 Jun 2024",-0.765,24-06-03
Merck,"ISRAEL21c
Biolojic Design signs Merck deal potentially worth $373M
Biolojic Design recently announced it has signed a deal with German science and technology giant Merck, potentially worth as much as 346 million euros.
.
20 Jun 2024",0.4215,24-06-20
Merck,"Medical Dialogues
US FDA directs risk of suicide disclosure on Merck antibaldness pill Propecia
New Delhi: The U.S. health regulators, the USFDA rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the market,...
.
12 Jun 2022",-0.7964,22-06-12
Merck,"Reuters
Merck COVID treatment priced at 1,500 yuan per bottle in China's Tianjin
Merck COVID treatment priced at 1,500 yuan per bottle in China's Tianjin ... BEIJING, Jan 10 (Reuters) - Merck & Co's (MRK.N) , opens...
.
10 Jan 2023",0.0,23-01-10
Merck,"STAT
Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster
Merck said Thursday it will license a new cancer drug from LaNova Medicines, a Shanghai-based firm, for $588 million upfront and as much as $2.7 billion in...
.
14 Nov 2024",-0.7096,24-11-14
Merck,"Merck KGaA
Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA
Merck, today announced the expansion of its facility in Lenexa, Kansas, USA adding 9,100 sq m2 of lab space and production capability to manufacture cell...
.
12 Jul 2023",0.3182,23-07-12
Merck,"Fierce Pharma
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Merck and Seagen/Astellas are running two trials combining the PD-1 inhibitor with Padcev in muscle-invasive bladder cancer.
.
5 Oct 2023",-0.7579,23-10-05
Merck,"Pharmaceutical Technology
Merck reports rise in group net sales in fiscal 2022
Merck reports rise in group net sales in fiscal 2022. The company reported an organic sales increase of 8.2% to €10.38bn in its Life Science business during the...
.
2 Mar 2023",0.3182,23-03-02
Merck,"CIDRAP
Merck announces promising data for adult-targeted pneumococcal vaccine candidate
An investigational, 21-valent (21-strain) pneumococcal conjugate vaccine produces an immune response for all 21 serotypes covered and is protective against the...
.
20 Mar 2024",0.5994,24-03-20
Merck,"Pharmaceutical Technology
Merck & Co bolsters neurogenerative portfolio with Caraway acquisition
Merck & Co bolsters neurogenerative portfolio with Caraway acquisition. Merck & Co (MSD) will acquire all outstanding shares of Caraway, which has a preclinical...
.
21 Nov 2023",0.7351,23-11-21
Merck,"Bloomberg.com
Keytruda Profits Show Why Merck Is Suing the US
filed suit against the US, arguing that the IRA violates the Constitution and is “tantamount to extortion.” The lawsuit calls the price negotiations a “sham”...
.
7 Jun 2023",-0.7506,23-06-07
Merck,"Merck KGaA
Merck's Shizuoka Investments Exceed €120M with New Advanced Materials Center
Merck, a leading science and technology company, today announced that it will invest over €70 million to construct a new Advanced Materials Development Center (...
.
19 Dec 2024",0.4588,24-12-19
Merck,"WSJ
Merck KGaA Earnings Growth Beats Expectations
Net sales in the quarter rose 1.8% to €5.27 billion, slightly missing analysts' expectations of €5.33 billion. Merck now expects 2024 net sales in the lower...
.
14 Nov 2024",0.1761,24-11-14
Merck,"Fierce Pharma
Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing
Merck's Capvaxive passed the next test in its bid to take on Pfizer and its dominant Prevnar franchise.
.
28 Jun 2024",0.1027,24-06-28
Merck,"Business Wire
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
Zilovertamab vedotin in combination with R-CHP achieved a 100% (n=15) complete response (CR) rate in patients treated with zilovertamab vedotin at 1.75 mg/kg.
.
8 Dec 2024",0.0,24-12-08
Merck,"PharmaVoice
How to build a cancer pipeline: Big Pharma oncology heads on driving science forward
Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug...
.
6 Jun 2022",-0.7184,22-06-06
Merck,"Forbes
After A 30% Fall In A Year, Is Pfizer Stock A Better Pick Over Merck?
we believe Pfizer stock (NYSE: PFE) is a better pick than its peer — Merck stock (NYSE: MRK). MRK trades at a higher valuation multiple of 5.6x revenues vs. 2.7...
.
2 Apr 2024",0.7003,24-04-02
Merck,"Business Wire
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC
Merck and Moderna have initiated Phase 3 randomized clinical trials evaluating mRNA-4157 (V940) in combination with KEYTRUDA as an adjuvant treatment in...
.
28 Oct 2024",-0.5106,24-10-28
Merck,"BioSpace
Merck Joins Obesity Pill Race With Up to $2B Hansoh Deal
Merck announced on Wednesday that it has inked a global licensing partnership with Chinese biotech Hansoh Pharma to advance a GLP-1 receptor agonist pill,...
.
18 Dec 2024",0.0,24-12-18
Merck,"citybiz
Merck Animal Health to Acquire Vence
Merck Animal Health will acquire Vence from its founders and shareholders. Vence is an innovator in virtual fencing for rotational grazing and livestock...
.
22 Sept 2022",0.0,
Merck,"Variety
Merck Mercuriadis to Exit as Hipgnosis Song Management Chairman Ahead of Blackstone Acquisition
Merck Mercuriadis, chairman of the music rights company that at one point held the rights to catalogs by Neil Young and the Red Hot Chili Peppers, is exiting...
.
2 Jul 2024",0.0,24-07-02
Merck,"PR Newswire
The Children's Inn Announces $14 Million Grant from Merck Foundation
The Inn is proud to announce that the Merck Foundation has awarded a $14 million grant to support its renovation and expansion.
.
12 Oct 2023",0.91,23-10-12
Merck,"Forbes
Merck Stock Looks Better Priced Compared To Its Sector Peer
We see that Eli Lilly has demonstrated better revenue growth over recent years and has a better debt position. On the other hand, Merck has seen better revenue...
.
28 Feb 2023",0.9313,23-02-28
Merck,"Newstrail
Peptide Synthesis Market SWOT Analysis by Key Players- AnaSpec, Biotage, Merck
HTF Market Intelligence published a new research document of 150+pages on Peptide Synthesis Market Insights, to 2030"" with self-explained Tables and charts...
.
25 Nov 2024",0.4767,24-11-25
Merck,"Investopedia
Merck Stock Hits Record High as FDA Approves Its Cardiovascular Disease Drug
Shares of Merck were up 3.9% to $130.46 as of 11:50 am ET Wednesday after hitting a record-high $133.10 earlier in the session. They are up almost 20% so far...
.
27 Mar 2024",0.5994,24-03-27
Merck,"BioSpace
Merck Gets FDA Fast Track for Efinopegdutide, Previews NASH Data Versus Novo’s Semaglutide
Merck announced that its GLP-1/glucagon receptor co-agonist efinopegdutide had won the FDA's Fast Track designation for treating non-alcoholic steatohepatitis.
.
14 Jun 2023",0.5719,23-06-14
Merck,"Merck.com
Podcast: How AI can improve insight into disease biology
Podcast: How AI can improve insight into disease biology ... We see the potential of data science, artificial intelligence (AI) and machine learning (ML) to help...
.
18 Dec 2024",0.836,24-12-18
Merck,"Merck KGaA
How ChatGPT & Co. Will Change Our Work: Four Hypotheses About Working with (Generative) Artificial Intelligence
Generative Artificial Intelligence tools have been around for a while, but it was the release of ChatGPT that enabled this technology to be used by the...
.
31 Jul 2023",0.4767,23-07-31
Merck,"Pharmaceutical Technology
Merck agrees to acquire Imago for $1.35bn
Merck agrees to acquire Imago for $1.35bn. The acquisition is anticipated to conclude in the first quarter of next year. ... The Imago takeover will extend...
.
22 Nov 2022",0.3818,22-11-22
Merck,"FirstWord Pharma
Biogen may follow Merck & Co.'s lead in US Medicare drug pricing suit: report
Biogen CEO Chris Viehbacher said that following Merck & Co.'s lawsuit this week challenging the Inflation Reduction Act (IRA) –...
.
7 Jun 2023",-0.0772,23-06-07
Merck,"Reuters
Merck's HIV treatment meets main goal in two late-stage studies
Merck's (MRK.N) experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in adults receiving another...
.
19 Dec 2024",0.0,24-12-19
Merck,"Fierce Biotech
C4 brings the Mercks to the yard, with Merck KGaA paying $16M to join protein degrader hunt
C4 brings the Mercks to the yard, with Merck KGaA paying $16M to join protein degrader hunt ... Apparently, C4 Therapeutics' protein degradation tech brings all...
.
4 Mar 2024",-0.7184,24-03-04
Merck,"Citywire
Hipgnosis: Merck ‘clearly overpaid’ as SONG suffers 33% writedown
Shares in Hipgnosis Songs (SONG) slid to a new all-time low today after Shot Tower Capital, the Baltimore-based valuer appointed after the fund's new board...
.
4 Mar 2024",-0.4588,24-03-04
Merck,"Merck.com
Supermodel Veronica Webb raises awareness of lung cancer screening
Supermodel Veronica Webb raises awareness of lung cancer screening ... Supermodel, mother, fashion icon and blogger Veronica Webb knew that because of her former...
.
17 May 2023",-0.8689,23-05-17
Merck,"Pharmaceutical Technology
Merck KGaA to advance mRNA vaccine platform with Afrigen
Merck and Afrigen Biologics have signed an MoU for mRNA platform technology to enhance regional manufacturing capacity.
.
4 Jul 2024",0.0,24-07-04
Merck,"University of Miami
Ph.D. Students Receive Research Internships at Eli Lilly, Merck
The prestigious Eli Lilly and Merck research labs will have a common element for 2024—interns from Ph.D. programs at the University of Miami and Miller School...
.
25 Mar 2024",0.0,24-03-25
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease
Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients.
.
17 Oct 2023",0.7269,23-10-17
Merck,"Business Wire
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
The first patient has been dosed in the Phase III MyClad trial (NCT06463587) evaluating the efficacy and safety of oral cladribine for the treatment of...
.
29 Aug 2024",0.4215,24-08-29
Merck,"TheStreet
Big movers: NVIDIA slumps; P&G, Merck down, PayPal up
Stocks are down despite higher consumer confidence.
.
30 Jul 2024",-0.4023,24-07-30
Merck,"GlobeNewswire
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany ... The partnership will leverage Biolojic Design's AI...
.
3 Jun 2024",0.0,24-06-03
Merck,"Forbes
Should You Buy Merck Stock At $120?
We estimate Merck's Valuation to be $112 per share, slightly below its current market price of $118.
.
9 May 2023",0.296,23-05-09
Merck,"Times of India
Healthcare firm Merck to expand hiring in Bengaluru
The healthcare and lifesciences company plans to continue hiring over the next two years. The centre was launched in 2020, and has around 300 employees.
.
3 Sept 2022",0.4215,
Merck,"Merck.com
Merck publishes Impact Report 2022/2023
We set a goal to enable 100 million more people to access our innovative portfolio globally, through access strategies, solutions and partnerships, by 2025.
.
9 Aug 2023",0.5574,23-08-09
Merck,"The Medicine Maker
MSD Files Lawsuit Against US Government
Merck Sharp & Dohme describes drug price negotiation program set by the US government as part of the Inflation Reduction Act as “sham” and “tantamount to...
.
8 Jun 2023",-0.2263,23-06-08
Merck,"Beef Magazine
Merck Animal Health launches herd health tool, feedlot diseases app
The Merck Feedlot Diseases Atlas app provides photographs of diseases impacting feedlot cattle – from the most common ailments to the rarest of conditions. A...
.
19 Apr 2022",0.0,22-04-19
Merck,"Medical Marketing and Media
Merck hires new VP, discovery oncology
Merck hires new VP, discovery oncology. Weinstock joins from Dana Farber Cancer Institute. ... Merck has hired David Weinstock as VP, discovery oncology, where he...
.
20 Jan 2022",-0.6597,22-01-20
Merck,"Reuters
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Moderna (MRNA.O) and partner Merck & Co (MRK.N) said on Monday their cancer vaccine in combination with blockbuster cancer therapy Keytruda improved survival.
.
3 Jun 2024",-0.6369,24-06-03
Merck,"Reuters
US FDA approves Merck's pneumococcal vaccine for adults
Merck currently has two approved pneumococcal shots — Vaxneuvance that is given to six weeks or older individuals and Pneumovax 23 for adults 50 years and older...
.
18 Jun 2024",0.6705,24-06-18
Merck,"insider.co.uk
Merck makes €35 million investment in Scottish sites
The company will expand testing capacity in its current buildings with biosafety testing, analytical development and viral clearance suites.
.
31 May 2023",0.3182,23-05-31
Merck,"Security Magazine
Merck wins $1.4B lawsuit over NotPetya attack
The legal dispute covered the losses Merck claimed to have suffered due to the attack, including $135 million in lost revenue, $175 in remediation costs to...
.
26 Jan 2022",-0.886,22-01-26
Merck,"African Business
Merck Foundation Chief Executive Officer (CEO) announce Nigerian winners of their Media Awards to break Infertility Stigma, Support Girl Education and Diabetes- Hypertension awareness
The winners were announced and acknowledged by Senator, Dr. Rasha Kelej, CEO of Merck Foundation and President of “More Than a Mother” campaign.
.
1 Jul 2024",0.8979,24-07-01
Merck,"Reuters
Merck's drug boosts exercise capacity in pulmonary hypertension patients
Merck & Co Inc said on Monday its experimental therapy helped increase exercise capacity in patients with a deadly disease that causes high pressure in...
.
6 Mar 2023",0.34,23-03-06
Merck,"Merck KGaA
ASCO GU 2024 - Avelumab Updates | Merck
Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) as a Standard of Care. Merck today announced new real-world data that continue to reinforce the...
.
22 Jan 2024",0.4939,24-01-22
Merck,"Merck KGaA
New CDMO Facility | Merck
Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies. Merck announced that its Life Science business sector has doubled its...
.
23 Jun 2022",-0.802,22-06-23
Merck,"Nature
Thinking differently: how AstraZeneca finds value in the competitive oncology sector through industry-leading dealmaking
Partnering with like-minded, focused innovators provides AstraZeneca with access to cutting-edge science and opportunities in oncology.
.
29 Apr 2022",0.8074,22-04-29
Merck,"Business Wire
Pearl Bio Inks Collaboration with Merck to Discover Novel Engineered Biologics
Pearl Bio (a synthetic biology company backed by Khosla Ventures) today announced that it has entered a license, collaboration and option agreement with Merck.
.
12 Mar 2024",0.6808,24-03-12
Merck,"Merck.com
How Merck scientists are driving next-generation cancer research
Driving research toward treating certain cancers earlier. With the ultimate goal of providing patients with the greatest chance for survival, our researchers...
.
3 Apr 2024",0.4404,24-04-03
Merck,"Business Wire
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616 · Contacts · Merck Data at ACC. · Merck Announces Positive Data from Phase 3...
.
25 Aug 2023",0.4588,23-08-25
Merck,"Pharmaceutical Technology
Merck agrees to build bioprocessing production plant in South Korea
Merck agrees to build bioprocessing production plant in South Korea. Merck also intends to forge partnerships in the field of bio-research with major Korean...
.
3 May 2023",0.3818,23-05-03
Merck,"Fierce Pharma
Merck's COVID pill Lagevrio comes up short in household COVID exposure study
Merck and Ridgeback's COVID-19 oral antiviral Lagevrio rang up sales of $5.7 billion last year, despite mounting evidence of its limited effectiveness.
.
21 Feb 2023",-0.2263,23-02-21
Merck,"Merck.com
Harnessing innovative technology in drug discovery
Merck Research Laboratories (MRL) scientists evaluate hundreds to thousands to up to billions of compounds to find a starting point for a new drug candidate. It...
.
16 Nov 2023",0.4404,23-11-16
Merck,"Scottish Construction Now
Merck to create 500 jobs with £30m investment into Glasgow and Stirling operations
“The biosafety testing services at our sites in Glasgow and Stirling have been experiencing strong, double-digit growth for several years. This investment is a...
.
31 May 2023",0.7906,23-05-31
Merck,"Reuters
Mexico grants emergency use approval for Merck's COVID-19 pill
Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's COVID-19 pill Molnupiravir, President Andres Manuel Lopez Obrador...
.
8 Jan 2022",0.2023,22-01-08
Merck,"Atlantic Council
A conversation with Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany
This conversation explored the convergence of biotechnology, electronics, and data and the importance of digital transformation for resilient global supply...
.
24 Mar 2023",0.3612,23-03-24
Merck,"Reuters
Merck shingles vaccine appeal will test controversial mass torts case management tool
Merck shingles vaccine appeal will test controversial mass torts case management tool ... Oct 18 (Reuters) - The federal trial judge overseeing a four-year-old...
.
18 Oct 2023",-0.3818,23-10-18
Merck,"Merck KGaA
Arpraziquantel | Merck
Arpraziquantel is a novel dispersible or orodispersible tablet (150mg). It can be taken with or without water, is palatable for preschool-aged children, and...
.
2 Dec 2022",0.0299,22-12-02
Merck,"BioSpace
GSK’s Jemperli Beats Merck’s Keytruda for Frontline Endometrial Cancer Approval
In the subset of patients who were MMR-proficient, Jemperli reduced the risk of disease progression or death by 24% in 24 months, while Keytruda achieved a 46%...
.
1 Aug 2023",-0.8074,23-08-01
Merck,"Business Wire
Universal Display Corporation Acquires Merck KGaA, Darmstadt, Germany’s Phosphorescent OLED Emitter Intellectual Property Assets and Enters into Multi-Year Collaboration Agreement
UDC has acquired the Phosphorescent OLED Emitter Intellectual Property (IP) assets of Merck KGaA, Darmstadt, Germany, a leading science and technology company.
.
3 May 2023",0.9042,23-05-03
Merck,"Business Wire
Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced two new strategic drug discovery collaborations.
.
20 Sept 2023",0.3182,
Merck,"Diabetes.co.uk
Merck’s Januvia and Janumet contaminated with cancer-causing chemical
Share article ... Cancer-causing chemicals called nitrosamines have been detected in the diabetes drugs Januvia and Janumet. The pharmaceutical company Merck & Co...
.
9 Feb 2023",0.296,23-02-09
Merck,"Fierce Pharma
Merck's Keytruda posts rare flop in head and neck cancer trial
Merck's PD-1 inhibitor failed to meet its primary endpoint in a late-stage trial for unresected locally advanced head and neck squamous cell carcinoma (HNSCC).
.
20 Jul 2022",-0.8555,22-07-20
Merck,"Reuters
Insight: Merck's COVID pill is last choice for U.S. patients, global use varies
Merck & Co's (MRK.N) new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four available options for at-...
.
31 Jan 2022",-0.0516,22-01-31
Merck,"Merck KGaA
USA 1890 - Country of the future | Merck
In 1890, he and a partner establish a company »domiciled in New York under the name of Merck & Co.«, the business is publicly established in 1891 as a »new...
.
7 Sept 2022",0.0,
Merck,"Freshfields
Freshfields advises Merck on the sale of its Surface Solutions Business to GNMI
Freshfields is advising Merck KGaA, the German multinational science and technology company (Merck), on the agreement to sell its global Surface Solutions...
.
25 Jul 2024",0.5994,24-07-25
Merck,"PMLiVE
Merck to acquire Caraway Therapeutics in a deal worth up to $610m
Merck to acquire Caraway Therapeutics in a deal worth up to $610m ... Merck & Co – known as MSD outside the US and Canada – has entered into a definitive...
.
22 Nov 2023",0.4215,23-11-22
Merck,"Asia Financial
Germany’s Merck to Build $82m China Semiconductor Plant
New facility near coastal city Shanghai will represent the company's biggest electronics investment in China to date. ... Merck's $82 million semiconductor...
.
31 May 2022",0.0,22-05-31
Merck,"WSJ
Merck Lifts Outlook After Quarterly Sales Rise 14%
The pharmaceutical giant on Thursday said sales climbed to $15 billion in the quarter ended Sept. 30, ahead of market expectations of nearly $14.1 billion.
.
27 Oct 2022",0.0,22-10-27
Merck,"Merck.com
Merck’s 2021 4Q and full-year earnings report
Merck's 2021 4Q and full-year earnings report ... Merck's (NYSE: MRK) fourth-quarter and full-year 2021 results reflect continued strong business momentum and...
.
3 Feb 2022",-0.8109,22-02-03
Merck,"Investopedia
Merck Stock Slides on Lowered Adjusted EPS Guidance
Shares of Merck & Co. (MRK) tumbled Tuesday after the pharmaceutical giant cut its full-year adjusted profit guidance.
.
30 Jul 2024",0.3612,24-07-30
Merck,"Reuters
Merck pauses Russia investments, to supply essential medicines
Drugmaker Merck and Co (MRK.N) said on Wednesday it would not make further investments in Russia, but continue to supply life-saving medicines and vaccines to...
.
16 Mar 2022",0.0,22-03-16
Merck,"Pharmaceutical Technology
Merck plans €300m investment at new German research centre
Merck plans €300m investment at new German research centre. The investment is part of Merck's broader €1.5bn commitment to the Darmstadt site by 2025. ... The...
.
25 Apr 2024",0.3818,24-04-25
Merck,"BioSpace
Merck Pays $4B Upfront for Daiichi Sankyo’s DXd-Based ADCs
Merck has closed a deal potentially worth $22 billion across three of Daiichi Sankyo's DXd antibody-drug conjugates for various solid tumor indications.
.
20 Oct 2023",-0.0258,23-10-20
Merck,"BreakingNews.ie | Irish News | Breaking News from Ireland
Merck to create 370 new jobs in €440m Cork expansion
Merck to create 370 new jobs in €440m Cork expansion ... Pharmaceutical company Merck has announced plans to invest €440 million in its Co Cork operations, which...
.
23 May 2022",0.4939,22-05-23
Merck,"Fierce Biotech
Merck KGaA turns to deals, 'leaner' organization to expedite R&D. Will layoffs follow?
The company wants half of its future product launches to come from other companies, placing increased emphasis on business development.
.
21 Nov 2022",0.2732,22-11-21
Merck,"Reuters
Germany's Merck sees return to organic earnings growth in 2024
In a statement on Thursday, the German group said that 2024 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs,...
.
6 Mar 2024",0.6808,24-03-06
Merck,"Music Week
Merck Mercuriadis to step down as chairman of Hipgnosis Song Management
Merck Mercuriadis to step down as chairman of Hipgnosis Song Management · Mercuriadis' departure from the company will be effective upon closing of the · It...
.
2 Jul 2024",0.4767,24-07-02
Merck,"Fierce Pharma Biopharma News & Insights
Merck mystified by sudden 'step down' in Gardasil sales in China
The HPV vaccine, which has been on a juggernaut trajectory this decade thanks to booming sales in China, generated revenue of $2.48 billion in the second...
.
30 Jul 2024",0.4404,24-07-30
Merck,"Pharmaceutical Technology
Merck reports 2% increase in worldwide sales in Q4 2022
Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous...
.
3 Feb 2023",0.5574,23-02-03
Merck,"Endpoints News
Merck closes $10.8B deal with Prometheus
Deputy Editor. Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the drugmaker's pursuit of an immunology blockbuster.
.
16 Jun 2023",0.5994,23-06-16
Merck,"Veeva
Veeva and Merck Form Long-Term Strategic Partnership
Veeva Systems (NYSE: VEEV) today announced a ten-year strategic partnership agreement with Merck (NYSE: MRK), known as MSD outside of the United States and...
.
1 Nov 2022",0.7184,22-11-01
Merck,"BioPharma Dive
German Merck’s MS drug falls short in pair of Phase 3 tests
Researchers found that the annualized relapse rate for Merck KGaA's evobrutinib was 0.11 in one trial and 0.15 in the other.
.
6 Dec 2023",0.0,23-12-06
Merck,"Reuters
Prosecutors say FBI trainee stole tips from lawyer-girlfriend to trade on Merck deal
Prosecutors say FBI trainee stole tips from lawyer-girlfriend to trade on Merck deal · Markin allegedly traded on tips stolen from lawyer-girlfriend · He...
.
26 Jul 2022",-0.4939,22-07-26
Merck,"Fierce Pharma
Has Merck's Lagevrio fueled evolution of COVID variants? Researchers say it's possible
Researchers say Merck's oral antiviral Lagevrio could have fueled the evolution of new coronavirus variants.
.
26 Sept 2023",0.0,
Merck,"Bloomberg
Merck Covid Drug Linked to New Virus Mutations, Study Says
Merck & Co.'s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to...
.
1 Feb 2023",0.0772,23-02-01
Merck,"BioSpace
Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development
It has proven to be a highly safe vaccine based on data from more than 50 million doses administered to children in India,” Dr. Krishna Ella, chairman and...
.
21 Jun 2022",0.4927,22-06-21
Merck,"Imperial College London
Merck Innovation Cup – Winner and Runner Up Team
Congratulations Vanessa and team: Abdulrahman Adam (Harvard Medical School), Daniel Griffith (Washington University St. Louis), Emily Zhang (Harvard University)...
.
14 Aug 2024",0.8834,24-08-14
Merck,"Investopedia
Merck Stock Hits Record High on Sales of Cancer Drugs, Vaccines
Merck & Co. (MRK) shares traded at an all-time high Thursday after the pharmaceutical company posted a surprisingly positive adjusted profit after sales jumped...
.
1 Feb 2024",0.6705,24-02-01
Merck,"Merck KGaA
China GMP CCM | Merck
Merck today announced the start of commercial production of its first GMP compliant manufacturing line for cell culture media in China.
.
16 Jul 2024",0.0,24-07-16
Merck,"KED Global
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the development of...
.
30 Jan 2023",0.8679,23-01-30
Merck,"BioSpace
Merck Axes Two Cancer Candidates After Disappointing Late-Stage Results
Merck announced on Monday that it will discontinue the development of two cancer assets, vibostolimab and favezelimab, following underwhelming Phase III data.
.
17 Dec 2024",-0.9062,24-12-17
Merck,"Fierce Pharma
UPDATED: AstraZeneca and Sanofi tweak stances on Russian operations as pharma contends with war in Ukraine
As Ukraine holds the line against the Russian invasion, pharma majors are making a renewed push to adjust operations in the region and supply the besieged...
.
23 Mar 2022",-0.5994,22-03-23
Merck,"Pharmaceutical Technology
Merck & Co’s Keytruda receives approval greenlight from EU CHMP -
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) confirmed a positive recommendation for Merck & Co's (MSD) Keytruda (...
.
13 Oct 2023",0.7717,23-10-13
Merck,"NBC10 Philadelphia
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Merck's shot protects against 21 strains of that bacteria to prevent a severe form of pneumococcal disease and a lung infection called pneumonia.
.
17 Jun 2024",0.3818,24-06-17
Merck,"Fierce Biotech
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
KEYNOTE-921 marked the second Keytruda setback in prostate cancer in less than a year. Before it, the KEYLYNK-010 trial failed to find the combination of...
.
16 Feb 2023",-0.9442,23-02-16
Merck,"North Carolina Agricultural and Technical State University
N.C. A&T, Merck Introduce High School Students to Biotechnology
A five-day biotechnology camp for 12 high school students at the Merck Biotechnology Learning Center located at the Gateway Research Park South Campus.
.
9 Oct 2024",0.0,24-10-09
Merck,"Fierce Pharma
AACR: Merck's Keytruda clashes with AstraZeneca's Imfinzi in biliary tract cancer
Both Keytruda and Imfinzi ""mark significant advances"" in treating biliary tract cancers, Robin “Katie” Kelley, MD, from the University of California, San...
.
16 Apr 2023",-0.5574,23-04-16
Merck,"Endpoints News
Merck evolves Keytruda ad campaign, building on patient insights and highlighting 16 approvals
Merck's latest campaign for its oncology blockbuster Keytruda emphasizes the passions and talents of people living with cancer.
.
24 Jul 2023",0.6908,23-07-24
Merck,"Business Wire
Dementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck
The companies have entered into a definitive agreement under which Merck will acquire Caraway Therapeutics for a total potential consideration of up to $610...
.
21 Nov 2023",0.4939,23-11-21
Merck,"Fierce Biotech
Chasing Merck, BioNTech and DualityBio post first clinical data on ADC
Duality Biologics and BioNTech have identified a trial in patients with small cell lung cancer or non-small cell lung cancer as the next step for their B7-H3...
.
6 Dec 2024",-0.8689,24-12-06
Merck,"Merck.com
Facing global shortage, Merck commits to meeting patient demand
Merck has been experiencing a supply shortage for TICE BCG. In October 2020, we announced our plans to construct a new manufacturing facility in Durham, North...
.
24 Jan 2024",-0.5267,24-01-24
Merck,"www.drugdiscoverytrends.com
AstraZeneca’s and Merck’s Lynparza wins new breast cancer approval from FDA
The PARP inhibitor Lynparza (olaparib) has become the first FDA-approved medicine targeting BRCA mutations in early breast cancer.
.
11 Mar 2022",-0.5106,22-03-11
Merck,"3BL Media
Life Science Business of Merck KGaA, Darmstadt, Germany, Wins Sustainability Excellence Award
Life Science Business of Merck KGaA, Darmstadt, Germany, Wins Sustainability Excellence Award ... Merck KGaA, Darmstadt, Germany, employee Shaun Russell (third...
.
9 Nov 2023",0.9738,23-11-09
Merck,"CHEManager
Germany’s Merck Restructures Life Science Segment
Merck has restructured its life science business to promote growth and to better cater to the needs of an evolving global customer base.
.
8 Feb 2022",0.7964,22-02-08
Merck,"Yahoo Finance
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
Merck's debt is 3.4 times its EBITDA, and its EBIT cover its interest expense 5.8 times over. Taken together this implies that, while we wouldn't want to see...
.
25 Apr 2024",-0.1083,24-04-25
Merck,"Merck KGaA
Using AI to eliminate the neglected tropical disease schistosomiasis, as a public health problem | Merck
Using Data & AI against a major neglected tropical disease. We're harnessing the power of Data and AI to help eliminate schistosomiasis, a devastating neglected...
.
14 Jun 2024",-0.9022,24-06-14
Merck,"Express Pharma
Merck launches international platform to discuss ‘Next-Gen Labs’ on 20th July, 2022
Merck is introducing an international platform to connect the industry with global industry experts to learn how to build 'Next-Gen Labs' and usher in an era...
.
4 Jul 2022",0.0,22-07-04
Merck,"Fierce Pharma
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck's Belsomra, Eisai's Dayvigo
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck's Belsomra, Eisai's Dayvigo ... The FDA blessed Idorsia's Quviviq (daridorexant), a sleeping...
.
10 Jan 2022",0.5994,22-01-10
Merck,"YouTube · CNBC Television
Three-Stock Lunch: Tesla, Merck, and RH
Jerry Castellini, Castle Ark Management president and CIO, joins 'Power Lunch' to discuss Castellini's investing take on three stocks: Tesla, Merck, and RH.
.
27 Mar 2024",0.0,24-03-27
Merck,"Reinsurance News
Merck reaches settlement with insurers over $1.4bn NotPetya cyber attack
Merck & Co. Inc. and its insurers have reached an agreement over the $1.4 billion in losses Merck alleged it suffered from the NotPetya cyberattack in 2017.
.
10 Jan 2024",-0.6369,24-01-10
Merck,"FirstWord Pharma
Merck KGaA bolsters protein degradation pipeline with $756M C4 pact
Merck KGaA bolsters protein degradation pipeline with $756M C4 pact ... C4 Therapeutics has inked a potentially lucrative deal with Merck KGaA to discover two...
.
4 Mar 2024",-0.7783,24-03-04
Merck,"BioPharma Dive
Merck to buy private biotech Caraway in neuroscience deal
In a deal worth up to $610 million, Merck will gain a pipeline of neuroscience and rare disease programs from a startup it previously backed.
.
21 Nov 2023",0.6597,23-11-21
Merck,"Business Wire
Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers
Merck, a leading science and technology company, today announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to...
.
5 Oct 2023",0.8074,23-10-05
Merck,"FirstWord Pharma
EU panel recommends against approval of Merck & Co.'s COVID drug Lagevrio
Merck & Co. and partner Ridgeback Biotherapeutics said Friday that they will appeal a decision in Europe not to recommend approval of Lagevrio...
.
24 Feb 2023",0.7176,23-02-24
Merck,"Drovers
Merck Opens Animal Health Intelligence Manufacturing Facility
Merck Animal Health announces the opening of a manufacturing facility in Louisiana to establish printing, production and distribution of Allflex Livestock...
.
4 Oct 2022",0.4767,22-10-04
Merck,"Business Wire
Merck Animal Health Completes Acquisition of Elanco’s Aqua Business
The completion of this acquisition bolsters Merck Animal Health's position in the aqua industry with a comprehensive approach to promote fish health, welfare...
.
9 Jul 2024",0.5574,24-07-09
Merck,"Fierce Pharma Biopharma News & Insights
Merck CEO Rob Davis dubs Keytruda market exclusivity loss as 'more of a hill than a cliff'
It took CEO Rob Davis less than a minute to tout newly approved pulmonary arterial hypertension (PAH) treatment Winrevair (sotatercept).
.
25 Apr 2024",-0.802,24-04-25
Merck,"CSRwire
Understanding EDISON: The Strategic Energy and Water Efficiency Program of Merck KGaA, Darmstadt, Germany
Understanding EDISON: The Strategic Energy and Water Efficiency Program of Merck KGaA, Darmstadt, Germany ... The EDISON program focuses on reducing energy...
.
29 Nov 2022",0.802,22-11-29
Merck,"Business Wire
Merck Closes Exclusive Global License Agreement for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody
LM-299 is an investigational bispecific antibody targeting both programmed cell death protein-1 (PD-1) and vascular endothelial growth factor (VEGF).
.
20 Dec 2024",0.34,24-12-20
Merck,"YouTube · CNBC Television
Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture
The CNBC 'Halftime Report' Investment Committee discusses today's market movers.
.
20 Dec 2024",0.0,24-12-20
Merck,"The Business Journals
Merck to hire another 100 at newly expanded Cambridge research lab
Merck to hire another 100 at newly expanded Cambridge research lab ... A scientist works in Merck's Cambridge research lab. Peter Gumaskas / Courtesy of Merck.
.
25 May 2022",0.3612,22-05-25
Merck,"New Jersey Business Magazine
Merck Sells Kenilworth Campus to Onyx Equities
Merck Sells Kenilworth Campus to Onyx Equities ... A joint venture between Onyx Equities, LLC and Machine Investment Group, LLC has acquired Merck's former world...
.
17 Feb 2023",0.0,23-02-17
Merck,"MedCity News
Merck Vaccines Pipeline Gets Boost Via Deal for Opko Candidate for Epstein-Barr
Merck has licensed global rights to an Opko Health vaccine in development for Epstein-Barr virus. The preclinical vaccine candidate, made with technology that...
.
8 Mar 2023",0.4019,23-03-08
Merck,"Merck KGaA
Helene von Roeder
Before joining Merck, Helene served on the Executive Board of Vonovia SE since May 2018, first as the Chief Financial Officer until 2021, and then as the Chief...
.
1 Jul 2023",0.0,23-07-01
Merck,"Merck.com
Our former CEO Dr. Roy Vagelos honored for role in helping China combat hepatitis B
Former Merck CEO Dr. Roy Vagelos honored for role in helping China combat hepatitis B.
.
16 Jul 2024",0.802,24-07-16
Merck,"Yahoo Finance
Merck closes exclusive global license agreement for LM-299 from LaNova Medicines
Merck (MRK) announced the closing of the exclusive global license agreement for LM-299, a novel investigational PD-1/VEGF bispecific antibody, from LaNova...
.
21 Dec 2024",0.8658,24-12-21
Merck,"Merck KGaA
Agreement With Abbisko for Pimocotinib | Merck
The agreement grants Merck a license to commercialize pimicotinib in mainland China, Hong Kong, Macau and Taiwan, with an option for rest of world.
.
4 Dec 2023",0.8074,23-12-04
Merck,"Merck KGaA
Letter from the CEO - Merck Sustainability Report 2023
First, to ensure we fully integrate sustainability into our value chains, we are gaining greater transparency into the performance of our global supplier...
.
11 Apr 2024",0.8519,24-04-11
Merck,"MobiHealthNews
Roundup: Canadian AI health measurement app Anura comes to Singapore and more briefs
Also, Standigm has partnered with Merck Korea for AI drug discovery research.
.
2 Jun 2022",0.0,22-06-02
Merck,"The Economic Times
Merck inaugurates healthcare R&D centre in Bengaluru
The Merck India R&D Excellence Centre contributes to the company's healthcare R&D that helps treat patients with unmet medical needs around the world. The...
.
1 Sept 2022",0.8555,
Merck,"Fierce Biotech
Deal-hungry Merck plans more phase 3 launches than in 2023
MK-1022 is the most recent, coming over in Merck's multibillion-dollar deal with Daiichi Sankyo announced in the fall. Candidates stemming from Merck's...
.
1 Feb 2024",0.0,24-02-01
Merck,"Universitas Gadjah Mada
Mengenal Evie Yulin, Pionir Country General Manager Perempuan di Merck Healthcare Asia Pasifik
Mengenal Evie Yulin, Pionir Country General Manager Perempuan di Merck Healthcare Asia Pasifik ... Presiden Direktur PT Merck Tbk, Evie Yulin, merupakan alumnus...
.
29 Nov 2024",0.0,24-11-29
Merck,"National Hog Farmer
Merck launches vaccine for PCV2, Mhp and Lawsonia intracellularis
CIRCUMVENT CML is the first ready-to-use, single-dose vaccine effective against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae...
.
10 Aug 2023",0.4767,23-08-10
Merck,"Yahoo Finance
Merck KGaA's Dividend Analysis
Merck KGaA (MKKGY) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29.
.
29 Apr 2024",0.296,24-04-29
Merck,"Fierce Biotech
Orion's rebooted R&D strategy pays off with $290M Merck deal for prostate cancer drug
Under the deal, Merck and Orion will co-develop and co-commercialize ODM-208. Of the $290 million upfront payment, Orion will book about $220 million as income...
.
13 Jul 2022",-0.6597,22-07-13
Merck,"Merck KGaA
Merck and Digital Trust Centre at NTU Singapore, collaborate to Enable Digital Trust
NTU Singapore are collaborating to pioneer a new digital trust technology designed to enable secure, automated, traceable and efficient digital processes.
.
21 Nov 2024",0.9337,24-11-21
Merck,"CNBC
J&J, Merck and Bristol Myers CEOs defend high drug prices in Senate hearing, as Biden tries to cut costs
The CEOs of Johnson & Johnson , Merck and Bristol Myers Squibb defended high drug prices in the U.S. at a Senate hearing Thursday, as the White House and...
.
8 Feb 2024",-0.2732,24-02-08
Merck,"Science | AAAS
Could a popular COVID-19 antiviral supercharge the pandemic?
A widely used COVID-19 drug may be driving the appearance of new SARS-CoV-2 variants, sparking concerns it could prolong and even reinvigorate the pandemic.
.
1 Feb 2023",0.7269,23-02-01
Merck,"Colby News
Learning to Lead
Briana Guillory '16, senior specialist, cross-functional project manager at Merck, found her voice at Colby and has spoken up ever since.
.
21 Oct 2022",0.0,22-10-21
Merck,"Merck KGaA
Millipore CTDMO Services in Martillac | Merck
Merck Boosts Commercial Capacity in France as Part of New Millipore® CTDMO Services · New 2,700-square-meter facility expands production capacity for monoclonal...
.
4 Oct 2022",0.4019,22-10-04
Merck,"Business Wire
Merck to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Merck Research Laboratories are scheduled to participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, Sept. 5...
.
29 Aug 2024",0.0,24-08-29
Merck,"Fierce Biotech
Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal
The German Big Pharma handing over the rights of its IL-12-targeting cancer med to PDS Biotech in a deal worth more than $120 million.
.
3 Jan 2023",-0.836,23-01-03
Merck,"Merck.com
Our Q3 2023 earnings report
Reporting on our commitment to operating responsibly to benefit society. ... An initiative to create a world where no woman has to die giving life. About Merck.
.
26 Oct 2023",0.4588,23-10-26
Merck,"Fierce Pharma
Akeso, Summit's Keytruda win draws 'explosive' interest at ASCO. But what does Merck think?
The China-only trial, coded HARMONi-2, found that ivonescimab significantly extended patients' progression-free survival (PFS) time compared with Keytruda those...
.
3 Jun 2024",0.5267,24-06-03
Merck,"Fierce Pharma
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Merck is looking to shake up how nonmetastatic non-small cell lung cancer (NSCLC) is treated by testing Keytruda both before and after surgery.
.
25 May 2023",-0.5859,23-05-25
Merck,"Healthline
Cancer-Causing Chemical was Found in These Diabetes Medications: Merck Says They Can Fix It
Merck has recently found the cause of what is contaminating their diabetes medications, Januvia and Janumet: nitrosamines. Consequently, they are working to...
.
20 Jan 2023",0.0,23-01-20
Merck,"Yahoo Finance
Merck & Co., Inc. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other undervalued wide moat stocks.
.
27 Sept 2024",0.0,
Merck,"KED Global
Daewoong Pharma, Merck team up for AI tech for new drug
In addition, Merck will support Daewoong with the necessary technology at all stages of drug development using ""Synthia"" and the ""Antimicrobial Stewardship"" (...
.
31 Oct 2023",0.4019,23-10-31
Merck,"James Madison University
ISAT alumnus creates app to oversee production for Merck
Salette created an app to monitor the fill line for the antibiotic and check when uncategorized or categorized downtimes occur.
.
30 May 2023",0.4767,23-05-30
Merck,"BioSpace
Merck Puts Up Potential $1.3B to Acquire Curon’s B Cell Depletion Therapy
Merck on Friday announced an agreement with Shanghai-based Curon Biopharmaceutical, paying $700 million upfront to buy CN201, an investigational bispecific...
.
9 Aug 2024",0.4939,24-08-09
Merck,"BioSpace
Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal
Merck announced a licensing deal Thursday with Shanghai-based LaNova Medicines to advance a next-generation cancer therapy that could help the pharma maintain...
.
14 Nov 2024",-0.34,24-11-14
Merck,"Reuters
Merck seeking to revive pigments sale - WirtschaftsWoche
Merck is seeking to revive the sale of its pigments division, German business news outlet WirtschaftsWoche reported on Thursday, citing unnamed industry...
.
13 Apr 2023",0.5859,23-04-13
Merck,"Investor's Business Daily
Renaissance In Cholesterol Treatments Could Drive A $42 Billion Market
The market for cholesterol treatments is expected to boom over the next several years, a potential boost for Merck stock and Novartis stock.
.
9 Jul 2024",0.4019,24-07-09
Merck,"BioPharma Dive
Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers
Aktis Oncology, a Massachusetts startup developing targeted radiation drugs for cancer, has raised $84 million in new funds from Merck & Co's venture arm and...
.
25 Aug 2022",-0.6808,22-08-25
Merck,"Fierce Biotech
While stacking on deals, Merck hopes internal ADC work will see the clinic in the 'next couple years'
Merck has bet tens of billions of dollars on antibody-drug conjugates in the last year through a couple of partnerships.
.
26 Oct 2023",0.4215,23-10-26
Merck,"Fierce Pharma
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
The approval in locally advanced unresectable or metastatic biliary tract cancer, combined with the chemotherapies gemcitabine and cisplatin, marks Keytruda's...
.
1 Nov 2023",-0.6908,23-11-01
Merck,"Fierce Pharma
Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator
Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended against the authorization of Lagevrio for recently infected, at-risk patients.
.
24 Feb 2023",-0.34,23-02-24
Merck,"Yahoo Finance
The Strong Earnings Posted By Merck (NYSE:MRK) Are A Good Indication Of The Strength Of The Business
In This Article: MRK. Even though Merck & Co., Inc.'s (NYSE:MRK) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests...
.
15 Nov 2024",0.8957,24-11-15
Merck,"Reuters
Merck's blood vessel disorder therapy receives US FDA's priority review
Merck (MRK.N) said on Thursday the US health regulator will review its experimental therapy to treat a type of progressive blood vessel disorder on a priority...
.
28 Sept 2023",-0.4019,
Merck,"pharmaphorum
AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy
The FDA has cleared AstraZeneca and Merck & Co's Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending its lead over pretenders to its...
.
13 Mar 2022",-0.8176,22-03-13
Merck,"Business Wire
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Data from Phase 3 Trials that Show Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir Maintained HIV-1...
.
14 Dec 2023",0.5267,23-12-14
Merck,"Business Wire
Merck Continues the Fight against Schistosomiasis in a Storytelling Lab
Merck Continues the Fight against Schistosomiasis in a Storytelling Lab ... ADDIS ABABA, Ethiopia--(BUSINESS WIRE)--Merck, a leading science and technology...
.
2 Apr 2024",-0.6369,24-04-02
Merck,"Fierce Pharma
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Big Pharma companies have finally decided to strike. Merck & Co. made the first jab, taking Prometheus Biosciences and its bowel disease candidate in a $10.8...
.
18 Apr 2023",-0.25,23-04-18
Merck,"STAT
Detailed data show Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial
The Summit drug, an antibody called ivonescimab, reduced the risk of tumor progression by 49% compared to Keytruda, according to data released here at the World...
.
8 Sept 2024",-0.6369,
Merck,"Fortune
Former Merck boss Ken Frazier wants CEOs to speak out
Ken Frazier, long one of the few Black Fortune 500 CEOs, is fighting against 'the vestiges of the way this country was run for 400 years' ... Kenneth Frazier,...
.
3 Oct 2023",-0.3612,23-10-03
Merck,"Law.com
ADA Discrimination Lawsuit Lodged Against Merck
ADA Discrimination Lawsuit Lodged Against Merck. This suit was surfaced by Law.com Radar. Read the complaint here. ... Merck, the New Jersey-based pharmaceutical...
.
3 Jun 2022",-0.6124,22-06-03
Merck,"Hits Daily Double
MERCK JOINS NO SHOES NATION
Merck Mercuriadis' Hipgnosis Song Management has purchased a healthy chunk of the royalty stream from the country superstar's catalog.
.
19 Jan 2022",-0.0601,22-01-19
Merck,"Amazon Web Services (AWS)
Executive Conversations: The promise of generative AI for the commercial pharma value chain
Merck & Co., Inc., Rahway, NJ, USA, one of the largest pharmaceutical companies in the world, has been using generative artificial intelligence (generative AI)
.
16 Aug 2023",0.8176,23-08-16
Merck,"www.statnews.com
With a potent new medicine, Merck marks a return to cardiology
A new medicine represents a dramatic advance for patients with a rare condition called pulmonary arterial hypertension — and a return to heart disease for Merck...
.
6 Mar 2023",0.0,23-03-06
Merck,"Norwich University Athletics
Women's Lacrosse: Merck scoops up first GNAC Rookie of the Week nod after 11-point week
WINTHROP, Mass. - After an 11-point week that included her heroics in securing the Cadets' first Great Northeast Athletic Conference (GNAC) win of the...
.
27 Mar 2023",0.9274,23-03-27
Merck,"Reuters
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna and its partner Merck said on Wednesday that they had begun enrolling patients in a late-stage study testing their personalized mRNA-based skin...
.
26 Jul 2023",-0.6597,23-07-26
Merck,"Business Wire
FDA Accepts Application for Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Colitis led to permanent discontinuation of KEYTRUDA in 0.5% (15) and withholding in 0.5% (13) of patients. All patients who were withheld reinitiated KEYTRUDA...
.
13 Apr 2023",0.5106,23-04-13
Merck,"Merck.com
Amplifying the power of women in chemistry
That's why she co-founded the Merck Research Award, given annually by the Women Chemists Committee (WCC) of the American Chemical Society, to recognize and...
.
8 Mar 2023",0.5423,23-03-08
Merck,"Reuters
Bayer defeats Merck in lawsuit over talc liabilities
A Delaware judge on Monday dismissed Merck & Co's lawsuit seeking to hold Bayer AG responsible for more talc-related liabilities stemming from its $14.2...
.
4 Apr 2023",-0.6597,23-04-04
Merck,"PharmaVoice
Roy Vagelos is retiring and leaving a legacy of leadership lessons
The longtime pharma leader is stepping down from his role as chair of Regeneron's board in June after decades in drug development.
.
25 Apr 2023",0.0,23-04-25
Merck,"BioSpace
Merck Bids Fond Farewell to Roy Baynes who Joins Eikon
Baynes joined Merck in 2013 and had a fruitful career, leading Merck into the oncological drug space. Under his leadership, the company achieved more than 140...
.
23 Mar 2022",0.4404,22-03-23
Merck,"Merck.com
Podcast: Why neuroscience is the ‘final frontier’
Podcast: Why neuroscience is the 'final frontier' ... Our scientists are revolutionizing how we discover and develop treatments to address unmet medical needs in...
.
11 Jul 2023",0.0,23-07-11
Merck,"Business Wire
Merck Foundation CEO and African First Ladies discussed Healthcare Capacity Building and Breaking Infertility Stigma at Africa Asia Luminary 2023
Merck Foundation has provided more than 1700 scholarships to young doctors from 50 countries in 42 critical and underserved specialties.
.
6 Nov 2023",-0.3182,23-11-06
Merck,"Business Wire
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy in First-Line Advanced or Unresectable Biliary Tract Cancer in KEYNOTE-966 Trial
In KEYNOTE-158, KEYTRUDA was discontinued due to adverse reactions in 8% of 98 patients with previously treated recurrent or metastatic cervical cancer. Serious...
.
25 Jan 2023",-0.802,23-01-25
Merck,"Korea JoongAng Daily
Merck urges chip industry to embrace digital transformation
Merck urges chip industry to embrace digital transformation ... Merck, a German chemical and technology giant, highlighted digital transformation as a key to a...
.
20 Sept 2023",0.5574,
Merck,"TechCentral.ie
Merck to create 370 jobs for Cork over the next five years
Merck will spend €150 million building the new filtration manufacturing facility at Blarney Business Park. Once fully operational, it will increase Merck's...
.
23 May 2022",0.5267,22-05-23
Merck,"MedCity News
Merck’s $11B Prometheus Acquisition Brings IBD Drug & Precision Medicine Platform
While Merck frames the Prometheus drug, PRA-035, as a potential blockbuster in ulcerative colitis and Crohn's disease, the company says the acquisition is about...
.
17 Apr 2023",0.5994,23-04-17
Merck,"Merck KGaA
M Lab™ Shanghai 2024 | Merck
Opened in 2020 and strategically located in Pudong, at the heart of the biomedical park in Shanghai, the M LabTM Collaboration Center offers customizable...
.
26 Mar 2024",0.0,24-03-26
Merck,"European Coatings
Merck: New facility for digital colour measurement of pigment products
Merck: New facility for digital colour measurement of pigment products. Merck has commissioned its first fully automated unit for the digital colour measurement...
.
5 Oct 2022",0.0,22-10-05
Merck,"Fierce Pharma
Should Merck buy Seagen—and at what price? Analysts and investors weigh in
Merck could buy Seagen for about $39.5 billion, or $215 per share, SVB Securities analysts assumed in an assessment Tuesday, while declining to comment on the...
.
22 Jun 2022",0.5267,22-06-22
Merck,"Cork Independent
Merck to create a further 370 jobs in Cork
A science and technology company has announced a €440 million investment in two sites in Cork which will create 370 new jobs.
.
23 May 2022",0.4939,22-05-23
Merck,"Business Wire
(letermovir) for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Adult Kidney Transplant Recipients
U.S. FDA Approves New Indication for Merck's PREVYMIS® for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Adult Kidney Transplant Recipients.
.
6 Jun 2023",0.4019,23-06-06
Merck,"PR Newswire
DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform
DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible, and deliver a new way to help detect cancer.
.
4 Jun 2024",-0.6705,24-06-04
Merck,"FirstWord Pharma
Merck & Co.'s Q4 sales top forecasts, led by growth for Keytruda, Lagevrio
Merck expects to generate sales of between $57.2 billion and $58.7 billion this year, including about $1 billion projected for Lagevrio, which is down from $5.7...
.
2 Feb 2023",0.5267,23-02-02
Merck,"RFI
Merck charged in France over failure to inform on changes to thyroid drug
Merck charged in France over failure to inform on changes to thyroid drug. The French unit of German pharmaceuticals firm Merck has been charged with willful...
.
20 Oct 2022",-0.875,22-10-20
Merck,"Endpoints News
Merck offers empathy to pandemic-battered parents in revamped HPV vaccine awareness campaign
Merck's latest HPV vaccine awareness campaign showcases those parent-tween moments in a new TV commercial. The message is delivered by a mom who says, as she...
.
11 May 2022",0.0,22-05-11
Merck,"Yahoo Finance
The three-year decline in earnings for Merck NYSE:MRK) isn't encouraging, but shareholders are still up 91% over that period
It could be that the revenue growth of 13% per year is viewed as evidence that Merck is growing. In that case, the company may be sacrificing current earnings...
.
7 Mar 2024",0.5517,24-03-07
Merck,"Business Wire
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
The trial is evaluating the noninferiority of subcutaneous administration of pembrolizumab, Merck's anti-PD-1 therapy, available for intravenous use as KEYTRUDA...
.
19 Nov 2024",0.0,24-11-19
Merck,"Endpoints News
Paving the way for Merck's buyout, Seagen loses arbitration dispute with Daiichi Sankyo over ADC tech
Seagen revealed Friday afternoon that it lost an arbitration dispute with Daiichi Sankyo relating to the companies' 2008 collaboration around the use of...
.
15 Aug 2022",-0.8402,22-08-15
Merck,"Business Standard
Merck Foundation thanks Burundi First Lady and Her Daughter for Dedicating Her Song to More Than a Mother Campaign to Break Infertility Stigma
Bujumbura [Burundi]/ Mumbai (Maharashtra) [India], March 3 (ANI/BusinessWire India): Merck Foundation, the philanthropic arm of Merck KGaA Germany,...
.
3 Mar 2022",0.4404,22-03-03
Merck,"Health Policy Watch
Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic
Share this: ... Bexlovid, the world's first generic of the successful Pfizer antiviral, is already on sale in Bangladesh. The first generic version of Paxlovid,...
.
11 Jan 2022",0.8402,22-01-11
Merck,"Investopedia
Top Stock Movers Now: Corteva, Aflac, Merck, and More
Key Takeaways · U.S. equities rallied back from Wednesday's selloff at midday Thursday, Feb. · Corteva shares surged after the agricultural products maker...
.
1 Feb 2024",0.4588,24-02-01
Merck,"Merck KGaA
Merck Launches Fertility Benefits Program for Employees
Comprehensive Fertility Benefit program offers employees financial support for fertility treatments.
.
13 Sept 2023",0.8519,
Merck,"Fierce Biotech
Merck's efinopegdutide bests Ozempic in tease of phase 2 NASH data
In addition to besting Ozempic on mean LFC reductions, Merck reported that 66.7% of patients given efinopegdutide achieved LFC levels below 5%, compared to 17.8...
.
14 Jun 2023",-0.3182,23-06-14
Merck,"Pharmaceutical Technology
Merck is on the lookout for more opportunities within immunology
Dr Eliav Barr discussed MSD's outlook and willingness to pursue additional opportunities in the sector.
.
29 Jan 2024",0.7837,24-01-29
Merck,"MedCity News
Merck pays Moderna $250M to share equally in cancer vaccine for melanoma
By exercising its option on the Moderna cancer vaccine, mRNA-4157/V940, Merck is agreeing to share in the therapy's development as well as its commercialization...
.
12 Oct 2022",-0.4404,22-10-12
Merck,"Indian Pharma Post
AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza
Results from the trial showed that LYNPARZA in combination with abiraterone plus prednisone significantly improved radiographic progression-free survival (rPFS...
.
22 Jun 2022",0.4767,22-06-22
Merck,"The Economic Times
Merck India appoints Pratima Reddy as country speaker
Merck has appointed Pratima Reddy as its country speaker for India. Reddy, who is currently the GM and managing director of Merck Specialities India, will also...
.
4 Jul 2023",0.0,23-07-04
Merck,"Successful Farming
Merck Animal Health Announces New BRD Antibiotic
In beef and non-lactating dairy cattle, the antibiotic treats BRD and controls respiratory disease in animals at high risk of developing the illness. It also is...
.
28 May 2022",-0.0,22-05-28
Merck,"Clinical Trials Arena
Merck’s Keytruda trial achieves secondary endpoint of OS
Keytruda improved OS in patients with renal cell carcinoma (RCC) at intermediate-high or high risk of recurrence after nephrectomy or nephrectomy with...
.
2 Nov 2023",0.25,23-11-02
Merck,"The Motley Fool
What's Wrong With Merck's Stock?
Merck's business is growing, but the stock's gains have been modest this year. The drug manufacturer remains heavily reliant on Keytruda, which accounts for...
.
5 Sept 2024",0.296,
Merck,"Fierce Pharma
As other pharmas get on the ESG bandwagon, Merck exec says it's in the company's DNA
According to Merck executive Carmen Villar, ESG “is in our DNA as a company.” And it's nothing new for the Kenilworth, New Jersey-based drug behemoth.
.
6 Oct 2022",0.0,22-10-06
Merck,"Fierce Pharma
Merck KGaA's CDMO unit continues to slide but company sees an uptick coming
Merck KGaA's CDMO services unit saw sales decrease by 17% year over year. But the company pointed to signs indicating that it will rebound in the second half...
.
15 May 2024",0.0,24-05-15
Merck,"Business Wire
[Ebola Zaire Vaccine, (rVSVΔG-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older
The duration of protection conferred by ERVEBO is unknown. ERVEBO does not protect against other species of Ebolavirus or Marburgvirus. Effectiveness of the...
.
7 Sept 2023",-0.2924,
Merck,"Merck.com
‘Wonder Angie’ enlists her ‘super friends’ to fight oral cancer
'Wonder Angie' enlists her 'super friends' to fight oral cancer ... In 2017, Maria Angelica Rosario Marquez — or Angie, as she likes to be called — joined Merck...
.
26 Jan 2024",-0.6369,24-01-26
Merck,"CNBC
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.
.
1 Aug 2023",0.3612,23-08-01
Merck,"Business Wire
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of CN201 from Curon...
.
1 Oct 2024",0.4215,24-10-01
Merck,"Contract Pharma
PeptiDream, Merck Enter Peptide Drug Conjugates Pact
PeptiDream, Merck Enter Peptide Drug Conjugates Pact. PeptiDream will provide peptide candidates from its discovery platform for use as PDCs against targets of...
.
28 Dec 2022",0.0,22-12-28
Merck,"Merck KGaA
Deutsche Philharmonie Merck
Deutsche Philharmonie Merck ... The Deutsche Philharmonie Merck, named after the Merck family, is one of the most highly acclaimed independent orchestras in the...
.
7 Sept 2022",0.0,
Merck,"Merck KGaA
Merck Completes Acquisition of Unity-SC and Strengthens Optronics Offering
Merck Completes Acquisition of Unity-SC and Strengthens Optronics Offering. The Electronics business of Merck completes acquisition of Unity-SC and strengthens...
.
31 Oct 2024",0.7184,24-10-31
Merck,"WSJ
Merck to Buy Elanco’s Aqua Business for $1.3 Billion
Merck MRK 0.20%increase; green up pointing triangle & Co. has struck a deal to buy Elanco ELAN 0.00%increase; green up pointing triangle Animal Health's...
.
5 Feb 2024",-0.25,24-02-05
Merck,"Fierce Pharma
Pfizer in catch-up mode with Merck shows data that could fetch Prevnar 20 a key approval
Pfizer has responded with clinical data that could clear the way for its shot, Prevnar 20, to be blessed for babies.
.
12 Aug 2022",0.8625,22-08-12
Merck,"BioSpace
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection
The FDA on Thursday rejected Merck and Daiichi Sankyo's investigational antibody-drug conjugate patritumab deruxtecan, which the partners were proposing for the...
.
27 Jun 2024",-0.7783,24-06-27
Merck,"Merck KGaA
Agreement with Inspirna for Ompenaclid | Merck
Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna. Merck has entered a licensing agreement with Inspirna, Inc. for ompenaclid...
.
4 Jan 2024",0.6808,24-01-04
Merck,"The Korea Herald
Merck boasts materials know-how at K-Display
Under the new company slogan of “Merck Materialize Light,” the firm is presenting materials with high luminance, high transmittance, short response time, high...
.
14 Aug 2024",0.0,24-08-14
Merck,"Pharmaceutical Technology
Merck and GTRI to produce gene therapy for Parkinson's disease
Merck and GTRI to develop gene therapy for Parkinson's disease. The parties will jointly establish an adeno-associated virus production platform to scale up...
.
24 Jul 2024",0.4019,24-07-24
Merck,"Yahoo Finance
Study: Merck and Daiichi's Lung Cancer Treatment Shows Promise
Merck MRK announced that a phase study evaluating its Daiichi Sankyo-partnered HER3-directed DXd antibody drug conjugate (ADC), patritumab deruxtecan,...
.
18 Sept 2024",-0.4767,
Merck,"Fierce Biotech
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Merck is running three phase 3 clinical trials of MK-0616. First up are two similar studies that will assess the effect of the oral peptide on LDL-C levels...
.
25 Aug 2023",-0.0772,23-08-25
Merck,"Merck KGaA
Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “game-changer” for Asia-Pacific (APAC)...
.
31 May 2023",0.0,23-05-31
Merck,"North Carolina Agricultural and Technical State University
Merck, A&T to Establish Biotech Training Center at Gateway Research Park
EAST GREENSBORO, N.C. (June 7, 2023) – North Carolina Agricultural and Technical State University and Merck (NYSE:MRK) announced a collaboration agreement...
.
7 Jun 2023",0.0,23-06-07
Merck,"FirstWord Pharma
Merck & Co., Moderna kick off second Phase III study of mRNA cancer therapy
The first trial in the INTerpath programme, dubbed INTerpath-001, got under way in July to evaluate V940 plus Keytruda as an adjuvant treatment in roughly 1100...
.
11 Dec 2023",-0.6597,23-12-11
Merck,"Merck.com
Here for Good: Bridging the gap between bedside and bench
Here for Good: Bridging the gap between bedside and bench · “Merck allowed me to not only fulfill my goals in life and my career but continue on my path to have...
.
24 May 2023",0.2953,23-05-24
Merck,"Fierce Pharma
With 9% pay hike, Merck CEO Robert Davis entered $20M compensation club in 2023
With 9% pay hike, Merck CEO Robert Davis entered $20M compensation club in 2023 ... Merck CEO Robert Davis has cracked the $20 million mark in annual pay for the...
.
12 Apr 2024",-0.296,24-04-12
Merck,"Clinical Trials Arena
Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug
Merck KGaA (Merck) has discontinued the Phase III TrilynX trial evaluating xevinapant in patients with unresected locally advanced squamous cell carcinoma of...
.
25 Jun 2024",-0.6908,24-06-25
Merck,"Medical Marketing and Media
Merck appoints VP, therapeutic area head
Merck appoints VP, therapeutic area head. Aileen Pangan will lead Merck's new immunology therapeutic unit. ... Merck has appointed Aileen Pangan as VP,...
.
8 Mar 2022",0.0,22-03-08
Merck,"Barron's
Competitor to Merck's Keytruda Worries Some Investors
Investors in Merck don't seem pleased with a competitor cancer-treatment candidate outperforming Keytruda. Summit Therapeutics says its monotherapy...
.
30 May 2024",-0.6377,24-05-30
Merck,"Fierce Biotech
Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis
The deal, which Merck expects to close in the first quarter of 2023, opens up several markets for the Big Pharma. Imago is running phase 2 clinical trials in...
.
21 Nov 2022",-0.6597,22-11-21
Merck,"Fierce Biotech
Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant
Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant ... Merck & Co. ... The FDA has delivered a boost to Merck's mission to...
.
23 Aug 2022",0.4019,22-08-23
Merck,"Feedstuffs
Merck introduces new branding for dairy monitoring technology
Previously available under SCR Dairy and Allflex brands, SenseHub Dairy reflects the full integration of advanced livestock monitoring within Merck Animal...
.
10 Aug 2023",0.25,23-08-10
Merck,"Fierce Pharma
On blockbuster mission, Merck says Welireg hit endpoint in renal cell carcinoma trial
Welireg also demonstrated a statistically significant improvement in objective response rate, plus a trend toward improvement in overall survival (OS) that didn...
.
18 Aug 2023",0.8934,23-08-18
Merck,"Merck KGaA
New Solar Panels at Merck’s Wisconsin, USA Site Add Renewable Energy to Power Grid
New Solar Panels at Merck's Wisconsin, USA Site Add Renewable Energy to Power Grid. The Life Science business of Merck adds 2.25 megawatts to the grid with...
.
19 Jul 2022",0.4939,22-07-19
Merck,"Investopedia
Top Stock Movers Now: PayPal, JetBlue, Merck, Procter & Gamble, and More
Shares of JetBlue Airways (JBLU) flew higher after the carrier reported a surprise profit as it cut some unprofitable routes and delayed jet purchases. Howmet...
.
30 Jul 2024",0.6478,24-07-30
Merck,"The Healthcare Technology Report.
Merck and Daiichi Sankyo Enter Landmark $5.5 Billion Partnership
Pharmaceutical giants Merck and Daiichi Sankyo have joined forces in a $5.5 billion deal to collectively develop three potential cancer treatments.
.
30 Oct 2023",-0.6249,23-10-30
Merck,"FirstWord Pharma
Merck KGaA puts larger-scale acquisitions back on the menu
Last year, Merck generated sales of €19.7 billion ($19.5 billion) overall, a figure it hopes will grow by more than €1 billion ($988 million) annually to around...
.
6 Oct 2022",0.4215,22-10-06
Merck,"Fierce Pharma
Fierce Pharma Asia—J&J's Tagrisso challenger; Merck's revised Kelun deal; The next biosecurity frontier
Fierce Pharma Asia—J&J's Tagrisso challenger; Merck's revised Kelun deal; The next biosecurity frontier ... Yuhan's Lazcluze, licensed by Johnson & Johnson, has...
.
23 Aug 2024",0.25,24-08-23
Merck,"Forbes
Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?
Merck has now reentered the LDL-c arena with its own PCSK9 inhibitor, and unlike the current drugs, Merck has an orally available candidate.
.
1 Feb 2022",0.2263,22-02-01
Merck,"European Coatings
Merck signs agreement to sell surface solutions business unit to GNMI
Merck signs agreement to sell surface solutions business unit to GNMI. Merck, a science and technology company, has signed an agreement to sell its global...
.
26 Jul 2024",0.9001,24-07-26
Merck,"Reuters
Merck wins UK approval for lung disease drug acquired in $11 billion deal
UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's (MRK.N) therapy to treat a rare lung condition.
.
31 Dec 2024",0.9062,24-12-31
Merck,"Merck KGaA
Digital Twins in Healthcare, Electronics and Life Science | Merck
Digital twins are dynamic, virtual representations of the physical environment, offering real-time insights. They can be created for a wide range of entities,...
.
26 Mar 2024",0.5574,24-03-26
Merck,"Fierce Pharma
Germany's Merck uses Barbie as an inspiration to showcase the company's 'vibrancy'
Germany's Merck uses Barbie as an inspiration to showcase the company's 'vibrancy' ... The Barbie marketing machine is in full swing, but Germany's Merck Group is...
.
3 Aug 2023",0.5267,23-08-03
Merck,"Fierce Pharma Biopharma News & Insights
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
CEOs (from left) Joaquin Duato of Johnson & Johnson, Robert Davis of Merck and Chris Boerner of Bristol Myers Squibb faced questions from the Senate about the...
.
8 Feb 2024",-0.34,24-02-08
Merck,"Business Wire
FDA Grants Priority Review to Merck’s New Biologics License Application for V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults
V116 is an investigational, 21-valent pneumococcal conjugate vaccine in Phase 3 development for the prevention of invasive pneumococcal disease and pneumococcal...
.
19 Dec 2023",0.5423,23-12-19
Merck,"Nasdaq
MRK vs. BMY: Which Pharmaceutical Stock is Better?
In this piece, I used TipRanks' comparison tool to evaluate two pharmaceutical stocks, Merck & Co. (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY),...
.
5 Apr 2023",0.4404,23-04-05
Merck,"Business Wire
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir...
.
19 Oct 2024",0.0,24-10-19
Merck,"Speciality Chemicals Magazine
Merck to grow speciality gases
Merck to grow speciality gases ... Merck KGaA has reached an agreement with the Commonwealth of Pennsylvania to support a €300 million investment to expand its...
.
17 Apr 2023",0.8225,23-04-17
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy
Merck Receives Positive EU CHMP Opinion for KEYTRUDA as Adjuvant Treatment for NSCLC at High Risk of Recurrence Following Resection and Chemotherapy.
.
15 Sept 2023",-0.1027,
Merck,"Merck KGaA
Photoelectrochemical cells for mitigating climate change | Merck
The most advanced negative emissions technology is bio-energy combined with carbon capture and storage (BECCS), where energy is extracted from plant biomass.
.
6 Dec 2022",-0.1494,22-12-06
Merck,"Bloomberg.com
Drugmakers Forced to Pay Up for R&D Neglect
Drugmakers Forced to Pay Up for R&D Neglect. With patents expiring and few new products in the pipeline, big US companies are having to acquire their way out of...
.
18 Apr 2023",-0.9153,23-04-18
Merck,"Business Wire
Teon Therapeutics Announces Clinical Trial Collaboration With Merck to Evaluate TT-816, a Novel Oral Immune Response Modifier, in Combination with KEYTRUDA® (pembrolizumab)
Teon's oral, immune response modifier, TT-816, in combination with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), for patients with advanced solid...
.
18 Jan 2023",0.7717,23-01-18
Merck,"Fierce Biotech
Merck advances lung cancer attack, pocketing $170M from Daiichi and plotting ADC-trispecific combo
Daiichi is paying $170 million to split the costs and profits of developing a T-cell engager outside of Japan, where Merck retains exclusive rights.
.
6 Aug 2024",-0.4588,24-08-06
Merck,"Bloomberg.com
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It ... Merck headquarters in Rahway, New Jersey, US, on Tuesday, April 18, 2023. ... This article is...
.
1 May 2023",0.0,23-05-01
Merck,"Fierce Biotech
Daiichi Sankyo ups revenue forecast thanks to massive Merck deal
Daiichi-Sankyo is preparing for a sweet few years thanks to a massive Merck & Co. licensing deal that could top $22 billion.
.
31 Oct 2023",0.8625,23-10-31
Merck,"Psychedelic Alpha
MDMA Patent Tracker
Powered by. Calyx Law Logo Medium. In 1912, chemists at Merck were trying to develop new drugs to control bleeding that were not covered by a patent owned...
.
7 May 2022",0.0,22-05-07
Merck,"Merck KGaA
Merck launches new cosmetics ingredients inspired by superfoods
Merck, a leading science and technology company, introduces two new cosmetic ingredients: RonaCare® Baobab and RonaCare® Hibiscus. These two products are...
.
7 Feb 2022",0.4939,22-02-07
Merck,"Fierce Pharma
Merck KGaA says it'll consider 'larger-scale' acquisitions from 2023 onward
The global conglomerate said it will consider “larger-scale” acquisitions beginning in 2023. Looking forward, the company expects to generate 80% of its growth...
.
6 Oct 2022",0.0,22-10-06
Merck,"SBS Australia
More than 100 countries to get access to cheaper COVID-19 pill
Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co's COVID-19 pill, under a landmark UN-backed deal to...
.
21 Jan 2022",0.0772,22-01-21
Merck,"BioSpace
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
A federal judge compelled Merck to release confidential information on its HPV vaccine as a part of discovery in a series of lawsuits spanning states dating...
.
11 May 2023",0.5806,23-05-11
Merck,"Merck.com
Our Q2 2024 sales and earnings report
Our Q2 2024 sales and earnings report ... Merck's (NYSE: MRK) Q2 2024 results demonstrate strong business momentum and further progress in our diverse pipeline.
.
30 Jul 2024",0.7269,24-07-30
Merck,"BioSpace
Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III
These findings suggest MK-0616 could become the first oral PCSK9 inhibitor on the market and potentially transform the treatment landscape for patients with...
.
7 Mar 2023",-0.1531,23-03-07
Merck,"Business Wire
(belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
FDA Accepts for Priority Review Merck's Supplemental New Drug Application for WELIREG® in Certain Previously Treated Patients With Advanced RCC.
.
19 Sept 2023",0.8176,
Merck,"Fierce Pharma
Merck, Pfizer, Lilly and J&J restored funding to legislators who stoked Jan. 6 Capitol attack, watchdog says
Merck, Pfizer, Lilly and J&J restored funding to legislators who stoked Jan. 6 Capitol attack, watchdog says ... The riot at the U.S. Capitol building last...
.
5 Jan 2022",-0.7184,22-01-05
Merck,"BioSpace
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
Merck has launched a Phase III NSCLC trial of its oral G12C inhibitor MK-1084, in combination with Keytruda, in pursuit of Amgen and Bristol Myers Squibb.
.
5 Apr 2024",0.5859,24-04-05
Merck,"Reuters
Merck, Glenmark settle antitrust case over cholesterol drug for $70 mln
A federal judge has approved a $70 million settlement reached by a class of drug purchasers with Merck & Co Inc and Glenmark Pharmaceuticals.
.
19 Oct 2023",0.4939,23-10-19
Merck,"Global Construction Review
German pharmaceutical company Merck to invest €440m in Irish facilities
German pharmaceutical company Merck to invest €440m in Irish facilities.
.
25 May 2022",0.0,22-05-25
Merck,"MarketWatch
Germany’s Merck Group shares drop 10% after scrapping trial of promising cancer drug
The Darmstadt-headquartered company said late on Monday that it had discontinued its Phase III TrilynX trial of Xevinapant in patients with head and neck cancer...
.
25 Jun 2024",-0.3818,24-06-25
Merck,"Business Wire
Ankyra Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ANK-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
ANK-101 is a novel first-in-class anchored IL-12 immunotherapy designed for limited intratumoral delivery to increase immune cell infiltration into tumors.
.
4 Oct 2023",0.8658,23-10-04
Merck,"Barron's
Merck Stock Falls After Rival Summit Beats Keytruda Cancer Drug in Trial
Merck Stock Falls After Rival Summit Beats Keytruda Cancer Drug in Trial ... Merck stock fell early Monday after a rival pharmaceutical company said its cancer...
.
9 Sept 2024",-0.8689,
Merck,"Insurance Business America
Merck settles $1.4 billion cyberattack case against insurers
Cyber ... Merck has struck up a settlement with insurers over its $1.4 billion NotPetya cyberattack claim, according to reports. The US pharmaceutical giant made...
.
5 Jan 2024",-0.25,24-01-05
Merck,"PMLiVE
Merck KGaA and Mersana partner in potential $830m deal
Merck KGaA and Mersana partner in potential $830m deal ... Merck KGaA and Mersana Therapeutics (Mersana) have entered into a research collaboration and commercial...
.
3 Jan 2023",0.0,23-01-03
Merck,"Merck KGaA
Merck Commissions Fully Automated Unit for the Digital Color Measurement of its Pigment Products
Merck, a leading science and technology company, today commissioned its first fully automated unit for the digital color measurement of its pigment products.
.
28 Sept 2022",0.0,
Merck,"Bovine Veterinarian
Merck Introduces Allflex CleanVax Nozzles and Shields for Intranasal Vaccination
Merck Introduces Allflex CleanVax Nozzles and Shields for Intranasal Vaccination · The CleanVax intranasal vaccination system includes shorter nozzles that are...
.
7 Feb 2024",0.0,24-02-07
Merck,"Fierce Biotech
Merck & Co. signs $208M deal to acquire startup in bid to improve ADC safety
Merck has signed a small deal worth up to $208 million, which includes milestone payments, to acquire a University at Buffalo startup called Abceutics.
.
8 Apr 2024",0.765,24-04-08
Merck,"BioProcess International
Merck buying Seagen would make strategic sense, says analyst
Merck buying Seagen would make strategic sense, says analyst. Merck buying Seagen would make strategic sense, says analyst. Merck & Co. is eying up the...
.
20 Jun 2022",0.0,22-06-20
Merck,"Fierce Pharma
Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH study
Merck's activin signaling inhibitor Winrevair, also known as sotatercept, met its primary endpoint of time to first morbidity or mortality event.
.
25 Nov 2024",0.0772,24-11-25
Merck,"Endpoints News
'Vaccines alone are insufficient': Merck, Aligos work with academic experts to find Covid antivirals as part of $65M NIH grant
Merck is throwing its weight behind a new consortium of academic, nonprofit and biotech scientists to discover oral antivirals that can fight Covid-19.
.
1 Jun 2022",-0.2732,22-06-01
Merck,"C&EN
7 graduate students receive first-ever ACS Pride Merck Graduate Research Awards
It validates the importance of diversity and inclusion efforts and inspires me to continue working toward a more equitable future in the chemical sciences. This...
.
21 Jun 2024",0.9042,24-06-21
Merck,"ET HealthWorld
Merck India inaugurates its R&D Excellence Centre in Bengaluru
The R&D Excellence Centre at Merck enables employees with an innovation-friendly environment, encouraging their curiosity. The Centre in Bangalore aims to...
.
2 Sept 2022",0.9118,
Merck,"Endpoints News
Merck KGaA to expand German headquarters with €300M+ research center
News Reporter. Merck KGaA is allocating over €300 million ($321.8 million) to build a new research building at its headquarters in Darmstadt, Germany to study...
.
25 Apr 2024",0.3182,24-04-25
Merck,"Reuters
Merck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugs
Merck & Co Inc said on Monday it will acquire cancer drug developer Imago BioSciences Inc for a total equity value of $1.35 billion to expand its portfolio...
.
21 Nov 2022",-0.5267,22-11-21
Merck,"The Guardian
Founder of Hipgnosis Songs Fund accuses ex-partner over failed business
The now dissolved Hipgnosis Music received funds that were proceeds of fraud, Merck Mercuriadis alleges in court documents.
.
12 May 2024",-0.8591,24-05-12
Merck,"News-Medical
Merck Foundation announces 2023 Africa Media Recognition Award winners for excellence in health reporting
Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany announced the Winners of Merck Foundation Africa Media Recognition...
.
22 Jun 2024",0.93,24-06-22
Merck,"YouTube · CNBC Television
Lightning Round: Merck is doing a teriffic job at reinventing itself, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Palantir, Tri Pointe Homes, Transmedics, Cheesecake Factory, Copa Holdings and more.
.
27 Jul 2023",-0.4939,23-07-27
Merck,"Reuters
Merck KGaA flags steeper profit drop on lower orders from drugmakers
Germany's Merck KGaA on Thursday warned of a steeper earnings decline due to a slump in demand for materials used to produce pharmaceuticals and...
.
3 Aug 2023",-0.4588,23-08-03
Merck,"Fierce Biotech
Seismic emerges with $101M, Harvard billionaire founder and leadership team fresh off $1.9B exit
The founders of Pandion Therapeutics have wasted no time in setting up another biotech in the months after a $1.9 billion exit to Merck in spring 2021.
.
9 Feb 2022",-0.4767,22-02-09
Merck,"Barron's
Merck and J&J’s Biotech Deals Are More Good News for a Troubled Sector
Two small acquisitions by Merck and Johnson & Johnson are a sign that things are looking up for the sector, which is coming off an unaccustomed two-month price...
.
8 Jan 2024",0.0498,24-01-08
Merck,"Barron's
Merck Earnings Top Expectations. More M&A Could Be Next.
Merck reported sales of $15 billion for the quarter, beating the FactSet consensus estimate of $14.5 billion, and up 3% from the same quarter last year.
.
1 Aug 2023",-0.296,23-08-01
Merck,"Forbes
Merck Deal Boosts Founder Of Little-Known Korean Biotech Company Into Billionaire Ranks
Alteogen, a pharmaceutical company with nothing to do with AI, saw its share price jump about 25% Friday to an all-time high after it announced a licensing deal...
.
23 Feb 2024",0.5423,24-02-23
Merck,"Politico
Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’
Merck sues HHS over drug negotiation, claims program 'tantamount to extortion' ... The company logo is seen on the doors of a building at Merck & Co.
.
6 Jun 2023",0.0,23-06-06
Merck,"Barron's
Strong Vaccine Data From Vaxcyte Pose a Threat to Pfizer and Merck. Here’s Why.
Biotech Startup Vaxcyte Is a Threat to Pfizer and Merck. A Vaccine Candidate Is Why. ... A win for the biotech Vaxcyte in an early-stage trial of its experimental...
.
3 Sept 2024",0.0772,
Merck,"Merck KGaA
Merck Expands Newest Biologics Testing Center in Shanghai
Merck Expands Newest Biologics Testing Center in Shanghai · Further develops its biosafety testing laboratories to meet local demand · New labs complete 2nd...
.
21 Nov 2023",0.0772,23-11-21
Merck,"Nature
Merck & Co. buys TNF-superfamily-targeting antibody for $10.8 billion
Merck & Co. buys TNF-superfamily-targeting antibody for $10.8 billion ... Merck & Co. has acquired Prometheus Biosciences for access to an antibody targeting...
.
10 May 2023",0.0,23-05-10
Merck,"Pharmaceutical Technology
Merck signs deal to commercialise Abbisko Therapeutics’ pimicotinib
Merck signs deal to commercialise Abbisko Therapeutics' pimicotinib. Abbisko is eligible to receive a down payment of $70m from Merck KGaA (Merck). ... Merck can...
.
5 Dec 2023",0.0,23-12-05
Merck,"Fierce Biotech
Merck is back in Alzheimer's saddle with $1B-plus Cerevance pact, years after dropping the BACE
Merck & Co. has signed a billion-dollar biobucks deal with Cerevance to identify new therapies for the devastating neurodegenerative disease.
.
9 Aug 2022",-0.6486,22-08-09
Merck,"Business Wire
Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies
Merck and Ridgeback's Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant.
.
28 Jan 2022",0.0,22-01-28
Merck,"STAT
A biotech’s binary bet ends badly
Today's biotech updates include the GLP-1 hype cycle, Merck winning approval for pneumonia vaccine, and Ethan Weiss raking in some cash.
.
18 Jun 2024",0.5267,24-06-18
Merck,"Axios
Exclusive: Transcarent hires ex-Merck CEO Ken Frazier
""It comes down to how many people do we help, and how do we help those people?""
.
21 Feb 2023",0.7096,23-02-21
Merck,"HITS Daily Double
RAINMAKERS' BACKSTORIES: MERCK MERCURIADIS
Hipgnosis founder/chief Merck Mercuriadis. Touting a thoughtful thesis about how streaming's impact could radically escalate the value of songs.
.
22 Feb 2022",0.5106,22-02-22
Merck,"Global Venturing
Rising Stars 2023: Michael Morgan -
Michael Morgan, senior associate at Merck GHI, is one of our top 50 Rising Stars in corporate venturing in 2023.
.
14 Mar 2023",0.2023,23-03-14
Merck,"BioSpace
Novartis, Lilly, Merck and More Halt Business Operations in Russia
One day after Pfizer announced it was halting its business practices within Russia, AbbVie, Abbott, Novartis, Merck and Eli Lilly have followed suit. This...
.
16 Mar 2022",0.0,22-03-16
Merck,"The Business Journals
N.C. A&T, Merck to establish a biotech training center at Gateway Research Park in Greensboro
N.C. A&T, Merck to establish a biotech training center at Gateway Research Park in Greensboro ... North Carolina A&T is bringing another expansion to Gateway...
.
8 Jun 2023",0.0,23-06-08
Merck,"Fierce Biotech
Merck, with GSK in its rearview, suffers second FDA rejection of cough drug gefapixant
Merck received its first FDA rejection for gefapixant, a P2X3 receptor antagonist designed to treat chronic cough, at the start of last year. The Big Pharma...
.
21 Dec 2023",-0.8834,23-12-21
Merck,"Fierce Pharma
Merck dodged billions in US taxes in offshoring Keytruda profits, Senate Democrats contend
Merck indicated that all profits from its $17 billion drug Keytruda—including sales to U.S. customers—are ""taxed in jurisdictions outside the United States,""...
.
28 Jul 2022",0.8316,22-07-28
Merck,"Forbes
Should You Pick Merck Stock At $115 After A Q2 Beat?
Although Merck posted an upbeat Q2, and despite its recent fall, we think its stock is fully valued at levels of around $115.
.
1 Aug 2024",0.4927,24-08-01
Merck,"Merck.com
Neuroscience
Our research is focused on discovering and developing novel therapeutics for a host of nervous system disorders. We're pursuing a variety of new approaches as...
.
10 Apr 2024",0.4215,24-04-10
Merck,"Fierce Pharma
Merck's Keytruda aims for updated stomach cancer label with positive data
Keytruda, used along with Roche's Herceptin and chemotherapy, showed an improvement in progression-free survival compared with the Herceptin-chemo combo, but...
.
16 Jun 2023",0.296,23-06-16
Merck,"Bloomberg.com
Merck Has Good Reason to Buy a Cancer-Drug Biotech Seagen
Merck & Co. has said nothing publicly about rumors that it is in talks to buy Seagen, a biotech company working on cancer treatments, for about $40 billion.
.
2 Aug 2022",-0.3612,22-08-02
Merck,"VOA - Voice of America English News
Moderna, Merck Drugs Combined Shown Effective Against Melanoma
A clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or...
.
14 Dec 2023",-0.0772,23-12-14
Merck,"Reuters
Merck KGaA says FY profit to fall to lower half of target range
Germany's diversified group Merck KGaA flagged that full-year operating earnings would likely be in the lower half of its target range on weak demand for...
.
9 Nov 2023",-0.5994,23-11-09
Merck,"ROI-NJ
Merck’s ribbon-cutting in Rahway: Celebrating the past — while planning for future
The campus itself is beyond impressive: More than 100 buildings and more than 300,000 square feet of Class A research space stretched across more than 200...
.
20 Jun 2023",0.7906,23-06-20
Merck,"BioPharma Dive
FDA approves Merck lung disease drug acquired in $11B deal
The Food and Drug Administration on Tuesday approved a new Merck & Co. drug to treat pulmonary arterial hypertension. Called Winrevair, the drug is the first...
.
26 Mar 2024",0.802,24-03-26
Merck,"Bloomberg.com
Merck CEO on Winrevair Approval, Obesity Drug, Health Costs
Merck CEO on Winrevair Approval, Obesity Drug, Health Costs · TV Shows · Bloomberg Surveillance. March 28th, 2024, 6:37 AM PDT. Merck Chair and CEO Robert...
.
28 Mar 2024",0.7351,24-03-28
Merck,"STAT
Merck pays $250 million to license a Moderna skin-cancer vaccine candidate
Moderna is getting $250 million from Merck to secure opt-in rights to the cancer vaccine candidate, called mRNA-4157. The two companies are jointly conducting a...
.
12 Oct 2022",-0.4588,22-10-12
Merck,"PharmaTimes
AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland
The Scottish Medicines Consortium (SMC) has approved Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone to treat adult patients...
.
18 Mar 2024",0.765,24-03-18
Merck,"YouTube · CNBC Television
Trade Tracker: Joe Terranova buys Amgen and Merck
Trade Tracker: Joe Terranova buys Amgen and Merck. 4.7K views · 10 months ago ...more. CNBC Television. 3.01M. Subscribe. 25. Share. Save.
.
15 May 2024",0.6597,24-05-15
Merck,"BioPharma Dive
Merck pays $250M to license Moderna cancer vaccine
The drugmaker's decision to grab rights to the shot deepens its ties with the COVID-19 vaccine developer and comes weeks before a key data release.
.
12 Oct 2022",-0.6597,22-10-12
Merck,"Fierce Pharma
UPDATED: Merck cuts 143 jobs at Acceleron right on heels of $11.5B buyout
“On Tuesday, March 15, Merck issued a Worker Adjustment and Retraining Notification Act (“WARN”) notice to 143 legacy employees of Acceleron Pharma who will be...
.
30 Mar 2022",0.802,22-03-30
Merck,"Business Wire
The Electronics Business of Merck KGaA, Darmstadt, Germany, Completes Acquisition of Unity-SC and Strengthens Optronics Offering to Better Serve the Semiconductor Industry
The acquisition of Unity-SC marks a significant step in enhancing and complementing the optical expertise of Merck KGaA, Darmstadt, Germany.
.
30 Oct 2024",0.7717,24-10-30
Merck,"Genetic Engineering and Biotechnology News
Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space
Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space ... Merck & Co. has agreed to acquire EyeBiotech (EyeBio) for up to $3 billion, the companies...
.
29 May 2024",0.2732,24-05-29
Merck,"Business Wire
CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older
CDC'S ACIP Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older ... The...
.
23 Oct 2024",0.4215,24-10-23
Merck,"Merck.com
Joseph Romanelli
Joseph Romanelli ... Joseph Romanelli is president, Human Health International for Merck. He has P&L responsibility for Merck's 75-plus markets outside of the...
.
13 Sept 2022",0.0,
Merck,"Music Week
UMPG MD Mike McCormack's message to Merck Mercuriadis and the big spenders buying up catalogues
Now it's time for UMPG's Mike McCormack to speak up, as he takes up his right of reply to Hipgnosis… Merck Mercuriadis has been very public in his...
.
10 Jan 2022",0.0,22-01-10
Merck,"Merck KGaA
hc-uc-13-02-2023 | Merck
Merck today announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial.
.
13 Feb 2023",0.0,23-02-13
Merck,"Forbes
Is There A Better Pick Over Merck Stock In Animal Health Space?
Is There A Better Pick Over Merck Stock In Animal Health Space? · Zoetis' operating margin of 35% over the last twelve-month period is better than 29% for Merck...
.
14 Jun 2022",0.8426,22-06-14
Merck,"Fierce Pharma
Pfizer, Merck and AstraZeneca led Big Pharma's growth in Q1 but they couldn't match mRNA hotshots
Pfizer, Merck, AstraZeneca, Novo Nordisk and GSK were among the companies that led growth in the biopharma industry in the first quarter of 2022.
.
17 May 2022",0.6369,22-05-17
Merck,"Fierce Pharma
Merck applies more pressure against IRA, asking for decision without trial in fight with US government
Merck has filed for a decision without a trial in its lawsuit against the US government and President Joe Biden's Inflation Reduction Act.
.
12 Jul 2023",-0.298,23-07-12
Merck,"The Motley Fool
Better Dividend Stock: Pfizer or Merck?
Pfizer and Merck offer similar dividend yields. Both companies have solid track records and are in good shape to fund their dividend programs.
.
26 May 2022",0.5423,22-05-26
Merck,"Business Wire
Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs
Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™. Collaborators will...
.
16 Feb 2022",0.0,22-02-16
Merck,"Fierce Pharma
Merck KGaA earmarks €35M for Scottish expansion, plots 500 new jobs
Merck KGaA unveiled a 35 euro million expansion of its biosafety testing facilities in Scotland. The project will create about 500 jobs when completed.
.
31 May 2023",0.2732,23-05-31
Merck,"Fierce Biotech
Chasing Moderna, Merck pays $50M to join race to develop cancer-preventing vaccine
Merck, which pioneered the idea of vaccinating to prevent cancer with HPV shot Gardasil, sees the evidence as an opportunity—and has identified ModeX as the...
.
8 Mar 2023",-0.4767,23-03-08
Merck,"Fierce Biotech
Merck admits defeat in race with Valneva to get first chikungunya vaccine to market
Once competing with Valneva to get a chikungunya shot to market, it looks like Merck & Co. has admitted defeat as its rival reaches the finish line.
.
2 Feb 2023",-0.1779,23-02-02
Merck,"citybiz
Merck Appoints Chirfi Guindo to Lead Marketing for Merck Human Health
As chief marketing officer for Human Health, Guindo will be responsible for leading the development and implementation of the company's long-term strategy for...
.
21 Jun 2022",0.3182,22-06-21
Merck,"Merck.com
Finding joy after surviving cervical cancer twice
Granado's cancer went into remission for three years, and she found joy again: She and her fiancé got married and decided to have a baby via surrogate.
.
17 Nov 2023",-0.0,23-11-17
Merck,"Reuters
Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial
Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some patients with a form of lung...
.
18 Sept 2024",-0.6597,
Merck,"The New York Times
Music Catalog Giant Hipgnosis Is Sold, and Merck Mercuriadis Exits
Music Catalog Giant Hipgnosis Is Sold, and Merck Mercuriadis Exits. The company, whose pricey acquisitions kicked off a rush on catalog sales, sold its assets...
.
9 Jul 2024",0.0,24-07-09
Merck,"Merck KGaA
Semiconductor Manufacturing | Merck
Merck and Intel Accelerate Sustainable Semiconductor Processes and Manufacturing Technologies Through Academic Research in Europe. Merck and Intel Corporation...
.
9 Mar 2023",0.0,23-03-09
Merck,"BioSpace
Merck KGaA Strikes $550M Deal with Proxygen in Latest Protein Degradation Deal
Proxygen announced that it has partnered with Germany-based Merck to jointly identify and develop molecular glue degraders for clinical research.
.
3 Jun 2022",-0.836,22-06-03
Merck,"Reuters
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova ... Nov 14 (Reuters) - Merck (MRK.N) , opens new tab...
.
14 Nov 2024",-0.8689,24-11-14
Merck,"Fierce Pharma
FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio
The FDA has determined that Lagevrio should only be prescribed by traditional prescribers,” the FDA wrote to Fierce Pharma in an email.
.
8 Jul 2022",0.4767,22-07-08
Merck,"Law.com
Merck Fights 'Unprecedented' Move to Boost Injury Claims Over HPV Vaccine
In a May 20 filing before the U.S. Judicial Panel on Multidistrict Litigation, Merck said the ""unprecedented"" move would lead to more lawsuits and inundate...
.
2 Jun 2022",-0.6697,22-06-02
Merck,"Business Wire
NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health's RNA-particle technology platform and is designed to deliver...
.
24 Sept 2024",0.0,
Merck,"Fierce Pharma
ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space
The combination of Merck KGaA's Bavencio and Pfizer's Inlyta has failed on the overall survival endpoint of a phase 3 trial.
.
23 May 2024",-0.8625,24-05-23
Merck,"Reuters
Morocco authorizes Merck's molnupiravir for COVID-19
Morocco has authorized the emergency use of Merck &Co's (MRK.N) molnupiravir medication for COVID-19 patients, Moroccan state news agency reported on Friday.
.
7 Jan 2022",-0.3818,22-01-07
Merck,"Merck.com
Chirfi Guindo
Chirfi Guindo ... Chirfi Guindo is chief marketing officer for Merck. He is responsible for leading the development and implementation of the company's long-term...
.
11 Jul 2022",0.3182,22-07-11
Merck,"Business Wire
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070 ... The companies will jointly develop and commercialize MK-...
.
6 Aug 2024",0.7506,24-08-06
Merck,"Fierce Biotech
Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end
Merck is placing a small bet to get a closer look at the two candidates. In return for the upfront payment, Merck has secured the option to license the vaccines...
.
26 Sept 2024",0.4019,
Merck,"Fierce Biotech
UPDATE: Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class
UPDATE: Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class ... Merck & Co. ... Merck & Co.'s TIGIT therapy tacked on to Keytruda did...
.
16 Mar 2023",-0.8481,23-03-16
Merck,"BioPharma Dive
Merck calls quits on two immunotherapies for cancer
In a statement, Merck said it will end development of two experimental cancer drugs that are currently in late-stage testing. One, called vibostolimab, is aimed...
.
16 Dec 2024",-0.8689,24-12-16
Merck,"YourStory.com
Hear from experts and their interactive sessions at Merck India's 'Open House for Techies’
To be held on January 21 in Bengaluru both online and offline (at Courtyard by Marriott), the event aims to tap into the vast IT talent pool that India has to...
.
9 Jan 2023",0.3182,23-01-09
Merck,"Fierce Biotech
Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
Merck & Co. has pushed further into the space by penning a $220 million biobucks deal with Unnatural Products.
.
23 Jan 2024",0.0,24-01-23
Merck,"Rochester Institute of Technology
Chemistry, Culture, and Career - How RIT Shaped a Merck Scientist
Chemistry, Culture, and Career - How RIT Shaped a Merck Scientist ... Nnamdi Akporji '16 came to RIT for its culture and discovered a passion for chemistry and...
.
10 Oct 2024",0.4588,24-10-10
Merck,"CBS News
Moderna-Merck vaccine cuts odds of skin cancer recurrence in half, study finds
Those with severe melanomas who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three...
.
14 Dec 2023",-0.9707,23-12-14
Merck,"Bloomberg.com
Merck’s Covid Pill Shows Activity Against Omicron in Lab
Merck & Co.'s Covid-19 pill showed activity against omicron in six laboratory studies that raise confidence in the ability of the new therapy to battle the...
.
28 Jan 2022",0.4588,22-01-28
Merck,"PR Newswire
Merck Animal Health Launches Sure Petcare Animo® GPS
In addition to its location tracking capabilities, Animo GPS utilizes smart technology to track a dog's unique activity levels and behavior within a user-...
.
18 Oct 2022",0.6124,22-10-18
Merck,"Fierce Biotech
Merck taps Owkin’s AI to boost microsatellite testing of GI cancers
Merck taps Owkin's AI to boost microsatellite testing of GI cancers ... Merck & Co. has tapped the artificial intelligence developer Owkin to help assemble a new...
.
19 Dec 2023",0.8807,23-12-19
Merck,"BioCentury
PAH treatment moves in a disease-modifying direction with Merck data
Sotatercept met the primary endpoint and eight of nine secondary endpoints in the Phase III STELLAR study.
.
11 Oct 2022",0.0,22-10-11
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for the Treatment of Resectable NSCLC at High Risk of R
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy...
.
23 Feb 2024",0.7269,24-02-23
Merck,"Merck.com
Black scientists, innovators and employees are key to Merck's history of invention and progress
A long history of Black inventors and innovators · Susan Jenkins paved the way for black women in science at Merck · William Bowers' advocacy for civil rights...
.
2 Feb 2023",0.4215,23-02-02
Merck,"Law.asia
Duo advises on GNMI’s EUR665m buy of Merck’s business unit
Duo advises on GNMI's EUR665m buy of Merck's business unit ... Baker McKenzie and Freshfields Bruckhaus Deringer have advised Hong Kong-listed Global New Material...
.
16 Aug 2024",0.0,24-08-16
Merck,"Fierce Pharma
Merck KGaA, Huma collab bears fruit with launch of bladder cancer patient support app
The app is designed to guide bladder cancer patients through their often-complex treatment plans by providing educational content about common treatments and...
.
29 Apr 2024",-0.7964,24-04-29
Merck,"Reuters
Mersana signs deal with Merck KGaA for cancer therapy development
Mersana Therapeutics Inc said on Thursday it had signed a deal for developing cancer drugs with Germany's Merck KGaA that has the potential to generate up...
.
22 Dec 2022",-0.8689,22-12-22
Merck,"Fierce Biotech
Merck & Co., in busy morning, taps Moderna's therapeutic cancer vaccine, Royalty in schizophrenia deal
Merck & Co., in busy morning, taps Moderna's therapeutic cancer vaccine, Royalty in schizophrenia deal.
.
12 Oct 2022",-0.8689,22-10-12
Merck,"ContagionLive
FDA Approves Merck's Capvaxive (V116) Vaccine to Combat Pneumococcal Disease in Adults
Tailored for adults, V116's effectiveness covers serotypes linked to 84% of invasive pneumococcal disease in those 50+, outperforming existing vaccines in...
.
17 Jun 2024",0.0772,24-06-17
Merck,"Business Wire
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
A collaboration agreement to discover, develop, and commercialize multiple programs, including vaccines and therapeutics in the areas of infectious disease and...
.
16 Aug 2022",0.4939,22-08-16
Merck,"IAVI
IAVI to accelerate promising investigational Sudan ebolavirus vaccine development for potential outbreak research and response
NEW YORK – OCTOBER 25, 2022 – IAVI, a nonprofit scientific research organization, and Merck, known as MSD outside the United States and Canada, intend to...
.
25 Oct 2022",0.6705,22-10-25
Merck,"Miami Herald
Publix, CVS, Walgreens and Walmart are offering COVID pills in Florida. What to know
Select Publix, CVS, Walgreens and Walmart pharmacies in Florida are offering Pfizer's Paxlovid and Merck's Molnupiravir antiviral COVID pills.
.
25 Jan 2022",0.0,22-01-25
Merck,"Bloomberg.com
India Medical Agency Flags Worries Over Merck Covid Drug
The head of India's main medical research agency said there were “major safety concerns” over Merck & Co.'s Covid-19 drug that may impede its addition to...
.
6 Jan 2022",0.0,22-01-06
Merck,"FirstWord Pharma
Nuformix eyes 'bio better' version of AstraZeneca, Merck & Co.'s Lynparza
Nuformix eyes 'bio better' version of AstraZeneca, Merck & Co.'s Lynparza ... Shares in Nuformix gained as much as 20% on Wednesday after the company said it is...
.
29 Jun 2022",0.8625,22-06-29
Merck,"CNBC
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales · Earnings per share: 3 cents adjusted vs. a loss of 11 cents per share...
.
1 Feb 2024",0.8442,24-02-01
Merck,"Reuters
CEO of Germany's Merck: decoupling from China would be at huge economic cost
The company's finance chief last month said that Merck would further invest in China and would build domestic supply chains there to curb imports of key raw...
.
6 Jun 2023",0.3182,23-06-06
Merck,"ET Telecom
Germany's Merck KGaA insists semiconductor market remains attractive
Merck KGaA: There is a significant shortage of chips and Merck's customers are building significant capacity to serve end consumers, but there is a...
.
20 Oct 2022",0.3071,22-10-20
Merck,"MedCity News
Merck Neuroscience Acquisition Brings a Startup With Parkinson’s, ALS Programs
Merck Neuroscience Acquisition Brings a Startup With Parkinson's, ALS Programs. Merck's acquisition of Caraway Therapeutics adds programs for genetically...
.
21 Nov 2023",0.0,23-11-21
Merck,"Amazon Web Services (AWS)
Data and Analytics environments at Merck KGaA, Darmstadt, Germany using AWS Services
Merck KGaA, Darmstadt, Germany had multiple teams from their business sectors exploring diverse enterprise-scale data & analytics (D&A) use cases.
.
12 Sept 2023",0.1779,
Merck,"Pharmaceutical Technology
Merck’s HIV pipeline shifts as islatravir PrEP program is discontinued
Merck & Co announced it is discontinuing a program to study monthly oral doses of islatravir as pre-exposure prophylaxis (PrEP) therapy.
.
30 Sept 2022",0.0,
Merck,"BioSpectrum India
Merck India announces 10th Bioforum India 2022
10th Merck Bioforum India 2022 is a thought leadership programme which is a part of the flagship Asia seminar series that Merck Life Sciences has been...
.
25 Aug 2022",0.1027,22-08-25
Merck,"Reuters
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Drugmaker Merck & Co Inc (MRK.N) on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy...
.
27 Apr 2023",0.7096,23-04-27
Merck,"FirstWord Pharma
Merck KGaA touts longer-term data for BTK inhibitor in MS
New follow-up data from Merck KGaA's evaluation of evobrutinib show the investigational oral treatment is associated with low disease activity and stable...
.
26 Oct 2022",-0.3612,22-10-26
Merck,"Merck KGaA
Curiosity Cube® Mobile Lab | Merck
Merck Expands Hands-On Science Education with Kick-off of Global Curiosity Cube® Mobile Lab. The Curiosity Cube—a retrofitted shipping container that features...
.
18 May 2022",0.1027,22-05-18
Merck,"FirstWord Pharma
Merck & Co. lifts full-year sales forecast as Keytruda, Gardasil surge
Merck & Co. now expects to generate sales this year of between $58.6 billion and $59.6 billion, boosted from an earlier estimated range of $57.7 billion to...
.
1 Aug 2023",0.3612,23-08-01
Merck,"أرقام
Merck opens regional HQ in Riyadh
Merck opens regional HQ in Riyadh ... Merck, a leading company in the fields of science, technology, and medicine, announced the opening of its new regional...
.
2 Mar 2024",0.0,24-03-02
Merck,"Yahoo Finance
How Much Would It Take To Earn $100 A Month From Merck Stock
How Can You Earn $100 Per Month As A Merck Investor? If you want to make $100 per month – $1,200 annually – from Merck dividends, your investment value needs to...
.
10 Dec 2024",0.4019,24-12-10
Merck,"YouTube · CNBC Television
3-Stock Lunch: Merck, Ecolab & Xylem Inc
3-Stock Lunch: Merck, Ecolab & Xylem Inc. 1.3K views · 4 months ago ...more. CNBC Television. 3.01M. Subscribe. 20. Share. Save.
.
25 Oct 2024",0.6597,24-10-25
Merck,"Business Wire
Merck Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing
Merck, a leading science and technology company, today announced the signing of a definitive agreement to acquire for US$ 600 million.
.
22 May 2024",0.7506,24-05-22
Merck,"Merck KGaA
Industrial partnerships – collaboration pays off
The examples show that collaboration pays off. This applies across the entire value chain and is already widely practiced in the research space.
.
8 May 2023",0.34,23-05-08
Merck,"Merck KGaA
Acquisition of MAST® Platform - News | Merck
Merck, a leading science and technology company, will advance its bioprocessing portfolio with the acquisition of the MAST® (Modular Automated Sampling...
.
5 Apr 2022",0.0,22-04-05
Merck,"Business Wire
Pragma Bio Secures $10M From The Venture Collective, Merck Global Health Innovation Fund, Viking Global, and CJ Investments To Expand Its Proprietary Technology Platform To Discover Novel Medicines
Pragma Bio, the technology-enabled platform for drug discovery formerly known as VastBiome, announced it has raised an additional $10 million in equity.
.
23 Mar 2023",0.8176,23-03-23
Merck,"Fierce Pharma
Merck, eyes on Roche’s immunotherapy first, returns perplexing Keytruda post-surgery lung cancer data
Keytruda topped placebo at keeping disease from returning and keeping patients alive, regardless of their PD-L1 biomarker status, Merck said Monday.
.
10 Jan 2022",-0.4215,22-01-10
Merck,"PPF Group
Kelun strikes third deal with Merck Co. for ADCs, this time with $175 million upfront
The Kelun-Biotech will receive $175 million up front from Merck, which also intends to make an equity investment in the Chinese company. Total milestones...
.
6 Mar 2023",-0.3612,23-03-06
Merck,"Merck KGaA
Merck Announces New Chief Human Resources Officer
Khadija Ben Hammada will become Chief Human Resources Officer (CHRO), reporting directly to Belén Garijo, Chair of the Executive Board and CEO of Merck.
.
7 Sept 2022",0.0,
Merck,"NBC 5 Dallas-Fort Worth
Cramer's week ahead: Earnings from Tesla, Merck and Big Tech
CNBC's Jim Cramer said next week's PCE index report will be the real gauge of inflation.
.
19 Apr 2024",0.2263,24-04-19
Merck,"Business Wire
Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) as Adjuvant Therapy Versus Observation in High-Risk Patients With Localized Muscle-Invasive and Locally Advanced Urothelial Carcinoma After Surgery
Merck's KEYTRUDA Significantly Improved DFS as Adjuvant Therapy in High-Risk Patients With Localized Muscle-Invasive and Locally Advanced UC.
.
26 Jan 2024",0.8481,24-01-26
Merck,"Fierce Biotech
Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic
In the 41-year HIV epidemic, no treatments have been approved to completely clear the virus largely because of its ability to live on in hidden form in the...
.
26 Jan 2022",0.8655,22-01-26
Merck,"Endpoints News
'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff
Editor. With megablockbuster Keytruda's patent cliff looming in 2028, Merck has made some bold M&A moves in an attempt to find its next big moneymaker,...
.
3 Feb 2022",-0.3612,22-02-03
Merck,"ET HealthWorld
Merck Opens Microbiology Application Lab in Jigani, Bengaluru
Merck Opens Microbiology Application Lab in Jigani, Bengaluru. Merck's first Microbiology Application and Training Lab in India that supports capability built-...
.
22 Jul 2022",0.3612,22-07-22
Merck,"Business Wire
New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio
New Data to be Presented at IDWeek 2024 Reinforce Merck's Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio · for use in patients who are...
.
9 Oct 2024",0.0,24-10-09
Merck,"Business Wire
BIOCORP and Merck KGaA, Darmstadt, Germany, Sign a New Partnership for Smart Drug Delivery
BIOCORP and Merck KGaA, Darmstadt, Germany, will develop a new version of Mallya to help patients monitor their injection during their treatment.
.
10 Oct 2022",0.6597,22-10-10
Merck,"McKinsey & Company
McKinsey and SAP join forces to maximize business transformation value through cloud solutions
The two companies have drawn on their individual strengths to create a strategic alliance that merges technology modernization with strategy execution.
.
10 May 2022",0.8442,22-05-10
Merck,"Reuters
Germany's Merck open to more M&A for its Life Science division
German science and technology group Merck (MRCG.DE) is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio...
.
17 Oct 2024",0.0,24-10-17
Merck,"Fierce Pharma
Merck's Keytruda excels in cervical cancer trial, showing an ability to extend lives. Will a broader FDA approval follow?
Merck's Keytruda excels in cervical cancer trial, showing an ability to extend lives. Will a broader FDA approval follow? ... While Merck has earned two FDA...
.
15 Mar 2024",0.8677,24-03-15
Merck,"FirstWord Pharma
ViewPoints: How AI is transforming clinical development at Merck & Co.
FirstWord sat down with Iya Khalil, VP and head of data, AI and genome sciences at Merck & Co., to discuss how new AI tools are being integrated into the...
.
29 Oct 2024",0.0,24-10-29
Merck,"ET HealthWorld
Merck Specialities names Pratima Reddy as MD in India
Pratima becomes the first woman CEO for Merck Healthcare in India. She has an extensive experience of over 17 years, with nine years in the pharmaceutical...
.
1 Aug 2022",0.0,22-08-01
Merck,"Merck KGaA
Merck Joins German Research Project ""Semiconductor-X""
Merck Joins German Research Project ""Semiconductor-X"" · Merck is part of a consortium of over 20 partners in Germany, led by Intel Germany and the Fraunhofer...
.
23 Jul 2024",0.0,24-07-23
Merck,"BioSpace
Merck’s Keytruda Combo Fails in Phase III Colorectal Cancer Study
Merck on Wednesday announced that its blockbuster PD-1 inhibitor Keytruda (pembrolizumab), when combined with the investigational anti-LAG-3 antibody...
.
25 Sept 2024",-0.5574,
Merck,"Fierce Pharma
Merck's Keytruda claims digital marketing crown, holding off challenges from AstraZeneca, BMS
Merck's Keytruda.com achieved the highest total traffic across NSCLC patient sites in the US, with over 2.4 million visitors from October 2022 to September...
.
15 Mar 2024",0.0772,24-03-15
Merck,"PR Newswire
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
We are thrilled to join forces with Merck KGaA, Darmstadt, Germany, to discover targets with the first-in-class potential to advance the next wave of...
.
4 Apr 2024",0.25,24-04-04
Merck,"Fierce Pharma
Fierce Pharma Asia—Merck inks $4B Daiichi tie-up, trims Kelun deal; AstraZeneca's ADC letdown
Merck & Co. agreed to pay Daiichi Sankyo $4 billion upfront to co-develop and co-commercialize three antibody-drug conjugates targeting HER3, B7-H3 and CDH6.
.
27 Oct 2023",0.1779,23-10-27
Merck,"Endpoints News
New biotech from Alexis Borisy will test Merck KGaA, Blueprint cancer drug combo in bid to fulfill Gleevec promise
The duo believes it's brought together two drugs that can be “best in class” as a combination therapy for certain cancers.
.
2 Aug 2022",0.2263,22-08-02
Merck,"ACS Publications
The Catalysis Laboratory at Merck: 20 Years of Catalyzing Innovation
The Catalysis Laboratory at Merck was established in 2002 to discover and develop asymmetric hydrogenation transformations for application to the company's...
.
20 Dec 2022",0.3818,22-12-20
Merck,"Fierce Pharma
Fierce Pharma Asia—Daiichi, Merck's FDA rejection; Wegovy's expansion; Takeda CEO's hunt for China deals
Daiichi Sankyo's Merck-partnered HER3 antibody-drug conjugate, patritumab deruxtecan, was rejected by the FDA because of third-party manufacturing issues. The...
.
28 Jun 2024",-0.7783,24-06-28
Merck,"Fierce Pharma Biopharma News & Insights
MilliporeSigma drops €300M on Korean biologics plant with plans to create 300 new jobs
Merck KGaA's life sciences arm MilliporeSigma is dropping 300 million euros on a new bioprocessing plant in Korea, where it plans to hire 300 people.
.
21 Mar 2024",0.2732,24-03-21
Merck,"Forbes
Is An Earnings Beat In The Cards For Merck Stock?
We expect the company to post revenue of $15.9 billion and adjusted earnings of $2.20, slightly ahead of the street estimates. As usual, Keytruda will be...
.
26 Jul 2024",0.0,24-07-26
Merck,"Business Wire
Merck’s V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-3, a Phase 3 trial...
.
28 Nov 2023",0.836,23-11-28
Merck,"Fierce Biotech
UPDATE: FDA AdComm shoots down Merck's chronic cough med in 12-1 vote
UPDATE: FDA AdComm shoots down Merck's chronic cough med in 12-1 vote ... An FDA advisory committee has voted 12-1 against approving Merck's gefapixant before a...
.
17 Nov 2023",0.0,23-11-17
Merck,"Reuters
Merck quarterly profit tops expectations on COVID pill surprise
Sales of molnupiravir, the COVID-19 antiviral pill sold under brand name Lagevrio, jumped 47% to $640 million in the quarter, crushing Wall Street estimates of...
.
26 Oct 2023",0.7003,23-10-26
Merck,"TechTarget
Comparing Merck and Pfizer’s 2022 ESG Ratings
Comparing Pfizer to Merck, the two companies share similar environmental goals but diverge in their governing practices and attitude toward employees and...
.
20 Jul 2023",0.1531,23-07-20
Merck,"Fast Company
The battle over prescription drug prices is heating up
The CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb just got grilled by Congress as they fight a new law to keep high drug prices in check.
.
12 Feb 2024",-0.6369,24-02-12
Merck,"astroawani.com
Tiga pengeluar ubat Korea Selatan bakal hasilkan pil COVID-19 Merck
SEOUL: Badan kesihatan awam yang disokong Pertubuhan Bangsa-Bangsa Bersatu (PBB) itu mengumumkan ia menandatangani perjanjian pelesenan dengan 27 pengeluar...
.
21 Jan 2022",0.0,22-01-21
Merck,"PR Newswire
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the completion of the first milestone.
.
12 Nov 2024",0.4404,24-11-12
Merck,"FirstWord Pharma
Merck & Co. looks to take on Pfizer's Prevnar with positive top-line data for V116
In both trials, V116 had a safety profile similar to the comparator vaccine. Results will be shared with the scientific community in the near future, with Merck...
.
27 Jul 2023",0.8316,23-07-27
Merck,"Medical Dialogues
Merck presents positive results from Pneumococcal conjugate vaccine study
Pneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus. Rahway: Merck, known as MSD outside the United...
.
22 Jun 2022",0.5574,22-06-22
Merck,"NBC News
Covid pills: How to get Pfizer or Merck pill after testing positive
the two antiviral pills — Pfizer's Paxlovid and Merck's molnupiravir — can be picked up at a pharmacy and taken at home...
.
26 Jan 2022",0.5574,22-01-26
Merck,"WSJ
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio · Acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the...
.
29 May 2024",-0.6124,24-05-29
Merck,"WSJ
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut
The company needs combinations to extend Keytruda sales after patent expires.
.
26 Apr 2023",0.1779,23-04-26
Merck,"Bloomberg.com
Merck in Deal With Sinopharm to Bring Covid Antiviral Molnupiravir to China
Merck has also agreed to allow Sinopharm subsidiary China National Biotec Group to use its technology to facilitate the production, supply and commercialization...
.
28 Sept 2022",0.4588,
Merck,"Irish Examiner
Merck to expand Cork operations adding 370 jobs
At Blarney Business Park, Merck is going to build a new filtration manufacturing facility for almost €150m. Up to 250 of the jobs will be located in Blarney...
.
23 May 2022",0.3182,22-05-23
Merck,"Nikkei Asia
Pfizer COVID pill approved in Japan, following Merck treatment
Japan's health ministry on Thursday approved Pfizer's COVID-19 pill Paxlovid for patients with mild to moderate symptoms.
.
10 Feb 2022",0.6808,22-02-10
Merck,"ET HealthWorld
Merck launches its Uptune Program in India for collaborating with Startups
The Merck Uptune startup collaboration program will start in mid-November 2022. The application period will run through September 4, 2022 via the website. The...
.
28 Jul 2022",0.0,22-07-28
Merck,"Reuters
Merck raises 2023 sales forecast as top drugs beat Street estimates
Merck raised its full-year sales forecast to $58.6 to $59.6 billion, from its prior view of $57.7 billion to $58.9 billion.
.
1 Aug 2023",0.2023,23-08-01
Merck,"Merck.com
Pioneering better chemical reactions
The team used a systematic approach to map the effect of over 700 diverse molecules that might interact with decarboxylative coupling, using a nanoscale high...
.
3 May 2023",0.4404,23-05-03
Merck,"Fierce Biotech
JPM24, Day 1: Novartis reportedly in late talks for Cytokinetics after nabbing a Merck KGaA spinoff; J&J, Merck tie up M&A deals
The first official M&A deal of JPM '24 sees Novartis snap up Merck KGaA autoimmune spin-off Calypso in an upfront deal worth $250 million with an extra $175...
.
8 Jan 2024",0.2263,24-01-08
Merck,"Merck.com
Stomach cancer: understanding the signs and symptoms
What are the signs and symptoms of stomach cancer? · Fatigue. · Heartburn, indigestion and anemia. · Swelling or fluid build-up in the abdomen, jaundice or...
.
3 Nov 2023",-0.8957,23-11-03
Merck,"KKTV
Merck, Moderna detail potential skin cancer vaccine progress
The drugmakers said a...
.
13 Dec 2022",-0.3818,22-12-13
Merck,"Health Policy Watch
105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir
27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income...
.
20 Jan 2022",-0.2732,22-01-20
Merck,"Business Wire
(pembrolizumab) Regimens as Treatment for Patients With Two Types of Gynecologic Cancers
Merck Receives Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Regimens as Treatment for Patients With Two Gynecologic Cancers.
.
20 Sept 2024",0.5574,
Merck,"CNBC
FDA approves Merck's drug for rare, deadly lung condition
The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the...
.
26 Mar 2024",0.9001,24-03-26
Merck,"Reuters
A son died, his parents tried to sue. How U.S. courts protect Big Pharma
Merck's asthma drug, Singulair, has been linked for years to suicides. But lawsuits over it are stymied by one of Corporate America's go-to legal defenses.
.
26 Jun 2023",0.1027,23-06-26
Merck,"Financialexpress
US FDA approves Merck’s pneumococcal vaccine for children
The US Food and Drug Administration (FDA) on Thursday granted approval for Merck's (MSD outside the US and Canada) pneumococcal 15-valent conjugate vaccine,...
.
24 Jun 2022",0.7783,22-06-24
Merck,"Fierce Biotech
Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail
Merck has lost interest in NGM621, an anti-complement C3 antibody being trialed in patients with an eye degenerative disease called geographic atrophy.
.
21 Dec 2022",-0.4215,22-12-21
Merck,"Pharmaceutical Technology
Merck’s Life Science Advanced Research Centre, Darmstadt, Germany
Expected Operations · The facility is scheduled to start its operations in early 2027. · Merck will build a new Life Science Advanced Research Centre in...
.
28 May 2024",0.4588,24-05-28
Merck,"TechTarget
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
A routine inspection of Merck's popular diabetes drug — Januvia — detected nitrosamine, a possible human carcinogen. ... Last week, Merck & Co made the FDA aware...
.
18 Aug 2022",0.4215,22-08-18
Merck,"Truthout
Warren, Sanders: Merck’s Hunt to Extend Cancer Drug Patent May Be Patent Abuse
Merck's request to extend the patent for a top cancer drug could represent another move from Big Pharma to abuse the patent system and maintain a monopoly on a...
.
23 Feb 2023",-0.9432,23-02-23
Merck,"GlobeNewswire
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
Quris-AI, the world's first BioAI clinical-prediction platform, ensures the safety of new drugs. Revolutionizing the drug development process, the company is...
.
28 Sept 2023",0.6249,
Merck,"Clinical Trials Arena
Gilead-Merck’s combination therapy maintains HIV suppression in trial
A combination of islatravir and lenacapavir demonstrated potential in maintaining viral suppression in virologically controlled adult HIV patients.
.
7 Mar 2024",0.0,24-03-07
Merck,"Fierce Pharma
Merck fined $38M in Spain for hindering generic competition for NuvaRing
Merck prevented Spanish generics maker Insud from entering the market with a generic version of Merck's NuvaRing, Spain's antitrust watchdog said.
.
25 Oct 2022",0.0258,22-10-25
Merck,"Fierce Pharma
Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China
Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China ... Merck KGaA's North American life science division, MilliporeSigma, has...
.
22 May 2024",-0.9001,24-05-22
Merck,"STAT
Merck, Daiichi Sankyo to partner on targeted chemotherapy drugs in deal worth up to $22 billion
Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy...
.
20 Oct 2023",-0.0772,23-10-20
Merck,"Medical Buyer
Merck taps Eliav Barr as CMO
Since joining Merck in 1995, Dr. Barr has held numerous leadership roles in oncology and infectious diseases clinical development. He oversaw the development of...
.
25 Mar 2022",0.0,22-03-25
Merck,"PAhomepage.com
More than 2 dozen drugmakers to make Merck’s COVID-19 pill
GENEVA (AP) — A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions...
.
20 Jan 2022",0.2732,22-01-20
Merck,"Medical News Today
What we know about molnupiravir: Data and safety concerns
In the search for effective COVID-19 treatments, many drugs failed to live up to their early promise. The antiviral molnupiravir performed well in trials,...
.
12 Mar 2022",0.7184,22-03-12
Merck,"Clinical Trials Arena
Merck’s MK-0616 may become the first oral PCSK9 inhibitor in the dyslipidemia market
Merck plans to start a Phase III pivotal study for MK-0616 in the second half of 2023. The main advantage of MK-0616 is its oral form, which provides...
.
9 Mar 2023",0.1779,23-03-09
Merck,"KoreaTimes
Merck considers further investment in Korea
As part of its Level Up growth investment plan announced in 2021, Merck said it would invest 600 million euros ($632 million) in Korea by 2025. As part of that...
.
26 Oct 2023",0.3818,23-10-26
Merck,"Fierce Biotech
Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program
Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program ... Gilead Sciences and Merck & Co. have guided their once-...
.
21 Oct 2024",0.0,24-10-21
Merck,"Reuters
Merck's COVID pill does not cut hospitalisation, death rates in many vaccinated adults - study
Merck & Co Inc's (MRK.N) COVID antiviral molnupiravir speeds up recovery but does not reduce the hospitalisation or death rate in higher-risk vaccinated adults.
.
22 Dec 2022",0.7717,22-12-22
Merck,"Business Wire
US FDA Approves Intramuscular Administration for Merck’s MMRV Family of Vaccines: M-M-RII (Measles, Mumps, and Rubella Virus Vaccine Live), VARIVAX (Varicella Virus Vaccine Live), and ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine
U.S. FDA Approves Intramuscular Administration for Merck's MMRV Family of Vaccines: M-M-R®II, VARIVAX®, and ProQuad®
.
6 Mar 2023",0.6597,23-03-06
Merck,"Yahoo Finance
Merck (NYSE:MRK) shareholders have earned a 9.4% CAGR over the last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...
.
25 Nov 2023",0.765,23-11-25
Merck,"Reuters
Merck KGaA Q3 earnings rise faster than expected on lower costs
Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug development and a rebound in...
.
14 Nov 2024",0.0,24-11-14
Merck,"BioSpace
Merck's Blockbuster Diabetes Drug Sitagliptin Found Contaminated with Potential Carcinogen
The U.S. Food and Drug Administration announced Tuesday that certain samples of sitagliptin were contaminated with the nitrosamine Nitroso-STG-19 (NTTP).
.
10 Aug 2022",0.7184,22-08-10
Merck,"Merck.com
Merck’s Q4 and full-year 2022 earnings report
Merck's Q4 and full-year 2022 earnings report ... Merck's (NYSE: MRK) Q4 and full-year 2022 results reflect sustained strong revenue growth. The company announced...
.
2 Feb 2023",0.7096,23-02-02
Merck,"BioPharma Dive
ADC developed by Daiichi, Merck outperforms chemo in lung cancer trial
The company on Sept. 17, 2024 reported data for an experimental lung cancer drug it's developing with Daiichi Sankyo.
.
17 Sept 2024",-0.8689,
Merck,"Fierce Biotech
Merck cuts ties to Moderna's early-phase KRAS vaccine, leaving mRNA specialist to mull next steps
Merck cuts ties to Moderna's early-phase KRAS vaccine, leaving mRNA specialist to mull next steps ... Merck still retains a stake in another Moderna cancer...
.
24 Feb 2022",-0.5267,22-02-24
Merck,"FirstWord Pharma
Merck & Co. deepens cancer tie-up with Otsuka's Astex unit
Merck & Co. entered into a new agreement with Otsuka's Astex Pharmaceuticals unit to identify small-molecule candidates with activity towards the p53 tumour...
.
8 Aug 2023",-0.296,23-08-08
Merck,"BioPharma Dive
Merck acquires cancer drug startup; Elevidys ex-US sales rise
Merck & Co. will pay $30 million upfront to acquire Modifi Biosciences, a Yale University spinout developing small molecule drugs for cancer.
.
23 Oct 2024",-0.8807,24-10-23
Merck,"Merck KGaA
Ecstasy
MDMA, its scientific abbreviation, achieves huge popularity as Ecstasy: The body and mind-altering effects of a white powder provoke wonder and alarm.
.
4 Aug 2023",0.8442,23-08-04
Merck,"BioProcess International
Merck KGaA to acquire Exelead in $780m deal
Merck will strengthen its mRNA offerings within its biopharma services division MilliporeSigma after signing a definitive agreement to acquire contract...
.
7 Jan 2022",0.6705,22-01-07
Merck,"Business Wire
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024 ($100.73), the last trading day before the date of...
.
22 Nov 2024",-0.3818,24-11-22
Merck,"BioPharma Dive
Merck pays $680M for struggling cancer biotech Harpoon
Merck pays $680M for struggling cancer biotech Harpoon. The acquisition will further build out Merck's pipeline of next-generation immunotherapies.
.
8 Jan 2024",-0.9371,24-01-08
Merck,"Scottish Legal News
Westwater Advocates welcomes John Laing and Terence Merck
Westwater Advocates has welcomed John Laing and Terence Merck to the stable after they called to the bar today. As a solicitor, Mr Laing has advised clients...
.
22 Jun 2022",0.7783,22-06-22
Merck,"Fierce Biotech
Merck finally gets FDA nod to relaunch HIV trials, but drops preventive therapy plans
Merck finally gets FDA nod to relaunch HIV trials, but drops preventive therapy plans ... A path forward for Merck & Co.'s struggling HIV strategy has opened up,...
.
20 Sept 2022",-0.5719,
Merck,"Merck KGaA
LNPs, silent heroes of Covid-19 mRNA vaccines. | Merck
For the new Covid-19 mRNA vaccines, the solution to this problem came through the development of lipid nanoparticles (LNPs).
.
7 Aug 2022",0.4404,22-08-07
Merck,"Merck KGaA
Strategische Kooperation: Merck und ENTEGA
Strategische Kooperation: Merck und ENTEGA · Spitzenleistung von ca. 7.000 kWp, jährliche Erzeugung von bis zu 7 Gigawattstunden · CO2-Ersparnis von ca. 3.500 t...
.
13 Feb 2023",0.0,23-02-13
Merck,"Business Wire
Merck to Participate in the Jefferies London Healthcare Conference
Merck Research Laboratories are scheduled to participate in a fireside chat at the Jefferies London Healthcare Conference on Thursday, Nov. 21, 2024.
.
14 Nov 2024",0.0,24-11-14
Merck,"Reuters
Merck in advanced talks to buy Seagen in nearly $40-bln deal - WSJ
Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more,...
.
7 Jul 2022",0.5994,22-07-07
Merck,"Barron's
Merck’s Deal for Prometheus Expected to Generate Billions in Additional Sales
Merck (ticker: MRK) said it has agreed to purchase Prometheus (RXDX) for $200 per share in cash, or roughly $10.8 billion.
.
17 Apr 2023",0.5106,23-04-17
Merck,"PMLiVE
Merck and Astellas/Pfizer’s bladder cancer combination receives MHRA approval
Keytruda (pembrolizumab) and Astellas/Pfizer's Padcev (enfortumab vedotin) have been approved by the Medicines and Healthcare products Regulatory Agency (MHRA)
.
11 Oct 2024",0.128,24-10-11
Merck,"RTE.ie
Merck brings 370 new jobs to Cork with €440m investment
Merck is to invest €440 million in two manufacturing plants in Co Cork. Merck said the investment will lead to the creation of 370 jobs at the two facilities...
.
23 May 2022",0.2732,22-05-23
Merck,"Pharmaceutical Technology
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
FDA accepts Merck's pneumococcal vaccine BLA for priority review. Merck (MSD)'s V116 vaccine is designed to prevent invasive pneumococcal disease in the adult...
.
20 Dec 2023",0.5719,23-12-20
Merck,"Pharmaceutical Technology
Merck’s Keytruda gets EC approval as adjuvant therapy for kidney cancer
Merck's (MSD) Keytruda (pembrolizumab) has received the European Commission (EC) approval as monotherapy for the adjuvant treatment in adult patients with renal...
.
27 Jan 2022",0.2023,22-01-27
Merck,"Fierce Pharma
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV preventive Beyfortus—isn't breaking a sweat. “We really welcome...
.
25 Oct 2024",0.5719,24-10-25
Merck,"Reuters
Merck signs up to $2 billion deal for oral weight-loss drug with China's Hansoh
Merck has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity on Wednesday,...
.
18 Dec 2024",0.5574,24-12-18
Merck,"Fierce Pharma
Fierce Pharma Asia—Merck KGaA and Hengrui's PARP deal; Novartis and Takeda's employee dispute; toripalimab's FDA nod
Merck KGaA is paying 160 million euros for ex-China rights to Jiangsu Hengrui Pharmaceuticals' PARP1 inhibitor, HRS-1167, with 1.6 billion euros lined up as...
.
3 Nov 2023",-0.4588,23-11-03
Merck,"Contract Pharma
TrialSpark Licenses Sprifermin from Merck KGaA, Forms High Line Bio
TrialSpark Licenses Sprifermin from Merck KGaA, Forms High Line Bio. Sprifermin promotes cartilage growth, and could be a potential disease modifying treatment...
.
10 Jan 2022",0.6124,22-01-10
Merck,"Business Wire
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19.
.
21 Feb 2023",0.0,23-02-21
Merck,"MarketWatch
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
Merck's $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology · Prometheus' key asset is a treatment for...
.
17 Apr 2023",0.8074,23-04-17
Merck,"Merck KGaA
Emanuel Merck Lectureship 2022 Awarded to John F. Hartwig
Merck named John F. Hartwig, Henry Rapoport Professor of Chemistry at the University of California, Berkeley, USA, as the seventeenth recipient of the...
.
23 May 2022",0.4019,22-05-23
Merck,"PYMNTS.com
House Judiciary Committee Examines Antitrust Issues in Medical Residency Market
Merck Closes $10.8B Prometheus Biosciences Acquisition ... Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the...
.
20 Jun 2023",0.0,23-06-20
Merck,"Fierce Biotech
Merck partners with N-Power for oncology trial platform after leading series B
Merck will use N-Power's network of platform-enabled oncology clinics for trials on non-small cell lung cancer. The new collaboration is the second CRO...
.
1 Jul 2024",-0.6597,24-07-01
Merck,"Fierce Biotech
Merck KGaA shrinks US research team as layoffs continue to batter industry
Merck KGaA is the latest company to downsize, shrinking its US research wing by more than 100 employees.
.
23 Jan 2023",0.0,23-01-23
Merck,"Business Wire
Domain Therapeutics Receives a Single Digit Multimillion Development Milestone Payment from Merck for M1069 Clinical Development in Immuno-Oncology
A2a/A2b antagonist candidate, M1069, jointly discovered by Domain Therapeutics and Merck entered into a first-in-human study to investigate the safety,...
.
28 Jun 2022",-0.4404,22-06-28
Merck,"PETA
Attacked and Starved: Bloated Merck Fails Monkey—PETA Statement
52 monkeys held in cages in one room at Merck weren't fed for a full day. Confinement to laboratories ravages these intelligent, highly social monkeys.
.
6 Oct 2022",-0.7506,22-10-06
Merck,"Business Wire
FDA Grants Priority Review to Merck’s New Biologics License Application for V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults
Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories. “If approved, V116 would be the...
.
19 Dec 2023",0.743,23-12-19
Merck,"Investopedia
Merck Buys Harpoon Therapeutics To Expand Its Oncology Portfolio
Merck & Co. said Monday that it would purchase Harpoon Therapeutics Inc. for about $680 million to expand its reach in cancer-fighting drugs.
.
8 Jan 2024",0.5719,24-01-08
Merck,"Pharmaceutical Technology
Ginkgo Bioworks and Merck partner to bolster biologic manufacturing
Ginkgo will offer its expertise for enhancing manufacturing efficiency and boosting yields in producing biologics.
.
8 Aug 2023",0.5994,23-08-08
Merck,"Philanthropy News Digest
Merck Foundation commits $20 million to cancer care initiative
Merck Foundation commits $20 million to cancer care initiative. The Alliance for Equity in Cancer Care initiative is focused on helping patients living in...
.
13 Sept 2022",-0.1531,
Merck,"Business Wire
Merck Launches Single-Use Reactor Designed to Accelerate Antibody Drug Conjugate Manufacturing
Merck's new Mobius® ADC Reactor is the first scalable single-use mixer specifically designed for antibody drug conjugate manufacturing.
.
10 Sept 2024",0.0,
Merck,"PYMNTS.com
Atkore Faces Shareholder Lawsuit Over Alleged Price-Fixing Scheme
Merck Closes $10.8B Prometheus Biosciences Acquisition ... Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the...
.
20 Jun 2023",-0.2263,23-06-20
Merck,"Investor's Business Daily
Could Merck's Next Keytruda-Like Drugs Top $10 Billion In Sales?
Merck Stock: $5.1 Billion In Potential Sales. Huynh now sees a 95% chance sotatercept gains Food and Drug Administration approval. He also expects the drug to...
.
7 Mar 2023",0.8074,23-03-07
Merck,"Reuters
Merck to buy Elanco's aqua health business for $1.3 billion
Merck (MRK.N) said on Monday would buy Elanco Animal Health's (ELAN.N) aqua business for $1.3 billion in cash, strengthening its portfolio of aquatic pet and...
.
7 Feb 2024",0.4939,24-02-07
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive...
.
21 Jul 2023",0.8481,23-07-21
Merck,"Reuters
Merck to take $10.3 billion R&D charge for Prometheus deal this year
Merck & Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as the drugmaker accounts its deal for Prometheus...
.
17 Apr 2023",0.296,23-04-17
Merck,"Merck KGaA
Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland
Merck, a leading science and technology company, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a...
.
31 May 2023",0.3818,23-05-31
Merck,"BioSpace
BMS and Merck Buy Big Into Amphista’s Protein Degradation Platform
The UK-based company announced partnerships with both Bristol Myers Squibb and Merck KGaA that have a combined value of more than $2 billion.
.
4 May 2022",-0.25,22-05-04
Merck,"Medical Marketing and Media
Pfizer revenues slide 54%, Merck raises full-year forecast
The company added that it expects its COVID-19 vaccine to produce $13.5 billion, down 64% from 2022, while Paxlovid is expected to generate $8 billion, down 58%...
.
1 Aug 2023",0.0,23-08-01
Merck,"BioSpace
Merck Makes Another Big R&D Investment with $3.5B Orna Deal
Merck is pouring a potential $3.5 billion into a partnership with circular RNA company Orna Therapeutics to develop and commercialize multiple oncology and...
.
16 Aug 2022",0.0,22-08-16
Merck,"BioSpace
Merck Highlights Growth Strategy at J.P. Morgan
The drugmaker's presentation highlights its strong revenue growth, dominant vaccine business and expanding oncology portfolio. ... Powered by its oncology and...
.
10 Jan 2023",0.8176,23-01-10
Merck,"PMLiVE
Merck KGaA’s Glucophage approved in Europe as first oral diabetic medication for use during pregnancy
Merck KGaA's Glucophage approved in Europe as first oral diabetic medication for use during pregnancy ... The decision allows Glucophage to be used as the first...
.
28 Feb 2022",0.6808,22-02-28
Merck,"Financial Times
Merck KGaA: MS drug failure is a sour note for growth hopes
The flop of its experimental multiple sclerosis medicine in late-stage trials drained 12 per cent from the German drugmaker's share price on Wednesday. Merck...
.
6 Dec 2023",-0.1531,23-12-06
Merck,"Feedstuffs
Merck Animal Health introduces FLOCKSECURE Poultry Health Portal
Designed for the broiler industry, FLOCKSECURE provides a seamless solution to collect post-mortem data and easily upload it into the web-based portal. The...
.
8 Apr 2024",0.5719,24-04-08
Merck,"Mishcon de Reya LLP
Patents Court rejects Merck's SPC appeal
The Patents Court rejected an appeal by Merck Serono SA of a UKIPO decision, which had determined that it was not entitled to a Supplementary Protection...
.
1 Feb 2024",-0.7108,24-02-01
Merck,"New Jersey Business Magazine
Merck Reestablishes Global HQ in Rahway
The global pharmaceutical giant held a ribbon-cutting ceremony for the “reimagining” of its historic Rahway campus, which now officially serves as the company'...
.
20 Jun 2023",0.0,23-06-20
Merck,"Merck KGaA
WCD 2023: Cancer Doesn’t Care. But We Do.
WCD 2023: Cancer Doesn't Care. But We Do. ... Cancer doesn't care where you live, what you do, or who you are. Which is why equality in care is so important.
.
1 Feb 2023",-0.9407,23-02-01
Merck,"Irvine Times
Merck to hold Irvine recruitment event with more than 50 jobs available
Irvine jobs: Merck looking for potential new employees ... AN Irvine-based science and technology company will hold recruitment events next week with more than 50...
.
17 Feb 2022",0.0,22-02-17
Merck,"Nature
FDA approves Merck & Co’s pulmonary arterial hypertension drug sotatercept
FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept ... The US FDA has approved Merck & Co's first-in-class activin signalling inhibitor...
.
27 Mar 2024",0.802,24-03-27
Merck,"Reuters
US FDA declines to approve Merck's chronic cough drug
The FDA's decision gives some breathing room to rival GSK's (GSK.L) , opens new tab chronic cough treatment camlipixant, which is in late-stage development with...
.
21 Dec 2023",0.0,23-12-21
Merck,"Business Wire
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
The companies have entered into an exclusive license and collaboration agreement to develop seven investigational preclinical antibody-drug conjugates (ADC)...
.
22 Dec 2022",0.4588,22-12-22
Merck,"KTVZ
COVID-19 treatment, Keytruda boost drugmaker Merck in Q1
By TOM MURPHY AP Health Writer. Merck soared past first-quarter expectations, helped by sales of its long-standing blockbuster cancer drug Keytruda and a...
.
28 Apr 2022",0.296,22-04-28
Merck,"Fierce Pharma
ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm
Using Keytruda around surgery reduced the risk of disease recurrence, progression or death by 42% in patients with resectable stage 2 to 3b NSCLC.
.
3 Jun 2023",-0.886,23-06-03
Merck,"Fierce Biotech
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager ... Buying Harpoon will give Merck control of T-cell engagers aimed DLL3, BCMA and...
.
8 Jan 2024",0.7351,24-01-08
Merck,"Merck.com
Podcast: A candid conversation about diversity in clinical trials
A candid conversation about diversity in clinical trials. Hear a patient and a doctor share why they want more people involved in medical studies.
.
2 May 2024",0.3612,24-05-02
Merck,"BioSpace
Merck Returns to Alzheimer’s Disease with $1.1B Cerevance Pact
With an investment valued at up to $1.1 billion, Merck is diving back into Alzheimer's research through a collaboration with Cerevance.
.
9 Aug 2022",0.4939,22-08-09
Merck,"The Motley Fool
Is Merck Too Dependent on Keytruda?
Although Keytruda is a significant part of its business today, Merck isn't being too dependent on it, as is demonstrated by a strong pipeline and a plan for...
.
9 Nov 2022",0.296,22-11-09
Merck,"Optics.org
Universal Display acquires Merck’s OLED emitter intellectual property
Universal Display Corp. (“UDC”) has announced that through its wholly-owned subsidiary UDC Ireland, the company has acquired the phosphorescent OLED emitter...
.
4 May 2023",0.5106,23-05-04
Merck,"Reuters
Merck picks Goldman Sachs to launch pigments sale in 2023 – sources
German diversified group Merck KGaA (MRCG.DE) has tapped Goldman Sachs (GS.N) to revive a $1 billion sale of its pigments division.
.
17 Nov 2022",0.34,22-11-17
Merck,"PR Newswire
Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
XtalPi has pioneered a new model for drug R&D that leverages a tightly interwoven trifecta of AI, autonomous labs, and expert domain knowledge. The company...
.
14 Apr 2023",0.4215,23-04-14
Merck,"Inquirer.com
Ex-Merck CEO Ken Frazier and his coalition of business leaders plan to hire or promote 1M Black workers
Merck's former CEO Kenneth Frazier is spearheading the OneTen organization, which he calls “a coalition of leaders” at nearly 70 companies, including IBM,...
.
1 Jun 2022",0.3818,22-06-01
Merck,"Johns Hopkins University
Lauren Gardner wins Merck prize to advance pandemic tracking with artificial intelligence
Merck awarded the €500,000 prize (approximately $541,160) to Gardner today for her contributions to the development of artificial intelligence systems capable...
.
10 Jul 2024",0.9595,24-07-10
Merck,"Port City Daily
Anthony (“Tony”) Joseph Merck, 71
WILMINGTON — Anthony (“Tony”) Joseph Merck, age 71, passed away Wednesday, January 27, 2022, with family at his side. Born in Riverdale, North Dakota…
.
31 Jan 2022",0.0,22-01-31
Merck,"BioSpace
Merck Eyes Next-Generation Obesity Drugs That Offer Additional Benefits
Merck is focusing its R&D efforts on next-generation GLP-1 therapies that offer additional benefits beyond weight loss, according to company executives.
.
12 Jun 2024",0.4404,24-06-12
Merck,"Merck KGaA
Florian Schick appointed Managing Director and General Manager Merck (Schweiz) AG as well as Country Speaker for Merck in Switzerland
Florian Schick has been appointed Managing Director and General Manager of Merck (Schweiz) AG – the Healthcare business of the science and technology company...
.
1 Jun 2022",0.2732,22-06-01
Merck,"Merck.com
Why we’re expanding and investing in our research and discovery efforts
We're making significant investments in our research and discovery facilities and infrastructure in the US and around the world.
.
8 Jun 2022",0.2023,22-06-08
Merck,"Pharmaceutical Technology
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Merck's MilliporeSigma agrees to acquire Mirus Bio for $600m. The deal bolsters capabilities in viral vector manufacturing for advanced cell and gene therapies.
.
23 May 2024",0.5574,24-05-23
Merck,"Fierce Biotech
Merck & Co. inks $11B Prometheus takeover, firing starting gun on race for blockbuster bowel market
Merck & Co. inks $11B Prometheus takeover, firing starting gun on race for blockbuster bowel market ... Merck & Co. is paying $10.8 billion to buy Prometheus...
.
17 Apr 2023",0.0516,23-04-17
Merck,"Merck KGaA
The Next Revolution in Semiconductor Processing: Atomic Layer Etching
An ALE process works like an ALD process, except that material is removed, instead of added, one layer of atoms at a time.
.
19 May 2022",0.3612,22-05-19
Merck,"YouTube · CNBC Television
Chart of the Day: Merck
Merck is down 10% today. The Investment Committee discuss the biotech sector. For access to live and exclusive video from CNBC subscribe to CNBC PRO:...
.
30 Jul 2024",0.128,24-07-30
Merck,"BioSpace
FDA Approves Merck’s Welireg for Treating Renal Cell Carcinoma
Welireg was approved in 2021 to treat adults with von Hippel-Lindau disease, which is a genetic condition that causes non-cancerous tumors in the body to grow.
.
15 Dec 2023",0.802,23-12-15
Merck,"Contract Pharma
Hanmi, Merck Enter Clinical Collaboration & Supply Agreement
Hanmi Pharmaceutical will conduct a phase 1 clinical trial to evaluate the safety and efficacy of its immuno-oncology drug, BH3120, in combination with MSD's...
.
24 Apr 2024",0.7184,24-04-24
Merck,"PR Newswire
BlueVoyant Welcomes Seasoned Cybersecurity Leaders from Merck and Paramount
NEW YORK, June 2, 2022 /PRNewswire/ -- BlueVoyant, an industry-leading internal and external cyber defense platform, today announced that two new industry...
.
2 Jun 2022",0.4939,22-06-02
Merck,"Merck KGaA
A Champion for Our People
Maggie Lester is a champion for our people. Not only does she strategically develop and implement benefit programs, but she also works to set up support...
.
12 Jul 2024",0.7096,24-07-12
Merck,"Business Wire
Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs
The companies will jointly develop and potentially commercialize these ADC candidates worldwide, except in Japan where Daiichi Sankyo will maintain exclusive...
.
19 Oct 2023",0.0,23-10-19
Merck,"Merck KGaA
Collaboration with Agilent Technologies | Merck
Merck, a leading science and technology company, today announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical...
.
14 Jun 2022",0.0,22-06-14
Merck,"Reuters
Merck's COVID-19 pill active against Omicron in lab studies
Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active...
.
28 Jan 2022",0.4019,22-01-28
Merck,"Fierce Biotech
Merck battled 2 other Big Pharmas to the end in pursuit of $11B Prometheus deal
Merck CEO Rob Davis calling in an offer to acquire Prometheus for $150 per share with a closing target date of April 21.
.
2 May 2023",-0.5574,23-05-02
Merck,"Labiotech.eu
Merck and Kelun-Biotech collaborating on seven ADC cancer candidates
Under the agreement, Kelun-Biotech has granted Merck exclusive global licenses to research, develop, manufacture and commercialize multiple investigational...
.
23 Dec 2022",0.0772,22-12-23
Merck,"Business Wire
Merck Announces Third-Quarter 2024 Financial Results
In the third quarter of 2024, total worldwide sales were $16.7 billion, an increase of 4% compared with the third quarter of 2023; excluding the impact of...
.
31 Oct 2024",0.3182,24-10-31
Merck,"medwatch.com
Merck Denmark joins Novo Nordisk's injection pen recycling campaign
The program was expanded to include all pharmacies in Denmark from February 1, ensuring that valuable material is recycled. The initiative was named Returpen (”...
.
9 Mar 2022",0.6369,22-03-09
Merck,"Financial Times
Merck Covid antiviral pill did not cut hospitalisation risk, study finds
UK trial shows 'no difference' between taking molnupiravir or placebo in reducing clinical admissions during Omicron wave.
.
6 Oct 2022",0.1098,22-10-06
Merck,"Medical Marketing and Media
Merck acquires ophthalmology startup EyeBio in a deal worth up to $3B
Merck acquires ophthalmology startup EyeBio in a deal worth up to $3B. By scooping up EyeBio, Merck is expanding its ophthalmology offerings and bolstering its...
.
29 May 2024",0.4215,24-05-29
Merck,"FirstWord Pharma
Merck KGaA’s latest pipeline woes place more urgency on deals
Merck KGaA's latest pipeline woes place more urgency on deals ... Merck KGaA's shares fell as much as 10% on Tuesday as the latest late-stage failure – this time...
.
25 Jun 2024",-0.7845,24-06-25
Merck,"Fierce Pharma
Merck's recent Keytruda label expansion in NSCLC is more of a 'long-term' opportunity, CEO says
Don't expect the approval to boost sales of the megablockbuster much in the near future, CEO Rob Davis said on Thursday as the company presented its fourth...
.
2 Feb 2023",-0.1003,23-02-02
Merck,"Merck KGaA
Merck Introduces Modular Automation for Laboratories – A First for the Chemical Industry
Merck Introduces Modular Automation for Laboratories – A First for the Chemical Industry · Modular approach enables the necessary flexibility and diversity in...
.
14 Jul 2022",0.34,22-07-14
Merck,"Namibia Economist
Merck Foundation and African First Ladies mark World Cancer Day 2022 through providing training for 90 Oncologists from 25 Countries
Merck Foundation marks World Cancer Day together with Africa First Ladies and Ministries of Health through building cancer care capacity.
.
4 Feb 2022",-0.9001,22-02-04
Merck,"Science | AAAS
Milestones of Science | Science | AAAS
This vibrant poster highlights some of the most important milestones in those journeys and others, clearly demonstrating how the accumulation and synthesis of...
.
19 May 2022",0.8016,22-05-19
Merck,"Fierce Pharma
Duo no more: After M&A spree, Pfizer parts ways with Merck KGaA on Bavencio
Merck KGaA will have sole ownership of the PD-L1 antibody as the duo have decided to end their nine-year partnership.
.
28 Mar 2023",-0.296,23-03-28
Merck,"Pharmaceutical Technology
ModeX and Merck sign deal to develop Epstein-Barr Virus vaccine
ModeX Therapeutics has signed an exclusive global licence and collaboration deal with Merck to develop a vaccine candidate for Epstein-Barr Virus (EBV).
.
9 Mar 2023",0.128,23-03-09
Merck,"Fierce Pharma
Amgen, BMS and Merck have the most exposure as Big Pharma eyes $183B patent cliff: analyst
Biopharma has $183 billion of revenue at risk because of upcoming losses of exclusivity. But the industry has $383 billion of firepower to address the...
.
15 Jul 2024",-0.34,24-07-15
Merck,"Yahoo Finance
Merck & Co., Inc. (MRK) is One of The Best Cheap Stocks to Buy According to Billionaire Ray Dalio
In this article, we will look at where Merck & Co., Inc. (NYSE:MRK) ranks among the best cheap stocks to buy according to billionaire Ray Dalio.
.
8 Oct 2024",0.8555,24-10-08
Merck,"Boston Children's Answers
Walter’s world: ‘Warrior’ toddler doesn’t let a brain tumor stop him
After Walter's first Christmas was marred by the discovery of a rare brain cancer, his parents sought care at the Brain Tumor Center. When Walter Merck...
.
12 Jan 2023",-0.8225,23-01-12
Merck,"Investor's Business Daily
Is Beleaguered Big Pharma Merck Finally Staging A Comeback?
After hitting a high point at 119.65 last May, Merck stock pulled back almost 17% to hit a recent low at 99.80 in December. Since then, shares have bounded...
.
8 Jan 2024",0.0258,24-01-08
Merck,"Business Wire
Merck Global Health Innovation Fund and P74 Ventures Make Strategic Investment in TransVoyant for Intelligent, ‘Self Aware’ Supply Chain Platform
TransVoyant, the world's only global intelligent supply chain execution platform, announced it has closed its first strategic growth equity financing.
.
13 Dec 2022",0.8807,22-12-13
Merck,"The Economic Times
Merck names Dhananjay Singh as MD of Life Science business in India
In his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance alongside other...
.
9 Apr 2024",0.5267,24-04-09
Merck,"John Guilfoil Public Relations LLC
Whitman Child Battling Cancer Receives $5,000 Donation from Cops for Kids with Cancer
WHITMAN — Whitman Police Chief Timothy Hanlon is pleased to announce that a local family received a donation recently from Cops for Kids with Cancer during...
.
18 Jan 2022",-0.9246,22-01-18
Merck,"Business Wire
Merck to Participate in the Citi 2024 Global Healthcare Conference
Merck Research Laboratories are scheduled to participate in a fireside chat at the Citi 2024 Global Healthcare Conference on Thursday, Dec. 5, 2024, at 8:00 am...
.
26 Nov 2024",0.0,24-11-26
Merck,"Business Wire
Merck Foundation announced ‘‘Diabetes and Hypertension’’ Media Recognition Awards 2024 for Asian Countries
Merck Foundation Announced ""Diabetes and Hypertension"" Media Recognition Awards 2024 for Latin American Countries. SAN JOSÉ, Costa Rica--(BUSINESS WIRE)--Merck...
.
3 Apr 2024",0.7184,24-04-03
Merck,"CSRwire
STEM Mentorship Program Helps Underrepresented Students Shine
Merck scientists launched the STEM Hub for Industry Networking and Exchange (S.H.I.N.E.) program to work collaboratively across the pharmaceutical and...
.
11 Jul 2022",0.4767,22-07-11
Merck,"Clinical Trials Arena
Daiichi Sankyo and Merck dose first subject in ovarian cancer trial
Daiichi Sankyo and Merck (MSD) have dosed the first subject in the global Phase II/III REJOICE-Ovarian01 clinical trial of raludotatug deruxtecan (R-DXd) in...
.
4 Apr 2024",-0.6597,24-04-04
Merck,"Fast Company
The key to leadership? Kenneth Frazier says it’s all about adopting your company’s values
Erectile dysfunction is not a condition that Merck & Co. wants to treat. Why? For Kenneth Frazier, executive chairman of the pharmaceutical conglomerate,...
.
26 Apr 2022",0.4515,22-04-26
Merck,"KoreaTimes
[INTERVIEW] Merck's chip material head vows to bolster investment in Korea
With its positive view on the chip industry, Merck already announced in 2021 that it would invest 830 billion won ($660 million) in Korea by 2025. As part of...
.
8 Feb 2023",0.8074,23-02-08
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1)
Merck Receives Positive CHMP Opinion for KEYTRUDA Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric Cancer.
.
13 Oct 2023",0.7003,23-10-13
Merck,"Korea JoongAng Daily
Merck Award and Merck Young Scientists Award announced
This year's winner of the Merck Award was Noh Yong-young, professor of chemical engineering at Pohang University of Science and Technology (Postech), who has...
.
25 Aug 2022",0.936,22-08-25
Merck,"Reuters
Merck picks Goldman Sachs to launch pigments sale in 2023 – sources
German diversified group Merck KGaA has tapped Goldman Sachs to revive a $1 billion sale of its pigments division after previous attempts to sell the...
.
17 Nov 2022",0.34,22-11-17
Merck,"Nature
Macrocycle drugs serve up new opportunities
Merck & Co.'s PCSK9 inhibitor MK-0616 showcases the potential of macrocycles as oral drugs for extracellular targets.
.
11 Sept 2023",0.3182,
Merck,"Chemistry World
Merck & Co identifies nitrosamine source in diabetes drugs
Merck & Co identifies nitrosamine source in diabetes drugs ... US drug giant Merck & Co has found the cause of nitrosamine contaminants in three blockbuster...
.
1 Feb 2023",0.0,23-02-01
Merck,"Reuters
Early research suggests Merck cancer drug may target dormant HIV
Researchers studying Merck & Co Inc's cancer drug Keytruda for HIV patients who also have cancer say the immunotherapy may help displace the virus from...
.
27 Jan 2022",-0.91,22-01-27
Merck,"Reuters
Merck's Keytruda fails head and neck cancer trial
Merck & Co Inc (MRK.N) said on Wednesday its cancer therapy Keytruda failed to meet the main goal of a late-stage trial testing it in patients with head and...
.
20 Jul 2022",-0.9423,22-07-20
Merck,"FirstWord Pharma
ASCO24: Merck & Co.’s TROP2-targeting ADC cuts risk of progression, death by 69% in TNBC
Gilead Sciences' TROP2-directed ADC Trodelvy (sacituzumab govitecan) gained full FDA approval in 2021 for unresectable, locally advanced or metastatic TNBC and...
.
23 May 2024",-0.128,24-05-23
Merck,"PMLiVE
Merck shares positive phase 3 results for pulmonary arterial hypertension therapy
Merck shares positive phase 3 results for pulmonary arterial hypertension therapy ... Merck & Co – known as MSD outside of the US and Canada – has shared positive...
.
2 Dec 2024",0.9186,24-12-02
Merck,"BioProcess International
Q1 2024: Merck KGaA cites volatile CDMO biz and destocking for declined sales
Q1 2024: Merck KGaA cites volatile CDMO biz and destocking for declined sales. Q1 2024: Merck KGaA cites volatile CDMO biz and destocking for declined sales.
.
21 May 2024",0.0,24-05-21
Merck,"Merck KGaA
Merck Announces Plans for New U.S. Healthcare HQ in Boston | Merck
Merck Announces Plans for New U.S. Healthcare Headquarters in Boston's Seaport District. Merck today announced that it plans to move its U.S. Healthcare...
.
14 Nov 2023",0.0,23-11-14
Merck,"FirstWord Pharma
Merck & Co. shells out $4 billion upfront in mega ADC pact with Daiichi Sankyo
Merck & Co. shells out $4 billion upfront in mega ADC pact with Daiichi Sankyo ... Merck & Co. agreed to pay Daiichi Sankyo $4 billion upfront, in a deal...
.
19 Oct 2023",0.1779,23-10-19
Merck,"Fierce Pharma
Merck ends last Keytruda trial in aggressive prostate cancer campaign, takes separate hit in lung cancer
Merck ends last Keytruda trial in aggressive prostate cancer campaign, takes separate hit in lung cancer ... The last of four pivotal trials for Merck's Keytruda...
.
28 Feb 2023",-0.9674,23-02-28
Merck,"Cleveland.com
Cleveland-area hospitals will dispense new Merck and Pfizer COVID-19 pills taken at home; low supplies hamper
This mage provided by Merck & Co. shows their new COVID-19 antiviral medication, which can be taken at home and reduces the risk of hospitalization and death.
.
10 Jan 2022",-0.7964,22-01-10
Merck,"ROI-NJ
Merck appoints Romanelli to lead international human health business
Merck has appointed Joseph Romanelli to lead its Human Health International business, effective Aug. 1. Romanelli will report directly to Robert Davis,...
.
20 Apr 2022",0.4767,22-04-20
Merck,"Merck.com
Triple-negative breast cancer: risks, signs and symptoms, and diagnosis
TNBC is considered non-invasive breast cancer, and 91% percent of people diagnosed with localized TNBC are alive five years after diagnosis.
.
3 Oct 2023",-0.8519,23-10-03
Merck,"SAP News Center
Merck KGaA, Darmstadt, Germany Further Drives Its Digitalization – Joint Innovation with SAP
SAP SE (NYSE: SAP) announced a strategic partnership with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to jointly drive...
.
8 Feb 2023",0.3818,23-02-08
Merck,"CNBC
Merck's challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
Merck's challenge to medicare drug pricing could cause 'narrative shift' in pharma, says Jared Holz · CEOs are worried about uncertainty more than anything else...
.
6 Jun 2023",-0.4588,23-06-06
Merck,"Merck.com
Acting early in cancer detection
Acting early in cancer detection ... Time is important with a cancer diagnosis. People with cancer may have the opportunity for better outcomes when the disease...
.
18 Aug 2023",-0.9201,23-08-18
Merck,"Financial Times
Merck struggles to win European approval for Covid antiviral pill
The European Medicines Agency is unlikely to grant conditional marketing authorisation to Merck's Covid-19 antiviral pill this month as it grapples with “...
.
15 Feb 2022",0.7845,22-02-15
Merck,"Nasdaq
Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals
For Merck & Co in the Pharmaceuticals industry, the PE, PB, and PS ratios are all low compared to peers, indicating potential undervaluation. However, the low...
.
3 Oct 2024",-0.1027,24-10-03
Merck,"Endpoints News
Chinese pharma giant Hengrui launches new company for globalization play — with a Merck KGaA vet at the helm
Serving as a wholly owned subsidiary of Hengrui Pharma, Luzsana will be provided Hengrui's pipeline of programs, spanning over 250 clinical studies, to develop...
.
18 May 2022",0.34,22-05-18
Merck,"CTech
Biolojic Design lands drug discovery collaboration with Merck potentially worth up to 346 million euros
The partnership will leverage Biolojic Design's AI-driven discovery platform to design therapeutic antibodies for the treatment of cancer and immunological...
.
3 Jun 2024",-0.5423,24-06-03
Merck,"Forbes
Why Did Merck Stock Rise 65%?
an increase of about 50% for the S&P 500 over this period. This can primarily be attributed to a significant 50% rise in the company's revenue to $62 billion...
.
6 Sept 2024",0.4767,
Merck,"Global Venturing
Merck Group's CVC to help South Korean uni assess startups -
M Ventures, the corporate venture capital arm of German pharmaceutical firm Merck Group, will assist university Korea Advanced Institute of Science and...
.
12 Jun 2024",0.5719,24-06-12
Merck,"Labiotech.eu
Merck contributing to Jacobio Pharma colorectal cancer clinical trial
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer. Jacobio is...
.
13 Oct 2022",-0.8689,22-10-13
Merck,"CNBC
Merck says experimental RSV shot protected infants in trial, paving way for potential approval
Merck on Thursday said its experimental shot designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial,...
.
17 Oct 2024",0.9042,24-10-17
Merck,"Fierce Biotech
Roche pays $7B to challenge Merck for bowel disease market, intensifying TL1A feeding frenzy
The Swiss drugmaker has agreed to pay Roivant and Pfizer $7.1 billion upfront for regional rights to a bowel disease candidate that is on the cusp of phase 3.
.
23 Oct 2023",-0.0772,23-10-23
Merck,"Reuters
Merck defeats 500 lawsuits over Fosamax bone-fracture risk warnings
Merck & Co has convinced a judge to toss more than 500 lawsuits alleging it failed to warn Fosamax users about the risks of developing thigh bone fractures.
.
24 Mar 2022",-0.872,22-03-24
Merck,"Business Wire
Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer to Stop for Futility
KEYTRUDA is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. This indication is...
.
25 Jan 2023",-0.8555,23-01-25
Merck,"Healio
FDA approves Merck’s pneumococcal vaccine for adults
US FDA approves Capvaxive (pneumococcal 21-valent conjugate vaccine) for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults. https...
.
18 Jun 2024",0.6597,24-06-18
Merck,"Drexel
Exposing the Possibilities with Graduate Co-op
After earning her undergraduate degree in management information systems, Zoe Weiner, MS cybersecurity '23, knew that she wanted a graduate program with...
.
20 Sept 2022",-0.2732,
Merck,"Fierce Pharma
Fierce Pharma Asia—Akeso, Summit's Keytruda-beating data; BIOSECURE's House passage; Candid's $370M debut
Akeso and Summit Therapeutics' ivonescimab showed strong efficacy against Merck's Keytruda in a phase 3 trial in China. The BIOSECURE Act sailed through a...
.
13 Sept 2024",0.5106,
Merck,"CNBC
Merck sues Biden administration over Medicare drug price negotiations
Global drugmaker Merck on Tuesday sued the Biden administration over Medicare's new powers to substantially reduce drug prices for seniors under the Inflation...
.
6 Jun 2023",0.0,23-06-06
Merck,"Science | AAAS
Merck locates frozen batch of undisclosed Ebola vaccine, will donate for testing in Uganda’s outbreak
An experimental vaccine for an ebolavirus (pictured) was thought destroyed by its developer, Merck, but may now be used in a clinical trial in Uganda.
.
23 Oct 2022",-0.2732,22-10-23
Merck,"BioSpace
Patent Proceedings: Merck’s Favorable Result and Amgen’s Supreme Court Case
The lawsuit involved two Merck patents. One is set to expire on Nov. 24, 2026, with pediatric exclusivity extending to May 24, 2027. The second patent is for...
.
23 Sept 2022",0.7003,
Merck,"CSRwire
Merck: Supporting Colleagues Working With Cancer
At Merck, we're dedicated to supporting people living and working with cancer around the world.
.
4 May 2023",-0.25,23-05-04
Merck,"BioSpace
Merck’s BTK Inhibitor Evobrutinib Slapped with Partial Clinical Hold
The FDA has placed a partial clinical hold on Merck KGaA Darmstadt Germany's Phase III EVOLUTION trial studying its investigational BTK inhibitor evobrutinib...
.
13 Apr 2023",-0.1531,23-04-13
Merck,"Fierce Biotech
ESMO: Merck, flush with ADCs, eyes differentiation in massive Daiichi deal
Merck & Co., known as MSD here, signed a multi-billion-dollar deal with Daiichi Sankyo, taking on the Japanese company's next round of ADCs.
.
20 Oct 2023",0.0,23-10-20
Merck,"The Washington Post
Merck sues over Medicare price negotiations
Merck sues over Medicare price negotiations ... The pharmaceutical giant Merck sued the Biden administration on Tuesday in a bid to block Medicare from...
.
6 Jun 2023",-0.4404,23-06-06
Merck,"Reuters
Merck raises outlook for electronics and healthcare, sees improved chip market demand
Raising its full year guidance of organic net sales growth on Thursday to 4% to 8% for electronics from 0 to 4% earlier, Merck said it expected ""the remaining...
.
1 Aug 2024",0.6369,24-08-01
Merck,"Fierce Pharma
ESMO: Merck's Keytruda-Lenvima flop hands Novartis-BeiGene, Hengrui a brighter liver cancer future
ESMO: Merck's Keytruda-Lenvima flop hands Novartis-BeiGene, Hengrui a brighter liver cancer future ... Merck's Keytruda-Lenvima failure leaves Jiangsu Hengrui...
.
8 Sept 2022",-0.9136,
Merck,"Yicai Global
Zhifei Gains as Chinese Vaccine Maker Renews Merck Deal Involving USD14.8 Billion of Jabs
Shares in Chongqing Zhifei Biological Products climbed as much as 4.3 percent today, before falling as investors cashed in.
.
30 Jan 2023",0.4588,23-01-30
Merck,"Seeking Alpha
Merck Vs. GSK: The Game-Changer Race In Pharma Excellence (GLAXF)
While we continue our analytics coverage of both companies with an ""outperform"" rating, GSK has a more diversified portfolio of experimental drugs and vaccines,...
.
22 Sept 2023",0.6249,
Merck,"Business Wire
Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
Merck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable...
.
12 Sept 2024",0.6597,
Merck,"BioWorld MedTech
War puts trials in jeopardy across Europe; Merck axes recruitment in Russia and Ukraine
Hundreds of clinical trials could be in jeopardy amid the chaos and destruction of war, with pharma giant Merck & Co. Inc. saying it is putting recruitment for...
.
9 Mar 2022",-0.9698,22-03-09
Merck,"Veterinary Practice News
Pour-on NSAID for mastitis-induced fever in cattle OKed by FDA
Merck Animal Health receives U.S. Food and Drug Administration (FDA) approval of expanded indication for BANAMINE TRANSDERMAL for the control of fever in...
.
22 Feb 2023",0.4767,23-02-22
Merck,"BioSpace
New Research and Innovation Hub to Open in Former Merck HQ in New Jersey
An R&D campus that formerly served as Merck's global headquarters is now set to reopen and become the Northeast Science and Technology (NEST) Center in...
.
6 Jun 2023",0.3818,23-06-06
Merck,"BioPharma Dive
Merck to buy inflammatory disease drugmaker Prometheus for $10.8B
Merck & Co. has reached a deal to acquire Prometheus Biosciences for about $10.8 billion, betting an experimental drug the biotechnology company is developing...
.
16 Apr 2023",0.1027,23-04-16
Merck,"BioPharma Dive
Merck cardiovascular drug succeeds in study, validating $11B buyout bet
Success with sotatercept is important for Merck as the patents for its biggest moneymaker, the cancer drug Keytruda, near expiration in 2028. If successful,...
.
10 Oct 2022",0.6908,22-10-10
Merck,"Medical Dialogues
Merck appoints Helene von Roeder as new CFO
Darmstadt: Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board of Merck as of June 30, 2023.
.
9 May 2023",0.0,23-05-09
Merck,"今日中国
A Merck of Partnership
The German pharmaceutical giant's plans for China remain long-term and its investment policy unchanged after eight decades despite geopolitics.
.
28 Nov 2022",0.0,22-11-28
Merck,"Independent Mail
Daniel wide receiver Eli Merck to Oklahoma football as preferred walk-on
Daniel wide receiver Eli Merck to Oklahoma football as preferred walk-on ... D.W. Daniel all-time leader in receiving yards Eli Merck announced Wednesday he has...
.
25 Jan 2023",0.0,23-01-25
Merck,"Fierce Pharma
ESMO: Merck unpacks a mixed bag of gynecological cancer results for Keytruda
The FDA approved Keytruda to treat patients with stage 3 to 4a cervical cancer alongside chemotherapy in January based on the first interim analysis of Merck's...
.
13 Sept 2024",-0.6486,
Merck,"Reuters
Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
.
17 Dec 2024",-0.9442,24-12-17
Merck,"BBC
Pharma giant Merck to create 500 jobs in Glasgow and Stirling
Pharma giant Merck to create 500 jobs in Glasgow and Stirling ... German pharmaceutical giant Merck has announced plans to create nearly 500 jobs in Scotland, as...
.
1 Jun 2023",0.6486,23-06-01
Merck,"The Motley Fool
Is Merck Stock a Buy?
Merck's Keytruda could face competition from a newer medicine. The company's crown jewel will also lose patent exclusivity in a few years.
.
29 Sept 2024",-0.4767,
Merck,"Fierce Biotech
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
Merck's V116—which is a 21-valent conjugate vaccine designed for adults—stacked up favorably against PPSV23, a 23-valent polysaccharide vaccine that was...
.
29 Apr 2024",0.6908,24-04-29
Merck,"Fierce Biotech
Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape'
Merck in September 2020 ponied up $600 million for the ADC, alongside a $1 billion investment in Seagen, at the time known as Seattle Genetics. The companies...
.
3 Aug 2023",0.0,23-08-03
Merck,"Medical Marketing and Media
Moderna lands Merck’s Garay as commercial chief
Garay Pharma marketing maven Arpa Garay is swapping the pharma C-suite for the biotech one. Moderna has wooed the 16-year Merck vet to join as chief commercial...
.
27 Apr 2022",0.296,22-04-27
Merck,"Fierce Pharma
Another Keytruda-Lenvima ambition is dashed as Merck, Eisai end head and neck cancer trial
Merck and Eisai found that their combination of Keytruda and Lenvima couldn't improve life expectancy compared with Keytruda alone in patients with PD-L1-...
.
25 Aug 2023",-0.8319,23-08-25
Merck,"The Daily Item
UPDATE Merck to close Cherokee plant in Riverside, impacting 300 full-time workers
Merck plans to phase out its Cherokee Plant, beginning in 2024, affecting approximately 300 full-time workers, the company confirmed on Wednesday.
.
24 Mar 2022",0.0,22-03-24
Merck,"Fierce Biotech
Merck KGaA nabs another baton in protein degradation race with $554M Proxygen deal
Merck KGaA has decided it needs more than one baton in the metaphorical clinical relay race, inking a $554 million deal with Austrian biotech Proxygen.
.
2 Jun 2022",-0.5267,22-06-02
Merck,"Fierce Pharma
Merck settles with insurance companies over $1.4B claim tied to 2017 cyberattack: report
Merck settles with insurance companies over $1.4B claim tied to 2017 cyberattack: report ... Merck has reportedly settled with insurance companies that contested...
.
5 Jan 2024",0.0,24-01-05
Merck,"Benedictine College
The Merck Family – Benedictine College’s 2022 Family of the Year
Michael and Kristin Merck raised a large family of 10 children in Ham Lake, Minnesota. As their oldest child approached college age in 2004, they began looking...
.
21 Sept 2022",0.0,
Merck,"Fierce Pharma
NICE gives thumbs-down to 5 COVID-19 drugs including AZ's Evusheld and Merck's Lagevrio
Related ... While cost is NICE's issue with Lagevrio and Veklury, effectiveness is the primary concern with the other three—all antibody treatments. “It is highly...
.
16 Nov 2022",0.5473,22-11-16
Merck,"Yahoo Finance
Strong Fundamentals And Weight Loss Entry Make Merck (MRK) A Buy
Merck has partnered with Hansoh, a Chinese biopharmaceutical company, for a global licensing deal to develop an oral GLP-1 receptor agonist for the...
.
18 Dec 2024",0.25,24-12-18
Merck,"Merck.com
Driving prostate cancer research forward
For those patients who are diagnosed with early stage prostate cancer, the prognosis is promising, with a five-year survival rate of nearly 100%. However, for...
.
4 Sept 2024",-0.7964,
Merck,"Merck.com
Dean Li: Agility is ‘about letting the data guide you’
Dean Li: Agility is 'about letting the data guide you' ... For Dean Li, knowing how to foster an environment of curiosity and cultivate the agility necessary to...
.
13 Jan 2022",0.0,22-01-13
Merck,"Financialexpress
Merck opens Microbiology Application Lab in Bengaluru’s Jigani
The science and technology company claimed that this lab will provide facilities and technical expertise to support India's life science community on microbial...
.
21 Jul 2022",0.4019,22-07-21
Merck,"Fierce Pharma
With new FDA approval, Merck's Welireg takes another step toward blockbuster goal
In the last three quarters, Welireg sales have climbed from $42 million to $50 million to $54 million. When it was approved in 2021, Bernstein analysts pegged...
.
15 Dec 2023",0.8689,23-12-15
Merck,"FirstWord Pharma
Merck & Co.'s 21-valent pneumococcal jab gears up for Prevnar 20 rivalry
Eliav Barr, chief medical officer at Merck Research Laboratories, said the STRIDE-3 results - which are being shared with regulatory bodies - provide ""strong...
.
28 Nov 2023",0.34,23-11-28
Merck,"Reuters
Merck to take legal action against unauthorized distributors of its COVID treatment in China
Merck & Co said on Wednesday it would take legal action against some pharmaceutical companies after noticing that some manufacturers were supplying COVID-19...
.
11 Jan 2023",0.25,23-01-11
Merck,"Fierce Pharma
Pfizer shines in doctor poll, winning praise for innovative ads and leadership across therapeutic areas
A survey of 160 doctors found the Big Pharma is seen as a leader in three out of five therapeutic areas and recognized for its innovative ads.
.
15 May 2023",0.9153,23-05-15
Merck,"Merck KGaA
Hengrui Oncology Collaboration | Merck
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate. Merck...
.
30 Oct 2023",0.4019,23-10-30
Merck,"Fierce Biotech
Merck finds drug discovery DALL-E, becoming early user of small molecule generative AI tool
Merck found the pitch sufficiently compelling to become an early-access user. The company, like its peers, is exploring the ways that teams across its...
.
25 Jan 2024",0.5267,24-01-25
Merck,"BioStock
Aqilion and Merck sever ties
Aqilion and Merck sever ties ... Aqilion announced the termination of the licensing and collaboration agreement with Merck for the joint development of the TAK1...
.
27 Jun 2024",0.4939,24-06-27
Merck,"South China Morning Post
Chinese firms approved to make Merck’s Covid-19 pills for poor countries
Shanghai Fosun Pharmaceutical, BrightGene Bio-Medical Technology, Shanghai Desano Pharmaceuticals and Lonzeal Pharmaceuticals have permission to produce both...
.
21 Jan 2022",-0.0772,22-01-21
Merck,"Successful Farming
Merck Animal Health to Acquire Virtual Livestock Fencing Developer
Merck Animal Health to Acquire Virtual Livestock Fencing Developer. Merck Animal Health has announced that it will acquire Vence, a California-based virtual...
.
27 Sept 2022",0.5859,
Merck,"Reuters
Germany's Merck under formal investigation in France over thyroid drug
German drugmaker Merck KGaA (MRCG.DE) said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading...
.
19 Oct 2022",0.0,22-10-19
Merck,"Fierce Biotech
Merck seals $610M biobucks deal to acquire preclinical neurodegenerative biotech Caraway
Merck seals $610M biobucks deal to acquire preclinical neurodegenerative biotech Caraway ... Merck & Co. has made no secret of its ongoing hunt for acquisitions,...
.
21 Nov 2023",-0.296,23-11-21
Merck,"PR Week
PRWeek 40 Under 40 2022 - Johanna Herrmann, Merck
Johanna Herrmann's 15-year career in PR included four years as a director at Gagen MacDonald where she oversaw integrated communications support for Johnson &...
.
2 Aug 2022",0.4019,22-08-02
Merck,"Merck.com
What is One Pipeline?
Our One Pipeline strategy enables us to advance breakthrough science, whether it comes from our own labs or from our partners' labs, and make medicines and...
.
30 May 2024",0.0,24-05-30
Merck,"PharmaVoice
Keytruda is the gift that keeps on giving for Merck, and here’s what’s next for the cancer juggernaut
Here, Lubiniecki talks about Keytruda's successes as it approaches a decade on the market, what the long-term benefit of the drug means for patients and the...
.
3 Oct 2022",0.7579,22-10-03
Merck,"Mesothelioma Center
Court Rules Merck, Not Bayer Responsible in Talc Lawsuits
Delaware's highest court clarified that Merck is responsible for claims that predate Bayer's acquisition. Lawsuits claim talc used in products like Dr. Scholl's...
.
5 Dec 2023",0.1625,23-12-05
Merck,"PPF Group
New LAG3 data advance Merck cancer strategy behind Keytruda
New LAG3 data advance Merck cancer strategy behind Keytruda. Merck's next class of checkpoint blockers took a step forward at ASCO with data suggesting anti-...
.
28 May 2022",-0.8689,22-05-28
Merck,"Financial Times
Merck bid for Japanese chip materials maker triggers state-backed fund deal
Four people with direct knowledge of the talks said it was Merck's bid for JSR, which was not disclosed to shareholders, that led to the $6.4bn tender offer in...
.
31 Dec 2023",0.0,23-12-31
Merck,"ACS Publications
Merck lung disease drug gets FDA nod
The US Food and Drug Administration has approved a fusion protein made by Merck & Co. for a life-threatening lung disorder. Sotatercept, which is marketed...
.
23 Aug 2024",0.0258,24-08-23
Merck,"Fierce Biotech
UK's Astex adds onto Merck partnership via $35M upfront for tumor suppressor protein candidates
UK's Astex adds onto Merck partnership via $35M upfront for tumor suppressor protein candidates ... Astex Pharmaceuticals knows a thing or two about working with...
.
8 Aug 2023",-0.6369,23-08-08
Merck,"Fierce Biotech
Pfizer, AstraZeneca, Merck KGaA-backed Israeli AI incubator launches first biopharma startup
AION Labs—described as an alliance of global pharmas, tech leaders and investors that launched late last year—is raising the curtain on OMEC.AI, a venture...
.
28 Sept 2022",0.128,
Merck,"Business Wire
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
Merck, through a subsidiary, will acquire Harpoon for $23.00 per share in cash for an approximate total equity value of $680 million.
.
8 Jan 2024",0.5574,24-01-08
Merck,"Reuters
US FDA staff flags concerns about Merck's chronic cough drug
The U.S. health regulator's staff on Wednesday flagged concerns that data on Merck's chronic cough drug might not be enough to prove the treatment's...
.
15 Nov 2023",0.0,23-11-15
Merck,"Fierce Pharma
Top 10 most anticipated drug launches of 2024
Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and...
.
29 Jan 2024",0.2023,24-01-29
Merck,"Reuters
Merck sues US government to halt Medicare drug price negotiation
Merck & Co (MRK.N) sued the US government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA...
.
6 Jun 2023",0.0,23-06-06
Merck,"Fierce Biotech
Merck pays $588M for bispecific to defend Keytruda’s kingdom from emerging threat
Merck pays $588M for bispecific to defend Keytruda's kingdom from emerging threat ... Merck & Co. is paying $588 million upfront to defend its Keytruda kingdom.
.
14 Nov 2024",-0.7783,24-11-14
Merck,"Fierce Biotech
Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data
Merck and Daiichi reported an objective response rate (ORR) of 54.8% in the 42 patients who received 12 mg/kg of I-DXd.
.
9 Sept 2024",-0.1779,
Merck,"EurekAlert!
International partnership may hold the key to new cancer therapies
WEHI has joined forces with the leading science and technology company Merck KGaA, Darmstadt, Germany on a drug discovery campaign to find new cancer...
.
6 Apr 2022",-0.69,22-04-06
Merck,"Fierce Pharma
Merck, Ginkgo Bioworks strike deal worth up to $490M to 'optimize' biologics manufacturing
Merck, Ginkgo Bioworks strike deal worth up to $490M to 'optimize' biologics manufacturing ... Merck & Co. ... After striking a deal centered on enzyme production...
.
7 Aug 2023",0.2023,23-08-07
Merck,"PR Newswire
Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
Share this article ... BOSTON, March 28, 2023 /PRNewswire/ -- Ratio Therapeutics Inc. ... Under the terms of the agreement, Merck will provide Ratio with several...
.
28 Mar 2023",0.8225,23-03-28
Merck,"Merck.com
Empowering others to speak up about HPV-related cancers
Esposito plans to continue helping men and women feel comfortable discussing HPV-related disease and get the preventative care they need.
.
5 Jan 2024",0.8271,24-01-05
Merck,"www.fenwick.com
Fenwick Represents Merck Global Health Innovation Fund in N-Power Medicine’s Series B Funding
The round, which brought N-Power Medicine's total funding to date to $72 million, was led by Merck Global Health Innovation Fund, with participation from a US-...
.
1 Jul 2024",0.6369,24-07-01
Merck,"Fierce Biotech
Merck looks to cardiovascular pipeline for $10B-plus peak sales—and diversification from Keytruda
Merck & Co. is looking to its cardiovascular portfolio in hopes of finding $10 billion in peak revenue by the mid-2030s—depending on the approval of eight...
.
5 Apr 2022",0.7096,22-04-05
Merck,"MedCity News
Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda
Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation...
.
19 Nov 2024",0.5106,24-11-19
Merck,"CNBC
Merck results beat expectations despite a big drop in sales of Covid antiviral treatment
Merck on Thursday reported first-quarter revenue and adjusted earnings that topped Wall Street's expectations, despite a steep drop in sales of its Covid...
.
27 Apr 2023",0.3875,23-04-27
Merck,"PMLiVE
Merck and Astellas/Pfizer’s bladder cancer combination granted EC approval
Keytruda (pembrolizumab) and Astellas/Pfizer's Padcev (enfortumab vedotin) have been approved by the European Commission (EC) as a first-line combination...
.
2 Sept 2024",0.3612,
Merck,"Indian Pharma Post
Merck Animal Health receives positive CVMP opinion for an injectable formulation of Bravecto
Merck Animal Health announced that the European Medicines Agency's Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BRAVECTO...
.
12 Dec 2023",0.802,23-12-12
Merck,"pharmaphorum
Merck sees big lift in Keytruda sales, as Senate probes its taxes
The lawmakers claim Merck could have avoided billions of dollars in tax by booking most of its sales and profits made on Keytruda through subsidiaries outside...
.
28 Jul 2022",0.128,22-07-28
Merck,"Medical Marketing and Media
Merck campaign is here to Outnumber PAH challenges
Though the Outnumber PAH campaign did not mention Winrevair, Wisler pressed that the ultimate goal of the campaign is not to promote a drug but rather to raise...
.
17 May 2024",-0.1134,24-05-17
Merck,"BioPharma Dive
Merck claims late-stage study success for RSV antibody
Merck claims late-stage study success for RSV antibody. Executives have said that the drug, called clesrovimab, may be differentiated from Sanofi and...
.
23 Jul 2024",0.8126,24-07-23
Merck,"Merck KGaA
Merck Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
Merck Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour · Curiosity Cube mobile science lab plans to reach 45,000 students in 14 countries...
.
17 Apr 2024",0.7096,24-04-17
Merck,"Speciality Chemicals Magazine
Merck KGaA breaks ground in Taiwan
Merck KGaA breaks ground in Taiwan ... Merck KGaA has broken ground for a new production facility on a 150,000 m2 site for its Semiconductor Solutions business at...
.
13 Feb 2023",-0.34,23-02-13
Merck,"Merck KGaA
Collaboration for more sustainable gas solutions | Merck
Merck and Micron join forces for more sustainable gas solutions in the semiconductor industry. Merck and Micron look back on a long-standing, trusted business...
.
3 Aug 2022",0.8035,22-08-03
Merck,"CNBC
Merck says Keytruda injection on par with approved IV version in trial
Merck says Keytruda injection on par with approved IV version in trial ... Merck said on Tuesday a study showed that its injectable version of cancer drug...
.
19 Nov 2024",0.0516,24-11-19
Merck,"BioSpectrum Asia
Korea's Genome and Company partners with Merck for cancer drug trial
Genome and Company will conduct a phase 2 clinical trial to evaluate the safety and efficacy of its immuno-oncology microbiome therapeutic, 'GEN-001', in...
.
4 Mar 2022",-0.3818,22-03-04
Merck,"Merck KGaA
Molsheim Expansion - News | Merck
Merck strengthens its manufacturing capabilities for single-use assemblies by investing more than € 130 million in Molsheim, France.
.
8 Sept 2022",0.4588,
Merck,"Reuters
Indonesia to produce Merck's HPV vaccines to combat cervical cancer
Indonesian authorities aim to give the shots to 1.4 million girls next year, the company said, adding it aimed to produce 2.8 million doses given the two-shot...
.
13 Dec 2022",-0.7783,22-12-13
Merck,"Fierce Biotech
Vera finally notches a win for Merck KGaA castoff in autoimmune kidney disease
Vera Therapeutics announced Tuesday after market that atacicept reduced a biomarker linked to improved kidney function in patients with a severe autoimmune...
.
3 Jan 2023",0.6486,23-01-03
Merck,"Financial Times
Merck/Prometheus: Big Pharma must swallow bigger premiums
Merck announced that it would acquire Prometheus Biosciences for $10.8bn. It is paying Prometheus shareholders a 72 per cent premium over the three-month...
.
17 Apr 2023",0.0,23-04-17
Merck,"Fierce Pharma Biopharma News & Insights
Merck KGaA forms new life sciences unit in push to strengthen its CDMO position
Under the LSS moniker, Merck KGaA will roll its existing CDMO, plus contract testing units and associated marketing, sales, R&D and more into one group. The...
.
8 Feb 2022",0.3182,22-02-08
Merck,"CIDRAP
Generic drug makers sign on to make Merck COVID-19 antiviral
The drug developers, which include Merck, Ridgeback Biotherapeutics, and Emory University, have agreed to forego sales royalties as long as COVID-19 is...
.
20 Jan 2022",0.2732,22-01-20
Merck,"Fierce Pharma
Merck KGaA, Haleon warn of more inflation challenges in 2023
Merck KGaA anticipates “slight to solid” revenue growth for the year. The company expects profits to decline, Reuters notes.
.
2 Mar 2023",0.6887,23-03-02
Merck,"Business Wire
Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Merck will gain global exclusive rights to develop and commercialize opevesostat and other candidates targeting CYP11A1 covered by the agreement.
.
1 Jul 2024",0.4404,24-07-01
Merck,"FirstWord Pharma
Merck & Co. starts late-stage study of TROP2-directed ADC in lung cancer
Merck & Co. has started a Phase III study of MK-2870 in patients with previously treated advanced or metastatic non-squamous non-small-cell lung cancer (NSCLC)
.
11 Oct 2023",-0.8316,23-10-11
Merck,"Fierce Biotech
Merck & Co. ditches oncolytic virus Cavatak 4 years after buying Viralytics
Merck & Co. ditches oncolytic virus Cavatak 4 years after buying Viralytics ... Merck & Co. ... Merck & Co. is bidding adieu to the oncolytic virus acquired from...
.
27 Oct 2022",0.0,22-10-27
Merck,"Indian Chemical News
Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at...
.
23 May 2022",0.5574,22-05-23
Merck,"Fierce Pharma
Merck KGaA suffers CDMO slump after 'sharp drop' in COVID-related sales, CFO says
The Darmstadt, Germany-based company's contract manufacturing division took a major hit from production timing and COVID-related sales downturns.
.
3 Aug 2023",-0.6369,23-08-03
Merck,"Reuters
Merck KGaA suffers major blow as MS drug fails in late-stage trials
Merck KGaA's (MRCG.DE) experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a major blow to the...
.
6 Dec 2023",-0.7964,23-12-06
Merck,"Yahoo Finance
Merck & Co. Inc. (MRK): A Good Undervalued Blue Chip Stock to Buy According to Analysts
What matters most is the overall trajectory of rates moving forward, and as long as employment data remains stable, the Federal Reserve and the market are...
.
26 Sept 2024",0.6369,
Merck,"BioPharma Dive
Merck gets FDA decision date for new pneumococcal vaccine
Merck also won a U.S. approval for a new pneumococcal vaccine, Vaxneuvance, in 2021. That shot, which protects against 15 strains, supplements the...
.
19 Dec 2023",0.7845,23-12-19
Merck,"Merck.com
Proteins in space: taking our research to the final frontier
Reichert was one of the first scientists in the pharmaceutical industry to propose studying protein crystallization under microgravity conditions.
.
29 Jun 2022",0.0,22-06-29
Merck,"The New York Times
A Covid pill from Merck showed more promise in reducing the risk of hospitalization in a recent study. (Published 2022)
The Food and Drug Administration in December authorized molnupiravir for emergency use by certain adults who were at high risk. The drug is available by...
.
19 Feb 2022",-0.2748,22-02-19
Merck,"Merck.com
Our Q2 2023 earnings report
Our Q2 2023 earnings report ... Merck's (NYSE: MRK) Q2 2023 results reflect sustained underlying growth. Our company announced Q2 worldwide sales of $15.0 billion...
.
1 Aug 2023",0.3818,23-08-01
Merck,"BioSpace
Bigger and Better: Merck, MBI, Element Add New Jobs and Facilities
This week, pharma giant Merck announced it is expanding in both area and headcount with its new Cambridge, Massachusetts, office at 320 Bent Street in Kendall...
.
27 May 2022",0.4404,22-05-27
Merck,"www.politico.eu
Why thyroids should be a NCD: spread the word
Why protecting the 'master controller' of our metabolism is key to health and wellbeing; and how classing thyroid disorders as noncommunicable diseases...
.
17 Jan 2022",0.0,22-01-17
Merck,"BioWorld MedTech
Merck KGaA presents MSC-4106, an orally active, potent inhibitor of the YAP/TAZ-TEAD interaction binding to the P-site of TEAD1
Merck KGaA presents MSC-4106, an orally active, potent inhibitor of the YAP/TAZ-TEAD interaction binding to the P-site of TEAD1 ... The chemical starting point to...
.
12 Sept 2022",0.5859,
Merck,"Reuters
Merck, Ridgeback withdraw COVID drug application in EU
Merck and Co (MRK.N) and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union.
.
27 Jun 2023",0.0,23-06-27
Merck,"Fierce Biotech
Merck & Co. digs into TIGIT fail, sharing survival data from phase 2 lung cancer trial
Merck & Co. digs into TIGIT fail, sharing survival data from phase 2 lung cancer trial ... Merck & Co. has cracked open the casket of its failed phase 2 TIGIT...
.
7 Dec 2023",-0.9382,23-12-07
Merck,"Pharmaceutical Technology
Merck reports drop in net income for fiscal 2023
Merck KGaA (Merck) has reported a decline in financial performance for the fiscal year 2023, with net income attributable to shareholders falling by 15.1% to €...
.
7 Mar 2024",-0.4019,24-03-07
Merck,"Emory University
Merck Prize boosts work on air sensor for pandemic pathogens
The Salaita lab's sensor, a rolling micro-motor called “Rolosense,” holds the potential to help mitigate, or even prevent, a pandemic. Khalid...
.
11 Jul 2023",0.8126,23-07-11
Merck,"BioSpace
Merck Sets $10 Billion Target for Cardiovascular Pipeline by Mid-2030
Merck's cardiopulmonary pipeline is poised to deliver eight potential approvals over the next eight years, bolstering its pipeline and revenue. By mid-2030, the...
.
5 Apr 2022",0.25,22-04-05
Merck,"Fierce Biotech
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Pfizer is the dominant force in the adult U.S. pneumococcal vaccine market, with Prevnar 20 holding a 95% share in the third quarter, but Merck believes its...
.
28 Nov 2023",0.1531,23-11-28
Merck,"Pharmaceutical Technology
Merck KGaA links with BenevolentAI and Exscientia to expand AI capabilities
Merck KGaA has announced two new strategic partnerships with Benevolent AI and Exscientia to support its artificial intelligence (AI)-driven drug discovery...
.
20 Sept 2023",0.8957,
Merck,"Multiple Sclerosis News Today
ModeX teams up with Merck to develop MDX-2201 vaccine for EBV |...
Share this article: ... This illustration shows a handshake, close up, between two people. ... A new collaboration between ModeX Therapeutics and Merck, known as...
.
15 Mar 2023",0.296,23-03-15
Merck,"Reuters
Merck to buy Prometheus Biosciences for about $11 billion
Merck will pay $200 per share for the California-based biotechnology company that specializes in treatments for autoimmune diseases, representing a 75.4%...
.
17 Apr 2023",0.2023,23-04-17
Merck,"National Hog Farmer
Merck Animal Health receives FDA approval for two new antibiotics
NUFLOR-S – a prescription antibiotic for swine, and AROVYN – a prescription antibiotic for cattle and swine – will be available from or on the order of a...
.
3 Mar 2022",0.4767,22-03-03
Merck,"Bloomberg Law News
Merck $1.4 Billion Cyberhack Settlement Ends 'Warlike' Act Claim
Merck $1.4 Billion Cyberhack Settlement Ends 'Warlike' Act Claim ... Pharmaceutical giant Merck & Co. Inc. struck an 11th-hour settlement with insurers Wednesday,...
.
4 Jan 2024",-0.25,24-01-04
Merck,"Fierce Biotech
Unable to hit licensing deal terms, Basilea to hand cancer drug rights back to Merck
Unable to hit licensing deal terms, Basilea to hand cancer drug rights back to Merck ... Basilea Pharmaceutica will hand back a license for cancer drug...
.
27 Jun 2022",-0.6808,22-06-27
Merck,"C&EN
Green Chemistry Awards to Bristol Myers Squibb, Merck & Co., and PharmaBlock Sciences
Teams at Bristol Myers Squibb and Merck & Co. have won its 2023 Peter J. Dunn Award for Green Chemistry and Engineering Impact and that PharmaBlock Sciences...
.
9 Jul 2023",0.8807,23-07-09
Merck,"Fierce Biotech
Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'
Organon is still one of the few companies with a pipeline nearly wholly built around healthcare innovations for women specifically.
.
16 Mar 2023",0.0,23-03-16
Merck,"STAT
Merck lays off workers amid rough pharma job market
The newsletter today to bring you the latest biopharma updates. It's a busy news day, especially for a summer Wednesday, so let's get straight into it.
.
24 Jul 2024",0.2878,24-07-24
Merck,"Financial Times
Merck defends tax approach against senator’s claims of avoidance
Chief financial officer says drugmaker complies with law amid congressional probe.
.
7 Aug 2022",-0.4019,22-08-07
Merck,"Imperial College London
Merck Cup Runners Up
Merck Cup Runners Up ... The 13th edition of the Merck Innovation Cup took place this year between 11th June and 16th June in Frankfurt. This competition gathers...
.
19 Jun 2023",0.3818,23-06-19
Merck,"Reuters
WHO recommends Merck's COVID pill for high-risk patients
A World Health Organization (WHO) panel on Wednesday backed the use of Merck & Co Inc's COVID-19 antiviral pill for high-risk patients.
.
2 Mar 2022",0.25,22-03-02
Merck,"Pharmaceutical Technology
Merck Biotech Development Center, Corsier-sur-Vevey, Switzerland
Pharmaceutical company Merck KGaA (Merck) opened its Biotech Development Center in Corsier-sur-Vevey, Switzerland, for research and manufacturing of novel...
.
19 Sept 2024",0.0,
Merck,"Financial Times
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
US group hopes EyeBio will refill its pipeline with treatments targeting causes of blindness.
.
28 May 2024",0.4215,24-05-28
Merck,"Built In
‘A New Program Supporting Startups’: Inside Merck Digital Sciences Studio
Merck Digital Sciences Studio is building new structures to support innovation that pushes work ahead for both startups and Merck's team.
.
1 Jun 2023",0.802,23-06-01
Merck,"Fierce Pharma
Merck, during a transition year, doled out nearly $30M to its pair of CEOs
Merck CEO Ken Frazier, who has continued as Merck's chairman of the board, maxed out his pay in 2019 when he received $27.6 million.
.
5 Apr 2022",-0.1027,22-04-05
Merck,"Pharmaceutical Technology
Merck Serono’s Pharmaceutical Manufacturing Facility, Nantong, China
Contractors · The plant complies with high standards of quality. · Merck Serono's new pharmaceutical manufacturing facility is located in Nantong, China. · The...
.
13 May 2022",0.0,22-05-13
Merck,"Reuters
Merck accused of downplaying early evidence of drug’s brain impact
The FDA in 2020 ordered its most serious warning, known as a “black box,” on Singulair's label. And Merck now faces a raft of lawsuits alleging it knew from its...
.
26 Jun 2023",-0.7245,23-06-26
Merck,"Fierce Pharma
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Merck said Tuesday that a phase 3 study of Keytruda in resected HNSCC has met its main goal. When added to standard of care both before and after surgery,
.
8 Oct 2024",0.3818,24-10-08
Merck,"Business Wire
Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly...
.
9 May 2024",-0.6597,24-05-09
Merck,"Fierce Pharma
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Merck's Keytruda will be able to challenge Bristol Myers Squibb's combination of Opdivo and Yervoy in newly diagnosed malignant pleural mesothelioma.
.
10 Mar 2023",-0.6249,23-03-10
Merck,"Merck KGaA
Oncology - BAVENCIO® (avelumab) | Merck
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-...
.
27 Mar 2023",0.5106,23-03-27
Merck,"Merck KGaA
Bioprocessing Production Center Daejeon | Merck
Merck invests more than € 300 million into a new Bioprocessing Production Center in Daejeon, South Korea. The new site is the largest investment by Merck's Life...
.
20 Mar 2024",0.0,24-03-20
Merck,"Merck.com
The Wall Street Journal names Merck among top 10 best-managed companies
We were named No. 10 on The Wall Street Journal's list of the 250 best-managed publicly traded US companies in 2023, advancing 78 places from the previous year.
.
11 Jan 2024",-0.1027,24-01-11
Merck,"Express Pharma
Merck India to hold 10th Bioforum India 2022 in Pune and Ahmedabad
Merck India is organising 10th Merck Bioforum India 2022 in Pune on 6th September, and in Ahmedabad on 8th September. The event is a thought leadership...
.
29 Aug 2022",0.0,22-08-29
Merck,"Reuters
Merck scraps two late-stage trials of cancer drug Keytruda
A trial of the drug in patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma was stopped for ""futility"", meaning it was likely...
.
29 Aug 2024",-0.8658,24-08-29
Merck,"Fierce Pharma
After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound
Merck KGaA reported what it deemed a “very strong” second quarter, growing sales 2% to reach 5.4 billion euros ($5.8 billion).
.
7 Aug 2024",0.7579,24-08-07
Merck,"Reuters
Merck's colorectal cancer therapy fails late-stage trial
Merck (MRK.N) said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously...
.
25 Sept 2024",-0.765,
Merck,"GlobeNewswire
Pfizer, Amneal Pharmaceuticals, and Merck & Co. Lead the
Pfizer, Amneal Pharmaceuticals, and Merck & Co. Lead the Global Muscle Relaxant Drugs Market with Innovative Drug Offerings and Strong Market Presence · Oral...
.
1 Aug 2023",0.802,23-08-01
Merck,"National Hog Farmer
Merck Animal Health introduces Sequivity with Microsol Diluvac Forte
The Sequivity technology is a revolutionary, flexible, rapid and targeted vaccine production platform incorporating immuno-precision capabilities that protect...
.
26 Mar 2024",0.2263,24-03-26
Merck,"SAP News Center
McKinsey and SAP Join Forces to Maximize Business Transformation Value Through Cloud Solutions
Together, SAP and McKinsey are merging technology modernization with strategy execution to drive results and address critical challenges.
.
10 May 2022",0.5106,22-05-10
Merck,"Fierce Biotech
Chutes & Ladders—Merck chief patient officer to retire to become CEO of NIH nonprofit
Julie Gerberding, MD, will retire from Merck in May after a 12-year stint with the New Jersey Big Pharma.
.
4 Mar 2022",0.0,22-03-04
Merck,"Reuters
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Merck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug Keytruda as interim data showed it was unlikely to meet the...
.
28 Feb 2023",-0.9081,23-02-28
Merck,"The City University of New York
CCNY alumni return for Merck Info Session and Networking Event on Sept. 28
Ma is an associate principal scientist at Merck and graduated in 2011 with his chemical engineering degree. He credits CCNY with setting the tone for his career...
.
25 Sept 2023",0.3612,
Merck,"STAT
Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing
Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing ... WASHINGTON — Senate Democrats, led by Sen. Bernie...
.
21 Nov 2023",-0.5574,23-11-21
Merck,"BioSpace
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
Merck has bought biotech startup Abceutics in a bid to develop safer antibody-drug conjugates and minimize their off-target effects on healthy cells, according...
.
8 Apr 2024",0.8807,24-04-08
Merck,"Fierce Biotech
Merck KGaA drops BTK inhibitor evobrutinib, marking end of road for blockbuster dreams
Merck KGaA was outlining hopes for a major commercialization push for the BTK inhibitor—and now the German pharma has dropped the drug completely. Merck told...
.
7 Mar 2024",0.8442,24-03-07
Merck,"Yahoo Finance
Why Investors Shouldn't Be Surprised By Merck & Co., Inc.'s (NYSE:MRK) P/E
As we suspected, our examination of Merck's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage...
.
13 Dec 2022",0.2344,22-12-13
Merck,"Reuters
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
A combination therapy being developed with partner Eisai (4523.T) failed a late-stage trial testing it as a first-line treatment for a type of cancer in the...
.
8 Dec 2023",-0.9423,23-12-08
Merck,"Fierce Biotech
Takeda joins Novartis and Merck in $45M funding for Koneksa Health
Takeda joins Novartis and Merck in $45M funding for Koneksa Health ... Medical examination and growth graph data of business on tablet with doctor's health report...
.
7 Feb 2022",0.3818,22-02-07
Merck,"ANI News
Central African Republic and Niger First Ladies acknowledge Merck Foundation 2021 Media Awards winners
Bangui [Central African Republic]/Mumbai (Maharashtra) [India], August 10 (ANI/BusinessWire India): CEO of Merck Foundation, the philanthropic arm of Merck...
.
10 Aug 2022",0.7269,22-08-10
Merck,"The Cattle Site
Merck Animal Health shares progress about two new cattle products
Merck Animal Health personnel and a feedlot owner shared their results with SenseHub Feedlot and WHISPER ON ARRIVAL recently in Amarillo, Texas, and Vega,...
.
18 Jan 2023",0.7506,23-01-18
Merck,"Fierce Pharma
Merck's Keytruda flunks pivotal studies in early-stage lung and skin cancers
In a second setback for Keytruda that Merck unveiled Thursday, the New Jersey pharma is discontinuing the phase 3 KEYNOTE-630 trial for Keytruda as an adjuvant...
.
29 Aug 2024",-0.4215,24-08-29
Merck,"Reuters
Dozens of firms to make cheap version of Merck COVID pill for poorer nations
Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co's COVID-19 pill, under a landmark U.N.-backed deal...
.
20 Jan 2022",-0.296,22-01-20
Merck,"White & Case LLP
White & Case advises Merck KGaA on agreement to acquire life science company Mirus Bio for US$600 million
White & Case LLP has advised Merck KGaA, Darmstadt, Germany (MKDG), a leading science and technology company, on the agreement to acquire life science company...
.
24 May 2024",0.7506,24-05-24
Merck,"Fierce Biotech News & Reports
Merck KGaA, with hold still clouding prospects, guides MS drug past durability test ahead of phase 3 data
Merck KGaA, with hold still clouding prospects, guides MS drug past durability test ahead of phase 3 data ... Merck KGaA is back with another update on the...
.
11 Oct 2023",0.5267,23-10-11
Merck,"McKinsey & Company
Voices of CEO excellence: Merck’s Ken Frazier
As CEO of Merck, Ken Frazier gained the respect of his employees, shareholders, and the broader community not only through the company's performance during his...
.
12 Jun 2023",0.8689,23-06-12
Merck,"Business Wire
Merck and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s research
Merck, a leading science and technology company, and The Michael J. Fox Foundation for Parkinson's Research (MJFF), are advancing research aimed at slowing...
.
18 Jun 2024",0.0,24-06-18
Merck,"Pharmaceutical Technology
Merck completes acquisition of Harpoon Therapeutics
Merck completes acquisition of Harpoon Therapeutics. MS has gained access to Harpoon's portfolio of T-cell engagers, including MK-6070. ... Merck & Co. (MSD) has...
.
12 Mar 2024",0.5574,24-03-12
Merck,"Fierce Pharma
Organon hopes straight talk will help level the field in women's health
It's just over a year since the launch of Merck's women's health spinoff, Organon, and Chief Communications Officer Wendy Lund emphasizes while there's been...
.
27 Jun 2022",0.7506,22-06-27
Merck,"PR Newswire
Merck Animal Health's Third Veterinarian Wellbeing Study Reveals Increased Health Challenges and Psychological Distress Among Veterinarians
PRNewswire/ -- Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA.
.
18 Jan 2022",0.2023,22-01-18
Merck,"Fierce Biotech
Avenzo, Merck KGaA and AbbVie each ink new deals to fortify cancer pipelines
Avenzo, Merck KGaA and AbbVie each ink new deals to fortify cancer pipelines ... Avenzo Therapeutics, Merck KGaA and AbbVie each inked new deals to top up their...
.
4 Jan 2024",-0.8402,24-01-04
Merck,"Merck.com
Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants
Clesrovimab has the potential to become the first and only approved immunization designed to protect infants with the same single dose regardless of weight.
.
17 Oct 2024",0.7964,24-10-17
Merck,"Irish Legal News
High Court: Merck Sharp & Dohme obtain injunction to prevent the sale of generic drug before patent expires in April 2023
In applying the principles for an interlocutory injunction as set out in Merck v. Clonmel, the court held that the plaintiff might obtain a permanent injunction...
.
24 Jan 2023",0.1531,23-01-24
Merck,"Cybersecurity Dive
Merck reaches settlement in closely watched NotPetya insurance case
Merck reached a settlement with its insurance providers in the closely watched dispute in a New Jersey Supreme Court case over $1.4 billion in claims stemming...
.
8 Jan 2024",0.3612,24-01-08
Merck,"Fierce Pharma
Lotte Biologics, Merck KGaA ink partnership deal for biopharma production
Lotte Biologics, Merck KGaA ink partnership deal for biopharma production ... South Korean CDMO Lotte Biologics and Merck KGaA have signed a partnership deal...
.
3 Jun 2024",0.0,24-06-03
Merck,"Pharmaceutical Technology
Merck partners with Hengrui in deal worth up to $1.48bn
Merck partners with Hengrui in deal worth up to $1.48bn. Merck has gained worldwide rights outside of China for PARP1 trapping inhibitor HRS-1167 and ADC drug...
.
30 Oct 2023",0.6249,23-10-30
Merck,"Fierce Pharma
Merck entitled to $1.4B in cyberattack case after court rejects insurers' 'warlike action' claim
A New Jersey court previously awarded Merck a $1.4 billion payout after the drugmaker sued its insurers who had denied coverage for the NotPetya cyberattack in...
.
2 May 2023",-0.3182,23-05-02
Merck,"Nikkei Asia
Germany's Merck ramps up chipmaking material investment
Merck has pledged to invest more than $3 billion over the five years through 2025 to boost its electronics business.
.
1 Sept 2022",0.4019,
Merck,"Reuters
S.Korea gives emergency approval for adult use of Merck's COVID pills - Yonhap
South Korea's drug safety agency said on Wednesday that it has decided to give emergency approval for the use of Merck & Co Inc's COVID-19 treatment pill...
.
22 Mar 2022",0.5859,22-03-22
Merck,"Yahoo
Germany's Merck KGaA insists chip market remains attractive
FRANFURT/LONDON (Reuters) -Merck KGaA does not anticipate that a projected decline in smartphone sales this year will weigh on its semiconductor chemicals...
.
20 Oct 2022",0.4404,22-10-20
Merck,"BioSpace
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
A combination of Merck's blockbuster cancer drug Keytruda and an mRNA vaccine from Moderna has demonstrated positive results at the three-year stage in a Phase...
.
14 Dec 2023",0.3612,23-12-14
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced, or High-Risk Early-Stage Triple-Negative Breast Ca
Merck Receives Positive EU CHMP Opinion for KEYTRUDA for High-Risk Early-Stage TNBC.
.
25 Apr 2022",0.8481,22-04-25
Merck,"Fierce Biotech
Proxygen, averaging a new collab every 10 months, sticks $2.5B molecular glue deal with Merck
Proxygen, averaging a new collab every 10 months, sticks $2.5B molecular glue deal with Merck ... Proxygen protein degradation Merck KGaA Merck & Co. ... Proxygen's...
.
5 Apr 2023",-0.5267,23-04-05
Merck,"FirstWord Pharma
ICER says Merck & Co.’s sotatercept in PAH cost-effective up to $36,200
ICER says Merck & Co.'s sotatercept in PAH cost-effective up to $36,200 ... Merck & Co.'s sotatercept would be cost effective for pulmonary arterial hypertension...
.
15 Nov 2023",0.4767,23-11-15
Merck,"Reuters
Merck KGaA says MS drug has blockbuster potential; key data expected in December
The CEO of Germany's Merck KGaA (MRCG.DE) said the company's experimental multiple sclerosis drug can be a ""blockbuster"", an industry term for annual sales...
.
18 Oct 2023",0.5994,23-10-18
Merck,"Fierce Pharma Biopharma News & Insights
ESMO: Merck, in flurry of studies, shows Keytruda's power and limitations
Merck's PD-1 juggernaut—in combination with other cancer meds—charted complete and partial wins in cervical cancer, early breast cancer and stomach cancer. At...
.
24 Oct 2023",-0.9423,23-10-24
Merck,"Nature
Merck: Innovation powered by digital and data
Merck: Innovation powered by digital and data · AI-powered drug discovery platform · From BayBE steps to giant leaps · Retrosynthesis software · Syntropy – for...
.
11 Jul 2024",0.6369,24-07-11
Merck,"Business Wire
Merck Animal Health to Acquire Elanco’s Aqua Business
Merck Animal Health to Acquire Elanco's Aqua Business ... The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory...
.
5 Feb 2024",0.0,24-02-05
Merck,"BioPharma Dive
Merck’s pneumococcal vaccine gets CDC panel backing
The CDC panel specifically voted to recommend a single Capvaxive dose in adults older than 65 with no prior pneumococcal vaccination or whose vaccination...
.
28 Jun 2024",0.1027,24-06-28
Merck,"BioSpace
Merck’s Acceleron Integration To Take Out 143 Jobs in Cambridge, MA
Merck announced that it will be laying off 143 people from the Cambridge, Massachusetts-based Acceleron. ... In November 2021, Merck completed its acquisition of...
.
30 Mar 2022",0.8555,22-03-30
Merck,"The Motley Fool
Where Will Merck Be in 5 Years?
Merck will face an important patent cliff by the end of the decade. The company has a plan to move beyond it. Competition from a new therapy shouldn't derail...
.
25 Oct 2024",-0.2732,24-10-25
Merck,"FirstWord Pharma
Merck & Co.'s Welireg meets PFS goal in Phase III renal cell carcinoma study
Marjorie Green, head of late-stage oncology at Merck Research Laboratories, said there is a need for new treatment options for advanced RCC patients who have...
.
18 Aug 2023",0.25,23-08-18
Merck,"Fierce Biotech
Kallyope, with ex-Merck exec at helm, skirts 'less desirable' public markets with $236M series D
The six-year-old biotech pivoted instead to raise $236 million in a series D that could set Kallyope up for an initial public offering as soon as the second...
.
15 Feb 2022",0.2516,22-02-15
Merck,"Fierce Pharma
CEOs of BioNTech, Bayer, Merck KGaA join German Chancellor Scholz in high-profile China visit
CEOs of BioNTech, Bayer, Merck KGaA join German Chancellor Scholz in high-profile China visit ... In the first visit by a G7 leader to China since the pandemic...
.
4 Nov 2022",0.5267,22-11-04
Merck,"Fierce Pharma
Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl's anemia nod
BMS is working on development and commercialization of Reblozyl with Merck following the New Jersey-based drugmaker's $11.5 billion acquisition of Acceleron...
.
25 Mar 2022",0.3182,22-03-25
Merck,"KBR
Merck's BD team driven by science-backed data to address unmet needs
Merck, a renowned global pharmaceutical company, has established a robust licensing division, playing a pivotal role in driving innovation and expanding its...
.
7 Jun 2023",0.7003,23-06-07
Merck,"Merck KGaA
Merck Completes Acquisition of the Chemical Business of Mecaro
Merck, a leading science and technology company, announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by...
.
2 Jan 2023",0.0,23-01-02
Merck,"Merck KGaA
Merck Signs MoU with KAIST to Advance Scientific Collaboration
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and...
.
29 May 2024",0.25,24-05-29
Merck,"Merck.com
FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
WINREVAIR is a breakthrough biologic for this rare, progressive disease. WINREVAIR on top of background therapy significantly improved exercise capacity.
.
26 Mar 2024",0.765,24-03-26
Merck,"Express Pharma
Merck opens Microbiology Application lab in Jigani, Bengaluru
With an investment of €200,000, the MAT Centre spans an area size of 1,100 sqft. The testing services offered in the lab include sterility testing, rapid...
.
3 Aug 2022",0.0,22-08-03
Merck,"WSJ
Merck Shares Fall After Drugmaker Cuts 2024 Outlook
Merck's struggles with HPV vaccine send stock to worst selloff in almost 17 years ... Merck's stock tumbled early Tuesday, after the drug company's softer-than-...
.
30 Jul 2024",-0.765,24-07-30
Merck,"Merck KGaA
Rockville Expansion | Merck
Merck invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA.
.
16 Nov 2022",0.0,22-11-16
Merck,"Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable...
.
10 Nov 2023",0.7003,23-11-10
Merck,"Veterinary Practice News
Screening program supports diabetes management in dogs, cats
Merck Animal Health, Purina, and Zoetis continue diabetes education and screening program, now in its ninth year.
.
22 Aug 2023",0.3612,23-08-22
Merck,"Fierce Pharma
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
In May of last year, after Seagen rejected Merck's offer to acquire it for $230 per share, the Seattle biotech saw its value tumble. Just three months later...
.
17 Apr 2023",0.0772,23-04-17
Merck,"Business Wire
Approval From European Commission With Two New Indications in Gynecologic Cancers
KEYTRUDA is now approved for 30 indications in the EU, including five in gynecologic cancers – three in endometrial cancer and two in cervical cancer.
.
24 Oct 2024",-0.5994,24-10-24
Merck,"PR Newswire
Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
The research test builds upon Illumina's commitment to broadly enable comprehensive genomic profiling and enhance research critical to realizing precision...
.
22 Jun 2022",-0.0772,22-06-22
Merck,"Fierce Pharma Biopharma News & Insights
In another Lynparza flop, AstraZeneca, Merck pull the plug on a colorectal cancer trial
As AstraZeneca and Merck try to prove Lynparza across tumor types, the companies stopped a phase 3 trial investigating the drug in colorectal cancer.
.
19 Jul 2022",-0.9403,22-07-19
Merck,"OPKO Health, Inc.
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
MDX-2201 leverages ModeX's innovative biologics platform to target multiple Epstein-Barr virus (EBV) proteins EBV is the leading cause of…...
.
8 Mar 2023",0.765,23-03-08
Merck,"Reuters
Merck loses bid to hold Bayer responsible for talc foot powder claims
Bayer AG is not responsible for liability stemming from certain lawsuits over talc-based foot powder products that it acquired from Merck & Co as part of a...
.
16 Nov 2023",0.5255,23-11-16
Merck,"BioPharma Dive
Pfizer returns cancer immunotherapy rights to Merck KGaA
Pfizer returns cancer immunotherapy rights to Merck KGaA. The companies are ending their alliance on the drug Bavencio, which in the U.S. is approved for...
.
27 Mar 2023",-0.7906,23-03-27
Merck,"Seeking Alpha
Merck on backfoot as blockbuster Keytruda fails another phase 3 study, this time in prostate cancer
Merck's (NYSE:MRK) blockbuster drug Keytruda did not meet the main goals of overall survival (OS) and radiographic progression-free survival ((rPFS)) in a...
.
3 Aug 2022",0.1531,22-08-03
Merck,"Barron's
Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.
Merck Licenses a Weight-Loss Pill. It's Bad News for Obesity Biotechs. ... Merck said Wednesday it had licensed an experimental GLP-1 obesity pill from a Chinese...
.
18 Dec 2024",-0.7906,24-12-18
Merck,"The Global Legal Post
Deutsche Bank appoints new general counsel from German pharma giant Merck
Deutsche Bank has hired Friederike Rotsch as its new general counsel, replacing Karen Kuder, who is moving to the bank's asset management business DWS.
.
26 Apr 2023",0.4588,23-04-26
Merck,"PMLiVE
Merck KGaA’s MS drug put on partial clinical hold by FDA
Evobrutinib is one of multiple Bruton's tyrosine kinase (BTK) inhibitors being developed to slow the progression of MS, and is not the first to spark concerns...
.
13 Apr 2023",-0.0258,23-04-13
Merck,"Fierce Pharma Biopharma News & Insights
J&J, Merck CEOs dodge subpoenas by agreeing to testify at Senate committee's pricing hearing
The CEOs of Johnson & Johnson and Merck & Co. have agreed to join their counterpart at Bristol Myers Squibb in testifying before the Senate Committee.
.
26 Jan 2024",0.6908,24-01-26
Merck,"Clinical Trials Arena
Merck’s multiple sclerosis therapy trials fail to meet primary goals
Merck KGaA (Merck) has reported that its two Phase III EVOLUTION clinical trials of evobrutinib in relapsing multiple sclerosis (RMS) patients failed to meet...
.
6 Dec 2023",-0.7783,23-12-06
Merck,"chemeurope.com
Merck and Mulliken Center for Theoretical Chemistry Collaborate in Machine Learning Project
Merck and Mulliken Center for Theoretical Chemistry Collaborate in Machine Learning Project · The three-year collaboration will focus on the development of new...
.
14 Jun 2022",0.0,22-06-14
Merck,"BioSpace
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
The FDA on Wednesday approved a new indication for Merck's blockbuster cancer therapy Keytruda (pembrolizumab), adding pleural mesothelioma to the already-...
.
18 Sept 2024",0.6124,
Merck,"Business Wire
Merck to Acquire EyeBio
Merck to acquire EyeBio for a $1.3 billion upfront payment and up to $1.7 billion in future milestone payments for a potential value of $3 billion.
.
29 May 2024",0.34,24-05-29
Merck,"Bloomberg
Merck & Co. (MRK US) Beats Profit Projections as Keytruda Sales Rise
Merck & Co.'s shares fell the most in three years as light sales of its Gardasil HPV vaccine in China dimmed quarterly profit and sales that beat Wall...
.
30 Jul 2024",0.7906,24-07-30
Merck,"BioSpace
Merck Finalizes $10.8B Prometheus Buy
Merck finalized its acquisition of immune-focused Prometheus Biosciences for approximately $10.8 billion, scoring five clinical and pre-clinical candidates for...
.
17 Apr 2023",0.0,23-04-17
Merck,"BioSpectrum India
Merck invests €200,000 in microbiology application lab in Bengaluru
With an investment of €200,000, the MAT Centre spans an area size of 1,100 sqft. The testing services offered in the Lab include sterility testing, rapid...
.
21 Jul 2022",0.0,22-07-21
Merck,"Contract Pharma
Merck KGaA, Inspirna Partner on Colorectal Cancer Portfolio
Inspirna will receive $45 million upfront and is eligible to receive milestone payments and royalties on sales outside of the U.S. Inspirna is eligible to also...
.
4 Jan 2024",-0.6597,24-01-04
Merck,"CSRwire
Merck Scientists Launch Research Award to Support Rising Che
Merck Scientists Launch Research Award to Support Rising Chemists of Color · Supporting underrepresented chemists of color · Honoring the 2021 recipients.
.
19 Jan 2022",0.9559,22-01-19
Merck,"BioSpace
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
Backed by Pfizer, Merck KGaA and J&J, Nucleome Therapeutics secured £37.5 million (about $42.16 million) in an oversubscribed Series A financing round to mine...
.
19 Oct 2022",0.4215,22-10-19
Merck,"Pharmaceutical Technology
Merck signs agreement to acquire Exelead for $780m
Merck signs agreement to acquire Exelead for $780m. Merck expects to continue investing in mRNA as a modality and will bolster the technology at Exelead...
.
7 Jan 2022",0.7506,22-01-07
Merck,"Fierce Pharma
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
Despite many economic challenges, the biopharma industry fared well in the second quarter as 15 of the top 24 companies saw revenues increase.
.
15 Aug 2022",0.6096,22-08-15
Merck,"Accenture
AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development
As part of this initiative, Merck selected AWS as its preferred cloud services provider and Accenture as its professional services partner to transition core...
.
29 Nov 2023",0.4019,23-11-29
Merck,"Business Wire
Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding BV (HUB).
.
17 Dec 2024",0.4939,24-12-17
Merck,"Fierce Pharma
3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field
AstraZeneca/Daiichi, Merck and Gilead, the three front-runners in the TROP2 ADC race, have developed extensive phase 3 programs for their rival offerings.
.
2 Aug 2024",0.0516,24-08-02
Merck,"Aidsmap
Once-weekly antiretrovirals on the horizon
Two antiretrovirals with the potential for once-weekly oral dosing were unveiled at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in...
.
6 Mar 2024",-0.0258,24-03-06
Merck,"Fierce Pharma
Playing catch-up with Merck, Pfizer scores pediatric approval for Prevnar 20
The FDA approval of Prevnar 20 covers children ages 6 weeks to 17 years and gives Pfizer a chance to continue to control a market it has dominated for two...
.
28 Apr 2023",0.8402,23-04-28
Merck,"WSJ
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
The German company sees greater value in teaming up with independent AI companies, rather than in an outright acquisition of a company that specializes in the...
.
7 Jun 2024",0.5994,24-06-07
Merck,"Merck KGaA
Compliance-Hotline
Violations of our Code of Conduct, applicable law, human rights or certain environmental risks and violations can be reported via our group-wide whistleblowing...
.
30 Apr 2024",-0.7783,24-04-30
Merck,"Merck KGaA
Merck Presents its Latest Cosmetics Innovations at “in-cosmetics” 2023
Merck Presents its Latest Cosmetics Innovations at “in-cosmetics” 2023 · Ronaflux® pigments: Metallic look without any metal content · Zinc oxide UV filters:...
.
23 Mar 2023",0.0,23-03-23
Merck,"Endpoints News
Updated: Merck looking at Seagen takeover bid in the wake of Clay Siegall's resignation — report
Merck is evaluating a potential buyout of embattled Seattle biotech Seagen, according to a report from the Wall Street Journal on Friday morning.
.
17 Jun 2022",-0.296,22-06-17
Merck,"KoreaTimes
Merck breaks ground for bioprocessing production center in Daejeon
Merck breaks ground for bioprocessing production center in Daejeon ... Merck Life Science (Merck) commenced the construction of its bioprocessing production...
.
29 May 2024",0.0,24-05-29
Merck,"Clinical Trials Arena
Merck's trial of KEYTRUDA regimen fails to meet primary endpoint
Merck's trial of Keytruda regimen fails to meet primary endpoint. The randomised, double-blind study involved 1,095 patients to assess adjuvant treatment with...
.
10 May 2024",-0.6808,24-05-10
Merck,"Berita Harian
Pil keluaran Merck berupaya kurangkan risiko kemasukan ke hospital
NEW YORK: Kajian baharu oleh kumpulan penyelidik India mendapati pil antiviral molnupiravir mampu mengurangkan risiko kemasukan ke hospital disebabkan...
.
19 Feb 2022",0.0,22-02-19
Merck,"Fierce Pharma
Merck targets stigma and screening reluctance in 'Focus on Your Lungs' cancer campaign
Merck targets stigma and screening reluctance in 'Focus on Your Lungs' cancer campaign ... Merck, marketer of the world's biggest oncology drug Keytruda, is...
.
10 Nov 2022",-0.9274,22-11-10
Merck,"BioSpace
Novartis Nabs Merck Veteran to Helm BioMedical Institutes
Fiona H. Marshall has been tapped as Novartis Institutes for BioMedical Research president after Jay Bradner's exit, while Tim Demuth will succeed Malte Peters...
.
1 Sept 2022",0.4939,
Merck,"Morningstar
Merck's COVID-19 Drug Posts Poor Data; No Change to FVE
Merck's (MRK) updated analysis showing less efficacy with coronavirus treatment molnupiravir doesn't impact our fair value estimate.
.
21 Apr 2022",-0.5943,22-04-21
Merck,"Reuters
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise
An experimental cancer vaccine from Moderna Inc (MRNA.O) based on the messenger RNA (MRNA) technology used in successful COVID-19 vaccines has been shown to...
.
13 Dec 2022",0.2732,22-12-13
Merck,"Fierce Biotech
After deeming success unlikely, Merck KGaA cuts lung cancer trial to consider future of ATR inhibitor
After deeming success unlikely, Merck KGaA cuts lung cancer trial to consider future of ATR inhibitor ... Merck KGaA's North American healthcare business, EMD...
.
3 Jun 2022",-0.7506,22-06-03
Merck,"Endpoints News
Merck-Novartis revolving door spins again as AI leader Iya Khalil switches pharmas
Senior Reporter. As talk of AI this-and-that gobbles up headline after headline, one Big Pharma is losing its AI leader as she transitions to another drug giant...
.
8 Feb 2023",-0.3818,23-02-08
Merck,"CIDRAP
Merck announces promising findings for its RSV monoclonal antibody for infants
If approved by federal regulators, clesrovimab (MK-1654-004) would be the second prophylactic monoclonal antibody injection against RSV for babies. In July 2023...
.
23 Jul 2024",0.6705,24-07-23
Merck,"The Record from Recorded Future News
Merck settles with insurers who denied $700 million NotPetya claim
Merck settles with insurers who denied $700 million NotPetya claim. Pharmaceutical giant Merck has reportedly reached a settlement with insurers over their...
.
5 Jan 2024",-0.6597,24-01-05
Merck,"Texas A&M Today
Chemistry Grad Student Earns 2023 Merck Research Award
Jeanette Piña '22 is one of 16 national recipients of the 2023 Merck Research Award for Underrepresented Chemists of Color. By Shana K. Hutchins, Texas A&M...
.
28 Jul 2023",0.7906,23-07-28
Merck,"Fierce Biotech
Merck KGaA takes 4th option on Big Pharma darling F-star's bispecific immunotherapies
Merck KGaA takes 4th option on Big Pharma darling F-star's bispecific immunotherapies ... Merck KGaA is taking a fourth option in its deal with bispecific...
.
5 Jan 2022",0.8225,22-01-05
Merck,"National Association of Manufacturers - NAM
Competing to Win Tour Visits Merck KGaA in Darmstadt, Germany, and VDMA in Frankfurt
The last word: The visit to Merck KGaA in Darmstadt underscored the importance of interconnectedness between the U.S. and Europe. It highlighted the vital role...
.
23 Mar 2023",0.8176,23-03-23
Merck,"BioPharma Dive
A biotech startup gives Merck its next shot at treating Alzheimer’s
Merck & Co. will acquire an early-stage Alzheimer's disease treatment from Boston-based Cerevance, which focuses on central nervous system diseases.
.
9 Aug 2022",-0.2732,22-08-09
Merck,"STAT
Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal
An experimental immunotherapy drug threatens to chip away at the dominance of Keytruda lung CT scan w/hand CT scan of a lung cancer patient.
.
5 Sept 2024",-0.891,
Merck,"Yahoo Finance
Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?
Healthcare stocks are often considered a defensive investment during times of economic uncertainty. This is because people typically do not cut back on...
.
24 Jun 2024",0.4242,24-06-24
Merck,"Fierce Pharma
In $500M expansion, Merck opens one Singapore facility and breaks ground on another
The new facilities are part of an outlay of up to $500 million, which brings Merck's total investment over nearly three decades in Singapore to $2 billion.
.
5 Oct 2022",0.0,22-10-05
Merck,"PR Newswire
Merck Manuals Shares Insights on Mental Health Challenges
Michael B. First, MD, a psychiatrist at Columbia University, shares some of the signs, symptoms – but also phrases and thought processes – that may indicate a...
.
20 Sept 2022",0.3291,
Merck,"Merck KGaA
Merck and Mulliken Center for Theoretical Chemistry Collaborate in Machine Learning Project
Merck and Mulliken Center for Theoretical Chemistry Collaborate in Machine Learning Project. The three-year collaboration will focus on the development of new...
.
14 Jun 2022",0.0,22-06-14
Merck,"Fierce Pharma
In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda
Although both GSK's Jemperli and Merck's Keytruda showed they can improve upon chemotherapy in front-line endometrial cancer, Keytruda's data appear to hold an...
.
27 Mar 2023",-0.5859,23-03-27
Merck,"The Global Legal Post
Around the house: Citadel lands top Goldman legal duo, Merck promotes auditing head to GC
Rusoff joins from Goldman Sachs, where he was general counsel for global banking and markets. At Citadel, Rusoff will be responsible for the legal and...
.
4 Aug 2023",0.7906,23-08-04
Merck,"Display Daily
BOE & Merck Clarify an LGD Mystery
There were a number of papers from BOE and Merck presented in the Symposium that explain how you can go even further than LG has done.
.
28 Jun 2022",0.0772,22-06-28
Merck,"Business Wire
Merck Completes € 180 Million Investment to Expand Schnelldorf Distribution Center
Merck, a leading science and technology company, has opened its newly expanded Life Science distribution center in Schnelldorf, Germany.
.
6 Jun 2024",0.3182,24-06-06
Merck,"Fierce Pharma
Kelun's Merck-partnered ADC snags first nod in China to kick off TROP2 fight with Gilead
Sac-TMT, the first asset in Kelun's multibillion-dollar ADC collaboration with Merck, has won its world-first approval in China.
.
27 Nov 2024",0.7717,24-11-27
Merck,"Merck KGaA
ZooMAb® Antibodies - News | Merck
Merck's ZooMAb® Antibodies Earns First-Ever ACT Label from My Green Lab · ZooMAb® antibodies becomes the first-ever antibody to be recognized for low-...
.
14 Apr 2022",0.0,22-04-14
Merck,"SecurityWeek
Court Rules in Favor of Merck in $1.4 Billion Insurance Claim Over NotPetya Cyberattack
Court Rules in Favor of Merck in $1.4 Billion Insurance Claim Over NotPetya Cyberattack. Court says insurers must pay Merck for losses related to the Russia-...
.
3 May 2023",0.3182,23-05-03
Merck,"Reuters
Helene von Roeder to become new CFO of Germany's Merck
Germany's Merck KGaA (MRCG.DE) has appointed Helene von Roeder as the new chief financial officer and member of the Executive Board.
.
8 May 2023",0.0,23-05-08
Merck,"Business Wire
Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational Zanzalintinib in Combination with KEYTRUDA® (pembrolizumab) in Head and Neck Cancer and in Combination with WELIREG® (belzutifan) in Renal Cell Carcinoma
“KEYTRUDA and WELIREG are approved therapies that have led to improved outcomes for some cancer patients, and we are pleased to collaborate with Merck's...
.
14 Oct 2024",-0.25,24-10-14
Merck,"Business Standard
Merck Foundation Chairman and CEO Meet the President and the Prime Minister of Mauritius
Merck Foundation, the philanthropic arm of Merck KGaA Germany underscore their commitment to building healthcare capacity in Mauritius.
.
6 Apr 2022",0.3818,22-04-06
Merck,"BioProcess International
Merck doubles down on life sciences biz in Germany
Merck doubles down on life sciences biz in Germany. Merck doubles down on life sciences biz in Germany. Merck KGaA has expanded its MilliporeSigma life sciences...
.
13 Jun 2024",0.0,24-06-13
Merck,"Financialexpress
Merck & Co Raises 2022 Forecast as COVID-19 Pill, Cancer Drug Fuels Profit Beat
Merck & Co on Thursday announced their quarterly profit and sales that beat estimates and raised its full-year forecasts on strong demand for top-selling...
.
29 Apr 2022",0.4939,22-04-29
Merck,"Fierce Pharma
Merck KGaA's MilliporeSigma devotes €62M to new quality control building in Germany
MilliporeSigma is plugging 62 million euros (about $66.3 million) into the build-out of a new quality control building at its Darmstadt, Germany, headquarters.
.
14 Jun 2024",0.3818,24-06-14
Merck,"Business Wire
Variational AI Announces Generative AI Project With Merck
Variational AI Announces Generative AI Project With Merck ... VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative...
.
25 Jan 2024",0.0,24-01-25
Merck,"pharmaphorum
Merck defends blockbuster Januvia franchise from patent challenge
That challenged the '708 patent – which expires in November 2026 – as well as one other (No. 8,414,921), which covers the co-formulation of sitagliptin and...
.
30 Sept 2022",0.7096,
Merck,"Fierce Pharma
Merck found the source of Januvia contamination, plans to fix the issue this year: report
Merck found the source of Januvia contamination, plans to fix the issue this year: report ... In a report to the FDA, Merck says it has figured out how its...
.
18 Jan 2023",0.0,23-01-18
Merck,"pharmaphorum
Another mRNA company gets snapped up as Merck buys Exelead
Another mRNA company gets snapped up as Merck buys Exelead. News. Exelead. The latest pharma company to make a move for an mRNA specialist is Germany's Merck...
.
6 Jan 2022",0.0,22-01-06
Merck,"Business Wire
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Concurrent Chemoradiotherapy as Treatment for Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
FDA Grants Priority Review to Merck's Application for KEYTRUDA + Concurrent Chemoradiotherapy for Newly Diagnosed Locally Advanced Cervical Cancer.
.
20 Sept 2023",-0.6124,
Merck,"Nasdaq
Where Will Merck Stock Be in 5 Years?
I believe Merck remains well-positioned to continue rewarding shareholders, with a good chance the stock will trade higher five years from now.
.
14 Sept 2024",0.8074,
Merck,"Reuters
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
The US Food and Drug Administration declined to approve Merck (MRK.N) and Japan-based Daiichi Sankyo's (4568.T) lung cancer treatment.
.
27 Jun 2024",-0.8689,24-06-27
Merck,"Merck.com
Collaborating to help make cancer care more accessible worldwide
Our company is helping patients at risk for and living with cancer access the care they need to stay well and lead fulfilling lives.
.
25 May 2023",0.128,23-05-25
Merck,"Inquirer.com
U.S. pharma companies are staying in Russia as other industries exit
Executives at Merck, Johnson & Johnson, and Pfizer have all stressed a need to keep providing their products in Russia.
.
11 Mar 2022",-0.34,22-03-11
Merck,"Reuters
Pfizer, Merck trim prices in China for Paxlovid, molnupiravir - reports
Pfizer and Merck have slightly lowered the prices of their respective Paxlovid and molnupiravir COVID-19 treatments in China, local media reported on...
.
4 Apr 2023",0.3804,23-04-04
Merck,"Free Press Journal
MCA Corporate cricket tournament: Shreyas Keskar, Ayush Vartak efforts help Merck India emerge champions
Medium pacers Kazim Sayyed (2/18) and Vaibhav Sawant (2/37) got the initial breakthroughs before Keskar and off-spinner Prashant Patil (2/13) scalped the...
.
4 Apr 2022",0.8555,22-04-04
Merck,"Cybersecurity Dive
Merck cyber coverage upheld in NotPetya decision, seen as victory for policyholders
A New Jersey appellate court upheld a prior ruling in favor of Merck, a major pharmaceutical company embroiled in a closely watched case involving $1.4 billion...
.
3 May 2023",0.4019,23-05-03
Merck,"Forbes
Is Merck Stock A Better Pick Over ABBV?
MRK stock trades at a slightly higher valuation of 4.8x trailing revenues, compared to 4.2x for AbbVie ABBV +1.5% , and this valuation gap will likely narrow...
.
1 Jun 2023",0.4404,23-06-01
Merck,"Yahoo Finance
Is Merck KGaA (MKKGY) Stock Undervalued Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have...
.
27 Nov 2024",0.5267,24-11-27
Merck,"Fierce Biotech
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
Merck & Co.'s renewed R&D oncology strategy focuses on three strategies. One of those prongs is improving immune responses, a pillar that stars Moderna-shared...
.
3 Jun 2024",-0.1027,24-06-03
Merck,"Bloomberg.com
Merck KGaA CEO Belen Garijo Speaks With Bloomberg in Davos
CC-Transcript · Merck KGaA CEO Belen Garijo Speaks With Bloomberg in Davos · Citi's Failed PE Club Underwhelms Wealthy Billionaires · Companies Shift Production...
.
18 Jan 2024",-0.2023,24-01-18
Merck,"U.S. Chamber of Commerce
Conversation with Jenelle Krishnamoorthy, PhD, Vice President and Head of Global Public Policy for Merck.
I am the Vice President and Head of Global Public Policy at Merck. In this role, I have the awesome responsibility of finding policy solutions that will help...
.
27 Jan 2023",0.7003,23-01-27
Merck,"The Pharma Letter
Merck announces replacement for retiring Roy Baynes as GCD
Merck announces replacement for retiring Roy Baynes as GCD.
.
23 Mar 2022",0.0,22-03-23
Merck,"3BL Media
Merck Scientists Launch Research Award to Support Rising Chemists of Color
The Merck Research Award for Underrepresented Chemists of Color recognizes graduate students and post-doctoral fellows for their chemical science research...
.
19 Jan 2022",0.8658,22-01-19
Merck,"BioPharma Dive
With PCSK9 pill, Merck aims to succeed where others failed
With PCSK9 pill, Merck aims to succeed where others failed. The company is planning an ambitious Phase 3 program testing its oral cholesterol-lowering drug,...
.
7 Mar 2023",0.4404,23-03-07
Merck,"Yahoo Finance
Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View
Merck MRK reported third-quarter 2024 adjusted earnings of $1.57 per share, which beat the Zacks Consensus Estimate of $1.50. Earnings declined 26% year...
.
31 Oct 2024",0.3612,24-10-31
Merck,"www.drugdiscoverytrends.com
Big Pharma's R&D ROI: Merck, Pfizer, J&J, AbbVie strategies
The average projected return on investment (ROI) for R&D fell from 6.8% in 2021 to just 1.2% in 2022 for the top 20 pharma companies.
.
8 Mar 2024",0.2023,24-03-08
Merck,"BioProcess International
Merck amplifies ADC focus in $5.5bn Daiichi Sankyo deal
Merck amplifies ADC focus in $5.5bn Daiichi Sankyo deal. Merck amplifies ADC focus in $5.5bn Daiichi Sankyo deal. Merck & Co. and Daiichi Sankyo will codevelop...
.
23 Oct 2023",0.0,23-10-23
Merck,"Business Wire
Merck Announces Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Advanced Epithelial Ovarian Cancer
The KEYTRUDA plus LYNPARZA regimen demonstrated a statistically significant and clinically meaningful improvement in PFS for these patients compared to...
.
9 Dec 2024",0.4019,24-12-09
Merck,"Business Wire
Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany
Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany · Facility to provide production-related quality control services for Life...
.
11 Jun 2024",0.0,24-06-11
Merck,"insider.co.uk
Merck Livingston announces 15 new jobs and £2.6 million investment
Merck's Livingston facility is the world's largest manufacturer of monoclonal antibodies for blood typing diagnosis, with more than 60% of the world market. The...
.
3 Mar 2023",0.0,23-03-03
Merck,"South African Broadcasting Corporation (SABC)
Merck to test single-dose regimen of HPV vaccine Gardasil 9
The United States Food and Drug Administration first approved Gardasil 9 in 2014 to prevent certain cancers, including cervical, vulvar, vaginal and anal...
.
13 Mar 2024",0.7783,24-03-13
Merck,"BioPharma Dive
German Merck buys manufacturer of key component in mRNA medicines
Exelead, which Merck KGaA is buying for $780 million in cash, specializes in lipid nanoparticles, the tiny bubbles of fat used to deliver synthetic messenger...
.
6 Jan 2022",0.0,22-01-06
Merck,"Reuters
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
NS) , opens new tab will launch its generic version of Merck's (MRK.N) , opens new tab antiviral COVID-19 pill, molnupiravir, and price it at 35 rupees ($0.4693)...
.
4 Jan 2022",0.0,22-01-04
Merck,"Yahoo Finance
Merck Pulls Plug On Two Keytruda Late-Stage Studies On Underwhelming Data
Thursday, Merck & Co Inc (NYSE:MRK) provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630. Merck is discontinuing the Phase 3 KEYNOTE-867...
.
29 Aug 2024",0.0,24-08-29
Merck,"Fierce Pharma
Gardasil's China troubles haunt Merck in Q3, with execs warning of more obstacles ahead
Merck attributed the decline to lower demand in China, which offset double-digit growth across “almost every other region,” CEO Robert Davis noted.
.
31 Oct 2024",-0.8777,24-10-31
Merck,"Fierce Biotech
Trailing AstraZeneca and Merck, Junshi reports phase 3 ovarian cancer success for Lynparza rival
A phase 3 trial of the candidate hit its primary endpoint, setting Junshi up to compete with products including AstraZeneca and Merck & Co.'s Lynparza for the...
.
12 Apr 2023",-0.1779,23-04-12
Merck,"Merck.com
Researching new uses for a therapy that targets cancer cells
Researching new uses for a therapy that targets cancer cells ... Female chemist at work in laboratory. More than two decades since the first approval of an...
.
11 Jul 2023",-0.7717,23-07-11
Merck,"ZAWYA
First Ladies of Niger & Central African Republic felicitate Merck Foundation 2021 Media Awards Winners
Merck Foundation (https://Merck-Foundation.com) and African First Ladies announced Call for Applications for 2 new categories of 2022 Awards for Media,...
.
10 Aug 2022",0.8442,22-08-10
Merck,"BioSpace
Merck Secures Bridion Patent Protection Through January 2026
Tuesday, the U.S. District Court for the District of New Jersey ruled in favor of Merck, finding that the company has correctly calculated the Patent Term...
.
15 Jun 2023",0.6124,23-06-15
Merck,"Merck KGaA
Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany
Merck, a leading science and technology company, announces an investment of € 62 million at its Darmstadt headquarters in a new quality control building for its...
.
11 Jun 2024",0.0,24-06-11
Merck,"WSJ
Drugmakers Fight Over Lucrative Pneumonia Vaccines
Rival drugmakers are seeking to upend Pfizer Inc.'s dominance of the $7 billion worldwide market for pneumonia vaccines.
.
31 Oct 2022",-0.2023,22-10-31
Merck,"www.drugdiscoverytrends.com
Merck forges Alzheimer’s pact with Cerevance
Merck & Co. could pay more than $1 billion to the Boston-based biotech startup Cerevance to develop potential drugs for Alzheimer's disease.
.
11 Aug 2022",-0.1027,22-08-11
Merck,"The Federalist Society
Litigation Update: Merck et al. v. Becerra et al.
Merck argues that the drug pricing program violates the First Amendment and the Takings Clause of the Fifth Amendment, claiming it forces them to accept...
.
2 Jul 2024",-0.7717,24-07-02
Merck,"Merck.com
Helping protect health from birth to adulthood
Recovering vaccination rates together. Now, more than ever, we have an opportunity to reimagine the role we all can play. At Merck, our broad portfolio of...
.
14 Apr 2023",0.8402,23-04-14
Merck,"RE-NJ
Onyx, Machine Investment Group buy 2 million sq. ft. Merck campus in Kenilworth
Merck & Co. has sold its 108-acre campus in Kenilworth to a joint venture of Onyx Equities and Machine Investment Group, with plans to lease back the nearly 2...
.
17 Feb 2023",0.0,23-02-17
Merck,"MedCity News
Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease
Merck is paying $700 million up front for global rights to Curon's CN201, a bispecific antibody in early-stage clinical development, the company announced...
.
12 Aug 2024",-0.4767,24-08-12
Merck,"Fierce Pharma
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop ... Merck & Co. ... Merck has talked up the value of its subcutaneous version of...
.
13 Jan 2023",-0.2023,23-01-13
Merck,"Pharmaceutical Technology
Merck’s Reagent Manufacturing Facility, Nantong, China
The reagent production plant in Nantong will provide high purity reagents for quality control and testing to customers.
.
20 Oct 2023",0.0,23-10-20
Merck,"Merck.com
Merck publishes 2023/2024 Impact Report
In 2023, we reached more than 550 million people with our medicines and vaccines through commercial channels, clinical trials, voluntary licensing and product...
.
16 Aug 2024",0.1027,24-08-16
Merck,"CSRwire
How Merck Is Using 3D Printing To Create Innovative Solutions
Merck's 3D Technologies (3DT) organization is transforming the way we work in the discovery, development and commercialization of our medicines and vaccines.
.
26 Aug 2022",0.6908,22-08-26
Merck,"Fierce Biotech
Chutes & Ladders—After 9 years at Merck, Roy Baynes follows Roger Perlmutter to Eikon
Welcome to this week's Chutes & Ladders, our ro.
.
25 Mar 2022",0.4588,22-03-25
Merck,"Contract Pharma
Merck Partners with Vector Institute to Advance AI in Healthcare
Merck Canada will have the opportunity to tap into Vector Institute's network of AI researchers, engineers, and startups.
.
8 Feb 2024",0.4215,24-02-08
Merck,"NCKU
Merck Taiwan Chairman John Lee Inspires Perseverance in Future Talents
“Difficulty is always present.” John Lee, Chairman of Merck in Taiwan, was invited to National Cheng Kung University to give a speech on May 13.
.
14 Jun 2022",0.7096,22-06-14
Merck,"Bloomberg
Merck KGaA Lifts Outlook on Strong Sales of Drugs, Electronics
Merck cited a “very strong operating performance” of its health care and electronics divisions compared to consensus estimates. The life science division is...
.
26 Jul 2024",0.8689,24-07-26
Merck,"Genetic Engineering and Biotechnology News
Merck Biomanufacturing Optimization Sees Major Production Gains
These optimizations reportedly increased production batch yields by 50–60%, reduced variability by 20%, and enabled each of its production lines to manufacture...
.
22 Mar 2023",0.7906,23-03-22
Merck,"Fierce Biotech
ASCO: Merck's Keytruda combo data could spark hope for lymphoma patients who lack options
The study confirmed what Merck has previously found: that adding an anti-LAG3 boosted Keytruda's efficacy, this time in lymphoma. Similar results were found...
.
26 May 2022",0.6124,22-05-26
Merck,"News-Medical
Merck introduces Aptegra CHO genetic stability assay for accelerated biosafety testing
The Aptegra™ CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for clients and...
.
23 Apr 2024",0.0,24-04-23
Merck,"Reuters
French drug agency says under investigation over thyroid drug
France's ANSM national drug agency said it is under formal investigation on suspicion of issuing misleading information regarding German drugmaker Merck's...
.
6 Dec 2022",-0.6486,22-12-06
Merck,"Business Wire
(Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
MAVENCLAD, approved by the U.S. Food and Drug Administration (FDA) on March 29, 2019, is the first and only short-course oral therapy for the treatment of...
.
10 Oct 2023",0.7003,23-10-10
Merck,"Forbes
Is Johnson & Johnson Stock A Better Pick Over Merck?
We see that J&J is more profitable and has a better financial position. Still, it trades at a lower valuation multiple than Merck. Now, looking at prospects,...
.
14 May 2024",0.7778,24-05-14
Merck,"Reuters
Merck to test single-dose regimen of HPV vaccine Gardasil 9
Merck & Co (MRK.N) said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and...
.
13 Mar 2024",0.0,24-03-13
Merck,"Merck KGaA
As One Against Malaria: The Programs
Drug Discovery & Development. Our innovative holistic approach focuses on prevention and investigates also potential treatment options towards controlling and...
.
21 Apr 2022",0.4404,22-04-21
Merck,"Fierce Pharma
MilliporeSigma opens $65M high-potency API facility focused on cancer meds
MilliporeSigma, Merck KGaA's North American subsidiary, opened the doors to its $65 million high-potency API manufacturing facility.
.
28 Jun 2022",-0.4215,22-06-28
Merck,"Merck KGaA
Igniting the “Developmental Light” Through Mentorship
Mentorship not only develops the mentee, but it also increases the capability of Merck to deliver upon our own spirit of caring, pioneering and outperforming.
.
15 Aug 2023",0.7469,23-08-15
Merck,"Investor's Business Daily
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics ... Merck (MRK) is playing defense against Summit Therapeutics (SMMT) with a...
.
14 Nov 2024",0.3182,24-11-14
Merck,"BioSpace
Keytruda Unlocked: How Should Merck Proceed with Trials?
Keytruda had a rocky start in the decades before its first approval. Merck initially deprioritized the project in 2009. When genetic biomarker testing became...
.
13 Mar 2023",0.4767,23-03-13
Merck,"Business Wire
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the...
.
26 Aug 2024",0.7351,24-08-26
Merck,"Corrs Chambers Westgarth
Extensions of term for patents covering multiple approved pharmaceutical substances clarified
The Full Federal Court has clarified extensions of term for patents covering more than one pharmaceutical substance with regulatory approval.
.
24 Mar 2022",0.7096,22-03-24
Merck,"Fierce Pharma
Merck takes a slim lead in oncologists' perceptions amid a 'fiercely competitive' environment
Merck takes a slim lead in oncologists' perceptions amid a 'fiercely competitive' environment ... Merck's cancer drug giant Keytruda has helped the Big Pharma top...
.
15 May 2024",-0.4588,24-05-15
Merck,"Fierce Pharma
Merck & Co. adds 100 new jobs as part of Irish expansion
Merck & Co. expects to add more than 100 new jobs as it expands operations at its Carlow, Ireland, manufacturing plant focused on oncology.
.
25 Aug 2022",0.4588,22-08-25
Merck,"Fierce Pharma
Merck telegraphs closure of Pennsylvania antibiotics plant that employs 300
Merck telegraphs closure of Pennsylvania antibiotics plant that employs 300 ... Some 300 Merck & Co. staffers' jobs are on the cutting board after the company...
.
24 Mar 2022",-0.128,22-03-24
Merck,"YouTube · CNBC International Live
'Europe is lagging behind' on innovation: Merck KGaA CEO
Belén Garijo, CEO of science and technology company Merck KGaA, discusses European regulation, growth and innovation with CNBC at Davos.
.
18 Jan 2024",0.6908,24-01-18
Merck,"Merck KGaA
Merck Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA
Merck has opened its new €290 million facility in Rockville, Maryland, USA, to meet the growing global demand for biosafety testing.
.
9 Oct 2024",0.0516,24-10-09
Merck,"Business Wire
Merck Recognized on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines
Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune's 2022 Change the World list. The annual list recognizes...
.
10 Oct 2022",0.4215,22-10-10
Merck,"Merck KGaA
Nasivin
Nasivin is soon revealed to have antiviral, antioxidant and anti-inflammatory properties – in 2009, Nasivin is voted »Medicine of the Year«.
.
4 Aug 2023",0.0,23-08-04
Merck,"Fierce Biotech
Roche's TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug
39 hours after the failure of Roche's TIGIT trial, iTeos revealed it and GSK are assessing “how best to proceed with additional clinical development.”
.
13 May 2022",-0.128,22-05-13
Merck,"Bloomberg
Harvard Names Ex-Merck CEO Frazier, KKR’s Bae to Its Board
Harvard University named two top business executives to its governing board at a time of intense scrutiny of the institution from alumni, lawmakers and...
.
4 Feb 2024",0.2732,24-02-04
Merck,"Nature
Merck Science Prizes, Awards, Grants and Challenges
The multitude of prizes, awards and grants that are available to entrepreneurs, scientists and students with great ideas.
.
24 May 2023",0.9595,23-05-24
Merck,"STAT
Merck executive plays down impact of new lung cancer drug data on Keytruda
In the study, called HARMONi-2, ivonescimab nearly doubled the time patients with non-small cell lung cancer went before their cancer returned, from 5.8 months...
.
9 Sept 2024",-0.9217,
Merck,"NJBIZ
At former Merck site, Onyx, Outshine Properties ready to ‘NEST’
At former Merck site, Onyx, Outshine Properties ready to 'NEST' ... Following Merck's exit from Kenilworth at the start of 2024, The Northeast Science and...
.
16 Feb 2024",0.6124,24-02-16
Merck,"Business Wire
Merck and EyeBio Announce Initiation of Phase 2b/3 Clinical Trial for Restoret™ for the Treatment of Diabetic Macular Edema
Merck and EyeBio Announce Initiation of Phase 2b/3 Clinical Trial for Restoret™ for the Treatment of Diabetic Macular Edema ... MK-3000 is an investigational,...
.
4 Sept 2024",0.0,
Merck,"Reuters
Merck raises 2022 forecast as COVID pill, cancer drug fuels profit beat
Merck & Co (MRK.N) on Thursday reported quarterly profit and sales that beat estimates and raised its full-year forecasts on strong demand for top-selling...
.
28 Apr 2022",0.4939,22-04-28
Merck,"Reuters
Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China
Drugmaker Merck & Co said on Wednesday that it agreed to allow China's Sinopharm to distribute and import its COVID-19 antiviral molnupiravir in China if...
.
28 Sept 2022",0.6908,
Merck,"Reuters
Price of COVID treatments from Pfizer, Merck, GSK align with patient benefits -report
The U.S. government has paid around $530 for a 5-day course of Paxlovid, $700 per five-day course of molnupiravir, and $2,100 for a course of sotrovimab - the...
.
3 Feb 2022",0.3818,22-02-03
Merck,"Fierce Pharma
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown: Evaluate
Thanks to its next-gen monoclonal antibodies, Roche should hoist the individual-company sales trophy by a slim margin, the report finds. As for top drugs,...
.
21 Aug 2023",0.6705,23-08-21
Merck,"The Healthcare Technology Report.
NC A&T and Merck Establish Biotechnology Training Center, Boosting North Carolina Workforce Development
NC A&T and Merck Establish Biotechnology Training Center, Boosting North Carolina Workforce Development ... North Carolina A&T State University (NCA&T) and...
.
30 Jun 2023",0.5859,23-06-30
Merck,"BioSpace
Valneva Reports Strong Phase III Chikungunya Vaccine Data After Merck’s Exit from Race
Data from a Phase III study showed Valneva's chikungunya vaccine candidate VLA1553 can elicit a strong immune response and could be an effective protective...
.
13 Jun 2023",0.8979,23-06-13
Merck,"TechTarget
Merck & Co.'s $40B Acquisition of Pharmaceutical Company Seagen
The acquisition of Seagen would support Merck's oncology business after they lose exclusivity to their cash cow Keytruda. ... The prospective Merck & Co.
.
4 Aug 2022",0.0,22-08-04
Merck,"Fierce Biotech
Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations
Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations ... Merck & Co. has bailed early on a phase 3 test of the anti-TIGIT...
.
13 May 2024",-0.6124,24-05-13
Merck,"Pan American Health Organization (PAHO)
PAHO and Merck to work together to improve maternal health in the Americas
PAHO and Merck to work together to improve maternal health in the Americas ... PAHO and MERCK signed a letter of intent on a potential collaboration to improve...
.
20 Sept 2023",0.7003,
Merck,"Cardiovascular Business
FDA grants speedy review to Merck's new drug for pulmonary arterial hypertension
Sotatercept would be the first drug in its class if approved for treating PAH. The FDA is expected to base its decision in part on data from the STELLAR...
.
28 Sept 2023",0.5719,
Merck,"Merck.com
A physician committed to advancing pneumococcal disease research
Dr. Kristen Feemster and her team work to help address pneumococcal disease for people of all ages.
.
11 Oct 2023",0.5859,23-10-11
Merck,"Precision Medicine Online
Keytruda Sales Climb 16 Percent in Q2 as Merck Pursues New Oncology Candidates
Sales of Merck's bestselling immune checkpoint inhibitor Keytruda (pembrolizumab) continued to climb during the second quarter of 2024.
.
30 Jul 2024",0.2263,24-07-30
Merck,"Business Wire
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults.
.
27 Jun 2024",0.4215,24-06-27
Merck,"Clinical Trials Arena
Merck releases new data on sotatercept in PAH
Merck (MSD) released new data analyses from two trials investigating sotatercept for adults with pulmonary arterial hypertension (PAH).
.
12 Sept 2023",0.0,
Merck,"Business Wire
Olatec Therapeutics Announces the Completion of First Dose Cohort in an Innovative Trial Investigating Olatec’s NLRP3 Inhibitor Dapansutrile and Merck’s Keytruda® in Patients with Advanced Refractory Melanoma at Duke Cancer Institute
Olatec's dapansutrile - considered to be the first oral NLRP3 inhibitor tested in patients with advanced refractory melanoma - is addressing the...
.
16 May 2023",-0.0258,23-05-16
Merck,"Bloomberg
China’s Chesir Eyes Merck KGaA’s €1 Billion Pigments Arm
Global New Material International Holdings Ltd., a Chinese colorant producer, is in talks on a potential acquisition of Merck KGaA's pigments arm,...
.
22 Jun 2023",0.0,23-06-22
Merck,"Merck.com
Prostate cancer: stigma, early screening and support
Statistics show there's still unease around prostate cancer diagnosis · 58% of patients agree there's a stigma around prostate cancer. · 39% didn't share their...
.
26 Apr 2024",-0.9272,24-04-26
Merck,"Business Wire
(pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer
FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer ... Median PFS was...
.
12 Jan 2024",-0.7964,24-01-12
Merck,"Merck KGaA
Merck Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
Merck Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis. Merck announced that its two Phase III EVOLUTION clinical trials of...
.
6 Dec 2023",0.0,23-12-06
Merck,"Reuters
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Keytruda sales rose 20% to $5.8 billion in the quarter, topping the estimates of $5.6 billion. Gardasil sales rose 35% to $2 billion, above expectations of $1.7...
.
27 Apr 2023",0.4939,23-04-27
Merck,"RegMedNet
Cell therapy weekly: Merck expands cell culture production capabilities
Merck has invested €23 million to build the company's largest dry powder cell culture media facility at their Lenexa (KS, USA) location. This will bring an...
.
21 Jul 2023",0.1027,23-07-21
Merck,"Merck KGaA
Sharks taking a bite out of the Internet? Remember this headline? The story about sharks biting undersea fiber optic cables that made the rounds a few years ago served as a reminder to the world: The digital world is not simply a formless phenomenon; it relie
The story about sharks biting undersea fiber optic cables that made the rounds a few years ago served as a reminder to the world: The digital world is not...
.
23 Apr 2024",0.0,24-04-23
Merck,"Taipei Times
Merck breaks ground on semiconductor mega site
The 15-hectare site in Kaohsiung is Merck's first move to integrate comprehensive product lines from different technology fields, including thin film and...
.
9 Feb 2023",0.25,23-02-09
Merck,"BioSpace
Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology
Merck announced on Wednesday it is acquiring privately held biotech EyeBio in a potential $3 billion bid to diversify its pipeline and reestablish itself as a...
.
29 May 2024",0.0,24-05-29
Merck,"Merck.com
Meet two women at the forefront of our HIV research
We spoke with two of our own researchers who are leading the charge, Bonnie Howell, Ph.D., and Rebeca Plank, M.D., about what drives them, what's changed, and...
.
18 Jul 2023",0.0,23-07-18
Merck,"Endpoints News
As Merck KGaA grows South Korean footprint, it also zeroes in on regional manufacturing
“We go where our customers are going… APAC is now the place where we need to develop local capabilities so that we are less sensitive to all geopolitical...
.
3 Apr 2024",0.0,24-04-03
Merck,"Business Wire
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)
FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced...
.
18 Sept 2024",0.7506,
Merck,"Fierce Biotech
Merck & Co.’s mAB prevents RSV in infants, teeing up talks with regulators
Merck & Co. hopes to be the next in line with new data showing a monoclonal antibody reduced the incidence of RSV-related infections in infants.
.
23 Jul 2024",0.4767,24-07-23
Merck,"Merck.com
Welcome home: Celebrating our new global headquarters
Welcome home: Celebrating our new global headquarters ... Colleagues across our company celebrated our “homecoming” and ushered in a new era of collaboration for...
.
29 Jun 2023",0.9524,23-06-29
Merck,"ROI-NJ
About Robert Davis, the new chair of Merck
As expected, Robert Davis was unanimously elected to serve as chairman of the board of Merck, effective Dec. 1. Davis, who succeeded Merck's longtime leader...
.
27 Oct 2022",0.7096,22-10-27
Merck,"Merck.com
In memory of President Jimmy Carter, 1924–2024
In memory of President Jimmy Carter, 1924–2024 ... Former President Jimmy Carter exemplified a life of service, first through his governorship and presidency, and...
.
29 Dec 2024",0.0,24-12-29
Merck,"Forbes
How Has Merck Stock Performed During The 2022-23 Inflation Shock?
We believe Merck's stock is now fully valued with limited upside, even if fears of a potential recession are allayed.
.
15 Jun 2023",-0.7328,23-06-15
Merck,"Delaware Business Times
Prelude signs a new partnership with pharma giant Merck
Prelude Therapeutics has now signed its second deal in two years, and this time, it's with $60 billion pharmaceutical company Merck.
.
1 Aug 2024",0.0,24-08-01
Merck,"PR Newswire
Dragonfly Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Solid Tumor Targeting TriNKET® Conducted by Merck
The first patient has been dosed in a clinical trial being conducted by Merck, known as MSD outside the United States and Canada, to evaluate a solid tumor...
.
1 Nov 2022",0.34,22-11-01
Merck,"BioStock
Major acquisition to strengthen Merck’s immunology pipeline
Prometheus Biosciences is a pharmaceutical company specialising in autoimmune diseases. The company's drug candidate PRA023 is intended for patients suffering...
.
20 Apr 2023",0.3182,23-04-20
Merck,"Fierce Pharma Biopharma News & Insights
Merck raises revenue guidance thanks to a surprising bump from COVID-19 pill Lagevrio
Merck said the COVID-19 pill generated a surprising $640 million in the third quarter, prompting the company to increase its 2023 revenue projection.
.
26 Oct 2023",0.8126,23-10-26
Merck,"CTech
Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm
The Israeli startup plans to use the funding to further deploy its AI algorithms for the prospective enrollment of patients in clinical trials – a first in the...
.
3 Apr 2024",0.0,24-04-03
Merck,"Merck.com
Here for Good: A steadfast commitment to health equity
Here for Good: A steadfast commitment to health equity ... For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she's...
.
10 Jun 2024",0.9186,24-06-10
Merck,"pharmaphorum
Merck trial of Keytruda, Lynparza combo in prostate cancer fails
Merck & Co's two powerhouse oncology drugs – Keytruda and Lynparza – have failed to show efficacy when used in combination for patients with previously treated...
.
16 Mar 2022",-0.8885,22-03-16
Merck,"FirstWord Pharma
Merck & Co., Daiichi's ADC directed against B7-H3 sprints into late-stage testing
The study of ifinatamab deruxtecan (I-DXd) is expected to get under way in March to evaluate the B7-H3–targeting ADC in patients with relapsed small-cell lung...
.
15 Jan 2024",0.0,24-01-15
Merck,"WSJ
Merck KGaA Shares Jump on Expectations of AI Boost
The life-sciences and chemicals group lifted its mid-term outlook for its electronics business, projecting organic sales growth of 5% to 9%.
.
17 Oct 2024",0.7579,24-10-17
Merck,"Reuters
Merck seeks more deals to prepare for Keytruda's revenue decline
The company's 2023 transactions are already significantly improving Merck's own outlook for future revenue. Merck said it now expects $20 billion from new...
.
1 Feb 2024",0.4215,24-02-01
Merck,"MarketBeat
Merck & Co., Inc. (MRK) Stock Forecast and Price Target 2025
According to the 23 analysts' twelve-month price targets for Merck & Co., Inc., the average price target is $117.12. The highest price target for MRK is $155.00...
.
11 May 2024",0.0,24-05-11
Merck,"MedCity News
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda. Merck is acquiring global rights to a bispecific antibody from LaNova...
.
14 Nov 2024",-0.7906,24-11-14
Merck,"Reuters
Merck combination treatment for lung cancer fails late-stage study
Merck said on Thursday a combination of two of its cancer drugs failed to meet the main goals of a late-stage study evaluating it as an initial treatment...
.
21 Mar 2024",-0.9423,24-03-21
Merck,"Business Wire
Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer
ODM-208 is an oral, non-steroidal inhibitor of CYP11A1 currently being evaluated in a Phase 2 clinical trial for the treatment of patients with metastatic...
.
13 Jul 2022",-0.7184,22-07-13
Merck,"Fierce Pharma
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
A new report from Leerink Partners outlining large pharma companies' loss of exclusivity (LOE) exposure between both 2025 and 2030, and 2030 through 2040.
.
13 Nov 2024",-0.4215,24-11-13
Merck,"BioPharma Dive
Seagen trial data impresses at ESMO, lifting Merck, Pfizer in the process
Seagen trial data impresses at ESMO, lifting Merck, Pfizer in the process. A combination of Seagen and Astellas' antibody-drug conjugate Padcev with Merck's...
.
23 Oct 2023",0.7351,23-10-23
Merck,"C&EN
Merck pays premium prices to acquire Prometheus Biosciences
Under the terms of the deal, Merck will purchase the clinical-stage firm for a total of $10.8 billion, or $200 per share. Prometheus stock was trading at around...
.
18 Apr 2023",0.296,23-04-18
Merck,"Merck.com
In Burkina Faso, a personal mission to make a difference in one community
In Burkina Faso, a personal mission to make a difference in one community ... Challenging life experiences united two Merck colleagues — Jules Millogo and Cathy...
.
23 Nov 2022",0.5267,22-11-23
Merck,"Indian Chemical News
Merck KGaA collaborates with University of Bonn to advance molecular machine learning
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations.
.
15 Jun 2022",0.2732,22-06-15
Merck,"Fierce Biotech
Merck sets sights on brain cancer with $30M Modifi acquisition
Merck sets sights on brain cancer with $30M Modifi acquisition ... Merck & Co. is putting down $30 million upfront to buy Yale spinout Modifi Biosciences, a deal...
.
23 Oct 2024",-0.8689,24-10-23
Merck,"Drovers
Merck Animal Health to Acquire Vence
Merck Animal Health announced it has signed a definitive agreement under which it will acquire Vence from its founders and shareholders. Vence is an innovator...
.
22 Sept 2022",0.4939,
Merck,"Johns Hopkins University
PhD student's team wins top prize at Merck KGaA Innovation Cup
Whiting School doctoral student Anastasia Georgiou and her teammates from all over the world developed a winning concept and business plan.
.
12 Jul 2023",0.93,23-07-12
Merck,"Business Wire
U.S. District Court for the District of New Jersey Rules in Favor of Merck in Patent Infringement Lawsuit Related to BRIDION (sugammadex)
U.S. District Court for the District of New Jersey Rules in Favor of Merck in Patent Infringement Lawsuit Related to BRIDION® (sugammadex) ... Patent Term...
.
13 Jun 2023",-0.5574,23-06-13
Merck,"Business Wire
Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab)
Merck To Present Data at ASCO Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Cancers With KEYTRUDA.
.
10 May 2022",0.9287,22-05-10
Merck,"Wiley Online Library
Innovation and Team Spirit: The Magic of Science Competitions Seen through the Lens of the Compound Challenge
For five years now, Merck KGaA, Darmstadt, Germany has hosted The Compound Challenge—a global retrosynthesis competition. When the event kicked off in 2018...
.
23 Feb 2024",0.5574,24-02-23
Merck,"BioPharma Dive
Merck moves into obesity with deal for Hansoh’s GLP-1 pill
Merck & Co. has made its first big move in obesity treatment, announcing Wednesday it is paying Hansoh Pharma $112 million for rights outside China to a...
.
18 Dec 2024",0.0,24-12-18
Merck,"Merck KGaA
Merck to acquire chemical business of Mecaro – News | Merck
Merck to Acquire Chemical Business of Mecaro. Merck has signed a definitive agreement to acquire the chemical business of Mecaro Co. Ltd. (Mecaro), a Korea-...
.
17 Aug 2022",0.4939,22-08-17
Merck,"Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
.
16 Apr 2023",0.8271,23-04-16
Merck,"Reuters
Merck discontinues some cancer drug development with China's Sichuan Kelun
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs...
.
23 Oct 2023",-0.9081,23-10-23
Merck,"BioSpace
Senator Sanders Warns J&J, Merck CEOs Could Be Subpoenaed on Drug Pricing
Sen. Bernie Sanders (I-VT), chairman of the Senate Health, Education, Labor, and Pensions Committee, on Thursday proposed serving subpoenas to the CEOs of...
.
19 Jan 2024",-0.1027,24-01-19
Merck,"Investopedia
Merck's Profit Beats Estimates on Sales of Its Cancer, COVID-19 Drugs and HPV Shot
Key Takeaways · Merck's profit and revenue beat estimates as sales of its drugs for cancer and COVID-19, along with its HPV shot, were higher than expected.
.
26 Oct 2023",-0.6124,23-10-26
Merck,"Fierce Pharma
Merck, defending its blockbuster Januvia, prevails in high-stakes patent lawsuit against Viatris
Merck won a high-stakes patent case against Viatris in defense of its blockbuster diabetes drug Januvia.
.
22 Sept 2022",0.9022,
Merck,"Fierce Pharma
After Supreme Court win, Merck prevails against 500 Fosamax cases: report
Merck has been defending itself against claims its osteoporosis drug Fosamax caused patients to suffer “atypical femoral fractures,"" even taking its fight to...
.
24 Mar 2022",0.3182,22-03-24
Merck,"Merck.com
Women in science? Absolutely
A new generation of women scientists. Niki Patel and Cindy Hong joined our company within the past six years — both drawn, in part, to our reputation as a...
.
3 Feb 2023",0.0,23-02-03
Merck,"The Global Legal Post
Paul Weiss secures big pharma double advising Merck and GSK on multi-billion dollar acquisitions
Paul Weiss Rifkind Wharton & Garrison has advised Big Pharma giants on two major deals this week: Merck's acquisition of drugmaker Prometheus Biosciences for...
.
18 Apr 2023",0.4215,23-04-18
Merck,"Genetic Engineering and Biotechnology News
Merck, Daiichi Sankyo Ink Up-to-$22B Cancer ADC Collaboration
Merck & Co. will co-develop three of Daiichi Sankyo's clinical-phase, DXd antibody-drug conjugate (ADC) candidates for various cancers, through a collaboration
.
23 Oct 2023",-0.6597,23-10-23
Merck,"Fierce Pharma
Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair
Merck has earned an FDA approval for Winrevair (sotatercept) to treat patients with pulmonary arterial hypertension (PAH).
.
26 Mar 2024",0.836,24-03-26
Merck,"Fierce Pharma
FDA relaxes impurity limit on Merck's Januvia after testing flags possible carcinogen. Are recalls next?
FDA relaxes impurity limit on Merck's Januvia after testing flags possible carcinogen. Are recalls next? ... A popular diabetes drug has fallen prey to...
.
10 Aug 2022",0.6868,22-08-10
Merck,"Music Business Worldwide
Merck Mercuriadis to exit CEO role at Hipgnosis Song Management, becoming Chairman; Ben Katovsky promoted to Chief Executive of company
Merck Mercuriadis to exit CEO role at Hipgnosis Song Management, becoming Chairman; Ben Katovsky promoted to Chief Executive of company ... Merck Mercuriadis,...
.
2 Feb 2024",0.6808,24-02-02
Merck,"KoreaTimes
Merck acquires chemical business of Korean firm Mecaro
Under the agreement, Merck will secure Mecaro's production facility in Eumseong, North Chungcheong Province and R&D center in Daejeon. ""In acquiring this...
.
18 Aug 2022",0.6808,22-08-18
Merck,"www.drugdiscoverytrends.com
Why Merck shelled out $30B+ on R&D in 2023
Why Merck shelled out $30B+ on R&D in 2023 ... In 2023, Merck & Co. made a considerable investment in research and development, spending more than $30 billion.
.
11 Mar 2024",0.0,24-03-11
Merck,"Fierce Pharma
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer
Keytruda showed its benefit when used after surgery in high-risk patients with localized muscle-invasive bladder cancer and locally advanced bladder cancer.
.
26 Jan 2024",-0.5106,24-01-26
Merck,"Bloomberg.com
Merck Is Set to Remove Cancer-Causing Chemical From Top Diabetes Drugs
The work has the potential to prevent hundreds of thousands of diabetes patients from being exposed to low levels of potentially cancer-causing nitrosamines, an...
.
17 Jan 2023",-0.128,23-01-17
Merck,"Reuters
Merck's Bridion faces generic threat from drugmaker Hikma
Merck (MRK.N) has received a letter that Hikma Pharmaceuticals (HIK.L) US unit has sought a pre-patent expiry approval from the US FDA to sell a generic...
.
26 Feb 2024",-0.0772,24-02-26
Merck,"3BL Media
How Merck Is Using 3D Printing To Create Innovative Solutions
3D technology is helping optimize workstreams, shorten turn-around times, reduce costs and drive innovation ... Merck's 3D Technologies (3DT) organization is...
.
25 Aug 2022",0.9136,22-08-25
Merck,"Fierce Pharma
Germany's Merck pulls back the curtains on its social media team, showing a rare glimpse behind the scenes
Merck is showing us a rare behind-the-scenes video of its three social media managers: Elsa, Romy and Nadine.
.
11 Jul 2023",0.0,23-07-11
Merck,"Fierce Pharma
Gardasil vaccine maker Merck appeals to parents of 9-year-olds in latest HPV awareness ad
Merck's new awareness ad reminds parents of school-age children that HPV vaccination can start as early as age 9.
.
17 May 2022",0.0,22-05-17
Merck,"PR Newswire
Merck Animal Health's Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary Teams
The results of the latest Veterinary Wellbeing study indicate our efforts in conjunction with Merck Animal Health are working and resulting in healthier and...
.
15 Jan 2024",0.4767,24-01-15
Merck,"Business Wire
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer
Merck's KEYTRUDA® Plus Chemotherapy Significantly Improved OS Compared to Chemotherapy Alone in Patients With Advanced or Unresectable BTC.
.
16 Apr 2023",0.2023,23-04-16
Merck,"Business Wire
(pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA...
.
26 Jul 2023",0.4215,23-07-26
Merck,"Yahoo Finance
Merck KGaA Full Year 2023 Earnings: In Line With Expectations
Key Financial Results · Revenue: €21.0b (down 5.6% from FY 2022). · Net income: €2.82b (down 15% from FY 2022). · Profit margin: 14% (down from 15% in FY 2022).
.
11 Mar 2024",0.4404,24-03-11
Merck,"Fierce Biotech
GSK coughs up $2B to buy Bellus for late-phase rival to Merck & Co.'s stuttering gefapixant
The British Big Pharma is set to pay $2 billion to buy Bellus Health, securing a late-phase rival to Merck's stuttering gefapixant program.
.
18 Apr 2023",-0.4019,23-04-18
Merck,"Reuters
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44%...
.
16 Apr 2023",-0.9792,23-04-16
Merck,"GlobeNewswire
Fertility Drugs Global Market Report 2022: Featuring Key Players Merck, Bayer, Novartis, Pfizer & Others
The global fertility drugs market is expected to grow from $2.77 billion in 2021 to $2.92 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%.
.
5 Aug 2022",0.3818,22-08-05
Merck,"Fierce Biotech
Chutes & Ladders—Romanelli returns to Merck to lead international human health team after brief CEO stint
Joseph Romanelli is returning to Merck to lead its international health business less than a year after he left the company to lead Ji Xing Pharmaceuticals.
.
22 Apr 2022",0.0,22-04-22
Merck,"Bloomberg.com
Why This Pharma Boss Isn’t Chasing the Obesity Hype
Why This Pharma Boss Isn't Chasing the Obesity Hype. Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group's...
.
18 Oct 2024",0.6369,24-10-18
Merck,"Fierce Pharma
Merck's Keytruda, on a losing streak, fails in once FDA-rejected liver cancer use and prostate cancer—again
The combination of Keytruda and Eisai-partnered Lenvima failed in newly diagnosed liver cancer, Merck said Wednesday. The pair didn't significantly extend...
.
3 Aug 2022",-0.9552,22-08-03
Merck,"Fierce Pharma
Merck’s Keytruda reaches coveted postsurgery lung cancer use with broader FDA nod than Tecentriq
The FDA has cleared Keytruda for use after surgery and chemotherapy for early NSCLC across stages 1B, 2 or 3A, Merck said Friday.
.
27 Jan 2023",-0.5859,23-01-27
Merck,"Feedstuffs
Merck donates to Iowa State University for Veterinary Diagnostic Laboratory
Merck Animal Health announced this week a $250,000 donation to Iowa State University (ISU) to support the new Veterinary Diagnostic Laboratory.
.
5 May 2022",0.4019,22-05-05
Merck,"Forbes
Is Merck Stock Fully Valued At $130?
MRK stock looks like it is appropriately priced. We estimate Merck's Valuation to be $135 per share, close to its current market price of $130.
.
1 May 2024",0.7841,24-05-01
Merck,"The Institute of Cancer Research
ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs
ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs ... The Institute of Cancer Research and science...
.
22 Sept 2023",-0.93,
Merck,"Labiotech.eu
BioMed X Institute and Merck start new oncology research project
Subscribe to our newsletter to get the latest biotech news! ... BioMed X, a German independent research institute, has started a new research project '...
.
1 Aug 2022",0.0,22-08-01
Merck,"BioSpace
Sanofi, Merck Shut Down Alport Syndrome, Colorectal Cancer Trials
The trial was designed to assess the safety and efficacy of the experimental drug. Results were expected in the second half of 2023. In the filing, Regulus said...
.
19 Jul 2022",-0.3818,22-07-19
Merck,"WSJ
Merck Explores Purchase of Biotech Seagen
Merck agreed to pay $600 million up front to Seagen, while buying five million shares for $1 billion.
.
17 Jun 2022",0.4404,22-06-17
Merck,"STAT
New Merck pneumococcal vaccine wins FDA approval
The vaccine, which will be sold under the name Capvaxive, is designed to protect against pneumococcal pneumonia, which hospitalizes about 150,000 adults in the...
.
17 Jun 2024",0.8555,24-06-17
Merck,"Merck KGaA
Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China
Merck plans to invest approximately € 100 million (RMB 700 million or USD 110 million) over six years by expanding the existing Wuxi production site to...
.
29 Apr 2022",0.0,22-04-29
Merck,"BioPharma Dive
New data could help Merck expand use of cardiovascular drug
Data from the ZENITH trial could potentially expand use of a drug that's now forecast to earn $5 billion a year at its peak. A trial steering committee stopped...
.
25 Nov 2024",0.743,24-11-25
Merck,"BioPharma Dive
Merck wagers $290M on a cancer treatment from Finnish drugmaker
The treatment, developed by Orion Corporation, is in Phase 2 testing for advanced prostate cancer, and adds to Merck's oncology pipeline.
.
13 Jul 2022",-0.8316,22-07-13
Merck,"The Business Journals
Life sciences firm MilliporeSigma doubling down on MoCo with $286M investment
The U.S. and Canadian life sciences arm of Germany's Merck KGaA plans to expand its biosafety testing capacity and local headcount.
.
16 Nov 2022",0.3182,22-11-16
Merck,"Fortune
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck...
.
20 Dec 2024",-0.886,24-12-20
Merck,"Reuters
US plans shift of Merck COVID treatment to commercial market
The US government will stop distributing free doses of Merck & Co's (MRK.N) COVID-19 antiviral treatment molnupiravir by the middle of next month.
.
4 Oct 2023",0.2732,23-10-04
Merck,"Business Wire
(enfortumab vedotin-ejfv) for the First-Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer
In KEYNOTE-048, KEYTRUDA monotherapy was discontinued due to adverse events in 12% of 300 patients with HNSCC; the most common adverse reactions leading to...
.
30 Nov 2023",-0.8126,23-11-30
Merck,"PharmaTimes
NICE overturns previous decision, recommends Merck and Pfizer’s Bavencio
NICE has overturned a previous decision against the routine NHS use of Merck KGaA and Pfizer's Bavncio (avelumab).
.
11 Apr 2022",0.8388,22-04-11
Merck,"Fortune
Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics
In this episode of Leadership Next, recorded live in Washington D.C. at a Deloitte Next Generation CEO event, Frazier tells host Alan Murray why these decisions...
.
9 Nov 2023",0.0,23-11-09
Merck,"STAT
Merck says study of under-the-skin version of Keytruda, a bid to extend the drug’s sales, succeeded
For Merck, the new under-the-skin, or subcutaneous, formulation of Keytruda could represent a major way of holding on to a larger share of Keytruda's $25...
.
19 Nov 2024",0.6908,24-11-19
Merck,"WSJ
Merck’s Insurers On the Hook in $1.4 Billion NotPetya Attack, Court Says
Merck's Insurers On the Hook in $1.4 Billion NotPetya Attack, Court Says · A court rejected arguments by insurers that they shouldn't have to cover Merck's...
.
2 May 2023",-0.9042,23-05-02
Merck,"Fierce Pharma
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
In testing Prevymis against Roche's standard of care treatment Valcyte in kidney transplant recipients, Merck's drug showed comparable efficacy and a...
.
24 Oct 2022",0.7906,22-10-24
Merck,"Merck KGaA
Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China
Merck is expanding production capacity for highly-purified reagents at its site in Nantong, China, a major transportation hub in the Yangtze River Delta...
.
29 Jun 2023",0.3182,23-06-29
Merck,"Clinical Trials Arena
Merck bets big on PRA023 with $10.8bn Prometheus acquisition offer
Merck & Co. announced its intention to acquire Prometheus Biosciences, pending board and regulatory approval, at $200.00 per share in cash price.
.
3 May 2023",0.6486,23-05-03
Merck,"Fierce Pharma
MilliporeSigma boosts drug substance production capacity with new facility in France
Three weeks after revealing a major investment at its site in Molsheim, France, Merck KGaA's life science arm MilliporeSigma has opened a new factory on the...
.
4 Oct 2022",0.3182,22-10-04
Merck,"Fierce Pharma
The top 20 pharma companies by 2021 revenue
It was a good year to be a pharmaceutical company, especially one that came up with a product to combat COVID-19. Of the world's top 20 pharmas ranked by...
.
12 Apr 2022",0.4767,22-04-12
Merck,"Fierce Biotech
Dewpoint, with a handful of Big Pharma partners from Merck to Pfizer, collects $150M to advance its 20 programs
Dewpoint, with a handful of Big Pharma partners from Merck to Pfizer, collects $150M to advance its 20 programs ... Pfizer, Merck, Bayer and Volastra Therapeutics...
.
3 Feb 2022",0.0,22-02-03
Merck,"CNBC
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
Moderna and Merck 's experimental cancer vaccine, when used in combination with Merck's blockbuster therapy Keytruda, reduced the risk of death or relapse in...
.
14 Dec 2023",-0.9349,23-12-14
Merck,"Business Wire
BigHat Biosciences Announces Research Collaboration with Merck
BigHat and Merck will collaborate to optimize up to three proteins by leveraging BigHat's platform to synthesize, express, purify, and characterize molecules.
.
29 Nov 2022",0.4939,22-11-29
Merck,"Clinical Trials Arena
Merck to start trials investigating single dosing regimen of HPV vaccine
The company plans to conduct two separate trials investigating Gardasil 9 in men and women aged 16-26 years to evaluate whether a single dose of the vaccine...
.
13 Mar 2024",0.0,24-03-13
Merck,"Bloomberg Law News
Merck KGaA Sues Intas to Block Accord Unit’s Copy of Mavenclad
Merck KGaA alleges that a generic version of Mavenclad proposed by Intas Pharmaceuticals Ltd.'s Accord Healthcare Inc. infringes two patents for the multiple...
.
26 Jul 2022",-0.4404,22-07-26
Merck,"Merck.com
‘Wonder Angie’ enlists her ‘super friends’ to fight oral cancer
'Wonder Angie' enlists her 'super friends' to fight oral cancer · It all started with pain in Angie's tongue · The toll of Angie's treatment for oral cancer · “...
.
26 Jan 2024",-0.9403,24-01-26
Merck,"PIB
Heavy Water Board signs agreement with M/s Sigma Aldrich Chemicals Private Limited, Bengaluru for the supply of Heavy Water for production of Deuterium Labelled Compounds and Allied Value Added Products
Heavy Water Board (HWB), a constituent unit of Department of Atomic Energy (DAE), today signed an agreement with for the supply of Heavy Water for a period of...
.
18 May 2023",0.8402,23-05-18
Merck,"FirstWord Pharma
Alteogen hoping for bumper windfall from Merck & Co.’s sub-Q Keytruda
Alteogen first announced in 2020 that it had partnered with an unnamed drugmaker to use its recombinant human hyaluronidase enzyme ALT-B4 non-exclusively across...
.
26 Feb 2024",0.4215,24-02-26
Merck,"Fierce Biotech
After a year as Merck KGaA healthcare CEO, Guenter reflects on I-O bispecific flop, spots new multiple sclerosis strategy
Merck KGaA is testing a promising multiple sclerosis candidate, which pharma CEO Peter Guenter said could set “a totally new treatment paradigm.”
.
16 Feb 2022",0.0772,22-02-16
Merck,"Forbes
Is Merck Stock A Better Pick Over AbbVie?
Looking at financial risk, Merck fares better. Its 13% debt as a percentage of equity is lower than 21% for AbbVie. Furthermore, its 10% cash as a percentage of...
.
21 Aug 2024",-0.0,24-08-21
Merck,"Le Monde.fr
Merck charged in France over changes to popular thyroid drug
Merck said Wednesday, October 19, that it had been charged with ""aggravated deceit"" for failing to inform patients of changes to a thyroid drug that could...
.
19 Oct 2022",-0.8402,22-10-19
Merck,"Reuters
Italy to receive 40,000 Merck antiviral drug doses next week - official
Italy will receive around 40000 doses of Merck & Co's COVID-19 antiviral drug next week, which will add to nearly 12000 already distributed to hospitals,...
.
9 Jan 2022",0.0,22-01-09
Merck,"Fierce Pharma
Merck and Seagen can't agree on a price for their rumored merger: Bloomberg
Merck and Seagen can't agree on a price for their rumored merger: Bloomberg ... An anticipated merger between pharma giant Merck and cancer powerhouse Seagen has...
.
26 Aug 2022",-0.8234,22-08-26
Merck,"Fierce Pharma
Merck’s Keytruda wins coveted FDA nod around surgery for early lung cancer—with a surprise
Merck's Keytruda is the first immunotherapy approved by the FDA for use both before and after surgery to treat resectable non-small cell lung cancer.
.
16 Oct 2023",0.7096,23-10-16
Merck,"PR Newswire
MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up
PRNewswire/ -- MilliporeSigma, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company,...
.
23 Feb 2022",0.0,22-02-23
Merck,"CNBC
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
The Food and Drug Administration on Monday approved Merck 's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious...
.
17 Jun 2024",0.8555,24-06-17
Merck,"ET HealthWorld
Novartis taps Merck executive Marshall to replace Bradner as research head
Zurich: Novartis said on Thursday it appointed Merck executive Fiona Marshall as president of the Novartis Institutes for Biomedical Research to replace Jay...
.
1 Sept 2022",0.0,
Merck,"BioPharma Dive
Moderna, Merck data support claim of cancer vaccine’s promise
An experimental vaccine may help stop tumors from recurring in people with a common form of skin cancer, detailed results from a mid-stage study run by...
.
16 Apr 2023",-0.6486,23-04-16
Merck,"PR Newswire
Micron to Select Athinia™ for Pioneering Data Collaboration
PRNewswire/ -- Today, Athinia™ announced that Micron Technology, Inc. (Nasdaq: MU), a global leader in innovative memory and storage solutions, plans to use...
.
13 Jul 2022",0.5574,22-07-13
Merck,"Pharmaceutical Technology
Merck Merck KGaA acquires Mirus Bio
Merck buys Mirus Bio to boost viral vector bioprocessing capacity. The acquisition of Mirus Bio's transfection re-agents, such as TransIT-VirusGEN, will enhance...
.
2 Aug 2024",0.4019,24-08-02
Merck,"Medical Marketing and Media
A timeline of Ken Frazier’s tenure at Merck
A timeline of Ken Frazier's tenure at Merck. Here's a timeline of notable moments during Frazier's three-decade career at the drugmaker.
.
28 Oct 2022",0.0,22-10-28
Merck,"Yahoo Finance
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
AI to power early identification and management of lung cancer and other diseasesNEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- Merck Global Health Innovation...
.
25 Jun 2024",0.3612,24-06-25
Merck,"Chemistry World
Merck & Co to buy immunology specialist Prometheus
The main focus of the deal is PRA023 – Prometheus' antibody directed at tumour necrosis factor-like ligand 1A (TL1A), a protein target associated with...
.
20 Apr 2023",0.0,23-04-20
Merck,"Amazon Web Services
MSD Builds HawkAVI Platform on AWS to Reduce Product Reject Rates
Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for...
.
23 Nov 2022",0.4588,22-11-23
Merck,"Reuters
US FDA approves Merck's therapy for rare lung condition
The U.S. Food and Drug Administration on Tuesday approved Merck's (MRK.N) , opens new tab treatment for adults with high blood pressure due to constriction of...
.
27 Mar 2024",0.5106,24-03-27
Merck,"Fierce Pharma
After recent M&A moves, Merck CEO says he's thinking beyond Keytruda's eventual downfall
With the performance, the company has adjusted its 2023 revenue projection upward slightly. Merck now expects to pull down between $57.7 billion and $58.9...
.
27 Apr 2023",0.0,23-04-27
Merck,"New Jersey Business Magazine
Davis to Succeed Frazier as Chairman of Merck
Glocer continued, “Rob Davis has shown himself to be an innovative leader with a deep understanding of Merck and our industry. We look forward to working with...
.
28 Oct 2022",0.7269,22-10-28
Merck,"BioSpace
Merck Drops Up to $610M on Neuro Disease-Focused Caraway Therapeutics
Merck bumped up its position from shareholder to acquirer in a move to scoop up neurodegenerative disease biotech Caraway Therapeutics for up to $610 million,...
.
21 Nov 2023",0.1531,23-11-21
Merck,"Healio
Merck’s RSV shot for infants shows promise, could be available in 2025
Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year.
.
23 Oct 2024",0.296,24-10-23
Merck,"FirstWord Pharma
Bavencio, Mavenclad growth helps Merck KGaA post rise in Q1 sales
Other results: · Oncology products: €433 million, up 14.3%. Erbitux: €250 million, up 3.1%; Bavencio: €167 million, up 30.7% · Glucophage: €218 million, up 0.1%...
.
11 May 2023",0.6369,23-05-11
Merck,"PR Newswire
Merck KGaA, Darmstadt, Germany, to Acquire Unity-SC Strengthening its Offering for Artificial Intelligence Semiconductors
Merck KGaA, Darmstadt, Germany, a leading science and technology company, intends to acquire Unity-SC, a France-based provider of metrology and defect...
.
18 Jul 2024",0.743,24-07-18
Merck,"Nature
Merck bets on sotatercept in pulmonary arterial hypertension
In October, Merck announced that sotatercept, its first-in-class drug for the treatment of pulmonary arterial hypertension, successfully met the primary...
.
17 Nov 2022",0.4939,22-11-17
Merck,"Yahoo Finance
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?
LIVE. Powell holds a press conference after the Fed's rate decision. Watch here. Zacks. Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold? ... Merck's...
.
21 Oct 2024",0.0,24-10-21
Merck,"Free Malaysia Today
Merck expects sharp drop in Covid pill sales
The company estimated sales of molnupiravir, which is sold under the brand Lagevrio, to fall to about US$1 billion this year from US$5.68 billion in 2022.
.
2 Feb 2023",0.296,23-02-02
Merck,"The New York Times
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The delayed vaccines means that girls in countries such as Sierra Leone, Burkina Faso and Mozambique who are now 14 will no longer be eligible for vaccination.
.
18 Apr 2024",-0.7506,24-04-18
Merck,"Rowan Today
New Jersey’s first veterinary school unveils Community Engagement Mobile Unit at Merck Animal Health headquarters
“Merck Animal Health is thrilled to support Rowan University's Shreiber School of Veterinary Medicine and the introduction of the school's new Shelter Medicine...
.
18 Nov 2024",0.8225,24-11-18
Merck,"CSRwire
Discover Which Female Role Models Inspired Our Own Women in STEM
The gender gap that exists in the science, technology, engineering and math (STEM) fields has been prominent for years. Meet some Merck's own women in STEM...
.
11 Mar 2022",0.6705,22-03-11
Merck,"Clinical Trials Arena
Unlearn.AI and Merck KGaA collaborate to expedite immunology trials
Unlearn.AI and Merck KGaA have signed a partnership to expedite late-stage immunology trials using new designs that comprise Digital Twins.
.
17 Feb 2022",0.0,22-02-17
Merck,"FirstWord Pharma
Merck & Co. hikes full-year view as Keytruda, Gardasil drive Q3 growth
Top Story. By: Anna Bratulic. Ref: Merck & Co., MarketWatch, Investing.com, Bloomberg, Merck & Co., ABC News, FinanzNachrichten, Investor's Business Daily,...
.
27 Oct 2022",0.5267,22-10-27
Merck,"Pharmaceutical Technology
Merck wins regulatory nod for combination therapy to treat la/mUC
Merck has secured approval from the US Food and Drug Administration (FDA) for KEYTRUDA (pembrolizumab) in combination with Padcev (enfortumab vedotin-ejfv) for...
.
4 Apr 2023",0.9042,23-04-04
Merck,"Clinical Trials Arena
Merck KGaA doses first subject in Phase III generalised Myasthenia Gravis trial
Merck KGaA (Merck) has dosed the first subject in a Phase III trial of oral Cladribine to treat generalised myasthenia gravis (gMG), a rare neuromuscular...
.
30 Aug 2024",0.4019,24-08-30
Merck,"Fierce Pharma
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears ... Merck & Co. ... What doctors described as a “messy” treatment landscape...
.
10 Oct 2023",-0.8689,23-10-10
Merck,"CNBC
Moderna and Merck cancer vaccine used with Keytruda reduces risk of deadly skin cancer spreading
Moderna and Merck's cancer vaccine reduced the risk of melanoma spreading to other parts of the body or death by 65% in patients with stage 3 or 4 of the...
.
5 Jun 2023",-0.9694,23-06-05
Merck,"Reuters
Merck scraps Keytruda trial for prostate cancer after dismal interim data
The interim data comes as a setback for Merck, which has been working to expand the use of Keytruda, a drug that has powered its growth for years but is nearing...
.
25 Jan 2023",-0.4118,23-01-25
Merck,"Financialexpress
Merck appoints Pratima Reddy as Managing Director of Merck Specialities in India
Before taking over as the Managing Director of India Operations, Pratima was the Regional Franchise Leader (RFL) of the Cardiovascular, Metabolism and...
.
1 Aug 2022",0.0,22-08-01
Merck,"Business Wire
Merck, Synergis & IPS Present on Engineering Document Management for Simplified Compliance & Validation
Together, Synergis and IPS bring life sciences and biotech companies the best possible solution for engineering document management software coupled with...
.
7 Nov 2022",0.7579,22-11-07
Merck,"PR Newswire
Definitive Agreement to Acquire Exelead will Strengthen the CDMO Offering for mRNA of the Life Science Business of Merck KGaA, Darmstadt, Germany
PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced the signing of a definitive agreement to acquire Exelead,...
.
6 Jan 2022",0.8271,22-01-06
Merck,"CNBC
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Many of the biggest drugs facing upcoming patent expirations are biologics, including Merck's Keytruda, J&J's Stelara and Bristol Myers Squibb's Opdivo. Those...
.
28 Jan 2024",0.296,24-01-28
Merck,"Merck.com
From stigma to strength: HIV activist from Lebanon shares his story
Elie Ballan discusses learning about his HIV status and his work to inspire others living with HIV.
.
27 Apr 2023",0.8442,23-04-27
Merck,"Business Wire
(pembrolizumab) Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial Carcinoma
FDA Grants Priority Review to Merck's Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial...
.
20 Feb 2024",0.5994,24-02-20
Merck,"ET HealthWorld
Merck India spearheads a discussion on 'Emerging Trends & Future of Indian Agricultural Research' - Aug 2, 2..
The session will focus on the emerging trends in Indian Agricultural research, to learn some critical lessons from these trends that can take Indian...
.
2 Aug 2022",-0.3182,22-08-02
Merck,"Variety
Hipgnosis CEO Merck Mercuriadis Lays Out His Company’s Vision and Goals at Canadian Music Week
“So I started to see institutional investors in London. And I would explain to them, 'Listen, these songs have really predictable and reliable income,' and I...
.
10 Jun 2022",0.25,22-06-10
Merck,"ROI-NJ
In huge life science transaction, Onyx Equities acquires 108-acre Merck site in Kenilworth
In one of the largest life science property transactions in state history, Onyx Equities announced Thursday that it has teamed with New York-based Machine...
.
16 Feb 2023",0.3182,23-02-16
Merck,"Business Wire
Hyfe Joins Forces with Merck to Deploy Its Artificial Intelligence-Powered Cough Detection and Counting Technology
Hyfe, Inc., the global leader in AI-powered cough detection, tracking and classification, has entered into an agreement with Merck, known as MSD outside the...
.
19 Jul 2022",0.4939,22-07-19
Merck,"CIDRAP
Merck announces positive trial data for pneumococcal vaccine candidate
The vaccine, V116, covers the 21 serotypes of Streptococcus pneumoniae that are responsible for 85% of invasive pneumococcal disease in adults ages 65 years and...
.
2 Aug 2023",0.7096,23-08-02
Merck,"STAT
Merck Ebola vaccine Ervebo shown to offer substantial protection
Ebola vaccine cuts fatality even in people who were infected before the jab, new study shows. “The main takeaway is that the vaccine is highly protective...
.
21 Aug 2024",-0.8442,24-08-21
Merck,"WSJ
Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again
Pfizer, Novartis, Merck executives say they are hunting for deals again. Lower-priced competitors could take away nearly a quarter of industry sales.
.
9 Feb 2023",0.0,23-02-09
Merck,"BioProcess International
Merck KGaA to build APAC plant - BioProcess Insider
Merck KGaA to build Asia-Pacific bioprocessing center. Merck KGaA to build Asia-Pacific bioprocessing center. Merck has signed a non-binding Mou with the Korean...
.
8 May 2023",0.0,23-05-08
Merck,"ROI-NJ
At Merck, desire to be fully involved in state’s life science community played role in consolidating HQ in Rahway
Paula Alston, who leads the global workplace and enterprise services organization at Merck, can easily rattle off why it was important for Merck to again...
.
22 Jun 2023",0.8074,23-06-22
Merck,"Reuters
Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator
Drugmaker Merck & Co (MRK.N) avoided billions of dollars of US taxes in recent years on its top-selling cancer drug Keytruda by booking all the profits from...
.
27 Jul 2022",-0.5267,22-07-27
Merck,"Fierce Pharma
On the heels of pulmonary arterial hypertension drug nod, Merck launches 'Outnumber PAH' campaign
Merck's new campaign is focused on providing information and resources to PAH patients to help navigate their diagnosis and daily life with the disease, with an...
.
16 Apr 2024",0.6486,24-04-16
Merck,"Merck KGaA
Merck Launches Ultimus Film to Offer Superior Strength and Leak Resistance | Merck
Merck, today announced the launch of its Ultimus Single-Use Process Container Film, designed to provide extreme durability and leak resistance for single...
.
24 Apr 2023",0.4404,23-04-24
Merck,"Pharmaceutical Technology
FDA grants approval for Merck’s Keytruda combo for gastric cancer
FDA grants approval for Merck's Keytruda combo for gastric cancer. Trial data has shown that the combination treatment reduced mortality risk by 22% versus...
.
17 Nov 2023",-0.4404,23-11-17
Merck,"Fierce Pharma
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer ... Merck has called it quits on another attempt to enhance its powerful PD-1 inhibitor...
.
7 Dec 2023",-0.7783,23-12-07
Merck,"BioSpace
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
Merck and Kelun-Biotech's antibody-drug conjugate achieved a 22% objective response rate and 80.5% disease control rate in heavily pretreated patients with...
.
10 Apr 2024",-0.4767,24-04-10
Merck,"Fierce Biotech
Merck bets big on circular RNA, paying $150M and dangling $3.5B in biobucks to work with Orna
The Big Pharma is making the upfront payment and committing to up to $3.5 billion in milestones to work with Orna to advance programs including engineered...
.
16 Aug 2022",0.0772,22-08-16
Merck,"Business Wire
Qurient Announces Collaboration Agreement with MSD to Evaluate Selective CDK7 Inhibitor Q901 in Combination With KEYTRUDA® (pembrolizumab)
Qurient will conduct a phase 1/2 study in the US to evaluate safety and efficacy of Q901 in combination with KEYTRUDA for the treatment of selected advanced...
.
14 Sept 2022",0.6908,
Merck,"Citywire
Merck is too cheap on pipeline potential
Merck & Co's (US:MRK) blockbuster cancer drug Keytruda will lose its patent in 2028, leaving the US pharmaceutical giant with a $33bn hole to fill.
.
1 Jul 2024",-0.4939,24-07-01
Merck,"Merck.com
Our Q4 and full-year 2023 earnings report
Our Q4 and full-year 2023 earnings report ... Take a look at the infographic below for more details on Q4 and full-year 2023 results. Download infographic.
.
1 Feb 2024",0.0,24-02-01
Merck,"Bloomberg
Watch Merck KGaA CEO Belen Garijo Speaks With Bloomberg in Davos
CC-Transcript · NOW PLAYING. Merck KGaA CEO Belen Garijo Speaks With Bloomberg in Davos · 44:51. Pres. · 04:10. Trump Puts Iran On Alert After Houthi Strike.
.
18 Jan 2024",0.4995,24-01-18
Merck,"Merck KGaA
Merck Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing
Merck, a leading science and technology company, has achieved EXCiPACT cGMP (current Good Manufacturing Practice) certification for Pharmaceutical Auxiliary...
.
5 Sept 2024",0.4404,
Merck,"Merck.com
4 historical designations highlight groundbreaking scientific achievements
This ACS program recognizes seminal achievements in the history of the chemical sciences and provides a record of the contributions to chemistry and society in...
.
2 Mar 2023",0.34,23-03-02
Merck,"PR Newswire
Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide
Greenphire, the global leader in financial lifecycle management for clinical trials, today announced an expansion of its agreement with Merck.
.
13 Mar 2023",0.8591,23-03-13
Merck,"Endpoints News
Merck to stop making APIs at Pennsylvania site and cut 300 jobs by 2024
Josh Sullivan. In 2024, Merck will discontinue its manufacturing of active pharmaceutical ingredients. And with that move, it will no longer need its Cherokee...
.
24 Mar 2022",-0.4215,22-03-24
Merck,"Business Wire
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Merck KGaA, Darmstadt, Germany focused on the discovery of novel small molecule drug...
.
20 Sept 2023",0.5994,
Merck,"Supply Chain Brain
China Approves Merck’s Covid Therapy Amid Shortage of Drugs
December 30's approval came after the U.S. drugmaker struck a deal in September with Chinese state-owned firm Sinopharm to import and market molnupiravir in...
.
6 Jan 2023",0.4215,23-01-06
Merck,"Yahoo Finance
Is Merck & Co., Inc. (MRK) the Best Defensive Stock According to Reddit?
September is typically the worst month for the markets, however with a much anticipated rate cut, 2024 might be a different story. The current market...
.
12 Sept 2024",-0.2263,
Merck,"University of Houston
Chemistry Postdoc Francisco Martins Honored by Merck with National Award
Chemistry Postdoc Francisco Martins Honored by Merck with National Award ... Francisco Martins, a postdoctoral fellow in chemistry at the University of Houston,...
.
17 May 2024",0.9393,24-05-17
Merck,"MarketScreener
Helene von Roeder to become new Merck CFO -May 08, 2023 at 07:57 am EDT
Merck has appointed Helene von Roeder as the new chief financial officer and member of the Executive Board after Marcus Kuhnert has decided to step down.
.
8 May 2023",0.0,23-05-08
Merck,"People Matters Global
News: Targeting 30% leadership from underrepresented groups by 2030: Merck's DEI report
The survey aimed to gather insights on gender equity, cultural and ethnic considerations, opportunities for underrepresented social groups.
.
25 Aug 2023",0.4019,23-08-25
Merck,"Fierce Pharma
Merck, Glenmark wrap up Zetia pay-for-delay case after pharmacies take settlement
The case hinges on a 2010 settlement between Merck and Glenmark, which plaintiffs argued was used to stall the entry of Glenmark's generic to Merck's Zetia for...
.
25 Apr 2023",-0.5106,23-04-25
Merck,"WSJ
Merck’s Patent Cliff Doesn’t Look So Frightening Anymore
Merck could be sitting on a blockbuster from a recent acquisition that would help reduce dependence on cancer drug Keytruda.
.
11 Oct 2022",-0.3167,22-10-11
Merck,"Bloomberg Law News
Eli Lilly, Merck Drugs Likely to Face Medicare Price Negotiation
Eli Lilly & Co.'s Trulicity and Merck & Co.'s Keytruda could face Medicare drug price negotiations by 2028, according to a study published Monday analyzing...
.
27 Feb 2023",0.0,23-02-27
Merck,"Merck.com
Betty Larson
Betty Larson ... Betty Larson joined the company in April 2024 as the executive vice president and chief human resources officer. She is responsible for global...
.
2 Apr 2024",0.3182,24-04-02
Merck,"C&EN
Merck KGaA and Intel pair on semiconductors
Advertisement ... A silicon semiconductor wafer being prepared in a lab. ... A single semiconductor wafer makes hundreds or thousands of individual computer chips.
.
18 Nov 2024",0.2263,24-11-18
Merck,"Fierce Pharma Biopharma News & Insights
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Sen. Bernie Sanders, I-Vermont, has released (PDF) a report shedding light on the system that allows the companies to charge more for drugs in the US than in...
.
6 Feb 2024",0.0,24-02-06
Merck,"Clinical Trials Arena
Merck and Moderna announce Phase III V940 trial for melanoma patients
Merck (MSD) and Moderna are initiating a Phase III trial evaluating V940, an investigational individualised neoantigen therapy (INT), in combination with...
.
27 Jul 2023",0.0,23-07-27
Merck,"Fierce Pharma
With Keytruda leading the way, Merck tallies 80-plus potential oncology approvals by 2028
That's on top of the 46 existing approved U.S. indications from Merck's oncology portfolio. More than 30 of those belong to Keytruda, the most of any oncology...
.
8 Jun 2022",0.5574,22-06-08
Merck,"Financial Express
There is surge in startups in Biotechnology & Diagnostics segment in India: Rajeev Nair, Global Head of Chemistry, Life Science business, Merck
India is the sixth largest economy in the world with 2.7Trillon US$ nominal GDP. There is tremendous potential for the Life Science Industry in both...
.
12 Jul 2022",0.0,22-07-12
Merck,"AgFunderNews
EXCLUSIVE: Shell, Merck Animal Health back regenerative agtech Vence for carbon & traceability capabilities
Image credit: Vence. Vence, a US startup that offers 'virtual fencing' for ranchers using regenerative ag practices, has secured funding from the venture arms...
.
16 Mar 2022",0.7603,22-03-16
Merck,"Fierce Biotech
Things don't look good for NGM's Merck-partnered eye asset as phase 2 fail sends stock plummeting
Things don't look good for NGM's Merck-partnered eye asset as phase 2 fail sends stock plummeting ... As NGM Biopharmaceuticals' phase 2 trial misses the mark,...
.
17 Oct 2022",-0.8277,22-10-17
Merck,"ET HealthWorld
Merck expands manufacturing capacity of HPV vaccines to meet global demands
Kenilworth NJ: Merck reaffirmed its commitment to enable broad equitable access to the company's HPV vaccines. To support this, the company has invested...
.
11 Apr 2022",0.6908,22-04-11
Merck,"YouTube · CNBC Television
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales. 508 views · 11 months ago ...more...
.
1 Feb 2024",0.8481,24-02-01
Merck,"Merck.com
A colleague enlists artist’s help to make peace with her diagnosis
A surprising diagnosis. Chiummo compares her first experience in an MRI machine to meditating. She was calm, almost soothed before she was given the news: she...
.
7 Jun 2023",0.8692,23-06-07
Merck,"Bloomberg Law News
Merck & Co. Sues Hetero to Block Copies of Delstrigo HIV Drug
Merck & Co. Sues Hetero to Block Copies of Delstrigo HIV Drug ... Merck & Co. alleges that a copy of Delstrigo proposed by Hetero Labs Ltd. infringes two patents...
.
29 Nov 2022",-0.7003,22-11-29
Merck,"BioSpace
Workforce Cuts Abound at Zealand Pharma, Merck and Orchard
Zealand Pharma announced that it is laying off 90% of its staff in the US by the third quarter of 2022 as part of a huge corporate restructuring move.
.
31 Mar 2022",0.0258,22-03-31
Merck,"Bloomberg
Merck KGaA Gets Female Leadership Duo in First for Germany’s DAX
Germany's Merck KGaA will soon have women occupying the top two posts on its executive board, marking a first in a corporate world more noted for its...
.
8 May 2023",0.2023,23-05-08
Merck,"South China Morning Post
Merck’s Covid-19 pill to be made for developing nations in new deal
China, Vietnam and Bangladesh are among the countries that will produce versions of Merck's pill, which is said to cut hospitalisation rates in half among...
.
20 Jan 2022",-0.2732,22-01-20
Merck,"Nasdaq
Merck Loses Around $32B in 3 Months: Time to Sell the Stock?
It has a strong cancer pipeline, including Keytruda. Merck is investing in M&A activity to strengthen its pipeline. However, Merck's shares have declined in the...
.
20 Sept 2024",0.0258,
Merck,"Forbes
Is MRK Stock Undervalued At $100?
We estimate Merck's Valuation to be $130 per share, reflecting a 25% upside from its current market price of $102.
.
7 Nov 2024",0.296,24-11-07
Merck,"BioSpace
Merck Dives Deep into AI with $610 Million+ Absci Pact
Absci will leverage its Bionic Protein non-standard amino acid technology and AI-integrated Drug Creation Platform to create enzymes for Merck.
.
7 Jan 2022",0.4939,22-01-07
Merck,"BioPharma Dive
Merck pays $50 million for early-stage Epstein-Barr vaccine
Merck & Co. has added another experimental vaccine to its pipeline, paying $50 million to Opko Health for a preclinical candidate aimed at the Epstein-Barr...
.
8 Mar 2023",0.0,23-03-08
Merck,"Reuters
Scholz promises support for pharma sector in Germany as Merck invests
German Chancellor Olaf Scholz said he was committed to supporting the pharmaceuticals sector with tax advantages for research and cutting red tape for trials.
.
25 Apr 2024",0.8834,24-04-25
Merck,"Fierce Pharma
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Before Monday's approval, Jemperli has been allowed as a second-line treatment for dMMR/MSI-H endometrial cancer. In the first six months of 2023, the drug...
.
31 Jul 2023",-0.5574,23-07-31
Merck,"Fierce Biotech
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
After closing the $2 billion deal in June, GSK is showcasing the phase 3 camlipixant program and ready to replace Merck as the market leader.
.
30 Nov 2023",0.6124,23-11-30
Merck,"Business Wire
Koneksa Announces Merck Joins Data Syndication Partnership Program Around Parkinson’s Digital Biomarkers Observational Study
NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced that Merck, known as MSD outside...
.
20 Mar 2024",0.0,24-03-20
Merck,"Pharmaceutical Technology
Merck and Moderna partner to develop and sell cancer vaccine
Merck and Moderna partner to develop and sell cancer vaccine. Moderna will receive $250m from Merck to exercise the option for mRNA-4157/V940. ... Merck has...
.
21 Apr 2023",-0.8689,23-04-21
Merck,"Investor's Business Daily
Merck Skids On Light Outlook, But Keytruda Wallops Sales Forecasts
Merck Plunges On Light Outlook, But Keytruda Wallops Sales Forecasts ... Merck (MRK) stock skidded Tuesday on full-year guidance that lagged Wall Street's...
.
30 Jul 2024",-0.4215,24-07-30
Merck,"Endpoints News
NIH foundation taps top Merck exec — and oft-cited woman of the year — Julie Gerberding to steer public-private R&D initiative
The Foundation for the NIH has turned to a prominent Big Pharma exec to take the helm, where she will take charge of some key public-private research...
.
2 Mar 2022",0.4767,22-03-02
Merck,"BioPharma Dive
Merck cancer drug deal caps pharma investment influx into ‘ADC’ field
Merck cancer drug deal caps pharma investment influx into 'ADC' field. The companies' alliance, worth up to $22 billion, follows deals by Pfizer, AstraZeneca,...
.
20 Oct 2023",-0.836,23-10-20
Merck,"Endpoints News
A former Merck director's Pfizer-backed biotech will take on his old bosses in nascent LILRB field
Zurich-area biotech ImmunOs Therapeutics reeled in a $74 million Series B to take that lead program into a Phase Ia study in Australia toward the end of this...
.
7 Jun 2022",0.0,22-06-07
Merck,"Fierce Pharma
Merck KGaA faces probe in France over whether it misled patients about drug reformulation
In March of this year, France's Cour de Cassation confirmed an earlier ruling and ordered Merck to pay 1,000 euros ($982.30) each to compensate more than 3,300...
.
19 Oct 2022",-0.1027,22-10-19
Merck,"Reuters
Germany's Merck under formal investigation in France over thyroid drug
German drugmaker Merck KGaA said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading information...
.
19 Oct 2022",-0.4019,22-10-19
Merck,"Merck.com
Merck publishes 2021/2022 Environmental, Social & Governance (ESG) Progress Report
Our four ESG focus areas are 1) expanding access to health; 2) developing and rewarding a diverse, inclusive and healthy workforce; 3) protecting the...
.
30 Aug 2022",0.836,22-08-30
Merck,"Merck.com
Magic Johnson shares what makes him work harder
“The messages he shared speak to both our company's longstanding commitment to the HIV space and our support of diversity, equity and inclusion to create...
.
26 Oct 2023",0.836,23-10-26
Merck,"Fierce Biotech
Merck KGaA, spying a major market, pays Aqilion €10M to tackle tough autoimmune target
Aqilion has persuaded Merck its preclinical project can overcome the barriers. The biotech has created selective TAK1 inhibitors with applications in autoimmune...
.
16 Feb 2023",-0.128,23-02-16
Merck,"FirstWord Pharma
Spotlight On: Daiichi’s collaborative pivot to Merck well timed to retain ADC leadership, says US CEO
Pharma has gone crazy for antibody drug conjugates (ADCs) over the past year. At this week's JP Morgan Healthcare conference FirstWord spoke to Ken Keller...
.
11 Jan 2024",0.3034,24-01-11
Merck,"Speciality Chemicals Magazine
Merck still driven by ‘Big Three’
Merck still driven by 'Big Three' ... Merck KGaA has revealed at its latest Capital Markets Day that it will continue to focus on its 'Big Three' businesses of...
.
11 Oct 2022",0.0,22-10-11
Merck,"Merck.com
Uniting research and manufacturing to help patients faster
We're bringing together our research and manufacturing teams for the first time to support stronger collaboration during the development and manufacturing of...
.
5 Oct 2023",0.7906,23-10-05
Merck,"Business Wire
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary...
.
28 Sept 2023",0.5859,
Merck,"Endpoints News
Merck scoops up new chief marketing officer from Biogen’s neurology business
“Chirfi is a purpose-driven leader, dedicated to saving and improving lives around the world. He has deep experience and a proven track record in strategy,...
.
21 Jun 2022",0.7003,22-06-21
Merck,"PR Newswire
MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities
PRNewswire/ -- MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today.
.
5 Apr 2022",0.0,22-04-05
Merck,"Norwich University Athletics
Women's Lacrosse: Contreras, Merck secure GNAC All-Conference nods to conclude 2023 season
WINTHROP, Mass. - Jasmin Contreras (Glendale, Calif.) and Athena Merck (West Yarmouth, Mass.) received All-Great Northeast Athletic Conference (GNAC)...
.
8 May 2023",0.34,23-05-08
Merck,"BioSpectrum India
Merck introduces Ultimus Film for leak resistance in single-use assemblies
Cutting-edge technology now available in Mobius 3D process containers. Merck has announced the launch of its Ultimus Single-Use Process Container Film, designed...
.
28 Apr 2023",-0.34,23-04-28
Merck,"Business Wire
(pembrolizumab) for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer
Seagen Inc. (Nasdaq: SGEN), Astellas Pharma Inc. (TSE:4503) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the...
.
20 Dec 2022",0.128,22-12-20
Merck,"The Arab Weekly
Morocco authorises emergency use of COVID-19 medication
Morocco has authorized the emergency use of Merck &Co's molnupiravir medication for COVID-19 patients, Moroccan state news agency reported on Friday.
.
8 Jan 2022",-0.6369,22-01-08
Merck,"Namibia Economist
Winners of the Merck Foundation ‘More Than a Mother’ 2021 media recognition awards announced
The winners of the Merck Foundation Africa Media Recognition Awards 'More Than a Mother' 2021 were announced recently.
.
12 Jan 2022",0.9042,22-01-12
Merck,"IAVI
IAVI scientists publish findings that suggest intranasal vaccination can prevent COVID-19 breakthrough infections in small animal models
Scientists at IAVI's Vaccine Design and Development Laboratory (DDL) in New York working in collaboration with scientists at Merck & Company, Inc.,...
.
20 Sept 2022",0.0258,
Merck,"AboutLawsuits.com
Merck Concealed Problems with Gardasil HPV Vaccine, Lawsuit Alleges
A Nevada man has filed a product liability lawsuit against Merck, indicating that the drug maker failed to honestly report potential Gardasil HPV vaccine side...
.
2 Nov 2023",-0.765,23-11-02
Merck,"Business Wire
Merck to Acquire Imago BioSciences, Inc.
Merck to acquire Imago BioSciences, Inc. Acquisition expands Merck's growing hematology portfolio.
.
21 Nov 2022",0.2732,22-11-21
Merck,"YouTube · CNBC Television
Merck CEO Rob Davis on Q2 results: We continue to see phenomenal growth
Merck chairman and CEO Rob Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which reported second-quarter revenue that topped...
.
1 Aug 2023",-0.6808,23-08-01
Merck,"Pensions & Investments
Cedars-Sinai Medical Center could get $800 million after Merck acquires Prometheus
Cedars-Sinai Medical Center could get $800 million after Merck acquires Prometheus ... Cedars-Sinai Medical Center of Los Angeles is expected to receive about...
.
19 Apr 2023",0.0,23-04-19
Merck,"Bloomberg.com
Merck & Co. (MRK) Narrows Sales Outlook With Gardasil Shot Lagging in China
Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight quarter in China.
.
31 Oct 2024",-0.1027,24-10-31
Merck,"Reuters
S.Africa allows use of Merck COVID pill but government not buying
South Africa's government said it was not planning to buy Merck's COVID-19 treatment pill molnupiravir on Thursday for cost reasons, despite the drug...
.
17 Feb 2022",0.0,22-02-17
Merck,"Seeking Alpha
Merck Stock: Ties To D.C. Correlated With Revenue (NYSE:MRK)
Merck: Ties To D.C. Correlated With Revenue · Overview. Merck's (NYSE:MRK) government contracts have grown to provide a significant revenue stream for the...
.
21 Apr 2022",0.2023,22-04-21
Merck,"pharmaphorum
Merck snaps up cancer drug from China's Kelun in $1.4bn deal
Merck snaps up cancer drug from China's Kelun in $1.4bn deal ... Merck & Co has quietly added another drug to its immuno-oncology pipeline via an agreement with...
.
18 May 2022",-0.765,22-05-18
Merck,"Reuters
Merck KGaA aims to build domestic supply chains in China
German technology group Merck KGaA (MRCG.DE) said it was determined to invest further in China and aims to build domestic supply chains there.
.
11 May 2023",0.34,23-05-11
Merck,"WSJ
Insurers Say Cyberattack That Hit Merck Was Warlike Act, Not Covered
Merck, which had an estimated $1.4 billion in losses after NotPetya invaded its computer systems in 2017, suffered the collateral damage of a warlike act not...
.
8 Feb 2023",-0.8442,23-02-08
Merck,"BioSpace
Merck Posts $60B in Sales for 2023 Driven by Keytruda, HPV Vaccine
Merck's blockbuster Keytruda (pembrolizumab) continues to be a top seller for the pharma giant as it posted over $25 billion in sales in 2023, a 19% jump from...
.
2 Feb 2024",0.6908,24-02-02
Merck,"Fierce Biotech
Merck leans into AI with $610M in biobucks for Absci drug discovery pact
The two companies have signed a research collaboration for up to three targets in a deal worth up to $610 million in upfront fees and milestone payments.
.
7 Jan 2022",0.2263,22-01-07
Merck,"Business Wire
(lenvatinib) in Patients With Certain Types of Metastatic Non-Small Cell Lung Cancer
Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA Plus LENVIMA in Patients With Certain Types of Metastatic NSCLC.
.
22 Sept 2023",-0.296,
Merck,"Pharmaceutical Technology
Merck obtains favourable US court ruling on sitagliptin patent lawsuit
Merck's second patent covers the co-formulation of sitagliptin and metformin present in Janumet. It is expected to expire on 21 January 2029, with paediatric...
.
23 Sept 2022",-0.2263,
Merck,"GlobeNewswire
Merck & Co., Roche, and BMS Among Leading Players in the
The current major players in NSCLC are Merck & Co., Roche, BMS, AstraZeneca, and Eli Lilly. Each player has either a single very successful agent or a...
.
20 Jul 2022",0.624,22-07-20
Merck,"Business Wire
Adjuvant Treatment With Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Statistically Significant & Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients With Resected Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-716 Tri
Adjuvant Treatment With KEYTRUDA Demonstrates Improvement in DMFS in Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-716 Trial.
.
5 Jun 2022",0.8442,22-06-05
Merck,"YouTube · CNBC Television
3-Stock Lunch: Merck, PayPal and JetBlue
3-Stock Lunch: Merck, PayPal and JetBlue. 2.9K views · 7 months ago ...more. CNBC Television. 3.01M. Subscribe. 21. Share. Save.
.
30 Jul 2024",0.6597,24-07-30
Merck,"Pharmaceutical Technology
Japan grants approvals for Merck’s Keytruda to treat different cancers
Japan grants approvals for Merck's Keytruda to treat different cancers. Cervical cancer and melanoma indications are based on results from the KEYNOTE-826 and...
.
28 Sept 2022",0.4215,
Merck,"Yahoo Finance
Why Merck (MRK) is Poised to Beat Earnings Estimates Again
Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its...
.
3 Jan 2023",0.7506,23-01-03
Merck,"Fierce Pharma Biopharma News & Insights
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer
Adjuvant treatment with Keytruda and chemotherapy—with or without radiotherapy—failed to hit the mark for disease-free survival (DFS) in newly diagnosed, high-...
.
9 May 2024",-0.6597,24-05-09
Merck,"BioProcess International
Gardasil pulls in $1.5bn, driving vaccine business for Merck
For the full year, 2021, vaccines pulled in around $9.7 billion in sales revenues for Merck. The division was driven by Gardasil and Gardasil 9, which saw sales...
.
14 Feb 2022",0.0,22-02-14
Merck,"Fierce Pharma Biopharma News & Insights
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences
Merck CEO Robert Davis warned at a Pharmaceutical Research and Manufacturers of America (PhRMA) panel Friday on the sidelines of this year's annual American...
.
2 Jun 2024",-0.4019,24-06-02
Merck,"The American Prospect
Merck Says Negotiating Drug Prices Is Unconstitutional
Merck Says Negotiating Drug Prices Is Unconstitutional. The Inflation Reduction Act took minor steps against Big Pharma price-gouging. Merck is outraged.
.
8 Jun 2023",-0.3182,23-06-08
Merck,"Fierce Pharma
Pressure's on, GSK. Merck's Keytruda drops endometrial cancer win in first-line treatment
Pressure's on, GSK. Merck's Keytruda drops endometrial cancer win in first-line treatment ... The positive data could potentially support an FDA approval for...
.
3 Feb 2023",0.802,23-02-03
Merck,"MarketWatch
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Merck's shot, designed to protect against pneumonia and other bacterial infections, is set to compete with Pfizer's Prevnar 20.
.
17 Jun 2024",0.3182,24-06-17
Merck,"CHEManager
Merck Opens New €20 Million Distribution Center in Brazil
Merck will open a new € 20 million distribution center in São Paulo, Brazil to better serve its Life Science customers in the region.
.
28 Feb 2024",0.4404,24-02-28
Merck,"BioPharma Dive
Merck bets $700M on an antibody drug’s potential in immune diseases
Merck will pay Curon Biopharmaceutical, a privately held, China-based biotechnology company, $700 million upfront for rights to a treatment code-named CN201.
.
9 Aug 2024",0.2023,24-08-09
Merck,"Merck KGaA
The Power and Promise of AI
AI is transforming the world as we know it. Find out some of the ways we harness this powerful technology to positively impact people's lives.
.
11 Jul 2024",0.8381,24-07-11
Merck,"STAT
The biotech news you need to read today
Today we take note of the antagonism between gene-editing players Prime Medicine and Tessera Therapeutics, consider the issue of whether the label should be...
.
28 Oct 2024",-0.4404,24-10-28
Merck,"WSJ
Moderna, Merck Show Progress Toward Cancer Vaccines
About 79% of high-risk melanoma patients who got the personalized vaccine and Merck's immunotherapy Keytruda were alive and cancer-free at 18 months, compared...
.
16 Apr 2023",0.0,23-04-16
Merck,"Clinical Trials Arena
Merck reports data from Phase III pneumococcal vaccine trial
Merck reports data from Phase III pneumococcal vaccine trial. V116 demonstrated a safety profile in line with PCV20 for both cohorts of the trial. ... According...
.
29 Nov 2023",0.4215,23-11-29
Merck,"Bloomberg
Merck and Partner Ridgeback Fill U.S. Order for Covid-19 Pill
Merck & Co. said that it had provided about 3.1 million courses of its Covid-19 pill to the US government, fulfilling the terms of a federal pact.
.
8 Feb 2022",0.0,22-02-08
Merck,"Pharmaceutical Technology
Merck plans €300m investment in South Korea’s bioprocessing unit
Merck to invest €300m in South Korean bioprocessing centre. The 43,000m² Daejeon site will supply critical biotech products for biopharma companies. ... The new...
.
21 Mar 2024",-0.3182,24-03-21
Merck,"BioPharma Dive
Gossamer sells rights to drug it hopes can rival a new Merck therapy
On Monday, Gossamer and Italy-based Chiesi Farmaceutici announced a collaboration and licensing agreement to develop and eventually sell the drug, which is...
.
6 May 2024",0.7184,24-05-06
Merck,"BioPharma Dive
Merck expands Singapore hub to support Keytruda, Gardasil
Merck's 72-acre manufacturing site in southwest Singapore has filled Keytruda vials since 2021. The expansion adds secondary packaging, cold storage and a...
.
6 Oct 2022",0.4767,22-10-06
Merck,"Merck KGaA
Merck Signs Agreement to Sell Surface Solutions Business Unit to GNMI
Merck, a leading science and technology company, has signed an agreement to sell its global Surface Solutions business unit to Global New Material International...
.
25 Jul 2024",0.8316,24-07-25
Merck,"Fierce Pharma
Merck Foundation funnels $20M to launch program aimed at making cancer care more equitable
Merck Foundation funnels $20M to launch program aimed at making cancer care more equitable ... Merck's philanthropic arm, the Merck Foundation, is launching a new...
.
13 Sept 2022",-0.3818,
Merck,"Australian Academy of Science
Merck joins Falling Walls Lab Australia 2024
As a global leader in science and technology, Merck brings invaluable support to the Falling Walls Lab Australia Partnership Program helping to foster career-...
.
17 Jun 2024",0.4019,24-06-17
Merck,"www.statnews.com
STATUS List | Kenneth Frazier
Frazier, one of America's most prominent Black executives, stepped down as CEO of Merck after a decade-long tenure during which he revitalized the drugmaker.
.
2 Mar 2022",0.3804,22-03-02
Merck,"Express Pharma
Merck India inaugurates its R&D Excellence Centre in Bengaluru
The R&D Excellence Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe.
.
5 Sept 2022",0.9509,
Merck,"BioPharma Dive
Merck pays startup Orna $150M as ‘circular RNA’ attracts industry interest
Merck will pay Orna $150 million upfront and invest another $100 million in a $221 million Series B round the Cambridge, Mass.-based biotech revealed...
.
16 Aug 2022",0.6486,22-08-16
Merck,"Truthout
Merck Sues Government, Saying Plan to Lower Medicare Drug Prices Is “Extortion”
Merck Sues Government, Saying Plan to Lower Medicare Drug Prices Is “Extortion”. The company claims that the plan to allow Medicare to negotiate drug prices...
.
6 Jun 2023",-0.3612,23-06-06
Merck,"Reuters
Germany's Merck raises 2024 forecast on healthcare, electronics units' performance
Germany's Merck on Friday raised its forecast for the group, mainly driven by a strong operating performance at its healthcare and electronics units.
.
26 Jul 2024",0.5106,24-07-26
Merck,"Bloomberg Law News
Merck's $1.4 Billion Insurance Win Splits Cyber From 'Act of War'
Merck's $1.4 Billion Insurance Win Splits Cyber From 'Act of War' ... Merck & Co. 's victory in a legal dispute with insurers over coverage for $1.4 billion in...
.
19 Jan 2022",-0.34,22-01-19
Merck,"Precision Medicine Online
Keytruda Revenues Grow 21 Percent in Q4 as Merck Focuses on Diversifying Oncology Pipeline
Merck brought in $14.63 billion in sales, up 6 percent from $13.83 billion in Q4 2022, and exceeded analysts' average expectations of $14.50 billion.
.
1 Feb 2024",0.0,24-02-01
Merck,"Fierce Pharma
Big sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Between 2026 and 2028, Medicare could parley on pricing for some 38 Part D drugs and 2 Part B drugs under Democrats' Inflation Reduction Act (IRA).
.
28 Feb 2023",-0.1027,23-02-28
Merck,"Business Wire
Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer
Merck, a leading science and technology company, today announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus...
.
24 Jun 2024",-0.5267,24-06-24
Merck,"Merck KGaA
Bilharziose
This condition is caused by parasitic flatworms. The worm larvae penetrate people's skin while they are bathing or wading in water.
.
7 Mar 2022",0.0,22-03-07
Merck,"Merck.com
Understanding lung cancer: 5 essential things to know as a patient or caregiver
There's no one type of person who develops lung cancer. Lung cancer strikes both men and women. While it is mostly diagnosed in older people, younger people can...
.
21 Aug 2024",-0.9578,24-08-21
Merck,"Fierce Biotech
Aktis makes waves with $84M extension as 3 big pharmas channel funds to radiopharmaceutical pipeline
Aktis Oncology has closed a series A extension round to the tune of $84 million, with big pharmas Merck, Novartis and Bristol Myers Squibb joining to expand...
.
25 Aug 2022",0.0,22-08-25
Merck,"Fierce Biotech
Merck puts eye-popping $9.3B on the line in lopsided ADC deal with Kelun-Biotech
Merck & Co. is offering $175 million upfront to Kelun-Biotech plus an eye-popping $9.3 billion in potential milestones on the tail end.
.
22 Dec 2022",0.0,22-12-22
Merck,"YouTube · CNBC Television
Merck CEO Robert Davis on Q3 results: Our portfolio sets us up for a good finish to the year
Merck CEO Robert Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped expectations as the company saw strong sales...
.
31 Oct 2024",0.7351,24-10-31
Merck,"GlobeNewswire
Portage Biotech Announces Collaboration with Merck to
Portage Biotech announces collaboration with Merck to evaluate two next-generation adenosine antagonists in combination with KEYTRUDA (Pembrolizumab) in solid...
.
5 Sept 2023",-0.4019,
Merck,"YouTube · Bloomberg Television
Merck-Moderna Vaccine Cuts Risk of Skin Cancer Returning
Today is a huge day of hope for cancer patients,” says Moderna CEO Stephane Bancel as he discusses data on a personalized vaccine developed by Merck & Co.
.
14 Dec 2023",-0.836,23-12-14
Merck,"Merck.com
How we’re addressing health literacy
We created a plain language glossary and established company-wide standards focused on improving the health literacy of the information in our resources and...
.
6 Dec 2024",0.7506,24-12-06
Merck,"Reuters
Merck wins bid to arbitrate RotaTeq vaccine antitrust case
Merck & Co Inc has won a bid to send a lawsuit accusing it of illegally stifling competition for its rotavirus vaccine RotaTeq to arbitration.
.
31 Mar 2022",0.7003,22-03-31
Merck,"Fierce Pharma
Who's No. 1? With $25B in sales, Merck's Keytruda looks to be the top-selling drug of 2023
Who's No. 1? With $25B in sales, Merck's Keytruda looks to be the top-selling drug of 2023 ... Merck's Keytruda rolled to $25 billion in sales in 2023, which...
.
1 Feb 2024",-0.5803,24-02-01
Merck,"Fierce Pharma
Bristol Myers joins AstraZeneca, Merck in touting positive lung cancer drug use around surgery
Bristol Myers Squibb is the latest to tout a phase 3 win for a cancer immunotherapy to be used both before and after surgery in early-stage non-small cell lung...
.
22 Sept 2023",-0.5574,
Merck,"Risk & Insurance
Merck Awarded $1.4 Billion for NotPetya After 5 Years of Legal Battle
Merck Awarded $1.4 Billion for NotPetya After 5 Years of Legal Battle. NotPetya malware first cropped up on computers worldwide in June 2017, setting the stage...
.
8 May 2022",0.0258,22-05-08
Merck,"SeafoodSource
Merck Animal Health to acquire Elanco Animal Health’s aquatic-focused business for USD 1.3 billion
Merck Animal Health said the deal includes all of Elanco's portfolio of medicines, vaccines, nutritionals, and supplements for aquatic species, two related...
.
6 Feb 2024",0.0,24-02-06
Merck,"Fierce Pharma
As HQ move nears completion, Merck finds a buyer for its sprawling Kenilworth campus
Merck has reached a deal with real estate business Onyx Equities to sell its 108-acre campus in Kenilworth, New Jersey, where the drug behemoth relocated its...
.
17 Feb 2023",0.1027,23-02-17
Merck,"Cato Institute
Ivermectin and Statistical Significance
Since the beginning of the COVID-19 pandemic, humanity has been searching for effective treatments and preventatives for the virus.
.
23 Mar 2022",0.6369,22-03-23
Merck,"STAT
A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids
A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids.
.
12 Sept 2024",-0.8316,
Merck,"Merck KGaA
Perovskite solar cells for powering the planet | Merck
A new photovoltaic material was discovered – a so-called perovskite semiconductor that initially had modest power conversion efficiency (PCE) of just 3.8%.
.
27 Aug 2022",0.3612,22-08-27
Merck,"Fierce Pharma
Merck inks deal with Sinopharm to commercialize COVID-19 pills in China
Merck has granted Sinopharm exclusive import and distribution rights to its COViD-19 oral antiviral Lagevrio in China.
.
28 Sept 2022",0.3612,
Merck,"Precision Medicine Online
Keytruda Sales Grow 19 Percent in Q2 as Merck Doubles Down Opposition to Medicare Price Negotiations
Merck reported that sales of its bestselling checkpoint inhibitor Keytruda (pembrolizumab) rose 19 percent compared to the same quarter last year.
.
1 Aug 2023",-0.0772,23-08-01
Merck,"Merck.com
Our Q1 2024 earnings report
Our Q1 2024 earnings report ... Merck's (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide...
.
25 Apr 2024",0.7096,24-04-25
Merck,"Fierce Biotech
Bayer ends work on cough med that passed phase 2b weeks after FDA rejected Merck's drug
Bayer ends work on cough med that passed phase 2b weeks after FDA rejected Merck's drug ... Bayer is ending work on a midstage drug from its Evotec collaboration,...
.
4 Feb 2022",-0.765,22-02-04
Merck,"University of California, Merced
Chemistry Postdoc Awarded Merck Research Award
Chacón-Terán was one of 16 scientists...
.
18 Sept 2023",0.7351,
Merck,"Fierce Pharma
Merck still in the market for deals in the $1B to $15B range, CEO says
Merck CEO Rob Davis said the company is interested in acquisitions in the $1 to $15 billion range, even after making buys in the last three years for Acceleron...
.
1 Feb 2024",-0.2263,24-02-01
Merck,"Fierce Biotech
Merck trims mushrooming ADC pipeline by pulling out of 2 preclinical Kelun programs
Merck trims mushrooming ADC pipeline by pulling out of 2 preclinical Kelun programs ... Merck contacted Kelun the day after disclosing the Daiichi Sankyo deal. (...
.
23 Oct 2023",0.0,23-10-23
Merck,"GlobeNewswire
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
Merck Global Health Innovation Fund has made a strategic investment into Qure.ai as part of its Series D round.
.
25 Jun 2024",0.8591,24-06-25
Merck,"Fierce Biotech
Merck ADC RORs into phase 3 with 100% complete response rate
Merck ADC RORs into phase 3 with 100% complete response rate ... Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a...
.
9 Dec 2024",0.0,24-12-09
Merck,"FirstWord Pharma
Merck KGaA bets on Aqilion's TAK1 programme for inflammatory diseases
Merck KGaA bets on Aqilion's TAK1 programme for inflammatory diseases ... Merck KGaA has struck an exclusive licensing and collaboration agreement with Aqilion to...
.
16 Feb 2023",0.4019,23-02-16
Merck,"BioCentury
Merck KGaA is avoiding big pipeline bets as it moves on from bintrafusp alfa
Following late-stage clinical disappointments for bintrafusp alfa, Merck KGaA's healthcare business is rethinking its risk tolerance and deploying a...
.
1 Apr 2022",-0.6486,22-04-01
Merck,"The Pharma Letter
Kelun-Biotech in second deal with Merck & Co
Kelun-Biotech announced that it has entered into a collaboration and exclusive license agreement with MSD (the tradename of Merck & Co), to develop an...
.
27 Jul 2022",0.5719,22-07-27
Merck,"Fierce Pharma
BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's
BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's ... Bristol Myers Squibb, Pfizer and Merck will face...
.
21 Jun 2022",0.7351,22-06-21
Merck,"Financial Times
Merck to open £1bn London research centre with plea for government support of industry
Scientists at the new site will be focused on the intersection of neuroscience, inflammation and immunology, hoping to use the latest technologies such as 3D...
.
14 Oct 2023",0.7964,23-10-14
Merck,"Genetic Engineering and Biotechnology News
Salt Burn: NFX and Merck Seed Pepper Bio to Develop Drugs with Transomics
Pepper Bio's computational approach that uses “functional” omics data, which they've dubbed “transomics,” will set them apart in their quest to combat...
.
1 Dec 2023",0.0,23-12-01
Merck,"Insurance Business America
Merck's $1.4 billion cyberattack claim – the specter of NotPetya
Cyber ... A US state appeals court last week dealt a blow to a group of insurers relying on a war exclusion to avoid paying up for a chunk of a $1.4 billion...
.
12 May 2023",-0.8074,23-05-12
Merck,"Endpoints News
Merck continues rare breast cancer campaign focused on challenges for Black women
Merck is continuing to drive its awareness efforts around breast cancer — especially focused on the rare triple negative subtype and Black women who are...
.
7 Nov 2022",-0.8402,22-11-07
Merck,"CSRwire
Merck Leaders Recognized As Influential Women Executives
They are Cristal Downing, EVP and chief communications and public affairs officer, Caroline Litchfield, EVP and chief financial officer, and Jennifer Zachary,...
.
19 Dec 2022",0.4404,22-12-19
Merck,"pharmaphorum
Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals
Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals ... German group Merck has revved up its artificial intelligence-powered drug discovery with...
.
20 Sept 2023",0.0,
Merck,"Contract Pharma
Merck’s WINREVAIR Shows Promise in PAH Treatment
Merck's WINREVAIR Shows Promise in PAH Treatment. Demonstrated a statistically significant and clinically meaningful reduction in the risk of morbidity or...
.
29 Nov 2024",0.6808,24-11-29
Merck,"Business Wire
Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the Treatment of Certain Patients With Essential Thrombocythemia
A pivotal Phase 3 clinical trial evaluating bomedemstat, an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor, for the treatment...
.
27 Aug 2024",0.2023,24-08-27
Merck,"Law.com
Antitrust Class Action Filed Against Merck for its Rotavirus Vaccine, RotaTeq
Antitrust Class Action Filed Against Merck for its Rotavirus Vaccine, RotaTeq. This suit was surfaced by Law.com Radar. Read the complaint here. ... Merck, the...
.
6 Mar 2023",-0.296,23-03-06
Merck,"Forbes
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
mRNA cancer vaccines are therapeutic and are for people who already have cancer. Each vaccine is developed using samples of their cancer and personalized to an...
.
4 Jun 2024",-0.9509,24-06-04
Merck,"Cork Independent
Life of Riley at Merck
Life of Riley at Merck ... Free period products are being made available to colleagues at Merck following a new partnership with Cork-based business Riley. Merck,...
.
6 Apr 2022",0.5106,22-04-06
Merck,"Forbes
Is Merck Stock A Better Pick Over ABBV?
MRK stock trades at a slightly higher valuation of 4.8x trailing revenues, compared to 4.2x for AbbVie ABBV -0.8% , and this valuation gap will likely narrow...
.
1 Jun 2023",0.4404,23-06-01
Merck,"Times of San Diego
Merck to Buy San Diego’s Prometheus Biosciences in $10.8 Billion Deal
Merck to Buy San Diego's Prometheus Biosciences in $10.8 Billion Deal. Avatar photo by Editor April 16, 2023, 11:55 p.m. April 17, 2023, 6:59 a.m....
.
16 Apr 2023",0.0,23-04-16
Merck,"Reuters
Spain antitrust watchdog fines Merck 39 mln euros in contraceptives case
Spain's competition watchdog has slapped a 39 million-euro ($38.45 million) fine on US-based Merck & Co Inc (MRK.N) for anti-competitive behaviour.
.
25 Oct 2022",0.2023,22-10-25
Merck,"Fierce Biotech
Merck & Co. signs $1.9B deal with Mestag to explore fibroblast therapies for inflammation
Merck & Co. wants in—penning a $1.9 billion biobucks deal to collaborate on new therapies for inflammatory diseases. Details remain vague, with Mestag providing...
.
8 Oct 2024",-0.1027,24-10-08
Merck,"BioPharma Dive
Merck’s latest deal turns up the spotlight on immune system drugmakers
Merck & Co. disclosed plans to buy Prometheus Biosciences, a biotechnology company with a promising medicine that regulates the immune system, for almost $11...
.
17 Apr 2023",0.7269,23-04-17
Merck,"BioPharma Dive
Startup Eikon, led by Merck vets, buys drugs from three biotechs and banks another $106M
The company announced deals for drug candidates from three biotech companies, each of which are in various phases of clinical stage testing.
.
1 Jun 2023",0.0,23-06-01
Merck,"Fierce Pharma
The 15 highest paid pharma CEOs of 2021
2021 marked a curious year in the realm of pharma CEO pay as several high-profile helmsman made for the exit. In the case of some, like Merck & Co.
.
27 Jun 2022",0.5267,22-06-27
Merck,"Yahoo Finance
Merck & Co., Inc.'s (NYSE:MRK) high institutional ownership speaks for itself as stock continues to impress, up 6.4% over last week
If you want to know who really controls Merck & Co., Inc. ( NYSE:MRK ), then you'll have to look at the makeup of its...
.
20 Nov 2022",0.4939,22-11-20
Merck,"Gavi, the Vaccine Alliance
Andrew (Drew) Otoo
A career pharmaceutical professional and executive leader, Dr Otoo has more than 20 years of experience in vaccines across diverse geographies.
.
3 Mar 2023",0.0,23-03-03
Merck,"Merck KGaA
Shedding new light onto the structure of ferroelectric hafnium oxide films
We discovered the presence of a transient crystal structure in hafnium oxide that forms just as it is heated above its crystallization temperature.
.
10 Mar 2022",0.0,22-03-10
Merck,"Fierce Biotech
Roche lining up potential $7B Roivant licensing deal to join Merck in bowel disease race: WSJ
Roche is nearing a deal to buy Roivant's rights to the molecule. Talks over the deal, which could be worth more than $7 billion, may still collapse.
.
14 Jul 2023",-0.0258,23-07-14
Merck,"Business Wire
(lenvatinib) In Certain Patients With Advanced Melanoma (LEAP-003) and Metastatic Colorectal Cancer (LEAP-017)
KEYTRUDA, in combination with enfortumab vedotin, is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC)...
.
5 Apr 2023",-0.0772,23-04-05
Merck,"The Hindu
Govt. likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
Health Ministry is likely to float in April a global tender for 16.02 crore doses of HPV vaccine, which will be supplied by 2026, an official source said.
.
29 Jan 2023",0.0,23-01-29
Merck,"J.P. Morgan
Merck Mitigates Import & Invoice Risk in China
To effectively manage risk, Merck KGaA wanted to maintain the same net-zero intracompany payment terms that it uses in unregulated markets. Together with J.P....
.
27 Dec 2024",-0.0772,24-12-27
Merck,"Barron's
Merck’s Keytruda Is the World’s Largest Drug. The Race Is On to Replace It.
A long history of patent expirations in the pharma industry suggests that Merck will face a revenue hole of some $16 billion by 2029 or 2030.
.
1 Aug 2024",0.0,24-08-01
Merck,"Fierce Pharma
ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival
The song remains the same for the kidney cancer drug as it continues to show benefits in progression-free survival (PFS) but no significant improvement in...
.
13 Sept 2024",0.1376,
Merck,"PMLiVE
Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate
Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate ... Merck & Co – known as MSD outside the US and Canada – has signed a worldwide...
.
9 Mar 2023",0.0,23-03-09
Merck,"Merck KGaA
Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
Merck today announced the closing of the transaction to acquire Mirus Bio for approximately US$ 600 million.
.
1 Aug 2024",0.0,24-08-01
Merck,"Merck.com
VIDEO: Here for Good – When passion and curiosity fuel innovation
VIDEO: Here for Good – When passion and curiosity fuel innovation ... Testing experiments in a lab can be a lot like raising kids. Sometimes your molecules do...
.
2 Feb 2023",0.9552,23-02-02
Merck,"Business Wire
Merck’s PREVYMIS™ Demonstrates Efficacy in Phase 3 Study for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation
Merck's PREVYMIS™ Demonstrates Efficacy in Phase 3 Study for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation.
.
22 Oct 2022",0.0,22-10-22
Merck,"Reuters
U.S. FDA says possible carcinogen found in some Merck diabetes drugs
U.S. FDA says possible carcinogen found in some Merck diabetes drugs ... Aug 9 (Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples...
.
9 Aug 2022",0.2732,22-08-09
Merck,"Fierce Pharma
Merck KGaA's MilliporeSigma production push rolls on with $76M ADC plant investment
MilliporeSigma, the US and Canada life science arm of Germany's Merck KGaA, plans to triple its production capacity at its St. Louis ADC plant with a $76...
.
29 Oct 2024",0.0,24-10-29
Merck,"Merck KGaA
Merck Launches M-Trace® | Merck
Merck, a leading science and technology company, has launched its M-Trace® Software & Mobile App, a comprehensive data tracking solution to digitize sterility...
.
28 May 2024",0.5859,24-05-28
Merck,"pharmaphorum
After cough drug setback, Merck partners Hyfe's tracking app
After cough drug setback, Merck partners Hyfe's tracking app. News. Hyfe_app. Merck & Co has signed a deal with digital health firm Hyfe that will see its cough...
.
21 Jul 2022",0.0,22-07-21
Merck,"Yahoo Finance
Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance
He mentioned that the market is already experiencing some volatility, as reflected in the elevated VIX. Despite this, he highlighted that the economy is still...
.
24 Oct 2024",-0.296,24-10-24
Merck,"Fierce Pharma Biopharma News & Insights
First real-world analysis of Merck's Ebola vaccine reveals 84% effectiveness during DRC outbreak
Merck's shot was 84% effective against the virus in people who were infected 10 or more days after vaccination.
.
22 Aug 2024",-0.0258,24-08-22
Merck,"Merck.com
Staying positive with pulmonary arterial hypertension
Staying positive with pulmonary arterial hypertension ... A decade ago, Nola Martin was having trouble breathing, and she was gaining weight. She assumed it was...
.
24 Oct 2023",0.8074,23-10-24
Merck,"Business Post
Merck to invest over €440m to expand its operations in Cork
The German multinational plans to inject €290 million into its existing Cork facility, and will spend a further €150 million building a new plant on the...
.
23 May 2022",0.3182,22-05-23
Merck,"ContagionLive
Gilead and Merck Report Successful Phase 2 Results for Investigational Once-Weekly HIV Treatment
The combination of the antiviral agents islatravir and lenacapavir demonstrates both efficacy and safety, leading to advancement into Phase 3 trials.
.
11 Nov 2024",0.765,24-11-11
Merck,"Yahoo Finance
Why Is Merck Stock Trading Higher On Monday?
Price Action: MRK stock is up 1.93% at $101.09 at last check Monday. Read Next: Nvidia Unveils Fugatto: AI Tool That Transforms Sound Creation For...
.
25 Nov 2024",0.2732,24-11-25
Merck,"Fierce Biotech
Merck KGaA buys into Abbisko’s late-stage joint tumor med for $70M upfront
A $70 million partnership with Chinese biotech Abbisko Therapeutics for rights to a late-stage joint tumor med called pimicotinib.
.
4 Dec 2023",-0.6369,23-12-04
Merck,"Seeking Alpha
Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out
Absci looks cheap and positioned for growth with AMD's AI backing. Myriam Alvarez Absci rises on $20M investment by Advanced Micro Devices.
.
10 Jan 2022",0.7269,22-01-10
Merck,"InformationWeek
Merck's Cyberattack Settlement: What Does it Mean for Cyber Insurance Coverage?
Pharmaceutical giant Merck reached a confidential settlement with its insurers regarding its 2017 $1.4B cyberattack damages claim.
.
12 Jan 2024",-0.3612,24-01-12
Merck,"FirstWord Pharma
Mersana, Merck KGaA call it quits on two ADC deals
Mersana, Merck KGaA call it quits on two ADC deals ... Mersana Therapeutics disclosed in a filing with the US Securities and Exchange Commission that it decided...
.
22 Dec 2023",0.296,23-12-22
Merck,"China Daily
Merck looking forward to next 90 years in China
Merck is well-positioned to contribute toward China's vision of building a healthier, greener, and digitally empowered nation for the well-being of its 1.4...
.
5 Jan 2024",0.25,24-01-05
Merck,"AP News
False claims circulate about HPV vaccine amid Gardasil lawsuits
CLAIM: Merck is on trial for fraud regarding its human papillomavirus vaccine, which has been banned in other countries and has been found to cause cancer.
.
7 Mar 2023",-0.9153,23-03-07
Merck,"BioProcess International
Merck adds ophthalmology assets with $1.3bn EyeBio buy
Under the terms of the deal, Merck will gain a pipeline of vision loss candidates from EyeBio, which came onto the biotech scene just three years ago. This...
.
29 May 2024",0.5859,24-05-29
Merck,"Merck.com
Merck’s legacy of antimicrobial innovation and action
Merck's legacy of antimicrobial innovation and action ... For more than 100 years, Merck has contributed to the discovery and development of novel medicines and...
.
12 Oct 2023",0.7579,23-10-12
Merck,"Arizona Commerce Authority
EMD Electronics Announces New Factory In Chandler To Expand Capacities Of Its Delivery Systems & Services Business
CHANDLER, AZ (January 11, 2022) – EMD Electronics, the North American Electronics business of Merck KGaA, Darmstadt, Germany, today announced a new factory...
.
11 Jan 2022",0.3818,22-01-11
Merck,"Healio
FDA grants fast track designation to Merck’s efinopegdutide for treatment of NASH
FDA grants fast track designation to Merck's efinopegdutide for treatment of NASH ... The FDA granted fast track designation to efinopegdutide for the treatment...
.
15 Jun 2023",0.5859,23-06-15
Merck,"Fierce Biotech
Merck KGaA's phase 3 rare tumor trial hits goal, teeing up rivalry with Daiichi and Ono
Merck reported statistically significant improvements in stiffness and pain. On the stiffness scale, Merck saw a 3.0 reduction in the pimicotinib group and a...
.
12 Nov 2024",-0.4215,24-11-12
Merck,"CNBC
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales · Earnings per share: $2.07 adjusted vs. $1.88 expected · Revenue: $15.78...
.
25 Apr 2024",0.8316,24-04-25
Merck,"STAT
Merck shares fall after drop in China HPV vaccine sales
Merck shares fall after drop in China HPV vaccine sales ... Shares of Merck fell 9% Tuesday after the company reported that in the second quarter, it saw a...
.
30 Jul 2024",0.34,24-07-30
Merck,"ACS Publications
Kilo-Scale Electrochemical Oxidation of a Thioether to a Sulfone: A Workflow for Scaling up Electrosynthesis
Organic electrosynthesis is a rapidly evolving field, providing powerful methods to assemble targets of interest in organic synthesis.
.
1 Jul 2022",0.7003,22-07-01
Merck,"Fierce Biotech
Merck pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead
Merck is buying PARP1-selective inhibitors to complement its own work on other DNA damage response (DDR) targets. The German drugmaker is working on DDR targets...
.
30 Oct 2023",-0.5994,23-10-30
Merck,"SynBioBeta
Pearl Bio Inks Lucrative Deal with Merck to Pioneer Innovative Biologic Therapies
Pearl Bio Inks Lucrative Deal with Merck to Pioneer Innovative Biologic Therapies. Pearl Bio secures a groundbreaking partnership with Merck to pioneer...
.
12 Mar 2024",0.7964,24-03-12
Merck,"Fierce Biotech
Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline
Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline ... Merck KGaA has become the latest biopharma to swell its oncology pipeline with further...
.
4 Apr 2024",0.5574,24-04-04
Merck,"Reuters
Germany's Merck sells pigments unit to China's GNMI for $721 mln
Germany's Merck KGaA (MRCG.DE) agreed to sell its pigments unit to China's Global New Material International (GNMI) (6616.HK) for 665 million euros ($721.46...
.
25 Jul 2024",0.2732,24-07-25
Merck,"WSJ
A Better Drug Than Merck’s Blockbuster Keytruda? Not So Fast
Summit reported data from a late-stage study that showed that its drug, ivonescimab, beat Keytruda as a first-line treatment option in patients with advanced...
.
9 Sept 2024",0.7783,
Merck,"YouTube · GeekWire
GeekWire Studios | Accenture at AWS re:Invent 2023: Merck
GeekWire Studios | Accenture at AWS re:Invent 2023: Merck Merck's value-based cloud program is fundamentally changing the company's IT landscape.
.
13 Dec 2023",0.0,23-12-13
Merck,"CNBC
Merck Covid drug linked to virus mutations that can spread between people, new study says
A new study released Monday said Merck 's widely used antiviral Covid pill can cause mutations in the virus that occasionally spread to other people, raising...
.
25 Sept 2023",0.0,
Merck,"pharmaphorum
Merck's challenge to Pfizer's Prevnar grows
V116 is a cocktail of 21 Streptococcus pneumoniae serotypes designed to have the most benefit in adult populations, and according to Merck has been shown to...
.
28 Jul 2023",0.5563,23-07-28
Merck,"CNBC
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion.
.
18 Dec 2024",-0.4019,24-12-18
Merck,"Merck.com
Individualized neoantigen therapies: exploring one medicine for one patient
As the treatment of cancer continues to evolve and advance, researchers are focusing on more individualized approaches. This includes a new area of research...
.
13 Apr 2023",-0.6597,23-04-13
Merck,"Fierce Biotech
FDA skeptical of Merck's gefapixant, even after cough recount
the FDA has raised questions about Merck's gefapixant—a P2X3 receptor antagonist medicine—after the agency's own analysis found little difference between...
.
16 Nov 2023",-0.6369,23-11-16
Merck,"Merck KGaA
Keeping the memory alive
Merck is still operating internationally in 1945. Consequently, the significance of this year to the company and its employee also varies greatly.
.
13 Jan 2023",0.5719,23-01-13
Merck,"KBR
Christoph Hamann appointed as GM of Merck Biopharma Korea
SNS 기사보내기 ... Merck Korea, a leading science and technology company, said on Thursday that it appointed Christoph Hamann as general manager of Merck...
.
10 Nov 2022",0.0,22-11-10
Merck,"Fierce Biotech
Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials
Merck is ending development of anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, both of which are in phase 3 development.
.
16 Dec 2024",0.3612,24-12-16
Merck,"Yahoo Finance
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
In This Article: MRK. (Reuters) — Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that...
.
28 May 2024",0.4939,24-05-28
Merck,"Clinical Trials Arena
Merck and Moderna start cancer vaccine and Keytruda combo trial in NSCLC
MSD and Moderna reported positive results from a Phase IIb trial in stage III/IV melanoma patients with a high risk of recurrence after surgery in April 2023.
.
12 Dec 2023",-0.4404,23-12-12
Merck,"Fierce Pharma
Warren urges US patent office to scrutinize Merck's efforts with Keytruda
Warren sent a letter to the US Patent and Trademark Office (PTO) asking for intense scrutiny of the company's attempt to extend its patent protection of the...
.
23 Feb 2023",0.25,23-02-23
Merck,"Barron's
Merck Stock Had Its Worst Drop in Years After Earnings. Here’s Why.
Merck Stock Had Its Worst Drop in Years After Earnings ... Merck stock dropped sharply Tuesday after the company flagged a potential wrinkle in demand for its...
.
30 Jul 2024",-0.9169,24-07-30
Merck,"City of Chandler (.gov)
EMD Electronics celebrates opening of new Arizona factory, contributing to the state’s growing semiconductor industry
CHANDLER, Ariz., – EMD Electronics, the Electronics business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, celebrated the grand opening of its...
.
11 Oct 2023",0.9022,23-10-11
Merck,"American Heart Association Journals
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
Macrocyclic peptides represent a novel approach to target proteins traditionally considered intractable to small-molecule drug design.
.
1 May 2023",-0.1779,23-05-01
Merck,"The Fiji Times
FDA says found possible carcinogen in certain samples of Merck’s Januvia
(Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia,...
.
11 Aug 2022",0.4939,22-08-11
Merck,"Business Wire
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy...
.
29 May 2024",0.4404,24-05-29
Merck,"The Economic Times
Merck will look to hire more talent, improve R&D efficiency: Danny Bar-Zohar, global head of R&D
Merck will look to hire more talent, improve R&D efficiency: Danny Bar-Zohar, global head of R&D ... The company is also looking at potential collaborations with...
.
7 Sept 2022",0.9481,
Merck,"ROI-NJ
N.J. life sciences building back better: Massive HELIX, Merck sites aim to be complementary
When the HELIX, a 12-story, 573,400-square-foot building in New Brunswick that is committed to doing translational research in life science, received a $271...
.
22 Feb 2023",0.6124,23-02-22
Merck,"Bloomberg.com
Pfizer, Merck Pneumonia Shots Get Backing for Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against...
.
23 Oct 2024",0.5267,24-10-23
Merck,"Endpoints News
Moderna CEO Stéphane Bancel plucks new commercial chief from Merck's top executive team
Garay's latest job at Merck was one of 3 new posts filled in the wake of Frank Clyburn's departure as he jumped ship to take a CEO job. And Moderna's statement...
.
27 Apr 2022",0.2023,22-04-27
Merck,"Fortune
Ex-Merck CEO Kenneth Frazier, who stood up to Trump, says CEOs have a responsibility to uphold American values
Ex-Merck CEO Kenneth Frazier, who stood up to Trump, says CEOs have a responsibility to uphold American values.
.
9 Nov 2023",0.6597,23-11-09
Merck,"Indian Pharma Post
Merck KGaA doubles HPAPI production capacity in Wisconsin
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area. By IPP Bureau | June 24, 2022. Merck KGaA...
.
24 Jun 2022",0.0,22-06-24
Merck,"Drug Discovery & Development
Merck and Culmination Bio's data alliance to unravel disease biology
A recent pact with Culmination Bio is giving Merck access to more than 40 years of data, including millions of biospecimens to fuel this aim.
.
1 Jun 2024",0.34,24-06-01
Merck,"BioSpace
Merck Capitalizes on Keytruda’s Combination Potential
Keytruda, in combination with standard of care abiraterone acetate and prednisone, produces anti-tumor activity in patients with metastatic castration-...
.
16 Sept 2022",0.4939,
Merck,"PR Newswire
Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies
PRNewswire/ -- Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent active...
.
23 Jun 2022",-0.802,22-06-23
Merck,"speexx.com
Merck Group & Speexx: Partnership Built on Trust and Innovation
Merck Group and Speexx: A 15-Year Partnership Built on Trust and Innovation ... Merck Group, a leading science and technology company, partnered with Speexx over...
.
20 May 2024",0.8957,24-05-20
Merck,"Business Wire
Merck’s MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study
Discovered and developed by Merck, MK-0616 is an investigational, potentially first oral PCSK9 inhibitor designed to lower low density lipoprotein (LDL)...
.
6 Mar 2023",-0.5994,23-03-06
Merck,"Cyprus Mail
Merck sees 2022 sales up nearly 20%, mostly on new Covid pill
Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new COVID-19 pill, molnupiravir.
.
3 Feb 2022",0.3182,22-02-03
Merck,"Fierce Pharma
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst.
.
7 Feb 2023",0.5267,23-02-07
Merck,"Barron's
Merck Tops Earnings Estimates but Lowers Full-Year Guidance
The company lowered its non-GAAP earnings guidance, saying it expects full-year 2024 earnings of between $7.72 and $7.77 a share. It had previously expected non...
.
31 Oct 2024",0.3506,24-10-31
Merck,"The Motley Fool
Is Merck Stock a Buy Now?
Merck is an excellent dividend stock that currently offers a yield of 2.78% and has increased its payouts by 52% in the past five years.
.
10 Aug 2023",0.4404,23-08-10
Merck,"Hong Kong Science & Technology Parks Corporation
Health Innovation: AusMed Global Signs Strategic Partnership with Merck
AusMed Global, a partner company of the Hong Kong Science and Technology Parks Corporation (HKSTP) signed a strategic partnership with Merck.
.
29 Jul 2024",0.3818,24-07-29
Merck,"Fierce Biotech
Merck's next-gen pneumococcal vaccine slated for July phase 3 after 2-part win
V116—one of three pneumococcal vaccines in Merck's clinical pipeline—targets serotypes that account for 85% of cases of invasive pneumococcal disease among...
.
21 Jun 2022",0.5859,22-06-21
Merck,"Merck.com
VIDEO: Patient with PAH shares her clinical trial experience
VIDEO: Patient with PAH shares her clinical trial experience · “I'm acutely aware that without clinical trials, we don't move forward.” · Participating in a...
.
15 May 2023",0.5267,23-05-15
Merck,"Barron's
Merck Didn’t Publicize the Results of a Key Cancer Trial
The trial, results of which haven't been previously reported, involved more than 500 lung cancer patients using an injectable form of Keytruda. The subcutaneous...
.
26 Jun 2024",-0.8689,24-06-26
Merck,"BioProcess International
Germany's Merck breaks ground on $321m biomanufacturing center
The €300 million ($321 million) investment is a part of Merck's €1.5 billion ($1.6 billion) investment program for the Darmstadt site by 2025. In October 2023,...
.
25 Apr 2024",0.0,24-04-25
Merck,"Nasdaq
Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck
In the past year, shares of Prometheus have skyrocketed 263.5% against the industry's 11.3% decline. Zacks Investment Research Image Source: Zacks Investment...
.
17 Apr 2023",0.296,23-04-17
Merck,"BioSpace
GSK Makes $2B Play to Challenge Merck in Chronic Cough Market
GSK signed an acquisition agreement with Bellus Health for $2 billion to gain access to the Canadian biotech's chronic cough candidate camlipixant.
.
18 Apr 2023",0.8519,23-04-18
Merck,"Investor's Business Daily
Merck Stock Dives As Guidance Cut Proves Gruesome; Januvia, Gardasil Sales Lag
Merck also cut its earnings outlook, reflecting a 24-cent negative hit due to business development transactions. Now, the company forecasts earnings of $7.72 to...
.
31 Oct 2024",-0.8519,24-10-31
Merck,"Fierce Pharma
Pharma's cyber vulnerabilities run deeper than Merck's 'NotPetya' attack: report
Among the pharma cyberattacks in recent memory, few stand out as much as Merck's NotPetya incident. The New Jersey drugmaker was among a slate of global...
.
7 Feb 2022",-0.5719,22-02-07
Merck,"Business Wire
Surendralal Karsanbhai Elected to Merck Board of Directors
Surendralal L. “Lal” Karsanbhai, president and chief executive officer, Emerson Electric Co. (NYSE: EMR), will join Merck's board of directors effective...
.
22 Nov 2024",0.296,24-11-22
Merck,"Investopedia
S&P 500 Gains and Losses Today: Pharma Stocks Fall After Pfizer, Merck Reports
Merck & Company. Merck (MRK) shares lost 1.3% after the company released its second quarter earnings. While revenue beat expectations due to strong sales of its...
.
1 Aug 2023",0.4404,23-08-01
Merck,"Merck KGaA
Digital twin solution for Primary Packaging - Gerresheimer and Merck Collaboration | Merck
Gerresheimer and Merck jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply...
.
27 Oct 2022",0.8591,22-10-27
Merck,"Reuters
Pfizer in talks to buy cancer drugmaker Seagen - WSJ
Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in a potential multi-billion dollar deal, the Wall Street Journal reported,...
.
27 Feb 2023",-0.8689,23-02-27
Merck,"unicef usa
Merck & UNICEF Fight River Blindness
Fighting River Blindness. Merck is one of UNICEF USA's largest in-kind supporters through its donation of Mectizan—a drug used to fight river blindness (...
.
4 Mar 2023",-0.5859,23-03-04
Merck,"Daily Mail
Merck downplayed severe psychological side-effects of its blockbuster children's asthma drug
Merck accused of downplaying severe mental health effects of its children's asthma drug Singulair which has been linked to dozens of SUICIDES - yet 9m Americans...
.
26 Jun 2023",-0.3612,23-06-26
Merck,"Fierce Pharma
Merck KGaA plots 800 hires, earmarks €130M to boost single-use capacity at site in France
Merck KGaA will pour 130 million euros ($132 million) into beefing up the ability of its manufacturing arm—MilliporeSigma—to employ single-use assemblies at...
.
12 Sept 2022",0.6124,
Merck,"Fierce Biotech
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test ... AstraZeneca's small molecule lowered levels of “bad” cholesterol by more than...
.
29 May 2024",-0.4767,24-05-29
Merck,"Business Wire
(enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With...
.
26 Jul 2024",0.5574,24-07-26
Merck,"Bloomberg.com
Merck Drug for Rare Form of High Blood Pressure Gets US Nod
The drug, known as sotatercept, will be sold as Winrevair in the US, according to information posted on the Food and Drug Administration website. It will cost...
.
27 Mar 2024",-0.296,24-03-27
Merck,"Bakingbusiness.com
Merck VP to join IFF as next CEO
Frank Clyburn, currently executive vice president and president of human health for Merck & Co. (Merck), has been named chief executive officer and a member of...
.
20 Jan 2022",0.296,22-01-20
Merck,"citybiz
Merck Appoints Eliav Barr as Head of Global Clinical Development and Chief Medical Officer
Dr. Roy D. Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July.
.
23 Mar 2022",0.0,22-03-23
Merck,"WSJ
Merck’s Covid-19 Pill Heavily Used So Far Despite Concerns
Doctors have turned to the drug, called molnupiravir, partly because a rival Pfizer pill has been in limited supply ... A new Covid-19 pill from Merck & Co. and...
.
14 Mar 2022",-0.2263,22-03-14
Merck,"Reuters
Merck's lung cancer drug combo fails trial in setback for new therapy class
Merck (MRK.N) said on Thursday a combination treatment testing a new type of immunotherapy failed to significantly slow disease progression in lung cancer...
.
7 Dec 2023",-0.8885,23-12-07
Merck,"Fierce Pharma
Merck KGaA starts awareness push to help docs unravel form of MS, opening new front in Sanofi fight
The German drugmaker has begun an awareness campaign to inform physicians about a form of the neurological disease that its treatment may be able to address.
.
16 Oct 2023",0.0258,23-10-16
Merck,"Universitas Gadjah Mada
Meet UGM Alumna Evie Yulin, First Female Country General Manager at Merck Healthcare Asia Pacific
Meet UGM Alumna Evie Yulin, First Female Country General Manager at Merck Healthcare Asia Pacific ... Evie Yulin, President Director of PT Merck Tbk, is an alumna...
.
2 Dec 2024",0.0,24-12-02
Merck,"Pharmaceutical Technology
Astex, Merck to discover small molecule candidates for cancer
Merck and Astex investigate small molecule candidates for cancer. The therapeutics will be provided to MSD for further optimisation and preclinical development.
.
9 Aug 2023",-0.802,23-08-09
Merck,"Merck KGaA
Intermolecular®
We are the trusted partner for materials innovation. We explore, test and develop advanced materials that are revolutionizing the next generation of...
.
14 Mar 2022",0.7717,22-03-14
Merck,"Labiotech.eu
MSD Offers €464M to Buy German Biotech Fighting Cancer with RNA
MSD is back in the RNA field with the acquisition of Rigontec, a German biotech harnessing RNA interference to make the immune system attack cancer cells.
.
23 Jun 2022",-0.9217,22-06-23
Merck,"Merck KGaA
New BioProcessing Center | Merck
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea. The planned...
.
3 May 2023",0.2732,23-05-03
Merck,"Fierce Pharma
Keytruda taught Merck how to build a blockbuster. But manufacturing a 2nd lightning bolt is easier said than done
Keytruda taught Merck how to build a blockbuster. But manufacturing a 2nd lightning bolt is easier said than done.
.
29 Sept 2022",0.9451,
Merck,"Health Affairs
Amicus Briefs In Merck Lawsuit Defend Constitutionality Of Medicare Drug Price Negotiation Program
Merck's lawsuit is one of several cases filed across the country challenging the constitutionality of the IRA drug negotiation program.
.
29 Sept 2023",-0.296,
Merck,"BioPharma Dive
Merck counting on heart drugs to boost business next decade
Heart drugs like the cholesterol-lowering treatments Zocor and Zetia fueled Merck's pharmaceutical sales in the 2000s and 2010s, but their patents have long...
.
5 Apr 2022",0.3818,22-04-05
Merck,"Fierce Pharma Biopharma News & Insights
Merck challenges HHS on Medicare drug price negotiations, alleging violations of the Constitution
Merck & Co. is suing the Department of Health and Human Services (HHS) for alleged violations of the First and Fifth Amendments to the US Constitution.
.
6 Jun 2023",-0.8225,23-06-06
Merck,"Bloomberg.com
Scholz Gets Another Pharma Boost With New Merck KGaA Site
Merck KGaA became the latest pharma company to begin construction of a new center in Germany, boosting Chancellor Olaf Scholz's push to turn the country...
.
25 Apr 2024",0.6249,24-04-25
Merck,"وكالة الأنباء السعودية
Merck Opens New Regional Office in Riyadh
Merck, a leading company in the fields of science, technology, and medicine, has inaugurated a new regional office in the Kingdom of Saudi Arabia.
.
3 Mar 2024",0.0,24-03-03
Merck,"Merck KGaA
Meet Merck at the ECS | Merck
Sophisticated Luxury. The global launch of our new Colorstream® Mineral Red, now at the ECS. Mineral Red stands for a bluish-red, intense, highly chromatic...
.
17 Feb 2023",0.5994,23-02-17
Merck,"Express Pharma
Merck Specialities appoints first woman CEO in India
She will lead India's healthcare strategy and operations, effective 1st August, 2022, as successor to Anandram Narasimhan, transitioning into a regional role at...
.
1 Aug 2022",0.6124,22-08-01
Merck,"CSRwire
Vaccines: Our History, Our Legacy
Merck and its legacy companies have been working to discover and develop vaccines for more than a century. Published 04-14-22. Submitted by Merck & Co.,...
.
14 Apr 2022",0.0,22-04-14
Merck,"Reuters
Belgium agrees to buy 10,000 courses each of Pfizer, Merck COVID-19 pills
Belgium agrees to buy 10,000 courses each of Pfizer, Merck COVID-19 pills ... BRUSSELS, Jan 3 (Reuters) - Belgium has agreed to buy 10,000 courses each of the...
.
3 Jan 2022",0.5719,22-01-03
Merck,"Pharmaceutical Technology
Keytruda remains Merck & Co’s biggest 2023 success story as patent expiry looms
Keytruda remains Merck & Co's biggest 2023 success story as patent expiry looms. Merck & Co (MSD) has reported a 1% revenue increase from 2022, and may face...
.
1 Feb 2024",0.8176,24-02-01
Merck,"AVMA Journals
Executive summary of the Merck Animal Health Veterinarian Wellbeing Study III and Veterinary Support Staff Study
This study revealed that wellbeing and mental health of some veterinarians declined over the past 2 years, driven in part by the COVID-19 pandemic and extreme...
.
1 Jul 2022",0.4019,22-07-01
Merck,"Merck KGaA
A Different Path to Parenthood
The path to parenthood was not a typical one. She was able to find balance between work and family by arranging flexible parental leave with her manager and...
.
24 Apr 2024",0.1779,24-04-24
Merck,"Barron's
Merck’s Cancer Shot Works. Its Post-Keytruda Plans Are Shaping Up Again.
Merck's Cancer Shot Works. Its Post-Keytruda Plans Are Shaping Up Again. ... Merck reported good news Tuesday on a more convenient version of its cancer drug...
.
19 Nov 2024",-0.9062,24-11-19
Merck,"pharmaphorum
Merck drug for rare tumour hits phase 3 target
Merck drug for rare tumour hits phase 3 target ... Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell...
.
12 Nov 2024",0.0,24-11-12
Merck,"Business Today
Merck India expands infrastructure to capitalise on growing pharmaceutical industry
Life science and technology firm Merck India is expanding its infrastructure in the country, recognising its significance in the global pharmaceutical industry.
.
3 Oct 2023",0.4939,23-10-03
Merck,"Fierce Biotech
Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cancer
Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cancer ... Merck & Co. is paying $700 million upfront to challenge...
.
9 Aug 2024",-0.7351,24-08-09
Merck,"Merck KGaA
AI @ Merck – a 360-degree perspective | Merck
Artificial Intelligence at Merck – an overview · Merck enables AI with its technology leadership in semiconductor materials, powering AI models with advanced,...
.
5 Dec 2024",0.4767,24-12-05
Merck,"FirstWord Pharma
Merck & Co. targets 'high-hanging fruit' in oncology with UNP collab
Under the terms of the partnership, UNP will receive an undisclosed upfront payment to design and develop macrocyclic candidates against an undisclosed target;...
.
23 Jan 2024",0.0,24-01-23
Merck,"Siemens press
Merck and Siemens enter Strategic Partnership on Digital Transformation Technology
Merck and Siemens enter Strategic Partnership on Digital Transformation Technology ... Merck, a leading science and technology company, and Siemens, a leading...
.
16 Sept 2024",0.0,
Merck,"Hong Kong Science & Technology Parks Corporation
HKSTP and Merck Scale Biotech Innovation and Digital Health
The partnership is Merck's first co-incubation programme in Hong Kong and will accelerate the growth of biomedical tech startups engaged in digital health...
.
20 Sept 2022",0.7845,
Merck,"Business Wire
Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024
Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International...
.
12 Nov 2024",0.6124,24-11-12
Merck,"Merck KGaA
Merck Invests More Than € 300 Million in New Life Science Research Center in Germany
As of the start of 2027, it will provide space for around 550 employees. Today, Merck laid the cornerstone for the building together with German Federal...
.
25 Apr 2024",0.0,24-04-25
Merck,"echo live
Merck invests more than €440m in major Cork expansion set to create hundreds of jobs
Merck has today announced an approximate €440m expansion of its facilities in Cork, creating more than 370 permanent jobs by the end of 2027.
.
23 May 2022",0.5106,22-05-23
Merck,"Inside Precision Medicine
Merck Snaps Up Parkinson’s Candidates For Up to $610M
Merck Snaps Up Parkinson's Candidates For Up to $610M ... Merck will acquire neurodegeneration start-up Caraway Therapeutics for a total of up to $610 million,...
.
22 Nov 2023",0.0,23-11-22
Merck,"Fierce Pharma
The top 10 most profitable pharma companies in 2021
The six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
.
14 Jun 2022",0.5922,22-06-14
Merck,"BioPharma Dive
Merck’s New Jersey campus is getting a biotech makeover
Merck's New Jersey campus is getting a biotech makeover. After buying the pharma giant's Kenilworth campus, Onyx Equities is looking to make the spot a go-to...
.
11 Jul 2023",0.0,23-07-11
Merck,"Purdue University College of Veterinary Medicine
Purdue Veterinary Student Receives Merck Animal Health Future Swine Practitioners Scholarship
Purdue Veterinary Student Receives Merck Animal Health Future Swine Practitioners Scholarship ... Kendall Sattler of the Purdue DVM Class of 2026 (front row, 4th...
.
22 Mar 2024",0.0,24-03-22
Merck,"Merck.com
How Wilson, N.C., plays a critical role in our commitment to supply
Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients. ... Information about insurance coverage and...
.
2 Mar 2022",0.7717,22-03-02
Merck,"Merck KGaA
Permanent laser marking for identification of plastics | Merck
Providing the ability to track and trace any plastic item - such as a car part, medical device or food package - over its entire lifetime.
.
23 Feb 2022",0.3182,22-02-23
Merck,"Business Wire
Ligand’s Collaborator Merck Announces V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials
Ligand's Collaborator Merck Announces V116 Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials.
.
27 Jul 2023",0.6808,23-07-27
Merck,"Fierce Biotech
Merck KGaA taps AI-focused biotech for new ADC pact worth $376M
Merck KGaA taps AI-focused biotech for new ADC pact worth $376M ... Merck KGaA is hoping to sprout some new oncology and immunology therapeutics with Biolojic...
.
4 Jun 2024",0.6808,24-06-04
Merck,"Genetic Engineering and Biotechnology News
Merck to Acquire Prometheus Biosciences for $10.8B
Merck to Acquire Prometheus Biosciences for $10.8B ... Merck & Co. has agreed to acquire Prometheus Biosciences for about $10.8 billion, the companies said Sunday...
.
17 Apr 2023",0.2732,23-04-17
Merck,"Reuters
Merck KGaA shares plunge after cancer drug hopeful fails
For Merck's medium-sized pharma unit, the aborted trials marks another major development setback after its experimental multiple sclerosis (MS) drug missed the...
.
25 Jun 2024",-0.5994,24-06-25
Merck,"Fierce Pharma Biopharma News & Insights
After Clyburn's recent departure, Merck promotes Garay and Oosthuizen to key human health posts
Merck Arpa Garay is the new human health global marketing chief while Jannie Oosthuizen takes over as human health US lead.
.
16 Feb 2022",0.34,22-02-16
Merck,"Yahoo Finance
Top Research Reports for Exxon Mobil, Merck & Qualcomm
Exxon Mobil's shares have outperformed the Zacks Oil and Gas - Integrated - International industry over the past year (+8.0% vs. +5.3%). The company is a...
.
12 Jul 2024",0.4588,24-07-12
Merck,"Fierce Pharma Biopharma News & Insights
Merck KGaA earmarks €300M for an advanced research center at its HQ site
Merck KGaA earmarks €300M for an advanced research center at its HQ site ... Merck KGaA will shell out 300 million euros ($321 million) to build a new research...
.
29 Apr 2024",0.4588,24-04-29
Merck,"Merck KGaA
Collaboration for Parkinson Research | Merck
Merck and The Michael J. Fox Foundation Offer Service to Advance Parkinson's research · SMC® immunoassay technology from Merck detects small changes in...
.
18 Jun 2024",0.0,24-06-18
Merck,"BioSpace
Merck’s Keytruda Takes Another Hit with Phase III Prostate Cancer Fail
Merck's Keytruda (pembrolizumab) has taken another hit after the drug failed to meet dual primary endpoints in the Phase III KEYNOTE-921 trial for metastatic...
.
3 Aug 2022",-0.9042,22-08-03
Merck,"Fierce Biotech
After 'masterful' development of Keytruda, Merck's CMO follows Roger Perlmutter to Eikon
Roy Baynes, Ph.D., has departed Merck to take up the chief medical officer role at Eikon, where he will reunite with Roger Perlmutter, MD, PhD.
.
23 Mar 2022",0.0,22-03-23
Merck,"The Fiji Times
Britain says 6,000 more people needed for trial of Merck COVID pill
LONDON (Reuters) - Britain said on Tuesday it needed to recruit 6000 more people onto a trial of Merck's COVID-19 antiviral pill molnupiravir to inform how...
.
26 Jan 2022",0.0,22-01-26
Merck,"Fierce Pharma
Democrats summon CEOs of J&J, Merck and BMS for Senate hearing on drug prices
Sen. Bernie Sanders and his Democratic colleagues want to know why the US is paying the highest drug prices in the world.
.
21 Nov 2023",0.0772,23-11-21
Merck,"Fierce Pharma
After metastatic disease win, Merck's Keytruda flunks trial in early stomach cancer
Keytruda was recently successful in prolonging EFS in a similar perioperative regimen in early-stage non-small cell lung cancer. Adding Keytruda in both the...
.
20 Jun 2023",-0.6124,23-06-20
Merck,"Merck KGaA
Marine Cosmetic Ingredients | Merck
Merck launches new marine cosmetic ingredients during in-cosmeticsTM Asia 2022 · RonaCare® JouvaMer and RonaCare® ReviMer, specifically developed for natural...
.
3 Nov 2022",0.0,22-11-03
Merck,"ROI-NJ
Merck announces new leadership for Human Health business
Kenilworth-based Merck on Wednesday announced new leadership for its Human Health business. Arpa Garay will lead Human Health global marketing,...
.
16 Feb 2022",0.0,22-02-16
Merck,"Law.com
Ending a 14-Year Battle, Merck Wins Dismissal of Suits Linking Fosamax to Fractured Femurs
The ruling brings an end to roughly 500 suits in litigation that has been ongoing since 2008 and has made a stop at the US Supreme Court.
.
23 Mar 2022",0.4019,22-03-23
Merck,"NC State University
Ashton Merck Wins SPS Poster Award
Congratulations to Applied Ecology postdoctoral researcher, Ashton Merck, for her latest award received at the Sustainable Phosphorus Summit!
.
10 Nov 2022",0.9422,22-11-10
Merck,"ET HealthWorld
Merck Foundation Marks World Cancer Day by Increasing the Limited Number of Oncologists in Africa Since 2012
Launched in 2016, the Merck Foundation Cancer Access Program provides one-, two- and three-years fellowship, Post Graduate Diploma and Master Degree of oncology...
.
5 Feb 2024",-0.872,24-02-05
Merck,"Latham & Watkins LLP
Latham & Watkins Advises Prometheus Biosciences in US$10.8 Billion Acquisition by Merck
Merck, through a subsidiary, has agreed to acquire Prometheus for US$200.00 per share in cash for a total equity value of approximately US$10.8 billion.
.
17 Apr 2023",0.6908,23-04-17
Merck,"Reuters
Focus: Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
U.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy Keytruda that can be injected under the skin,...
.
2 Dec 2022",-0.7906,22-12-02
Merck,"Texas Farm Bureau
LED ear tags can help detect sick cattle in feedlots
Merck's SenseHub Feedlot features electronic ear tags with an LED light, which illuminate when an animal's behavioral and biometric data indicate it may need...
.
4 Feb 2022",-0.1531,22-02-04
Merck,"The Irish Times
Merck announces €440m investment in Cork, creating 370 new jobs
Merck said it plans to expand its membrane and filtration manufacturing capabilities in Ireland. The investment will increase capacity at its current...
.
23 May 2022",0.7003,22-05-23
Merck,"Fierce Biotech
Merck launches healthcare startup incubator for AI developers
Merck launches healthcare startup incubator for AI developers ... Merck has begun taking applications for a new biotech accelerator program and is on the hunt for...
.
29 Jun 2022",0.0,22-06-29
Merck,"African Business
Merck Foundation Chief Executive Officer (CEO) together with Zambia First Lady to acknowledge their 126 scholarships provided to doctors in 39 critical specialties - celebrating our legacy to transform patient care landscape in Africa
126 scholarships to doctors in 39 critical specialties during their annual Alumni Summit – Celebrating their legacy of transforming patient care landscape in...
.
2 Aug 2023",0.8807,23-08-02
Merck,"Fierce Biotech
Merck bets up to $1B on Pearl's 'smart' biomaterial jewels as biotech begins to raise fresh funds
Merck is paying an undisclosed upfront fee and offering up to $1 billion in milestone payments for Pearl to identify biologics to treat cancer. The biotech...
.
12 Mar 2024",0.3818,24-03-12
Merck,"Aidsmap
Merck restarts islatravir HIV treatment studies, but abandons monthly PrEP
In December, Merck announced that the US Food and Drug Administration (FDA) had placed a partial clinical hold on seven trials of islatravir plus doravirine for...
.
23 Sept 2022",-0.4497,
Merck,"Pharmaceutical Technology
Merck Bioprocessing Production Centre, Daejeon, South Korea
Expected Operations ... Merck will build a new bioprocessing production facility in South Korea. Credit: Merck. ... Merck will build a Bioprocessing Production...
.
23 Apr 2024",0.3818,24-04-23
Merck,"The Hollywood Reporter
Merck Mercuriadis Departing as Hipgnosis Song Management Chairman
Merck Mercuriadis Departing as Hipgnosis Song Management Chairman. His departure from the company he founded comes ahead of Blackstone-managed funds getting set...
.
2 Jul 2024",0.0,24-07-02
Merck,"CNBC
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda · Earnings per share: $2.28 adjusted vs. $2.15 expected · Revenue: $16.11...
.
30 Jul 2024",0.7,24-07-30
Merck,"BioSpace
Merck to Close Cherokee API Manufacturing Plant, Cut 300 Jobs
Pharmaceutical giant Merck & Co. has announced the company will shutter the doors of its Cherokee Plant, located in Riverside, Penn. The manufacturing facility...
.
25 Mar 2022",-0.2732,22-03-25
Merck,"BioSpace
Pfizer, Merck Beat Wall Street Expectations Amid Strong Biopharma Q2 Earnings Season
Total revenue for Q2 was $13.2 billion, a 2% increase from the same period last year, beating the consensus of $12.96 billion. Pfizer has raised its year-end...
.
30 Jul 2024",0.3818,24-07-30
Merck,"Merck KGaA
Ambitious climate targets and the role of the semiconductor industry
Many companies in the industry have set ambitious targets for massively reducing greenhouse gas emissions in production so as to support the fight against...
.
26 Mar 2023",0.7624,23-03-26
Merck,"Managed Healthcare Executive
Merck Receives Complete Response Letter for Cough Drug Gefapixant
P2X3 receptors are one of the receptor types found on sensory nerve fibers in the airway lining. It thought that gefapixant works by reducing sensory nerve...
.
21 Dec 2023",0.0,23-12-21
Merck,"Business Wire
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
PeptiDream will provide peptide candidates identified from PeptiDream's proprietary Peptide Discovery Platform System (PDPS) technology for use as PDCs against...
.
27 Dec 2022",0.6705,22-12-27
Merck,"Bloomberg.com
Merck KGaA CEO Confident on Delivery Targets
CC-Transcript · NOW PLAYING. Merck KGaA CEO Confident on Delivery Targets · 01:39. It's Time to Abolish the UK's House of Lords · 06:32. Will Tim Cook Be Pulled...
.
16 May 2022",0.8374,22-05-16
Merck,"Fierce Pharma
Merck's Keytruda extends life for kidney cancer patients after surgery, while Bristol's Opdivo fails again
Keytruda slashed the risk of death by 38% compared with placebo when used after kidney removal in patients with clear cell renal carcinoma, the most common form...
.
27 Jan 2024",-0.9001,24-01-27
Merck,"Fortune
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
Dave Williams, chief information and digital officer at Merck, says cybersecurity has become integral since the NotPetya cyberattack.
.
22 Oct 2024",-0.4019,24-10-22
Merck,"GlobeNewswire
Unnatural Products, Inc. Enters Research Collaboration with Merck
A collaboration with Merck, known as MSD outside the United States and Canada, to apply UNP's technology to design and develop macrocyclic candidates against...
.
23 Jan 2024",0.4215,24-01-23
Merck,"Reuters
Merck's Keytruda gets FDA nod for expanded use in lung cancer
Merck, earlier in the day, also reported that the European Commission has approved Keytruda as a follow-up treatment for adult NSCLC patients who are at a high...
.
17 Oct 2023",-0.3818,23-10-17
Merck,"Manufacturing Digital Magazine
Merck’s US$500m Singapore manufacturing facility expansion
Merck's US$500m Singapore manufacturing facility expansion ... Pharmaceutical manufacturing company Merck has opened a new packaging facility for vaccines in...
.
10 Oct 2022",0.0,22-10-10
Merck,"Fierce Biotech
With trial win, Merck's RSV antibody clesrovimab looks poised to take on Sanofi and AZ's Beyfortus
Clesrovimab, also known as MK-1654, scored on multiple trial endpoints, demonstrating its ability to protect infants against the virus in their first RSV...
.
17 Oct 2024",0.8658,24-10-17
Merck,"KBR
Merck’s superovulation induction drug Pergoveris gets expanded coverage
SNS 기사보내기 ... Merck Biopharma Korea's superovulation induction injection Pergoveris (follitropin alpha) will receive expanded reimbursement to treat patients...
.
1 Apr 2024",0.4019,24-04-01
Merck,"The Korea Herald
Biocytogen Enters into Antibody Agreement with Merck
BEIJING, April 29, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and...
.
29 Apr 2022",0.4939,22-04-29
Merck,"Reuters
Merck's endometrial cancer therapy fails trial
Merck said on Thursday its therapy being tested in certain patients with a type of cancer in the uterus lining failed a late-stage trial.
.
9 May 2024",-0.93,24-05-09
Merck,"Business Wire
Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Adults with Increased Risk for Pneumococcal Disease
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-8, a Phase 3 trial...
.
16 Oct 2024",0.8225,24-10-16
Merck,"Reuters
China grants licence to Merck's KEYTRUDA for stomach cancer treatment
China's National Drug Administration has granted Merck's KEYTRUDA therapy a licence for first-line treatment of certain stomach cancer patients in the...
.
25 Jun 2024",-0.7003,24-06-25
Merck,"Fierce Biotech
What is C4? Merck offers up to $610M for one of C4’s protein degraders
C4 is one of a growing number of targeted protein degradation biotechs that have entered the fold in recent years, including the likes of Nurix, Amphista,...
.
12 Dec 2023",-0.3818,23-12-12
Merck,"The Korea Herald
Standigm Signs MOU with Merck Korea for AI drug Discovery Research
Merck's retrosynthesis AI software 'SYNTHIA™ retrosynthesis software' accelerates Standigm's synthesis capability SEOUL, South Korea, June 9,...
.
9 Jun 2022",0.0,22-06-09
Merck,"Fierce Biotech
Merck KGaA goes again in AI, expanding Quris toxicity prediction pact days after inking 2 deals
The enlarged deal sets Merck up to use BioAI to identify liver toxicity risks in a selection of drug candidates.
.
28 Sept 2023",-0.2732,
Merck,"Fierce Pharma
As COVID vaccine market slows, AstraZeneca, Merck, Takeda and more get their chance to shine in Q3
As COVID vaccine market slows, AstraZeneca, Merck, Takeda and more get their chance to shine in Q3 · Pandemic push and pull · Related · Number crunch.
.
15 Nov 2022",0.5896,22-11-15
Merck,"Fierce Pharma
JPM24: Merck expects $20B+ in new cancer sales thanks to Daiichi ADC deal, Moderna vaccine
Merck laid out a projection to potentially have more than $10 billion in sales from oncology drug candidates in its pipeline. On Monday, Davis increased that...
.
9 Jan 2024",-0.1027,24-01-09
Merck,"Fierce Biotech
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Merck and Moderna have delivered clinical evidence that the approach works. Investigators enrolled 157 people with stage 3 or 4 melanoma in the open-label phase...
.
13 Dec 2022",-0.7351,22-12-13
Merck,"BioSpace
Merck KGaA, Caris Sign Potential $1.4B Deal to Develop First-in-Class ADCs for Cancer
Merck KGaA has inked a potential $1.4 billion deal with Texas-based Caris Life Sciences for the discovery and development of first-in-class antibody-drug...
.
4 Apr 2024",-0.6597,24-04-04
Merck,"The Indian Express
Merck Life Science sets up plant in Patalganga, Navi Mumbai
Prabhat Verma, India Head of Integrated Supply Chain Operations (ISCO) at Merck Life Science, said the main objective of Patalganga's introduction was to ensure...
.
9 Nov 2022",0.0,22-11-09
Merck,"Forbes
Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study
Topline. Merck and Ridgeback Biotherapeutics' Covid-19 antiviral pill molnupiravir reduced the risk of hospitalization by over 65% in a clinical trial conducted...
.
19 Feb 2022",0.2023,22-02-19
Merck,"Business Wire
Dr. Rasha Kelej Welcomed 13 African First Ladies to 9th Merck Foundation “Africa Asia Luminary” 2022 in Dubai
Senator Dr. Rasha Kelej with 13 African First Ladies during the 9th Edition of Merck Foundation Africa Asia Luminary.
.
14 Dec 2022",0.34,22-12-14
